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Resumen 
La investigación presentada en esta tesis doctoral se centra en la síntesis de complejos 
organometálicos de oro(I) y oro(III) con ligandos iluro de fosforo, alenilo, carbeno 
N-heterocíclico y propargilo y, también en el estudio de algunas propiedades de los compuestos 
como la luminiscencia y la actividad biológica. 
 
Se describe la síntesis de derivados de oro(I) y de oro(III) a partir de la sal de fosfonio, cloruro 
de cianometiltrifenilfosfonio. Estos incluyen complejos mononucleares en los que la sal de 
fosfonio se ha desprotonado una vez para formar el iluro, permitiendo la coordinación a un 
centro metálico, y complejos polinucleares en los que la sal de fosfonio se desprotona dos veces 
para dar la unidad ildiuro que puede formar puente entre dos centros metálicos. También se 
describen complejos heterometálicos en los que hay un centro metálico adicional coordinado 
al átomo de nitrógeno del grupo nitrilo, que incluyen dos ejemplos luminiscentes que presentan 
emisiones fosforescentes a 77 K. Varios de los complejos muestran actividad antiproliferativa 
en la línea celular de cáncer de pulmón A549. 
 
El bromuro de trifenilpropargilfosfonio sufre a una isomerización prototrópica al tautómero 
alenilo en disolución en varios disolventes, sin embargo, no se observa un tautomerismo 
análogo en las sales de amonio funcionalizadas con propargilo. Se describe la síntesis de 
complejos de oro con ligandos alenilo sin precedentes derivados del bromuro de 
trifenilpropargilfosfonio en el que se observa una regioselectividad que depende del estado de 
oxidación del oro. En los complejos de oro(I) se observa una coordinación del átomo de 
carbono α al centro de oro, mientras que en los derivados de oro(III) una coordinación del 
átomo de carbono γ al centro metálico da lugar a complejos con una quiralidad axial inusual. 
También se describen derivados de oro(I) de sales de amonio funcionalizadas con propargilo, 
sin embargo, en estos complejos, la unidad de propargilo se mantiene y la coordinación al 
centro de oro se produce a través del átomo de carbono alquino terminal. Los complejos 
resultantes muestran actividad antiproliferativa en células A549. Los intentos de preparar un 
derivado de oro(I) de una sal de sulfonio funcionalizada con propargilo produjeron una mezcla 
de los complejos propargilo y alenilo de oro. 
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Se describe un nuevo método para la síntesis general de complejos de oro(I) NHC. La reacción 
de sales de imidazolio, con diferentes requerimientos estéricos y electrónicos, con derivados 
de [AuX(tht)] (tht = tetrahidrotiofeno), en  presencia de NBu4 (acac), al aire y a temperatura 
ambiente produce la especie de oro NHC con buenos rendimientos y  tiempos de reacción muy 
cortos. Una serie de complejos de NHC oro(I) funcionalizados con propargilo se han 
sintetizado mediante este método, que incluyen los derivados [AuBr(NHC)], [Au(NHC)2]Br, 
[Au(C6F5)(NHC)] y [Au(NHC)(PR3)]BF4, y muchos ejemplos se han caracterizado por 
estudios de difracción de rayos-X de monocristal. Todos los complejos muestran actividad 
antiproliferativa en células A549, siendo los derivados de fosfina los más potentes. Estos 
complejos son también luminiscentes y presentan emisiones fosforescentes a temperatura 
ambiente y a 77 K. 
 
Se describe la síntesis de complejos de propargilo oro(I) fosfina por dos métodos diferentes. 
Los complejos se han caracterizado estructuralmente por difracción de rayos-X de monocristal 
y en todos los casos se observa la coordinación del carbono alquino terminal de la unidad de 
propargilo al oro. También se describe un derivado heterometálico luminiscente dinuclear de 
oro(I) y cobre(I) que presenta emisiones fosforescentes a temperatura ambiente y a 77 K. Los 
complejos son activos en células A549 con el derivado heterometálico dinuclear mostrando la 
mejor actividad antiproliferativa. 
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Abstract 
The research presented in this PhD thesis concerns the synthesis of organometallic complexes 
of gold(I) and gold(III) with phosphorus ylide, allenyl, N-heterocyclic carbene and propargyl 
ligands. The luminescence and biological properties of the complexes are also reported.  
 
The synthesis of gold(I) and gold(III) derivatives of the phosphonium salt, 
cyanomethyltriphenylphosphonium chloride, is described. These include mononuclear 
complexes in which the phosphonium salt has been deprotonated once to form the ylide, 
allowing coordination to one metal centre, and polynuclear complexes in which the 
phosphonium salt is deprotonated twice to give the yldiide unit which can bridge two metal 
centres. Heterometallic complexes bearing an additional metal centre at the nitrogen atom of 
the nitrile group are also described, including two luminescent examples which exhibit 
phosphorescent emissions at 77 K. Several of the complexes exhibit antiproliferative activity 
in cancer cell line A549. 
 
Triphenylpropargylphosphonium bromide undergoes a prototropic isomerisation to the allenyl 
tautomer in solution in several solvents, however, an analogous tautomerism is not observed in 
propargyl functionalised ammonium salts. The synthesis of unprecedented allenyl gold 
complexes derived from triphenylpropargylphosphonium bromide is described in which a 
regioselectivity is observed depending on the oxidation state of gold. In the gold(I) complexes 
a coordination of the α-carbon atom to the gold centre is observed, whereas in the gold(III) 
derivatives a coordination of the γ-carbon atom to the metal centre results in highly unusual 
axially chiral complexes. Gold(I) derivatives of propargyl functionalised ammonium salts are 
also described, however in these complexes the propargyl unit is maintained and coordination 
to the gold centre occurs through the terminal alkyne carbon atom. The resulting complexes 
exhibit antiproliferative activity in A549 cells. Attempts to prepare a gold(I) derivative of a 
propargyl functionalised sulfonium salt led to a mixture of the propargyl and allenyl 
complexes. 
 
A new method for the general synthesis of NHC gold(I) complexes is described. The reaction 
of imidazolium salts, of different steric and electronic requirements, with [AuX(tht)] (tht = 
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tetrahydrothiophene) derivatives, in the presence of NBu4(acac), in air and at room temperature 
leads to the NHC gold species in good yields and with very short reaction times. A series of 
propargyl functionalised NHC gold(I) complexes have been synthesised by this method, 
including [AuBr(NHC)], [Au(NHC)2]Br, [Au(C6F5)(NHC)] and [Au(NHC)(PR3)]BF4 
derivatives, and many examples have been characterised by single crystal X-ray diffraction 
studies. All of the complexes show antiproliferative activity in A549 cells with the phosphine 
derivatives being the most potent. These complexes are also luminescent, exhibiting 
phosphorescent emission at room temperature and at 77 K.   
 
The synthesis of propargyl gold(I) phosphine complexes by two different methods is reported. 
The complexes were structurally characterised by single crystal X-ray diffraction and in all 
cases coordination of the terminal alkyne carbon of the propargyl unit to gold is observed. A 
luminescent heterometallic dinuclear gold(I) copper(I) derivative is also described which 
exhibits phosphorescent emissions at room temperature and at 77 K. The complexes were 
active in A549 cells with the dinuclear heterometallic derivative showing the best 
antiproliferative activity.  
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Abbreviations 
Å Angstrom 
acac Acetylacetonate 
ADC Acyclic Diamino Carbene 
APT Attached Proton Test 
Bu Butyl 
BuLi Butyllithium 
CAAC Cyclic Alkyl Amino Carbene 
calcd. Calculated 
cod Cyclooctadiene 
Cy Cyclohexane 
CyJohnPhos 2-(Dicyclohexylphosphino)biphenyl 
d Doublet 
DAPTA 3,7-Diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane 
DMEM Dulbecco's Modified Eagle's Medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dppe 1,2-Bis(diphenylphosphino)ethane 
dppf 1,1'-Bis(diphenylphosphino)ferrocene 
dppm 1,1-Bis(diphenylphosphino)methane 
δ Chemical Shift 
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Et Ethyl 
FAD Flavin Adenine Dinucleotide 
FT Fourier Transformed 
g Grams 
h Hours 
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Chapter 1 – General Introduction 
1.1. Gold 
Gold, one of the noble metals, has fascinated people of all cultures and civilisations for 
millennia.1 Although it is not known when this metal was first discovered by humans, flakes 
of gold have been found in Palaeolithic caves dating back as far as 40 000 BC. Its glowing 
yellow colour and resistance to corrosion led to gold becoming a symbol of immortality and 
power in many ancient cultures and its attractive properties such as high durability and 
malleability have meant that it has been highly valued throughout history.2 The extensive 
chemistry of gold has only relatively recently started to receive attention and has led to this 
metal, in the form of complexes, finding application in fields as diverse as luminescence, 
medicine and catalysis. The ever-increasing number of novel complexes with exciting and 
unusual properties ensures that gold remains an important element to this day. 
 
1.1.1. Relativistic Effects 
The name ‘gold’ is thought to be derived from the Germanic or Old English ‘ghel’ or ‘geolu’ 
meaning ‘yellow’, and the Latin name ‘aurum’ from which its chemical symbol, Au, is derived 
translates to ‘shining dawn’, reflecting one of the most dominant characteristics of this metal, 
its yellow colour.3 This unusual mellow hue along with the immunity of gold to tarnishing and 
corrosion are all a result of a phenomenon known as special relativity, the significance of which 
in the chemistry of gold was first noted by Pitzer4 and Pyykkö and Desclaux5 almost 40 years 
ago. 
  
Einstein’s Theory of Special Relativity states that the mass of any moving object changes as 
its velocity changes according to Equation 1.1, where 𝑚𝑟𝑒𝑙  is the relativistic mass, 𝑚 is the 
rest mass, 𝑣  is the velocity and 𝑐 is the vacuum speed of light. 
 
 𝒎𝒓𝒆𝒍 =  
𝒎
√𝟏−(
𝒗
𝒄
)
𝟐
  (1.1) 
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In most ordinary conditions, the term (
𝑣
𝑐
)
2
 is so small that the resultant change in mass is 
insignificant, however, when the velocity of an object approaches the speed of light, this change 
in mass can have important consequences. In the case of gold, the intense electrostatic 
attraction experienced by the s electrons as a result of the 79 protons in the nucleus results in 
an increase in their velocity to near enough to the speed of light to cause a substantial relativistic 
increase in their mass. This increase in mass causes a relativistic contraction of the orbit since 
the radius of an orbit with constant angular momentum will shrink proportionately as mass 
increases. The ratio of the relativistic radius, 𝑟𝑟𝑒𝑙, to the normal radius, 𝑟𝑛𝑜𝑛−𝑟𝑒𝑙, is given by 
Equation 1.2. 
 
 
𝒓𝒓𝒆𝒍
𝒓𝒏𝒐𝒏−𝒓𝒆𝒍
=  √𝟏 − (
𝒗
𝒄
)
𝟐
  (1.2) 
 
The contraction of the orbital radii mainly affects the s electrons, even those in outer shells, 
since their probability density remains close to the nucleus. This effect occurs in several heavy 
metals but is most pronounced for gold with a contraction of ~ 18% (Figure 1.1). 
 
 
Figure 1.1. Ratio of relativistic radius of the 6s electrons to their non-relativistic radius as a function of atomic 
number for elements Cs (Z = 55) to Fm (Z = 100) (Adapted from Acc. Chem. Res., 1979, 12, 226, Copyright 
(1979) American Chemical Society).5 
 
The outermost d electrons are somewhat shielded from the nucleus by the s electrons, and the 
d orbitals therefore actually experience a slight expansion. The energy levels of the outermost 
6s orbital are consequently shifted closer towards the 5d orbitals (Figure 1.2).  
 1.1. Gold 
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Figure 1.2. Calculated relativistic and non-relativistic (n-1)d and ns orbital energies for Ag (n = 5) and Au (n = 6). 
Relativistic d-orbital energies are the weighted average of the d³/₂ and d⁵/₂ spin-orbit components (Adapted from 
Acc. Chem. Res., 1979, 12, 226, Copyright (1979) American Chemical Society).5 
 
These relativistic effects have several significant effects in the chemistry of gold and 
consequently many of the usual periodic trends do not hold true for the coinage metals triad.  
 
Although gold and silver have virtually identical metallic radii in close packed cubic lattices 
(the lattice constants are 4.0862 Å (Ag) and 4.07825 Å (Au),6 and the nearest-neighbour 
interatomic distances are 2.889 Å (Ag-Ag) and 2.884 Å (Au-Au) for coordination number 12),7 
the covalent radius of gold(I) is anomalously small and has been reported by Schmidbaur to be 
around 0.09 Å smaller than that of silver when comparing crystal structures of the complexes 
[M(PMes)2]BF4 (M = Cu, Ag, Au). For two coordinate M(I) complexes the radii were estimated 
to be 1.13 Å for copper, 1.33 Å for silver and 1.25 Å for gold.8 The usual periodic trend would 
be for the radius to increase down a group. 
 
The usual trend of increasingly stable high oxidation state on descending the group does not 
hold true for the group 11 metals; for copper the +2 oxidation state dominates, whereas silver 
is usually found in the +1 oxidation state and for gold oxidation states +1 and +3 are most 
common. The relative ease with which gold can be oxidised to gold(III) with respect to the 
other coinage metals, can be explained by the small 5d-6s orbital separation since two electrons 
can more easily be removed from the expanded 5d orbital. Silver(III) and copper(III), on the 
other hand, are very rare but are accessible with highly oxidising fluoride ligands e.g. [AgF4]⁻ 
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or [CuF6]³⁻.9  The stabilisation of the 6s orbital in gold can also explain the formation of the 
gold(-I) oxidation state10 which is unknown for copper and silver. 
 
Gold(I) complexes are predominantly linear, two-coordinate, diamagnetic, 14 electron species 
whereas copper(I) and silver(I) generally adopt three or four-coordinate trigonal planar or 
tetrahedral geometries. The tendency for gold(I) to adopt a linear geometry is a result of the 
relativistic contraction of the 6s orbital and the resulting large 6s-6p separation. Molecular 
orbital calculations generally suggest that the bonding in gold(I) species involves mainly the 
6s and 5dz²
 which combine to form the ψ1 and ψ2 hybrid orbitals. The electron pair originally in 
the 5dz² will occupy ψ1 away from the two ligands considered to lie along the z axis. The ψ2 
orbital will combine further with the 6pz to give a further two bonding orbitals ψ3 and ψ4 with 
empty lobes pointing along the z axis which can accept pairs of electrons from two ligands, 
and hence a linear coordination is favoured (Figure 1.3).11 Gold(III) complexes are typically 
four-coordinate, diamagnetic, 16 electron species and adopt a square planar geometry. 
 
 
Figure 1.3. Mixing of atomic orbitals to give hybrid orbitals capable of linear coordination (Adapted from 
J. E. Huheey, Inorganic Chemistry, Harper and Row, London, 1975).11 
 
One of the most significant consequences of relativity in the chemistry of gold is the formation 
of gold-gold interactions. This phenomenon was first noted in the 1980s when based on 
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increasing evidence from crystal structure data it was noted that in many cases gold(I) centres 
appear to be drawn together to sub van der Waals Au···Au distances in the range 2.8-3.5 Å.12-
16 The lower limit of this range is smaller than the interatomic distance in metallic gold and the 
upper limit is still shorter than the estimated sum of two van der Waals radii of a gold atom 
(3.65 Å). The binding energy of these interactions has been estimated base on several systems 
to be in the range 5-15 kcal mol⁻¹ and hence comparable to typical hydrogen bonds.14-16 
Classical theories of chemical bonding cannot explain such short Au···Au interactions since it 
would normally be expected that two Au(I) centres with equal charge and closed 5d¹⁰ 
configuration would repel one another on close contact.17,18 However, taking into account the 
relativistic effects, the attractive Au···Au contacts can be interpreted as the donation of electron 
density from the expanded filled 5d orbitals on one metal centre to the empty p orbital on 
another. These interactions are one of the most significant intermolecular forces in gold 
chemistry and the phenomenon has been named “aurophilicity” by Schmidbaur.19 It should be 
noted that this phenomenon is not exclusive to gold and “metallophilicity” has also been 
observed for the neighbouring elements in the periodic table,20-24 however the effect is by far 
the most pronounced in gold due to the steric accessibility of the metal atoms as a result of the 
two-coordinate linear geometry.  
 
One final consequence of the relativistic effects in gold is the unusual colour of the metal. For 
the majority of metals, the absorption of light, primarily due to the 5d to 6s transition has an 
energy corresponding to ultraviolet light, hence frequencies in the visible band are not absorbed 
and are all reflected equally, meaning that these metals are observed as “silvery”. In gold, 
however, the contraction of the 6s orbital means that the 5d-6s energy gap is lowered to around 
2.4 eV and light in the visible blue range is strongly absorbed. All other frequencies in the 
spectrum, the reds and greens, are reflected, combining to give the golden yellowish colour 
that has attracted humans to gold since ancient times. 
 
1.1.2. History 
It is believed gold was first smelted by the ancient Egyptians around 3600 BC25 and from then 
on it has found use in a wide variety of applications. The earliest examples of gold jewellery 
date back to 2600 BC in Mesopotamia,26 and gold coins from around 700 BC have been found 
in Turkey, marking the first use of gold in currency.27 Specimens of gold dental fillings from 
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as early as 600 BC have been found in Italy28 and it is known that colloidal gold has been used 
since ancient Roman times to colour glass intense shades of yellow, red or mauve.29 The history 
of gold has by far been dominated by the metallic form of this element, and its high resistance 
to oxidation, a consequence of relativistic effects and the tighter binding of the 6s electron, 
meant that for many years it was believed to be completely unreactive.  
 
The first chemical reactions of gold were reported towards the end of the eighteenth century 
by Scheele30 when he found that metallic gold could be dissolved in cyanide solutions to give 
what we now know to be salts of [Au(CN)2]⁻, however throughout the following century the 
main focus was on the use of this reaction for electroplating or mining processes and little 
interest was shown in gold chemistry. The first attempts to prepare organogold complexes were 
made over 150 years ago by Frankland and Duppa31 at what was really the beginning of 
organometallic chemistry, although it was many years before the existence of such complexes 
was proven32 and many more before the number of practical applications was realised. In the 
long history of this element, the organometallic chemistry of gold only really started to receive 
attention in the last 40 years and with an ever-increasing number of practical applications as 
well as simpler and more facile routes for the synthesis of organogold complexes, the field of 
organogold chemistry has grown at a phenomenal pace. Novel organometallic complexes of 
gold are constantly being found with properties that can be utilised in a number of different 
fields, highlighting the richness of organogold chemistry.  
 
1.2. Organogold Complexes 
1.2.1. Basic Concepts 
Organogold complexes are defined as those in which an organic group is linked directly to gold 
through at least one carbon atom, either in the form of an Au-C σ-bond or through π-bonding. 
The majority of organogold complexes involve gold in the +1 or +3 oxidation states, however 
since the 1980s an increasing number or gold(II) complexes have also been reported. Gold is 
unusual among the transition metals in that, even in the +1 oxidation state, it shows reluctance 
to form stable π-complexes with alkenes, alkynes or aromatic hydrocarbons and therefore its 
organometallic chemistry is dominated by complexes with Au-C σ-bonds. 
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Simple alkyls and aryls AuR or AuR3 are electron deficient and generally unstable and highly 
reactive. The only stable examples of such compounds are those in which the nature of the R 
group allows polymerisation or oligomerisation by coordination to neighbouring gold atoms 
and coordinative saturation is achieved, such as the pentanuclear mesityl gold(I) complex 
(Figure 1.4), the first isolated example of a homoleptic aryl gold(I) complex. Carbon atoms 
bridge the gold atoms resulting in three-centre, two-electron bonds.33 
 
        
Figure 1.4. Molecular structure of (AuMesityl)5 determined by single crystal X-ray diffraction. Hydrogen atoms 
are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(10) 2.13(3), Au(1)-C(16) 2.20(2), 
Au(2)-C(16) 2.19(2), Au(2)-C(22) 2.12(2), Au(3)-C(22) 2.18(2), Au(1)-Au(2) 2.697(3), Au(2)-Au(3) 2.7081(29), 
Au(1)-Au(1B) 2.692(4), C(10)-Au(1)-C(16) 150.4(6), C(16)-Au(2)-C(22) 152.9(8), C(22)-Au(3)-C(22B) 
148.3(7), Au(1)-C(10)-Au(1B) 78.2(1), Au(1)-C(22)-Au(2) 75.9(7), Au(2)-C(22)-Au(3) 78.1(8). 
 
Alkynyl gold(I) complexes are one of the principle examples of stable gold compounds with 
empirical formula AuR, since the triple bond can occupy the free coordination site on an 
adjacent gold atom thus removing the electron deficiency and giving oligomeric or polymeric 
structures (Figure 1.5).  
 
 
Figure 1.5. Alkynyl gold(I) polymer. 
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The alkynyl gold(I) complex [Au(C≡CtBu)]n was for many years assumed to have a tetrameric 
structure,34 however successful determination of the crystal structure by Mingos in the mid-
1990s revealed  far more complex catenane structure involving both σ- and π-bound gold atoms 
(Figure 1.6).35 
 
 
Figure 1.6. Molecular structure of [Au(C≡CtBu)]n determined by single crystal X-ray diffraction. Tert-butyl 
groups are omitted for clarity.35 
 
When additional anionic or neutral ligands are present to make up the normal coordination 
numbers of 2 for gold(I) and 4 for gold(III), organogold complexes of all possible 
stoichiometries are known, with one or two R groups for gold(I) and one to four R groups for 
gold(III). Three coordinate trigonal planar organometallic complexes of gold(I) have also been 
characterised but are not as numerous.36,37 
 
For the majority of organogold compounds the R groups are considered as carbanions acting 
as conventional mononegative, two-electron ligands, however, recently attempts have been 
made to prepare novel organogold compounds with neutral carbene type ligands and higher 
Au-C bond orders. Organic ligands are among the softest ligands known due to their high 
polarisability and consequently they transfer a lot of electron density to the gold atom, 
demonstrated by Mössbauer spectroscopic data.38,39 This results in a high trans influence and 
hence gold complexes in which the R groups are mutually trans are generally of lower stability. 
In Au(III) complexes soft ligands generally adopt a position cis to the R group. Complexes 
 1.2. Organogold Complexes 
27 
[AuR2]⁻ and [AuR4]⁻ are usually highly reactive although derivatives of the harder perfluoro-
organic groups -CF3 and -C6F5 show greater stability.
40,41 
 
1.2.2. Early Work on Organogold Complexes 
The first reported attempts to prepare organogold compounds were made in 1864 by Frankland 
and Duppa during the very early stages of organometallic chemistry. They had successfully 
prepared a series of organozinc reagents by transmetallation reactions with zinc metal and 
organomercury compounds (Scheme 1.1) and went on to attempt the same reactions with other 
metals. The reaction of gold leaves with diethylmercury was unsuccessful giving only an 
amalgam and no organogold compound was isolated.31 Since there was little interest in 
organogold chemistry at that time, further attempts were not made and attention was focussed 
on the organometallic chemistry of other metals. 
 
 
Scheme 1.1. Synthesis of diethylzinc from diethylmercury and zinc metal (a) and attempted formation of 
diethylgold (b). 
 
The existence of organogold complexes was conclusively demonstrated by the pioneering work 
of Gibson at the beginning of the twentieth century. He carried out reactions of gold(III) 
bromide and chloride with Grignard reagents to give dialkyl gold(III) complexes32 
(Scheme 1.2). 
 
 
 
Scheme 1.2. Synthesis of bromo(diethyl)gold(III). 
 
Isolation was difficult due to the instability of the complexes, and the lack of characterisation 
techniques at that time meant that the dimeric structure of such complexes was not realised 
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until 1930, some 23 years later. This was again achieved by Gibson when following 
experiments to determine the molecular weight by a cryoscopic method in benzene he found 
the compound to have double the predicted molecular weight and hence concluded it should 
more correctly be written as a dimer.42 He also stated that all gold(III) complexes must be 
four-coordinate to be stable.43 
 
Gilman went on to further develop the work of Gibson by using the more reactive 
organolithium reagents in place of the Grignard reagents to form what he believed to be the 
very unstable trimethyl gold (Scheme 1.3).44 The reaction was carried out at -65 °C with 
decomposition observed at temperatures above -35 °C meaning that characterisation was again 
difficult. Despite previous reports by Gibson claiming that three-coordinate gold(III) 
complexes would be impossible to form, Gilman believed that he had successfully prepared 
the first AuR3 type compound, although he did also propose a possible coordination of diethyl 
ether to give a four-coordinate structure. It is probable that what actually formed in this reaction 
was the lithium salt Li[AuBrMe3] since a bromide ion will readily bind to gold(III). 
 
 
Scheme 1.3. Synthesis of “AuMe3” proposed by Gilman.44 
 
Further important developments of this work on organogold chemistry were made by Coates 
in the 1960s with the preparation of stable alkyl gold(III) derivatives by the addition of tertiary 
phosphine ligands (Scheme 1.4).45 
 
 
Scheme 1.4. Synthesis of [AuMe3(PEt3)] 
 
Coates was also able to prepare the first alkyl gold(I) complexes using the same stabilising 
phosphine ligands (Scheme 1.5).45 
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Scheme 1.5. Synthesis of the first alkyl gold(I) complex. 
 
It was believed that the great stability of these compounds arises from the formation of a dπ-dπ 
bond between gold and phosphorus and that such π-bonding ligands would be necessary for 
the formation of thermally stable organogold complexes. This was later proven not to be the 
case as exemplified by the work of Usón and Laguna in which the complexes NBu4[Au(C6F5)2] 
and NBu4[Au(C6F5)4], which do not possess any π-bonding ligands, were prepared and isolated 
as air and moisture stable crystalline solids.46 
 
The stability of organogold(III) compounds was later explained by Kochi by analysis of the 
decomposition pathways. [AuMe3(PPh3)] decomposes by first dissociation of the phosphine 
ligand and subsequent reductive elimination of ethane (Scheme 1.6).47  
 
 
Scheme 1.6. Decomposition pathway for [AuMe3(PPh3)]. 
 
The decomposition of the methyl gold(I) complex was described to proceed in a similar 
manner, again the first step being the dissociation of the phosphine (Scheme 1.7).48 
 
 
Scheme 1.7. Decomposition pathway for [AuMe(PPh3)]. 
 
It was therefore concluded that the thermal stability of an organogold complex with formula 
[AuMe3L] or [AuMeL] depends solely on the strength of the Au-L bond. In the case of the 
phosphine derivatives the strong Au-P bond is not easily cleaved and hence very stable 
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compounds may be prepared. The anions [Au(C6F5)2]⁻ and [Au(C6F5)4]⁻ are thermally stable 
due to the strength of the gold-carbon bond. 
 
1.2.3. Organogold Complexes with Bridging Carbon Ligands 
Early gold chemistry focussed on the preparation of complexes in which the organic ligand 
binds to a single gold atom, and polygold derivatives were initially rare. Multiple auration of 
carbon was first achieved in the 1970s in which ferrocenylgold(I) and arylgold(I) complexes 
with three-centre, two-electron CAu2 units were prepared and characterised by Nesmeyanov 
and co-workers, indicating that aggregation of gold atoms at a carbon centre is surprisingly 
facile (Figure 1.7).49  
 
 
Figure 1.7. First examples of complexes with diaurated carbon atoms. 
 
Schmidbaur went on to prepare the first example of a complex with two gold atoms bound to 
a tetrahedral carbon atom by reaction of a carbodiphosphorane (or “bis-ylide”) with 
[AuMe(PMe3)] (Scheme 1.8). The resulting complex was air-sensitive but thermally stable up 
to 80 °C and was characterised by NMR spectroscopy.50 
 
 
Scheme 1.8. Synthesis of first dinuclear gold complex with two gold atoms bound to a tetrahedral carbon atom. 
 
The first tri-gold substituted carbon was reported by Schmidbaur in the late 1980s. Reaction of 
a silylated ylide precursor with [AuCl(PPh3)] in the presence of caesium fluoride led to the 
formation of the trigold phosphonium salt (Scheme 1.9) in which the R3-P unit caps a triangle 
of gold atoms.51 
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Scheme 1.9. Synthesis of first complex with triaurated carbon atom. 
 
It was later found that complete auration and even hyperauration of carbon with up to six Au-C 
σ-bonds was possible. Reaction of polyborylmethanes with [AuCl(PR3)] leads to the tetra-,52 
penta-53 and hexagold19 methane compounds or cations. In fact, tetragold methanes are only 
obtained when very bulky phosphine groups are used, and with smaller ligands penta- or hexa-
auration occurs to give electron deficient trigonal bipyramidal or octahedral structures, 
respectively (Figure 1.8). 
 
           
Figure 1.8. Molecular structures of trigonal bipyramidal organogold complex (a) and octahedral organogold 
complex (b) determined by single crystal X-ray diffraction. Hydrogen atoms and phenyl groups are omitted for 
clarity. 
 
The driving force for the formation of such polynuclear gold compounds is the formation of 
multiple aurophilic interactions which stabilise the structures.13 
 
a) b) 
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1.2.4. Recent Developments in Organogold Chemistry 
The recent upsurge in interest in organogold chemistry as a result of the increasing applications 
of gold complexes, particularly within homogeneous catalysis, has led to significant 
developments within the last decade. Many novel organogold complexes have been prepared, 
either in the hunt for new catalysts, to help better understand catalytic mechanisms or in 
attempts to find complexes with unique and unusual structures and properties. 
 
1.2.4.1. Gold(III) Complexes 
Many organogold(III) complexes are now known but most are relatively unstable and undergo 
reductive elimination reactions to give carbon-carbon coupling products and gold(I) species. 
Recent interest has therefore focussed on the development of organogold(III) complexes of 
higher stability.  
 
Cyclometallated gold(III) complexes bearing a tridentate (C^N^C)²⁻ 2,6-diphenylpyridyl 
ligand were introduced by Che and co-workers in their search for luminescent gold(III) 
derivatives.54 Many similar cyclometallated gold(III) complexes, such as those bearing  
2-2’-2’’-terpyridine or 6’-phenyl-2-2’-bipyridine (C^N^N) ligands have been known for 
several years and are relatively stable (Figure 1.9).55-57 However, the cyclometallated gold(III) 
derivatives bearing the 2,6-diphenylpyridyl ligand feature two robust gold-carbon bonds and 
the strong σ-donor capacity of the ligand renders the gold(III) centre more electron rich, 
enhancing the stability of the complexes towards reductive elimination.58  
 
 
Figure 1.9. Cyclometallated gold(III) complexes. 
 
 1.2. Organogold Complexes 
33 
The group of Bochmann took advantage of the high thermal stability of these cyclometallated 
2,6-diphenlypyridine gold(III) derivatives in order to prepare a series of novel organogold(III) 
complexes (Scheme 1.10).  
 
 
Scheme 1.10. Synthetic routes to gold(III) hydride, superoxide and alkene complexes. 
 
Initially the chloro derivative was prepared in which the chloride ligand may readily be 
substituted allowing synthesis of the hydroxide complex.59 A number of other gold(III) 
hydroxides are known,60-62 however, their reactivity has not been extensively studied. 
Bochmann and co-workers were able to successfully react the [(C^N^C)*AuOH] complex with 
LiHBEt3 to form the first example of an isolable and thermally stable oranogold(III) hydride 
complex.63 Following this, they went on to prepare several other novel organogold(III) 
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complexes including the first gold(III) superoxide64 and the long sought after gold(III)  
π-alkene complexes.65 Gold(III) π-alkene complexes are analogous to the platinum complex 
Zeise’s Salt (Figure 1.10), reported in 1827,66 however, despite the isoelectronic relationship 
between Pt(II) and Au(III), the gold adducts have been considerably more challenging to 
prepare. 
 
 
Figure 1.10. Zeise’s Salt and hypothetical gold(III) analogue. 
 
Che and co-workers were also able to take advantage of the stabilising 2,6-diphenylpyridine 
ligand to prepare the first example of a gold(III) allenylidene complex (Figure 1.11). They 
found it to be phosphorescent, with intense bright yellow emission in the solid state, and also 
to exhibit efficient cytotoxic activity in HeLa cells.67 
 
 
Figure 1.11. First gold(III) allenylidene complex. 
 
Another significant recent contribution to organogold(III) chemistry comes from the group of 
Tilset with the isolation of a gold(III) complex of 1,5-cyclooctadiene from a cyclometallated 
gold(III) precursor (Scheme 1.11).68 This is the first example of a gold(III) complex bearing 
two olefinic groups whereas platinum(II) analogues have been known for several decades.69 
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Scheme 1.11. Synthesis of gold(III) cod complex and molecular structure determined by single crystal X-ray 
diffraction. Selected bond lengths [Å]: Au(1)-C(3) 2.3712, Au(1)-C(4) 2.4149, Au(1)-C(7) 2.3620, Au(1)-C(8) 
2.4064. 
 
The first gold(III) arene complexes were reported by the group of Bourissou in 2017 and were 
prepared by the insertion of olefins into gold-aryl bonds (Scheme 1.12). The η²-coordination 
of the phenyl ring was demonstrated spectroscopically and crystallographically, allowing 
important information on the interactions between arenes and gold(III) species to be obtained 
in the context of the gold-catalysed functionalisation of aromatic C-H bonds.70  
 
 
Scheme 1.12. Formation of gold(III) norbornyl complexes by insertion of norbornene into the Au(III)-Ar bond. 
 
1.2.4.2. Gold(I) Complexes 
One of the most significant developments in organogold(I) chemistry has been the preparation 
of singlet carbene derivatives (Figure 1.12). Although first prepared in the 1970s and 1980s by 
the groups of Bonati and Mighetti,71,72 acyclic diamino carbene (ADC) and N-heterocyclic 
carbene (NHC) complexes of gold(I) were initially of little interest. The recent development of 
more facile syntheses as well as the discovery of the potential of such complexes to act as 
catalysts or precatalysts has led to a huge increase in their research. More recently 
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cyclic(amino)(alkyl)carbenes (CAAC), another type of singlet carbene, have attracted attention 
due to having an even greater nucleophilic character that NHCs and ADCs and hence they can 
form some very robust complexes of gold(I).73,74  
 
 
Figure 1.12. Singlet carbene gold(I) complexes. 
 
The stabilising influence of these carbene ligands on gold(I) complexes is comparable to that 
of phosphines, and the steric and electronic properties of the complexes can be altered with 
relative ease by variation of the substituents of the carbene ligand. The use of very bulky NHC 
ligands has allowed the isolation of the first gold(I) hydride (Figure 1.13(a))75 and fluoride 
(Figure 1.13(b)),76 both of which had been elusive targets in preparative chemistry.2 
 
 
Figure 1.13. First gold(I) hydride (a) and fluoride (b) complex. 
 
1.2.4.2.1. Catalytic Intermediates – σ complexes 
Although homogeneous gold catalysis is now a well-developed field, there is still considerable 
uncertainty regarding the mechanisms involved in many processes. The recent isolation of 
several novel organogold(I) complexes which are intermediates in catalytic cycles has allowed 
further understanding to be gained.  Examples are shown in Figure 1.14. 
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Figure 1.14. Recently isolated organogold(I) complexes. 
 
Vinylic gold(I) complexes were suggested as intermediates in the first reports of homogeneous 
gold catalysis, in the cleavage reactions of bicyclo[1.1.0]butanes, over 40 years ago,77 and are 
now considered key intermediates in many gold-catalysed reactions. However, it was not until 
2007 that the first example was isolated and crystallised by Sadighi and co-workers (Figure 
1.14(a)). The crystal structure allowed the trans arrangement of gold and fluorine to be 
confirmed in the intermediate, allowing a key step in the catalytic cycle of the hydrofluorination 
of alkynes to be determined.78  
 
A more general access to vinyl gold(I) complexes was later introduced by Hashmi and 
co-workers by suppression of the protodeauration step of the catalytic cycle, in the gold-
catalysed cycloisomerisation of propargylamides, by addition of a base (Scheme 1.13).79,80  
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Scheme 1.13. Synthesis of vinylgold(I) complexes (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ylidene) 
 
The first alkylgold(I) intermediate to be isolated and characterised by single crystal X-ray 
diffraction was achieved by the group of Toste in 2010 (Figure 1.14(b)). Aminoaurated 
complexes were isolated using the same method of suppression of protodeauration previously 
established by Hashmi and co-workers for the isolation of vinylgold intermediates, by addition 
of excess triethylamine to the reaction. Surprisingly the protodeauration of these alkylgold(I) 
complexes, which had previously been proposed in the mechanism of gold-catalysed 
hydroamination of alkenes, was unsuccessful and upon treatment with acid the complexes 
reverted back to the starting aminoalkenes. However, addition of sodium tetraborohydride did 
give the desired cyclic amine products (Scheme 1.14).81 
 
 
Scheme 1.14. Attempted protodeauration of alkylgold(I) complexes (a), and reaction of alkylgold(I) complexes 
with NaBH4 (b). 
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Geminally diaurated complexes have been known since the 1970s,49 however they were 
initially only considered curiosities and it was not until 2008 when Toste and co-workers 
suggested a gem-digold complex as a catalytic intermediate (Figure 1.14(c)) that a resurge in 
interest began. Gold-catalysed transformations involving terminal alkynes had always 
previously been assumed to proceed via π-activation by just one gold centre (Scheme 1.15).  
 
 
Scheme 1.15. General mechanism for a gold-catalysed reaction involving a terminal alkyne. 
 
 
Scheme 1.16. Mechanistic proposal involving dual σ,π-activation and the formation of gem-diaurated species. 
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Toste and co-workers reported the first evidence of dual σ,π-activation by a gold catalyst. 
Computational studies supported by experimental data suggested the most plausible 
mechanism to involve the formation of a gem-diaurated species which would react with a new 
substrate molecule to release the final product (Scheme 1.16).82 This work raised many 
questions about the mechanisms by which gold complexes catalyse organic transformations 
involving terminal alkynes. 
 
In 2009 Gagné and co-workers reported the isolation of a geminally diaurated intermediate in 
the gold(I) catalysed intramolecular hydroarylation of an allene.83 They suggested that this 
digold species could be a catalyst resting state rather than a reactive species in the catalytic 
cycle. The same group also reported that depending on the silver to gold ratio in the catalytic 
reaction an alternative hetero geminally dimetallated species could be the resting state 
(Scheme 1.17).84  
 
 
Scheme 1.17. Formation of gem-dimetallated catalyst resting states. 
 
Whilst the digold complex was proposed to have three-centre two-electron bonding, the 
heterometallic species would be dominated by the stronger Au-C bond, similar to the 
structurally characterised related Au-Ag complex published by the group of Laguna in 1994 
(Figure 1.15).85 
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Figure 1.15. Molecular structure of geminally dimetallated mesityl complex [{(PPh3)Au(μ-Mes)Ag(tht)}2]+ 
determined by single crystal X-ray diffraction. Hydrogen atoms are omitted for clarity. Selected bond lengths [Å] 
and angles [°]: C(1)-Au(1) 2.085(4), C(1)-Ag(1) 2.327(4), Au(1)-P(1) 2.289(1), Au(1)-Ag(1) 2.8244(6), 
Ag(1)-S(1) 2.477(1), Ag(1)-S(1A) 2.839(1), C(1)-Au(1)-P(1) 177.3(1), C(1)-Ag(1)-S(1) 160.0(1), 
centroid-C(1)-Au(1) 170.10, centroid-C(1)-Ag(1) 110.50. 
 
Gagné’s work showed that even if reactants were untouched by the silver cations, they could 
still have a huge influence on gold-catalysed reactions by intercepting key organogold 
intermediates to form heteronuclear complexes with different reactivity. This could be one 
explanation for the “silver effect” in gold catalysis.86 
 
Work published by the group of Fürstner in 2010 allowed further insight into the role of 
geminally diaurated complexes in catalysis to be gained. They developed an efficient synthesis 
for such complexes from a vinyl borane and [Au(NTf2)(PPh3)] and were able to structurally 
characterise two examples by single crystal X-ray diffraction analysis. They found that the 
nature of the bond between the two gold centres and the olefin can either be a three-centre two-
electron system, or two regular Au-C σ-bonds flanked by a stabilised cationic centre 
(Figure 1.16). They also found gem-diaurated species to be quite resistant to protodeauration, 
suggesting that the protodeauration step in catalytic cycles must proceed through a vinyl 
intermediate (Scheme 1.18).87  
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Figure 1.16. Possible bonding situations in geminally diaurated complexes. 
 
 
Scheme 1.18. Conclusions from Fürstner’s studies on protodeauration of geminally diaurated complexes. 
 
The increased interest in geminally diaurated complex led to new methods for their preparation 
to be developed by the groups of Gray88 and Nolan89, although there was speculation as to the 
involvement of such diaurated species in catalytic cycles. The lack of mechanistic insights also 
led to many groups to study σ,π-digold acetylides based on the original mechanistic proposal 
by Toste. Such species are not uncommon in organometallic chemistry and have been reviewed 
by Schmidbaur,90 however, the suggested reactivity, in which they are precursors to the 
geminally diaurated species in catalytic cycles, was new.  
 
Widenhoefer and co-workers found that [Au(IPr)]+ could form a π-complex with 
phenylacetylene at low temperatures which converts to a σ,π-digold acetylide at temperatures 
above -20 °C (Scheme 1.19). The ease with which such species formed in the absence of a base 
led them to suggest that they may be generated in catalytic reactions involving terminal alkynes 
although their role in the catalytic cycle was uncertain.91  
 
 
Scheme 1.19. Formation of σ,π-digold acetylide reported by Widenhoefer. 
 
In the same year the group of Corma synthesised a series of σ,π-digold acetylides92 and found 
them to possess good catalytic activity in the intermolecular alkene/alkyne [2+2] cycloaddition 
developed by Echavarren (Scheme 1.20).93  
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Scheme 1.20. [2+2] Cycloaddition catalysed by σ,π-digold acetylides. 
 
Another interesting recent example, although unrelated to homogeneous catalysis, is the 
σ,π-digold acetylide complex published by the group of Laguna in 2012. The π-coordinated 
gold bears two phosphine ligands and the structure of the complex which was determined by 
X-ray diffraction analysis shows a very unusual unsymmetrical coordination of the alkyne and 
the presence of gold-gold interactions (Figure 1.17).94 
      
Figure 1.17. Molecular structure of σ,π-digold acetylide complex determined by single crystal X-ray diffraction. 
Hydrogen atoms and PPh3 phenyl rings are omitted for clarity. Selected bond lengths [Å]: Au(1)-Au(2) 2.9165(5), 
Au(1)-C(1) 2.033(5), Au(2)-C(1) 2.602(6), Au(2)-C(2) 3.134(6). 
 
Following on from the work of Toste, Hashmi and co-workers carried out extensive studies on 
the dual activation of diynes to give gem-diaurated intermediates and developed a novel type 
of gold-catalysed transformation that requires dual activation of the substrate by the gold 
catalyst.95 Studies of the cycloaddition between a diyne and benzene found that two different 
products formed with the β-isomer favoured in the presence of basic additives (Scheme 1.21).  
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Scheme 1.21. Gold-catalysed cycloaddition reaction between diyne and benzene. 
 
While the formation of the α-isomer can be explained by the standard π-activation of the 
substrate by gold(I) and subsequent nucleophilic attack, the formation of the β-isomer must 
proceed through dual σ,π-activation. The catalytic cycle proposed by Hashmi involves initial 
formation of a gold(I) acetylide species which subsequently undergoes π-activation by a second 
[Au]+ unit at the other triple bond (dual activation) to activate the system for nucleophilic attack 
in the β-position (Scheme 1.22).  
 
 
Scheme 1.22. Catalytic cycle proposed by Hashmi ([Au] = [Au(SbF6)(IPr)]). 
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In attempts to gain further insight into the mechanism the gem-diaurated species was isolated. 
Employing this as the catalyst led to formation of the β-isomer in high yields. Further 
investigations revealed and equilibrium between this gem-diaurated species and the arylgold(I) 
complex and free catalyst at high temperatures (Scheme 1.23) and for this reason the reaction 
proceeds. It was therefore concluded that the gem-diaurated complex is an excellent “off-cycle” 
or “reservoir” catalyst for this transformation.  
 
 
Scheme 1.23. Equilibrium between gem-diaurated complex and arylgold(I) complex and free catalyst. 
 
Many more reports of dual gold catalysis have been published in the last two years and novel 
digold catalysts have been designed to enable the dual activation of the substrates. Very 
recently dual catalysis with one gold and one copper complex has been described as an 
alternative, more cost-effective method for the hydroxyphenylation of alkynes.96 
 
Gold vinylidenes (Au=C=CR2) were suggested in the catalytic cycle for dual gold catalysis 
proposed by Hashmi in 2012 and were also independently suggested by the group of Zhang97 
in the same year, however neither group was able to successfully isolate any examples. In 2013, 
the group of Hashmi did successfully isolate the first higher cumulene of gold(I), a gold 
allenylidene (Figure 1.14(d)), which although not itself a catalytic intermediate could provide 
important bonding information. The nature of the ligands present had a huge influence on the 
Au-C bond: strong π-acidic ligands were found to compete for electron density on gold and 
weaken the Au-C bond, while strong π-donors shortened the Au-C bond, however, no 
significant Au-C double bond character could be confirmed.98  
 
In 2015, Widenhoefer was able to isolate the first gold vinylidene (Figure 1.14(e)) by carrying 
out a hydride abstraction reaction with a (disilylethyl)acetylide complex (Scheme 1.24). 
Although the complex was unstable at temperatures above -20 °C, they were able to fully 
 Chapter 1 General Introduction 
46 
characterise it by NMR spectroscopy at -80 °C.99 This is to date the only species of its kind to 
be characterised by NMR spectroscopy.  
 
 
Scheme 1.24. Synthesis of gold (β,β-disilyl)vinylidene complex. 
 
Recently, the group of Fürstner studied the fate of gold vinylidene complexes finding that they 
can rearrange into gold carbenes (Scheme 1.25). In their studies they were able to isolate and 
characterise by X-ray diffraction the first example of an acylgold(I) species (Figure 1.14(g)).100 
 
 
Scheme 1.25. Conversion of vinylidenegold(I) complex into acylgold(I) complex. 
 
Gold(I) carbenes are suggested as intermediates in many catalytic cycles and also have a broad 
reactivity. They therefore have attracted significant interest. A huge effort has been made into 
gaining insight into the nature of the Au-C bond, and there has been debate as to whether such 
species are more carbocation-like or carbene-like.101-103 In 2014, Fürstner and co-workers were 
able to isolate the first gold(I) carbene complex with no heteroatom stabilisation, a species 
closely related to gold-carbene intermediates in gold(I) catalysed reactions (Figure 1.18).104 
However, the strong electron donating character of the 4-methoxy substituent stabilises the 
carbene centre and there is little back-donation from gold. In the same year the group of Straub 
successfully prepared a gold carbene complex with significant Au-C double bond character by 
using a sterically demanding IPr ligand. The Au-CMes2 distance was found to be 2.014(6) Å.
105 
The group of Bourissou went on to synthesise and structurally characterise a gold(I) 
diphenylcarbene complex with a o-carborane diphosphine ligand (Figure 1.14(f)). The bending 
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induced by the diphosphine raises the energy of the gold dxz orbital which increases 
significantly the π-back-donation. This complex has the shortest Au-C bond to date at just 
1.984(4) Å.106 
 
 
Figure 1.18. Characterised gold(I) carbene species and corresponding Au-C bond lengths. 
 
1.2.4.2.2. Catalytic Intermediates – π complexes 
The vast majority of gold(I) catalysed reactions involve activation of a C-C multiple bond by 
π-coordination to gold(I). The isolation of such complexes is therefore of interest to gain a 
better understanding of catalytic mechanisms. 
 
Gold(I) π-alkene complexes were first described by Chalk in 1964 with the preparation of the 
gold(I) cyclooctadiene complex which was characterised by elemental analysis and infrared 
spectroscopy.107 The first example to be characterised by X-ray crystallography was [AuCl(cis-
cyclooctane)], prepared by Weiss in 1987.108 Many gold(I) π-alkene complexes have very poor 
thermal stability in solution and hence well characterised examples are scarce. In 2009 
Widenhoefer made significant progress by introducing a general approach for the synthesis of 
π-alkene complexes by halide abstraction from a chloro-gold(I) JohnPhos or IPr complex using 
AgSbF6 and subsequent addition of alkene (Scheme 1.26).
109,110 The π-alkene complexes which 
formed were stable and several examples were characterised by X-ray diffraction. The 
analogous reaction with [AuCl(PPh3)] did give the alkene complexes at low temperatures but 
they were unstable above -20 °C and the formation of the bis-phosphine complex [Au(PPh3)2] 
was observed.111 The same methodology with the JohnPhos and IPr ligands also allowed the 
isolation and structural characterisation of the first gold(I) π-allene complex.112  
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Scheme 1.26. Gold(I) π-alkene complexes prepared by Widenhoefer. 
 
Gold is generally known for its high affinity to C-C triple bonds rather than double bonds, 
previously assumed to be a result of the higher electron density of the bond attracting the highly 
electrophilic gold(I). An interesting study into the π-bonding situation in an enyne at 223 K, a 
temperature at which the catalytic cyclisation reaction is avoided, found the presence of two 
distinct π-complexes (Scheme 1.27).113 Spectra show a close 1:1 ratio of the gold complexes, 
however the catalytic reaction always proceeds via the π-alkyne complex. Electrophilic and 
nucleophilic attacks are more thermodynamically favoured for alkynes and hence the 
alkynophilicity of gold(I) in catalytic reactions is more a result of the reactivity of the 
π-complex than the preference in coordination. 
 
 
Scheme 1.27. Equilibrium between gold π-alkyne and gold π-alkene complexes in enyne. 
 
The first examples of gold(I) π-alkyne complexes to be characterised by X-ray diffraction were 
reported in 1998. These complexes were prepared by the reaction of [AuCl(tht)] with the 
cycloheptynes 3,3,6,6-tetramethyl-1-thiacyclohept-4-yne-1,1-dioxide and 3,3,6,6-tetramethyl-
 1.2. Organogold Complexes 
49 
1-thiacyclohept-4-yne and in both cases a trigonal planar geometry about the gold centre was 
observed (Figure 1.19).114  
 
        
       
Figure. 1.19. Molecular structures of gold π-alkyne complexes. 
 
Non-cyclic π-alkyne gold(I) complexes have been reported but are generally unstable and 
decompose rapidly at room temperature. Some interesting examples were prepared by the 
group of Russell using TMS-protected alkynes and [AuCl(PtBu3)], with AgSbF6 as a halide 
abstractor. With short reaction times the mono-gold π-alkyne complex was obtained, as 
expected, however, increasing the reaction time led to desilylation and a triaurated species. 
When a doubly silylated alkyne was employed the tetra-aurated alkyne bearing two 
σ-coordinated and two π-coordinated gold centres was obtained (Scheme 1.28). The complexes 
were successfully characterised by single crystal X-ray diffraction, although the authors did 
note that it is likely that a different structure exists in solution since only one peak is observed 
in the 31P{1H} NMR spectrum, even at low temperatures.115 
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Scheme 1.28. Synthesis of mono, tri and tetra-aurated alkyne species. 
 
In 2007, Bertrand and co-workers were able to successfully prove the formation of a gold(I) 
terminal alkyne complex in a catalytic cycle. Using the very strongly σ-donating CAAC ligand 
they first prepared a catalytically active toluene derivative by reaction of the chloro gold(I) 
complex with a silylium-like salt, [(Tol)SiEt3][B(C6F5)4]. The product was fully characterised 
by X-ray diffraction and was found to catalyse the cross-coupling reaction of enamines with 
terminal alkynes to give allene products. Addition of phenylacetylene in the absence of 
enamine afforded the alkyne complex (Scheme 1.29), which was successfully characterised by 
NMR spectroscopy. This is one of very few examples of a terminal alkyne π-bound to 
gold(I).116 
 
 
Scheme 1.29. Synthesis of a gold(I) complex bearing π-bound terminal alkyne. 
 
1.2.4.3. Gold(0) Complexes 
In 2013 the group of Bertrand made a significant discovery in the field of organogold chemistry 
by the successful isolation of the first organogold complex with gold in oxidation state 0. 
Reduction of the cationic bis-CAAC gold(I) precursor using potassium in THF gave the 
paramagnetic product in which gold is a radical with electronic configuration 5d106s1 
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(Scheme 1.30). ESR spectroscopy and crystal structure analysis confirmed the identity of the 
gold(0) complex (Figure 1.20).  
 
 
Scheme 1.30. Synthesis of a gold(0) complex. 
 
  
Figure 1.20.  Molecular structure of gold(0) complex determined by single crystal X-ray diffraction. Hydrogen 
atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 1.991, N(1)-C(1) 1.344(2), 
C(1)-C(2) 1.519(4), C(1)-Au(1)-C(1A) 180.0.  
 
Using the same ligand, the group was also able to prepare the first authentic complex of the 
neutral digold molecule, Au2, previously only known as a component of gold vapour. In this 
case reduction of the chloro gold(I) complex with lithium in THF gave the product 
(Scheme 1.31) which was again successfully characterised by X-ray diffraction (Figure 1.21). 
A quasi-linear C-Au-Au-C arrangement is observed which is isolobal to dihydrogen, H-H. 
 Chapter 1 General Introduction 
52 
 
Scheme 1.31. Synthesis of the first complex of neutral Au2 molecule. 
 
 
Figure 1.21.  Molecular structure of the first complex of Au2 determined by single crystal X-ray diffraction. 
Hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-Au(2) 2.542(1), 
Au(1)-C(1) 2.101(8), Au(2)-C(2) 2.043(9), N(1)-C(1) 1.316(9), C(1)-C(3) 1.52(1), N(2)-C(2) 1.33(1), 
C(2)-C(29) 1.53(1), C(1)-Au(1)-Au(2) 170.6(2), Au(1)-Au(2)-C(2) 172.3(3). 
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1.3. Applications of Organogold Complexes 
Many early studies into the organometallic chemistry of gold had the simple aim of gaining 
further understanding of the fundamental coordination chemistry of this metal. Early 
organogold complexes were considered laboratory curiosities with little potential for any useful 
application. More recently, however, organogold complexes have found potential use in a huge 
variety of different applications as a result of their photophysical, biological and catalytic 
properties. Many of the most recent developments in organogold chemistry have arisen in the 
search for new complexes with enhanced properties for specific applications. The most 
important applications of organogold complexes are summarised in Figure 1.22.   
 
 
Figure 1.22.  Applications of organogold complexes. 
 
The huge number of different application shows just how versatile organogold complexes are 
and highlights the need for further research in this area. 
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1.4. Objectives 
The main objective of this PhD thesis was to prepare novel organogold complexes which, in 
addition to providing further insight into the structure and bonding in coordination complexes 
of gold, could also possess properties such as luminescence or biological activity. Phosphorus 
ylide, allenyl, NHC and propargyl derivatives of gold were chosen as suitable synthetic targets. 
The objectives for each chapter are outlined below. 
 
1.4.1. Phosphorus Ylide Gold Complexes 
Phosphorus ylides complexes of gold are known to be highly stable and the coordination 
chemistry of many simple phosphorus ylides with gold has been widely studied. However, 
complexes of gold with the cyano-functionalised ylide triphenylphosphoniumcyanomethylide 
have been little explored.117 This ylide could potentially have a very rich coordination 
chemistry with gold since their exists the possibility for coordination through not only the ylide 
α-carbon, but also the nitrogen of the nitrile group  (Figure 1.23). 
 
 
Figure 1.23.  Coordination sites of triphenylphosphiumcyanomethylide.  
 
Our first objective was to explore the coordination chemistry of 
triphenylphosphoniumcyanomethylide with gold by preparing simple mononuclear complexes 
of both gold(I) and gold(III) with different anionic and neutral ligands at the gold centre. The 
preparation of derivatives of the other coinage metals, copper and silver, would allow 
comparisons to be made between the coordination chemistry of these elements (Scheme 1.32).  
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Scheme 1.32.  Preparation of complexes of the coinage metals with triphenylphosphoniumcyanomethylide. 
 
Triphenylphosphoniumcyanomethylide can be further deprotonated to give the yldiide unit 
which can act a bridging ligand between two metal centres (Scheme 1.33). Polynuclear gold 
derivatives are of interest since complexes in which gold atoms are in close proximity often 
exhibit luminescence. An additional objective was therefore to prepare dinuclear or 
polynuclear derivatives of the yldiide with gold and the other coinage metals and to explore 
their luminescence. 
 
 
Scheme 1.33.  Dinuclear derivatives of triphenylphosphoniumcyanomethyldiide.  
 
Despite their high stability and generally high solubility, the potential biological activity of 
phosphorus ylide gold complexes has not previously been studied. Our final objective in this 
area was to study the anticancer properties of the phosphorus ylide gold complexes. 
 
1.4.2. Allenyl Gold Complexes 
The phosphonium salt triphenylpropargylphosphonium bromide is known to readily 
tautomerise to the allenyl form in solution in different solvents and in the presence of a base 
(Scheme 1.34).118,119 This phosphonium salt is also the precursor to a phosphorus ylide and 
hence has the potential for the preparation of stable derivatives of gold. Allenyl gold derivatives 
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are unknown in the literature and hence their potential synthesis from 
triphenylpropargylphosphonium bromide is of interest.  
 
 
Scheme 1.34.  Tautomerisation of triphenylpropargylphosphonium bromide to the allenyl form. 
 
Our first objective was to explore the coordination chemistry of the ylide 
triphenylphosphoniumpropargylide or its allenyl tautomer with gold with the aim of preparing 
the first allenyl derivatives of gold(I) and gold(III) (Scheme 1.35).  
 
 
Scheme 1.35.  Synthesis of allenyl gold complexes from triphenylpropargylphosphonium bromide. 
 
Our second objective was to explore the importance of the heteroatom in the tautomerisation 
of this phosphonium salt. Therefore, we aimed to prepare propargyl functionalised ammonium 
and sulfonium salts and explore their coordination chemistry with gold (Figure 1.24). 
 
 
Figure 1.24.  Propargyl functionalised phosphonium, ammonium and sulfonium salts. 
 
1.4.3. NHC Gold Complexes 
NHC gold complexes are of ever-increasing interest for their potential use in homogeneous 
gold catalysis as well as for their luminescence and biological properties. Many synthetic 
methods for the preparation of these complexes are known, the most straightforward involve 
starting from the corresponding imidazolium salts. A huge range of complexes are possible due 
to the variety of substituents which can be introduced at the nitrogen atoms. Propargyl- and 
allenyl- functionalised NHC gold complexes, however, are unknown.  
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Continuing our study into propargyl-allenyl tautomerism, we aimed to prepare propargyl 
functionalised imidazolium salts and their corresponding NHC gold complexes (Scheme 1.36). 
Since the propargyl side-arm is sterically small, the previously reported methods for the 
synthesis of NHC gold complexes from imidazolium salts are not suitable. Therefore, our first 
objective was to find a suitable synthetic method for the synthesis of the propargyl 
functionalised NHC gold complexes. 
 
 
Scheme 1.36.  Synthesis of propargyl functionalised NHC gold complexes. 
 
NHC gold phosphine complexes are rare in the literature, but could potentially possess 
interesting photophysical properties due to the presence of two strongly σ-donating ligands. 
Cationic bis-NHC complexes are known to have potent anticancer activity120 and hence 
cationic NHC gold phosphine complexes could show similar biological activity since 
phosphines and NHCs are comparable. We therefore aimed to prepare gold phosphine 
derivatives of our propargyl functionalised NHCs and study their luminescence and anticancer 
activity (Figure 1.25).  
 
 
Figure 1.25.  Propargyl functionalised NHC gold phosphine complexes. 
 
Another objective was to explore the potential functionalisation of the propargyl side-arm. This 
could provide an additional coordination site for the preparation of dinuclear or polynuclear 
complexes. However, it could also undergo tautomerisation to the allene or participate in a 
copper catalysed “click” reaction with an azide (Scheme 1.37). 
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Scheme 1.37.  Functionalisation of the propargyl side-arm. 
 
1.4.4. Propargyl Gold Complexes 
Alkynyl gold complexes have recently been found to show promising anticancer activity.121-123 
Due to the ease of synthesis of both the substrates and the corresponding gold complexes, we 
aimed to prepare a series of propargyl gold phosphine complexes, where gold is bound at the 
terminal alkyne. In order to explore the effect of the heteroatom on the activity of the complex, 
we chose to compare propargylamines, proparglyethers and propargylsulfides (Figure 1.26). In 
these cases, the lack of positive charge at the heteroatom would disfavour deprotonation at the 
α-carbon atom and therefore tautomerism to the allene would be extremely unlikely.  
 
 
Figure 1.26.  Propargylamine, propargylether and propargylsulfide gold phosphine complexes. 
 
Our first objective was to prepare the mononuclear propargyl gold phosphine derivatives and 
study their anticancer activity with the aim of observing any effect caused by changing the 
heteroatom in the substrate or the nature of the phosphine bound to the gold centre. We then 
aimed to prepare dinuclear derivatives which could potentially have enhanced anticancer 
activity due to the presence of two metal centres. 
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Chapter 2 – Phosphorus Ylide Complexes 
2.1. Introduction 
Phosphorus ylides are today classed amongst some of the most important reagents in organic 
chemistry, finding use in the synthesis of a wide variety of fundamental biologically active 
compounds, pharmaceuticals and natural products.124-126 These zwitterionic species were first 
discovered over 100 years ago,127 however it is only really in the last 50 years that the true 
synthetic potential of these compounds has been realised and there has been rapid growth in 
this field.124 
 
The application of phosphorus ylides as ligands in organometallic chemistry is an active area 
of research. This is due not only to the outstanding potential of ylides to form transition metal-
carbon bonds, but also the range of possible bonding modes and incredible versatility of these 
compounds.128 The steric and electronic requirements of ylides can be tuned and it is possible 
to design ylides with several potential donor atoms allowing polynuclear species to be 
synthesised.129 The enormous variety of oxidation levels, coordination numbers and complex 
geometries characteristic of metals, along with the bonding features of phosphorus ylides give 
rise to incredible possibilities in this branch of coordination chemistry.  
 
Complexes of gold with phosphorus ylides initially sparked interest because of their possible 
application in the treatment of arthritis and use in catalysis.130,131 Subsequent studies found that 
ylide-gold complexes are particularly stable towards oxidation and hydrolysis, a feature which 
is uncommon in the organometallic chemistry of gold132 and one which led a considerable 
amount of attention to be given to this area. Despite this, there are still many areas of the field 
of phosphorus ylide-gold chemistry, such as the synthesis of gold derivatives of functionalised 
phosphorus ylides, that have until now been relatively untouched.  
 
2.1.1. Basic Concepts 
The most widely accepted definition of an ylide is “a substance in which a carbanion is 
attached directly to a heteroatom carrying a substantial degree of positive charge and in which 
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the positive charge is created by the sigma bonding of substituents to the heteroatom”.128 Ylides 
with a variety of different heteroatoms are known, including nitrogen,133,134 oxygen,135 sulfur136 
and arsenic.137 However, phosphorus ylides are by far the most widely used and extensively 
studied.128  
 
Phosphorus ylides can be described by two canonical structures: ylide and ylene (Figure 2.1). 
 
 
Figure 2.1. Canonical forms of phosphorus ylides 
 
The ylide form is a zwitterion, reflecting the highly polar nature of the phosphorus-carbon 
bond, whereas the ylene or phosphorane canonical form comprises a double bond between the 
carbon and the phosphorus atoms and no formal charges are present. Many theoretical 
calculations have shown that the highest occupied molecular orbital of most ylides is strongly 
localised on the ylide carbon and it is therefore the polar ylide canonical structure which makes 
the major contribution to the ground state of phosphorus ylides and the contribution of the 
ylene form is minimal.138  
 
Phosphorus ylides may also be classified according to the nature of the substituents at the ylide 
α-carbon atom. The presence of groups which allow the delocalisation of the negative charge 
from the carbanionic centre confer stability to the ylide and reduce its basicity. Three main 
types of ylide exist: “stabilised” in which there is at least one strong electron withdrawing 
group on the α-carbon, stabilising the formal negative charge; “semi-stabilised” in which the 
presence of at least one moderately conjugating group such as an alkenyl or aryl substituent 
has a stabilising effect; “non-stabilised” which usually have only alkyl substituents or hydrogen 
on the α-carbon (Figure 2.2).139 Stabilised ylides are weak bases and are generally unreactive 
towards moisture and oxygen. Consequently, they can often be prepared under ambient 
conditions and stored for weeks or months without decomposition. Non-stabilised ylides, 
however, are far more reactive and often have to be generated in situ under inert atmosphere to 
avoid undesired reactions with oxygen or moisture. 
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Figure 2.2. Types of ylides 
 
Many stabilised and non-stabilised ylides have been structurally characterised by single crystal 
X-ray diffraction, such as the non-stabilised ylide, triphenylphosphoniumisopropylide 
(Figure 2.3(a)),140 and the ester stabilised ylide (Figure 2.3(b)),141 allowing important bonding 
information to be obtained. 
 
 
Figure 2.3. Molecular structures of complexes non-stabilised ylide (a) and stabilised ylide (b) determined by 
single crystal X-ray diffraction. Selected bond lengths [Å] and angles [°] a: P(1)-C(1) 1.678(2), C(1)-C(2) 
1.503(2), C(1)-C(3) 1.508(3), P(1)-C(1)-C(2) 122.1(1), P(1)-C(1)-C(3) 120.1(1), C(2)-C(1)-C(3) 114.1(2); b: 
P(1)-C(19) 1.745(2), C(19)-C(20) 1.438(3), C(19)-C(22) 1.457(3), P(1)-C(19)-C(20) 115.6(1), P(1)-C(19)-C(22) 
120.1(2).  
 
a) b) 
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Stabilised ylides feature a trigonal planar carbanion, whereas non-stabilised ylides can have a 
slightly pyramidal structure. The P-Cylide bond in phosphorus ylides is typically in the range 
1.63-1.75 Å, somewhat shorter than a classical P-C single bond (1.87 Å).142 This would suggest 
a degree of double bond character; however, calculations have found there to be very little 
resistance to rotation about the P-Cylide bond. Comparison of the simplest ylides of phosphorus, 
oxygen, nitrogen and sulfur found the barrier for rotation for the phosphonium ylide H3P-CH2 
to be 0.24 kcal mol-1, compared to 5.6 kcal mol-1 for H2O-CH2, 2.3 kcal mol
-1
 for H3N-CH3 and 
21.2 kcal mol-1 for H2S-CH2.
143 This is particularly surprising since nitrogen ylides are found 
to have C-N distances in the range typical for a C-N single bond.  
 
Phosphorus ylides are generally more stable than the ylides of other elements. This was initially 
believed to be a result of an interaction of the lone pair of electrons in the ylide α-carbon 
p-orbital with the empty d-orbitals on the phosphorus atom (Figure 2.4).144 Ylides of nitrogen 
would not have this interaction since the d-orbitals on nitrogen are far too high in energy to 
participate in bonding and hence it could explain their lower stability compared to the 
phosphorus analogues. However, theoretical studies suggest very little participation of the 
phosphorus d-orbitals in the P-Cylide bond and other theories about the nature of the ylide bond 
in phosphorus ylides are now favoured.145,146 
 
 
Figure 2.4. π-bond formed by back donation from carbon p-orbital to phosphorus d-orbital. 
 
In 1977, Bernardi and co-workers suggested an alternative model for the bonding in 
phosphorus ylides in which the double bond is again formed by a σ-bond from phosphorus to 
carbon and a π-back-bond from carbon to phosphorus, but in this case the carbon p-orbital 
interacts with the σ* LUMO orbital of the phosphine (Figure 2.5(a)). This type of interaction 
would also be possible in the perpendicular orientation (Figure 2.5(b)) and hence could explain 
the low barrier to rotation in phosphorus ylides.147 Although phosphorus ylides were one of the 
p d 
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first types of compounds to have their bonding described in this way, this bonding description, 
termed negative hyperconjugation, is now relatively common.148-151  
 
                    
Figure 2.5. π-bond formed by back donation from carbon p-orbital to phosphine σ* antibonding orbital in two 
different orientations. 
 
Another explanation for the bonding in phosphorus ylides suggests that rather than the 
existence of a σ-bond and π-back-bond, there are actually two electron pairs in two Ω bonds or 
“banana bonds” (Figure 2.6). This bonding description was given by Dixon in the early 1980s 
and would explain the shorter P-Cylide bond length compared to a normal P-C single bond.
152 
However, this model clearly suggests that the P-C bond has a significant degree of double bond 
character and the low barrier for rotation about the P-C bond cannot be well explained.  
 
 
Figure 2.6. Banana bonding model for the bonding in phosphorus ylides. 
 
One final explanation for the short P-C bond in ylides is a simple electrostatic shortening in 
which a coulombic attraction between the positively charged phosphorus and the negatively 
charged carbon atom results in a reduction in bond length.146 
 
2.1.2. Phosphorus Ylides as Ligands 
The excess negative charge on the ylide carbon atom results in ylides having high Brønsted 
basicity, donor activity and nucleophilicity; properties which make them very good ligands.132 
Even stabilised ylides, despite being less nucleophilic, will readily coordinate to transition 
metals. Phosphorus ylides generally act as σ-carbon ligands with very little back-bonding. A 
p σ* 
p σ* 
a) b) 
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variety of different coordination possibilities exist, which can be classified into three main 
types (Figure 2.7). These are: complexes in which the phosphorus ylides occur as simple 
monodentate terminal ligands (A), those in which the ylide is a bridging group (B) and those 
in which the ylide acts as a chelating moiety (C).  
 
  
Figure 2.7. Phosphorus ylide coordination possibilities. 
 
The exceptional donor character of phosphorus ylides with respect to practically all metals is 
often sufficient to drive all other ligands out of the coordination sphere.132 Thus, alkylgold(I) 
monoylide derivatives are readily prepared by the reaction of alkylgold(I) phosphine 
complexes with phosphorus ylides, liberating phosphine (Scheme 2.1(a)),153 and bis-ylide 
gold(I) complexes may be formed in a two-step process using phosphinegold(I) halides. In this 
case initial reaction with the ylide gives the isolable monoylide gold(I) phosphine species, 
following displacement of the chloride ligand from the coordination sphere of gold, and this 
species can be converted into the bis-ylide species by addition of excess ylide and displacement 
of the phosphine (Scheme 2.1(b)).154  
 
 
Scheme 2.1. Synthesis of alkylgold(I) ylide complexes (a) and bis-ylide gold(I) complexes (b). 
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Exceptions to such ligand displacement reactions can occur when there exists the possibility 
for ylide attack at one of the ligands already present at the metal centre, for example in the 
nucleophilic attack on an alkene-platinum(II) complex by a carbonyl-stabilised ylide (Scheme 
2.2).155 
 
 
Scheme 2.2. Nucleophilic attack by carbonyl-stabilised phosphorus ylide 
 
The great potential of phosphorus ylides with respect to the formation of 
transition metal-carbon bonds is due to the presence of the phosphonium group which blocks 
a major decomposition pathway: β-H elimination. This allows phosphorus ylides to form 
relatively stable coordination complexes in comparison with simple alkyls. In fact, phosphorus 
ylide gold complexes are particularly stable towards oxidation and hydrolysis and are among 
the most thermally stable organometallic complexes of gold.  
 
2.1.3. History 
The first example of a phosphorus ylide was prepared in 1894 by Michaelis and co-workers. 
Addition of triphenylphosphine to 2-bromoacetophenone led to the formation of the 
phosphonium bromide salt and subsequent addition of potassium hydroxide gave the ylide127 
(Scheme 2.3). However, the lack of characterisation techniques available at that time led 
Michaelis to incorrectly propose a structure with a pentavalent phosphorus atom due to the 
formation of a phosphorus-oxygen bond and it was not until 65 years later, in 1961, that the 
correct structure was determined by Aksnes,156 Ramirez and Dershowitz.157 This, along with 
the fact that no reactions were carried out with the ylides meant that the significance of the 
pioneering work carried out by Michaelis was not recognised for many years. 
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Scheme 2.3. Synthesis of the first phosphorus ylide. 
 
In 1919, it was shown by Staudinger and co-workers that heating phosphazenes causes a 
thermal decomposition, evolving nitrogen and producing a phosphorus ylide (Scheme 2.4).158 
Little work was done at the time into studying the reactions of the phosphorus ylides and in the 
subsequent years, development of this work and further study of phosphorus ylides was 
minimal.  
 
 
Scheme 2.4. Thermal decomposition of phosphazene. 
 
The breakthrough for phosphorus ylides came in 1949 with a serendipitous discovery by Wittig 
whilst attempting to prepare pentavalent phosphorus compounds. Wittig showed that 
phosphonium salts could readily be generated by an SN2 reaction of a trialkyl- or 
triarylphosphine with an alkyl halide, and that subsequent reaction with strong base yields the 
corresponding ylide (Scheme 2.5).159 
 
 
Scheme 2.5. Synthesis of phosphorus ylide carried out by Wittig. 
 
Wittig went on to carry out the reaction of triphenylphosphoniummethylide with benzophenone 
(Scheme 2.6), showing that the reaction of a phosphorus ylide with an aldehyde or ketone will 
form an alkene product.160 Very quickly was this new method for the preparation of alkenes, 
now known as the “Wittig reaction”, shown to be widely applicable in organic synthesis due 
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to high selectivity and the fact it can proceed without isomerisation or rearrangement. Wittig 
was later awarded a Nobel Prize as recognition of the great importance of his work and a 
renewed interest in phosphorus ylides led to rapid progression in this field of chemistry. 
However, despite importance of phosphorus ylides in organic chemistry, the great potential for 
ylides within inorganic and organometallic chemistry was overlooked for several years. 
 
 
Scheme 2.6. Reaction of triphenylphosphoniummethylide with benzophenone. 
 
In 1961 Seyferth and Grim synthesised the first examples of transition metal-ylide coordination 
complexes through nucleophilic displacement reactions with metal halides. Reaction of 
triphenylphosphonium methylide with mercury(II) bromide led to the formation of a cationic 
bis-ylide complex (Scheme 2.7) which was isolated as a stable solid and characterised by 
elemental analysis.161 
 
 
Scheme 2.7. Reaction of phosphorus ylide with metal halide 
 
The first phosphorus ylide transition metal complex to be structurally characterised by single 
crystal X-ray diffraction was the nickel complex tricyclohexylphosphoniumethylidenickel 
tricarbonyl (Figure 2.8), reported in 1972 by Barnett and Krüger. This provided the first 
structural evidence that phosphorus ylides bond to metals through the α-carbon atom. The 
P-Cylide bond distance, 1.743(8) Å, was found to be in the range for a typical stabilised ylide, 
and shorter than that for a typical carbon-carbon single bond.162 
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Figure 2.8. Molecular structure of tricyclohexylphosphoniumethylidenickel tricarbonyl determined by single 
crystal X-ray diffraction. Selected bond lengths [Å] and angles [°]: P(1)-C(18) 1.743(8), C(18)-C(19) 1.558(3), 
C(18)-Ni(1) 2.0960, Ni(1)-C(1) 1.7426, Ni(1)-C(12) 1.7416, Ni(1)-C(17) 1.7762, C(1)-O(1) 1.1600, C(12)-O(2) 
1.1373, C(17)-O(3) 1.1361, P(1)-C(18)-C(19) 114.26, P(1)-C(18)-Ni(1) 118.23, C(19)-C(18)-Ni(1) 111.35. 
 
The first phosphorus ylide gold complexes were prepared by Schmidbaur in 1973. The reaction 
of chloro(trimethylphosphine) gold(I) with trimethylphosphoniummethylide was carried out to 
produce a phosphonium-gold chloride. Further reaction with the ylide resulted in the formation 
of a bis-ylide-gold derivative and even further addition led to the formation of the dinuclear 
ylide-gold complex (Scheme 2.8).163 
 
 
Scheme 2.8. Synthesis of the first phosphorus ylide gold complex. 
 
Dinuclear gold complexes with bridging ylide ligands are of particular interest because the 
close proximity of the gold atoms favours oxidative addition reactions in which metal-metal 
bonds can be formed and cleaved. Dimers containing two gold(I) centres may be oxidised by 
the addition of halogens to give gold(II) and subsequently gold(III) (Scheme 2.9). Mixed 
valence dimers containing one gold(I) centre and one gold(III) centre are also possible. 
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Examples of each oxidation state have successfully been characterised by single crystal X-ray 
diffraction (Figure 2.9).164-166 The gold(II) derivative (Figure 2.9(b)) was the first example of 
a  phosphorus ylide gold complex to be structurally characterised.166 
 
 
Scheme 2.9. Dinuclear complexes of gold with bis(ylide) [R2P(CH2)2]⁻. 
 
 
Figure 2.9. Molecular structure of ylide gold complexes determined by single crystal X-ray diffraction. Selected 
bond lengths [Å] and angles [°] a: P(1)-C(1) 1.761, P(1)-C(4) 1.83, C(1)-Au(1) 2.09, C(4)-Au(1) 2.10, 
Au(1)-Au(1)’ 3.02, C(1)-Au(1)-C(4) 178.68; b: P(1)-C(1) 1.724, P(1)-C(2) 1.779, C(1)-Au(1) 2.051, C(2)-Au(1) 
1.946, Au(1)-Cl(1) 2.382, Au(1)-Au(1)’ 2.594, C(1)-Au(1)-C(2) 169.39, Cl(1)-Au(1)-Au(1)’ 176.93; c: P(1)-C(1) 
1.83(3), P(1)-C(2) 1.81(3), C(1)-Au(1) 2.12(3), C(2)-Au(1) 2.10(2), Au(1)-Cl(1) 2.273(7), Au(1)-Cl(2) 2.301(7), 
Au(1)-Au(1)’ 3.088, C(1)-Au(1)-C(2) 178(1), Cl(1)-Au(1)-Cl(2) 168.5(3).  
 
2.1.4. Triphenylphosphoniumcyanomethylide 
Triphenylphosphoniumcyanomethylide is an example of a stabilised phosphorus ylide. The 
stability arises from the fact the electron density may be delocalised onto the nitrogen atom, 
resulting in three resonance forms (Figure 2.10). 
 
Figure 2.10. Resonance forms of triphenylphosphoniumcyanomethylide. 
a) b) c) 
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This delocalisation of electron density results in an ambidentate behaviour since the ylide may 
coordinate to metals through the carbon or the nitrogen atom. In fact, a variety of different 
coordination geometries are possible (Figure 2.11). As well as the typical C-coordination, a, 
there is the possibility for an end-on N-coordination with the nitrile group, b, or an angular 
N-coordination, c.167 
 
 
Figure 2.11. Coordination modes of triphenylphosphoniumcyanomethylide. 
 
The ylide may be further deprotonated to form the yldiide species which can act as a bridging 
ligand allowing the synthesis of dinuclear complexes, and even trinuclear complexes via an 
additional N-coordination (Figure 2.12). 
 
 
Figure 2.12. Coordination modes of triphenylphosphoniumcyanomethyldiide.  
 
The coordination chemistry of triphenylphosphoniumcyanomethylide was first reported in 
1997 with the preparation of palladium complexes. The authors reported two different 
coordination modes depending on the starting complex used. Reaction of the orthometallated 
palladium complex bearing two acetonitrile ligands led to the formation of a dinuclear complex 
in which the ylide coordinates to one palladium centre through the α-carbon atom and to 
another through the nitrogen of the nitrile group (Scheme 2.10(a)). However, if the 
orthometallated palladium complex bearing a triphenylphosphite and a chloride ligand is 
reacted with the ylide, a complex bearing the ylide coordinated only through the nitrogen of 
the ylide is observed (Scheme 2.10(b)). This complex was successfully characterised by single 
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crystal X-ray diffraction with the nitrogen coordination of the ylide clearly shown 
(Figure 2.13).167 
 
 
Scheme 2.10. Synthesis of palladium derivatives of triphenylphosphoniumcyanomethylide with C-coordination 
(a) and N-coordination (b). 
 
 
Figure 2.13. Molecular structure of triphenylphosphoniumcyanomethylide complex determined by single crystal 
X-ray diffraction. Selected bond lengths [Å] and angles [°]: Pd(1)-C(1) 2.003(4), Pd(1)-P(1) 2.2070(9), Pd(1)-
N(1) 2.133(3), Pd(1)-N(2) 2.076(3), N(2)-C(13) 1.155(4), C(13)-C(14) 1.379(5), P(2)-C(14) 1.709(4), 
C(1)-Pd(1)-N(2) 170.2(1), P(1)-Pd(1)-N(1) 175.80(9), Pd(1)-N(2)-C(13) 177.1(3), N(2)-C(13)-C(14) 177.7(4), 
C(13)-C(14)-P(2) 118.4(3). 
 
Coordination complexes of triphenylphosphoniumcyanomethylide with gold are of interest 
because there exists the possibility of coordinating multiple gold atoms and the aurophilic 
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interactions that will arise from the close proximity of the gold atoms could give interesting 
optical properties such as luminescence. 
 
Despite being a weak nucleophile, triphenylphosphoniumcyanomethylide has been shown to 
readily displace the labile tetrahydrothiophene ligand from [AuCl(tht)] (Scheme 2.11(a)). The 
authors also reported that the phosphonium salt precursor can be deprotonated by the 
acetylacetonato ligand from [Au(acac)(PPh3)], generating the ylide ligand in situ. However, 
attempts to carry out this reaction to form an ylide gold complex resulted in a mixture of the 
phosphonium salt, the mononuclear derivative and the dinuclear complex (Scheme 2.11(b).117 
 
 
Scheme 2.11. Synthesis of triphenylphosphoniumcyanomethylide gold derivatives. 
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2.2. Synthesis of Starting Reagents 
2.2.1. (Cyanomethyl)triphenylphosphonium Triflate 
For the preparation of ylide gold complexes, the use of a phosphonium salt with a weakly 
coordinating or non-coordinating anion rather than a halide is often more desirable to remove 
the possibility for the formation of any undesired chloro-gold products, hence giving cleaner 
reactions. (Cyanomethyl)triphenylphosphonium triflate, 2, can readily be prepared from the 
commercial chloride salt, 1, by reaction with silver triflate in dichloromethane (Scheme 2.12). 
The precipitation of silver chloride drives this anion exchange reaction, leaving 
(cyanomethyl)triphenylphosphonium triflate in solution which may be isolated as a solid by 
removal of solvent. 
 
 
Scheme 2.12. Synthesis of (cyanomethyl)triphenylphosphonium triflate, 2. 
 
In the 1H NMR spectrum of the phosphonium triflate salt the CαH2 protons are observed as a 
doublet at 5.05 ppm with a coupling constant 2JHP = 15.1 Hz due to coupling with the 
phosphorus atom. The position of this doublet is significantly less shifted than in the analogous 
chloride salt where it appears as a doublet at around 6.13 ppm.168 This phenomenon has 
previously been observed for other phosphonium salts when a halide anion is exchanged for a 
larger weakly coordinating anion and can be explained by a loss of hydrogen bonding.169 In the 
crystal structure of (cyanomethyl)triphenylphosphonium chloride intermolecular C-H‧‧‧Cl 
hydrogen bonds link the molecules and may be responsible for the stabilisation of the structure 
(Figure 2.14).170 These contacts cause a significant deshielding of the CαH2 protons. In the 
triflate salt, however, these hydrogen bonds are not present and hence in the 1H NMR spectrum 
the CαH2 appear at a lower chemical shift. 
 
The successful formation of the triflate salt can also be confirmed by 19F NMR spectroscopy 
in which a singlet at -78 ppm due to the triflate anion is observed as the only signal in the 
spectrum. 
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Figure 2.14. Molecular structure of (cyanomethyl)triphenylphosphonium chloride determined by single crystal 
X-ray diffraction with hydrogen bonds shown as dashed lines. Phenyl hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å] and angles [°]: P(1)-C(19) 1.8046(17), C(19)-C(20) 1.445(3), C(20)-N(1) 1.133(3), 
Cl(1)-H(19A) 2.456, Cl(1)-H(19B) 2.343.170 
 
2.2.2. Triphenylphosphoniumcyanomethylide 
Gold-ylide complexes can also be prepared by reaction of a gold precursor with the free ylide. 
Many non-stabilised ylides are highly reactive and may not be isolated or stored for periods of 
time. Triphenylphosphoniumcyanomethylide, however, is stabilised by the delocalisation of 
electron density onto the nitrogen atom of the cyano group and may be stored under ambient 
conditions for weeks without decomposition, therefore making it a convenient starting reagent 
for the synthesis of complexes. It was prepared by a modification of the procedure first reported 
by Trippett and Walker in 1959171 (Scheme 2.13). (Cyanomethyl)triphenylphosphonium 
chloride, 1, was dissolved in deionised water and the solution made alkaline by the addition of 
dilute sodium hydroxide solution, resulting in the precipitation of a white solid.  
 
 
Scheme 2.13. Synthesis of triphenylphosphoniumcyanomethylide. 
 
Phosphorus NMR studies of this crude product showed the presence of considerable amounts 
of triphenylphosphine oxide, however, recrystallisation from toluene allowed the ylide, 3, to 
be obtained cleanly (Figure 2.15).  
 2.2. Synthesis of Starting Reagents 
75 
  
 
Figure 2.15. 31P{1H} NMR spectra in CDCl3 of crude product (a) and product following recrystallisation in 
toluene (b). 
 
Table 2.1. Infrared absorption frequencies 
Compound ν(C≡N) (cm-1) 
1 2231 
2 2250 
3 2136 
 
 
The infrared absorption frequency for the C≡N bond of the free ylide, 3, is considerably lower 
than for the phosphonium chloride and triflate salts, 1 and 2 (Table 2.1). This is due to the fact 
the free ylide exists as three resonance forms and hence the C≡N will have significantly less 
triple bond character. Such resonance is not possible in the phosphonium salts. 
 
Despite the weaker nucleophilic character of triphenylphosphonium cyanomethylide compared 
to non-stabilised phosphorus ylides, it still has a strong enough coordination capacity to 
displace other ligands from the coordination sphere of the coinage metals which can lead to the 
formation of some very stable and interesting complexes. 
a) 
b) 
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2.3. Synthesis of Mononuclear Ylide Complexes 
2.3.1. Neutral Gold(I) and Gold(III) Complexes 
The synthesis of pentafluorophenyl gold derivatives of triphenylphosphoniumcyanomethylide 
was of particular interest because of their predicted high stability. The pentafluorophenyl group 
as a ligand confers great thermodynamic and kinetic stability on gold complexes because of 
the strong electron withdrawing effect of the C6F5 group and the fact that the Au-C bond is 
relatively resistant to cleavage by mild acids. The C6F5 group can also impart crystallinity on 
gold complexes.172 
 
Several different synthetic routes were attempted to prepare 
pentafluorophenyl[cyano(triphenylphosphonio)methyl] gold(I), 5 (Scheme 2.14). 
 
 
Scheme 2.14. Syntheses of complex 1. 
 
Since a method with fewer synthetic steps is preferable, initial attempts were made starting 
from the commercially available phosphonium chloride salt, 1. The first (Scheme 2.14(i)) was 
a one pot reaction in which addition of a stoichiometric amount of 
pentafluorophenyl(tetrahydrothiophene) gold(I), [Au(C6F5)(tht)], to the phosphonium salt led 
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to the formation of phosphonium aurate salt, 4, cleanly, which could be isolated in a high yield, 
81%, and fully characterised. The 1H NMR spectrum clearly shows the presence of the CH2 
protons as a doublet at 5.07 ppm (3JHP = 14.8 Hz), and an infrared absorption at 316 cm
-1 
confirms the presence of the newly formed Au-Cl bond. Subsequent reaction of salt 4 with 
NaH was attempted in order to mono-deprotonate the CH2 and allow coordination to Au(C6F5), 
with the chloride removed as NaCl. Although the desired complex did form, this reaction was 
not clean and considerable amounts of free ylide, 3, were obtained along with another 
unidentifiable product which could not be separated and hence an alternative route was 
required. 
 
Reaction of (cyanomethyl)triphenylphosphonium chloride, 1, with a stoichiometric amount of 
n-butyllithium in diethyl ether and subsequent addition of a stoichiometric amount of 
[Au(C6F5)(tht)] did give the desired complex, 5 (Scheme 2.14(ii)). Recrystallisation from 
dichloromethane to remove lithium salts allowed the pure product to be obtained with a 
reasonable yield of 69%. This route essentially involves the formation of the free ylide, 
although it is never isolated, and subsequent displacement of the labile tetrahydrothiophene 
from [Au(C6F5)(tht)]. Although complex 5 was obtained cleanly, the fact that an inert argon 
atmosphere is required and the need for recrystallisation to remove lithium salts formed as side 
products make this route undesirable.  
 
The third route was the stoichiometric reaction of the phosphonium triflate salt, 2, with 
[Au(C6F5)(tht)] in dichloromethane in the presence of excess caesium carbonate which gave a 
mixture of complex 5 and the free ylide, 3 (Scheme 2.14(iii)). These could readily be separated 
due to the solubility of complex 5 in diethyl ether, which following recrystallisation was 
obtained in a yield of 63%. In this case no intermediate aurate salt is formed in the reaction as 
the triflate anion has only a very weak coordination capacity with gold and is not able to 
displace the tetrahydrothiophene ligand from [Au(C6F5)(tht)]. Instead, the caesium carbonate 
base deprotonates the phosphonium salt to form the ylide which then reacts with 
[Au(C6F5)(tht)], displacing tht to form complex 5. This route does not require the use of an 
argon atmosphere nor anhydrous solvents, however, although the desired complex could 
readily be separated from unwanted side products, the final yield was not particularly high. 
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Since triphenylphosphoniumcyanomethylide, 3, may readily be prepared and is stable enough 
to be isolated and stored, reactions were attempted using this free ylide as a starting reagent 
(Scheme 2.15), rather than generating it in situ from the phosphonium salt, with the aim of 
achieving the desired products more cleanly. The reaction of the free ylide with [Au(C6F5)(tht)] 
in dichloromethane gave complex 5 in an excellent yield of 97%. The only side product in this 
case is tetrahydrothiophene which is a volatile liquid and is removed during the reaction work 
up.  
 
Scheme 2.15. Synthesis of neutral ylide gold complexes 5 – 8. 
The use of triphenylphosphoniumcyanomethylide to displace the labile tetrahydrothiophene 
ligand from the gold(I) complex chloro(tetrahydrothiophene)gold(I), [AuCl(tht)], to form the 
chloro-gold ylide complex 6 was first reported in 1999,117 however the synthetic method was 
limited to the formation of this one complex and the molecular structure was not determined 
by X-ray diffraction methods. This complex is of interest since the chloride ligand may readily 
be displaced by other groups to form new complexes, therefore making it a convenient entry 
point for the formation of new triphenylphosphoniumcyanomethylide gold(I) derivatives. 
Knowledge of the crystal structure could also provide further understanding of the stability and 
reactivity of such complexes and therefore the synthesis of complex 6 was also attempted. Two 
gold(III) derivatives, 7 and 8, were also prepared by the same method and obtained in yields 
of 96% and 90%, respectively. These are the first reported gold(III) derivatives of this 
particular ylide.  In all cases the reaction of 3 and [AuX(tht)] or [AuX3(tht)] in a 1:1 molar ratio 
in dichloromethane at room temperature gave the complex (5-8) after just 1 hour reaction time. 
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The reactions proceeded cleanly with the desired complexes forming uniquely and in high 
yield.  All of the complexes were air stable solids that could be handled and stored under 
ambient conditions. Complex 8 could also be prepared by the oxidation of complex 6 with 
chlorine. 
Table 2.2 Selected NMR Peaks for Complexes 5-8 in CD2Cl2. 
Complex 1H NMR Cα-H (ppm) 31P{1H} NMR (ppm) 
5 3.33 27.28 
6 3.59 25.89 
7 2.36 24.60 
8 5.09 24.87 
 
Complexes 5-8 show similar 1H NMR spectra since all display peaks arising from the ylide 
unit: the Cα-H proton and aromatic protons from the Ph groups. In all cases the Cα-H signal is 
observed as a doublet due to coupling with the phosphorus atom. Comparing the chemical shift 
of this doublet in the two gold(I) derivatives, 5 and 6, we find that it appears at higher chemical 
shift in the chloro complex but the difference is only slight (Table 2.2). However, comparing 
the two gold(III) complexes, 7 and 8, a significant difference is observed, with the C-H 
appearing at 5.09 ppm in the 1H NMR spectrum of the trichloro derivative, 8, compared to 2.27 
ppm for the pentafluorophenyl derivative, 7. This is due to the presence of Cl‧‧‧H contacts 
causing a deshielding of the proton in the chloro derivatives. The 31P{1H} NMR spectra of 
complexes 5-8 show a single sharp peak due to the ylide phosphorus atom. 
 
For complexes 5 and 7 19F NMR studies were also carried out with characteristic spectra for 
the Au(C6F5) and Au(C6F5)3 units observed. For the gold(I) derivative, complex 5, the para 
fluorine atoms, Fp, are observed as a triplet (Figure 2.17(a)) with 
3JFF = 20.1 Hz as a result of 
coupling to the two meta fluorine atoms, whilst signals due to the ortho, Fo, and meta, Fm, 
fluorine atoms are observed as more complex multiplets. For the gold(III) derivative, complex 
7, the 19F NMR spectrum is slightly more complex with six signals observed (Figure 2.17(b)). 
This is because the two pentafluorophenyl groups trans to one and other are equivalent and can 
also rotate freely, hence giving three signals, one for each of Fo′, Fm′ and Fp′ (see Figure 2.16). 
The C6F5 group trans to the ylide is inequivalent and hence a further three signals are observed 
for Fo, Fm and Fp.  
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Figure 2.16. Complexes 5 and 7 with pentafluorophenyl F atoms labelled. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17. 19F NMR spectra of complexes 5 (a) and 7 (b). 
 
Fo Fm Fp 
a) 
b) 
Fo 
Fo′ Fp 
Fp′ 
Fm′ 
Fm 
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Table 2.3. Infrared absorption frequencies 
Complex ν(C≡N) (cm-1) ν(Au-Cl) (cm-1) 
4 2255 316 
5 2201 - 
6 2202 325 
7 2227 - 
8 2228 315, 342, 360 
 
The infrared absorption frequencies of the C≡N bond in the complexes can also be compared 
(Table 2.3). The phosphonium aurate salt, 4, has and absorption frequency comparable to the 
phosphonium chloride and triflate salts (see Table 2.1), as would be expected since no change 
in triple bond character of the C≡N occurs. Coordination of the ylide to gold in complexes 5-8 
results in an increase in the absorption frequency of the C≡N compared to the free ylide, 
indicating the greater triple bond character in these complexes. The values are, however, 
slightly lower than in the phosphonium salts likely because of the inductive effects caused by 
the high electrophilicity of gold. Complexes 6 and 8 and salt 4 also show bands corresponding 
to the Au-Cl bond. For the gold(I) complex, 6, this is a single absorption band at 325 cm-1. The 
gold(III) complex, 8, exhibits bands at 315 cm-1 corresponding to ν(Au-Cl) for the chloride 
trans to the ylide and 360 cm-1 for the asymmetric stretch νasim(Cl-Au-Cl). A weaker band at 
342 cm-1 is a result of the symmetric stretch νsim(Cl-Au-Cl). 
 
The molecular structures complexes 5-8 were determined by single crystal X-ray diffraction. 
In all cases crystals were obtained by the slow diffusion of n-pentane into a solution of the 
complex in dichloromethane. The molecular structures are shown in Figure 2.18. The unit cell 
of the structure of complex 7 featured two molecules and unfortunately one of these was badly 
disordered and could not be resolved and hence no structural parameters can be obtained. 
However, coordination of the ylidic carbon to the gold(III) centre can clearly be seen. Complex 
6 was a twin crystal. 
 
In both complexes 5 and 6 a linear coordination about the gold centre can clearly be seen with 
angles very close to 180° (C(1)-Au(1)-C(7) 177.16(11)° for 5 and Cl(1)-Au(1)-C(1) 177.64° 
for 6). In complex 5 the gold-carbon bond to the pentafluorophenyl ligand 
(Au(1)-C(1) 2.014(3) Å) is slightly shorter than the gold-carbon bond to the ylide ligand 
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(Au(1)-C(7) 2.099(3) Å) which could indicate that the gold-pentafluorophenyl bond is 
stronger. For complexes 7 and 8 a square planar geometry is observed about the gold centre. 
For complex 8 the Au-Cl bond trans to the ylide carbon is slightly longer than the other two 
Au-Cl bonds, likely due to the strong trans effect of the strongly σ-donating ylide ligand.  
 
 
Figure 2.18. Molecular structures of 5-8 determined by single crystal X-ray diffraction. Hydrogen atoms, except 
the one at the ylidic carbon atom, are omitted for clarity. Selected bond lengths [Å] and angles [°] 5: 
Au(1)-C(1) 2.014(3), Au(1)-C(7) 2.099(3), C(7)-C(8) 1.450(4), C(7)-P(1) 1.785(3), C(8)-N(1) 1.146(4), 
C(1)-Au(1)-C(7) 177.16(11), C(7)-C(8)-N(1) 176.7(4); 6: Au(1)-Cl(1) 2.2870, Au(1)-C(1) 2.0487, 
C(1)-P(1) 1.7923, C(1)-C(2) 1.4531, C(2)-N(1) 1.1440, Cl(1)-Au(1)-C(1) 177.64, C(1)-C(2)-N(1) 178.59; 
8: Au(1)-Cl(1) 2.252(3), Au(1)-Cl(2) 2.310(1), Au(1)-Cl(3) 2.254(2), Au(1)-C(1) 2.083(4), C(1)-P(1) 1.821(3), 
C(1)-C(2) 1.447(8), C(2)-N(1) 1.136(9), Cl(1)-Au(1)-Cl(3) 177.20(8), Cl(2)-Au(1)-C(1) 173.1(1), C(1)-C(2)-
N(1) 177.1(6). 
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2.3.2. Cationic Complexes 
Cationic gold(I) derivatives of triphenylphosphoniocyanomethylide, complexes 9-11, were 
prepared by reaction of the free ylide, 3, with a gold precursor of the form [AuCl(L)] in the 
presence of a silver salt (Scheme 2.16). Since 3 is not a strong nucleophile the silver salt helps 
drive the reaction by abstracting the chloride ligand from the gold(I) precursor and allowing 
the ylide to coordinate to gold. For the silver and copper triphenylphosphine derivative, 
complexes 12 and 13, the ylide displaces the weakly bound anion from the corresponding 
precursor, [Ag(OTf)(PPh3)] or [Cu(NO3)(PPh3)2]. 
 
 
Scheme 2.16. Synthesis of cationic ylide complexes 9–13. 
 
These reactions were carried out in conditions analogous to those for the neutral complexes i.e. 
dichloromethane as solvent, 1 hour reaction time, room temperature. Since in the synthesis of 
complexes 9-12 silver salts were used, the reactions were protected from light to avoid any 
decomposition. The silver chloride formed as a by-product in the formation of complexes 9-11 
could readily be removed by filtration of the reaction solution through celite.  
 
Complexes 9 and 10 were both very stable white solids. Their 1H NMR spectra are comparable 
in that in both cases the Cα-H proton appears as a doublet, at 3.05 ppm (
2JHP = 13.5 Hz) and 
3.04 ppm (2JHP = 14.3 Hz) respectively, and in both cases a single peak is observed in the 
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31P{1H} NMR spectrum at 28.1 ppm and 28.7 ppm. The absorption frequencies for the C≡N in 
the infrared spectrum appear at 2211 cm-1 for complex 9 and 2214 cm-1 for complex 10, 
evidence of the similar sigma donor capacity of these two NHCs. 
 
Complex 10 was successfully characterised by single crystal X-ray diffraction. Suitable 
crystals were grown by the slow diffusion of n-hexane into a solution of the complex in 
dichloromethane. In this complex a slight deviation from linear coordination about gold 
(C(21)-Au(1)-C(1) 171.48(13)°) is observed in the molecular structure (Figure 2.19) due to the 
bulkiness of the NHC ligand and the hindrance with the triphenylphosphine group of the ylide. 
The gold-carbon bond to the NHC ligand (Au(1)-C(21) 2.012(3) Å) is shorter than the 
gold-carbon bond to the ylide ligand (Au(1)-C(1) 2.098(3) Å), likely due to the stronger sigma 
donor capacity of the NHC ligand which will form a stronger bond to gold compared to the 
ylide ligand.  
 
Figure 2.19. Molecular structure of 10 determined by single crystal X-ray diffraction. Anions and hydrogen 
atoms, except the one at C1, are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 2.098(3), 
Au(1)-C(21) 2.012(3), C(1)-C(2) 1.446(5), N(1)-C(2) 1.145(5), P(1)-C(1) 1.783(3), C(21)-Au(1)-C(1) 
171.48(13). 
 
Complex 11 was also formed as a highly stable white solid. In this case in the 1H NMR 
spectrum the Cα-H is observed as a doublet of doublets due to coupling with both the ylide 
phosphorus and the phosphorus of the JohnPhos ligand with 2JHP = 12.2 Hz and 
3JHP = 7.5 Hz, 
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respectively (Figure 2.20(a)). Likewise, in the 13C APT spectrum the signal due to the ylide 
carbon atom is observed as a doublet of doublets with 1JCP = 68.6 Hz and 
2JCP = 53.7 Hz 
(Figure 2.20(b)). The 31P{1H} NMR spectrum shows the phosphorus-phosphorus coupling 
with two doublets observed at 64.31 ppm (JohnPhos P) and 26.94 ppm (ylide P) with 
3JPP = 8.4 Hz (Figure 2.20(c)). 
 
 
 
 
 
 
 
 
 
 
Figure 2.20. 1H NMR spectrum (a), 13C APT spectrum (b) and 31P{1H} NMR spectrum (c) for complex 7 in 
CD2Cl2. 
a) 
b) 
c) 
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Complex 11 was structurally characterised by single crystal X-ray diffraction (Figure 2.21). 
Suitable crystals were grown by the slow diffusion of n-hexane into a solution of the complex 
in dichloromethane. The expected linear coordination about the gold centre is observed with 
the P(2)-Au(1)-C(2) angle of 175.5(3)°. The gold-carbon bond to the ylide, Au(1)-C(2) 
2.096(8) Å, is very similar to that for complex 10 (2.098(3) Å) which bears the NHC ligand, 
highlighting the similarity of the phosphine and NHC bonds to gold.  
 
 
Figure 2.21. Molecular structure of 11 determined by single crystal X-ray diffraction. Anions and hydrogen 
atoms, except the one at C1, are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-P(2) 2.291(2), 
Au(1)-C(2) 2.096(8), P(1)-C(2) 1.801(9), C(2)-C(3) 1.45(1), C(3)-N(1) 1.17(1), P(2)-Au(1)-C(2) 175.5(3), 
C(2)-C(3)-N(1) 179(1). 
 
For the silver and copper phosphine derivatives, 12 and 13, no coupling between the ylide and 
the triphenylphosphine ligands is observed. In both cases the Cα-H is observed as a simple 
doublet since coupling with the ylide phosphorus atom is maintained, and the 31P{1H} NMR 
spectra at room temperature show two singlets. For complex 12 a sharp peak at 25.92 ppm is 
observed due to the ylide phosphorus atom, whereas the triphenylphosphine phosphorus is 
observed as a broad singlet at 12.44 ppm (Figure 2.22(a)). Such broad signals are typical for 
silver-bound phosphine groups due to the weak Ag-P bond. The 31P{1H} NMR spectrum 
at -70 °C is significantly different since at this temperature the phosphorus-silver coupling can 
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be observed. The signal from the PPh3 ligand is observed as two doublets at 11.80 ppm with 
1J109Ag-P = 628.2 Hz and 
1J107Ag-P = 544.1 Hz (Figure 2.22(b)).  
 
 
 
Figure 2.22. 31P{1H} NMR spectrum of complex 12 in CD2Cl2 at room temperature (a) and -70 °C (b). 
 
These silver and copper complexes differ from the gold derivatives since a linear coordination 
about the metal is no longer favourable and additional stabilisation of the structures by 
coordination of the C≡N can occur. This is evidenced by a significant decrease in the infrared 
absorption frequency of the C≡N bond to 2188 cm-1 for 12 and 2153 cm-1 for 13, values only 
slightly higher than for the free ylide, 3 (2136 cm-1), as a result of a loss of electron density 
from the triple bond. 
 
The molecular structure of complex 12 was determined by single crystal X-ray diffraction 
(Figure 2.23). Suitable crystals were grown by the slow diffusion of n-pentane into a solution 
of the complex in dichloromethane. This complex has a dimeric structure with a distorted 
tetrahedral coordination around the silver. In addition to bonding to the ylide carbon atom and 
the triphenylphosphine group, the silver also forms a bond with the nitrogen of the C≡N and a 
bond with one of the oxygen atoms of the triflate anion. The bond distance Ag(1)-O(2) 
a) 
b) 
107Ag-P 
109Ag-P 
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2.7949(19) Å is long for a silver-oxygen bond, indicating the triflate anion is only weakly 
bound to the silver. 
 
 
Figure 2.23. Molecular structure of 8 determined by single crystal X-ray diffraction. Hydrogen atoms, except the 
one at C1, are omitted for clarity. Selected bond lengths [Å] and angles [°]: Ag(1)-C(1) 2.286(2), Ag(1)-P(1) 
2.4021(8), Ag(1)-N(1) 2.3567(19), Ag(1)-O(2) 2.7949(19), C(1)-C(2) 1.422(3), N(1)-C(2) 1.156(3), P(2)-C(1) 
1.760(2), C(1)-Ag(1)-P(1) 147.70(5), C(1)-Ag(1)-N(1) 97.28(7), N(1)-Ag(1)-P(1) 110.99(5), C(1)-Ag(1)-O(2) 
79.553(70), P(1)-Ag(1)-O(2) 114.605(48), N(1)-Ag(1)-O(2) 89.952(60). 
 
Although complexes 9 and 10 bearing the bulky IMes or IPr NHC ligands formed cleanly in 
high yields as highly stable solids, the analogous reaction with a gold precursor bearing a 
sterically smaller NHC ligand in an attempt to prepare complex 14 (Scheme 2.17) led to a 
mixture of products. The same effect was observed with phosphine derivatives. Complex 11 
bearing the bulky JohnPhos ligand formed in high yield, however reaction of the free ylide 
with [AuCl(PPh3)] in the presence of a silver salt to form complex 15 led to a complex mixture 
(Scheme 2.17).  
 
 
Scheme 2.17. Attempted synthesis of cationic ylide gold complexes 14-15 bearing sterically small L groups. 
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This can be explained because the AuL+ fragment is isoelectronic with H+. Coordination of the 
ylide to AuL+ will give complexes in which the acidity of the Cα-H is comparable to, or indeed 
greater than, the corresponding phosphonium salts. When L is bulky this C-H is protected from 
further deprotonation and the formation of the mononuclear cationic complexes proceeds 
cleanly. However, with sterically smaller L, further deprotonation can occur, giving complex 
mixtures of mononuclear and dinuclear complexes. No external base is present in these 
reactions, however, the ylide can act both as base and a nucleophile. In the presence of an acidic 
proton the ylide will act as a base, abstracting the proton to form the phosphonium salt. 
(Scheme 2.18). 
 
 
Scheme 2.18. Reaction of cationic complexes (L = small ligand) with further ylide. 
 
Alternative methods for the preparation of complex 15 avoiding the use of the free ylide, 3, 
were attempted (Scheme 2.19), however all were unsuccessful: 
 
Reaction of the phosphonium triflate salt, 2, with [AuCl(PPh3)] in the presence of caesium 
carbonate base led to the formation of a mixture of a dinuclear complex, a trinuclear derivative 
and the free ylide, 3 (Scheme 2.19(i)). Complex 15 was not observed by NMR experiments. It 
is likely that the high stability of the polynuclear complexes as a result of aurophilic interactions 
leads preferentially to their formation.  
 
Reaction of the phosphonium triflate salt, 2, with a stoichiometric amount of [Au(acac)(PPh3)] 
led only to formation of the dinuclear complex (Scheme 2.19(ii)). In this reaction, the acac 
ligand acts as the base, deprotonating the phosphonium salt to form the ylide which will then 
coordinate to the AuPPh3 unit. However, although complex 15 will form as an intermediate in 
this reaction, the fact that it is more reactive than the initial phosphonium salt means that it 
acidic 
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immediately reacts with further [Au(acac)(PPh3)] to form the dinuclear derivative, leading 
ultimately to a mixture of only the dinuclear complex and unreacted phosphonium salt.  
 
In the third route (Scheme 2.19(iii)) the use of a base was avoided altogether. The chloro-gold 
complex, 6, was reacted with a stoichiometric amount of PPh3 in the presence of AgOTf to 
abstract the chloride ligand. The desired complex 15 can be observed in the 31P{1H} NMR 
spectrum as two doublets at 38.72 (3JPP = 10.6 Hz) and 27.92 (
3JPP = 10.6 Hz) (Figure 2.24), 
however signals corresponding to the dinuclear complex and the phosphonium salt are also 
observed. Over time complex 15 evolves into the more thermodynamically stable dinuclear 
derivative and the phosphonium salt (Scheme 2.20). This effect is not observed with the 
analogous silver complex 12 or copper complex 13, probably due to the additional stabilisation 
which arises from the Ag‧‧‧N≡C or Cu‧‧‧N≡C contacts in these complexes.  
 
 
Scheme 2.19. Attempted syntheses of complex 15. 
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Figure 2.24. 31P{1H} NMR spectrum for the product mixture from reaction (iii) (Scheme 2.19) in CDCl3. 
 
 
Scheme 2.20. Evolution of complex 15. 
 
Synthesis of the dicationic dinuclear complex 16 (Scheme 2.21) was also attempted. In this 
case reaction of two molar equivalents of the free ylide with [Au2Cl2(dppe)] and two molar 
equivalents of AgOTf gave the product, however the reaction was not clean and the 
31P{1H} NMR spectrum shows significant amounts of [Au(dppe)2]OTf as well as some other 
minor impurities (Figure 2.25). 
 
 
Scheme 2.21. Synthesis of complex 16. 
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Figure 2.25. 31P{1H} NMR spectrum for complex 16 with peaks corresponding to each diastereoisomer indicated. 
 
Complex 16 exists as different isomers due to the two asymmetric carbon atoms in the 
structure. There are two possible diastereoisomers, one of which has two enantiomers, (R,R)-
16 and (S,S)-16, and the other is the meso compound (Figure 2.26). The diastereoisomers do 
not form in equal amounts as can be seen in the 31P{1H} NMR spectrum; each diastereoisomer, 
indicated as a and b in Figure 2.25 is observed as two multiplets. 
 
 
Figure 2.26. Isomers of complex 16. 
The molecular structure of the meso isomer of complex 16 was determined by single crystal 
X-ray diffraction analysis (Figure 2.27). In this case crystals were grown by slow diffusion of 
n-pentane into a solution of the mixture of reaction products in dichloromethane. This complex 
displays an aurophilic interaction between the two gold atoms with a distance of 3.0368(9) Å. 
The geometry about each gold is distorted significantly from linear coordination of the two 
ligands with angles C(1)-Au(1)-P(2) 169.4(2)° and C(47)-Au(2)-P(3) 168.6(2)°, likely due to 
steric hindrance between the phosphine ligand and the triphenylphosphine group of the ylide 
ligand. The two different gold-carbon bonds are quite different with Au(1)-C(1) 2.125(9) Å 
and Au(2)-C(47) 2.085(9) Å. 
a 
b b a 
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Figure 2.27. Molecular structure of 16 determined by single crystal X-ray diffraction. Phenyl hydrogen atoms, 
anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-Au(2) 
3.0368(9), Au(1)-C(1) 2.125(9), Au(1)-P(2) 2.271(2), Au(2)-C(47) 2.085(9), Au(2)-P(3) 2.267(3), C(1)-C(2) 
1.445(11), N(1)-C(2) 1.151(10), P(1)-C(1) 1.778(9), C(47)-C(48) 1.463(12), N(2)-C(48) 1.153(11), P(4)-C(47) 
1.802(8), C(1)-Au(1)-P(2) 169.4(2), C(47)-Au(2)-P(3) 168.6(2).  
 
2.3.3. Bis-Ylide Complexes 
Reaction of the free ylide, 3, in a 2:1 molar ratio with a gold, silver or copper precursor bearing 
labile ligands led to the formation of bis-ylide complexes 17-19 (Scheme 2.22). Complex 17 
can also be prepared from complex 18 by a transmetallation reaction. 
 
Scheme 2.22. Synthesis of bis-ylide complexes 17-19. 
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These bis-ylide complexes all have two asymmetric carbon atoms and hence can exist as 
different diastereoisomers, however the formation of more than one isomer is only observed 
for the gold derivative, 17, whereas one isomer of complexes 18 and 19 forms uniquely. 
Similarly to complex 16, the fixed 180° geometry about the gold atom and the fact that the 
groups attached to each carbon atom are equivalent, leads to three possible configurational 
isomers for complex 17. Two of these, (R,R)-17 and (S,S)-17, are enantiomers, and the third 
non-optically active isomer, meso-17, is a diastereoisomer of the other two (Figure 2.28).  
 
 
Figure 2.28. Isomers of complex 17. 
 
NMR studies show that both diastereoisomers (the racemic mixture of (R,R)-17 and (S,S)-17 
and meso-17) form in the reaction. In the 1H NMR two doublets are observed for the C(α)-H 
(Figure 2.29(a)). Enantiomers (R,R)-17 and (S,S)-17 are indistinguishable by NMR and only 
one doublet would be observed for the racemic mixture of these two. The other doublet is due 
to the presence of the meso complex. In the 31P{1H} NMR spectrum two signals are observed, 
one corresponding to the racemic mixture of (R,R)-17 and (S,S)-17 and the other corresponding 
to the meso complex (Figure 2.29(b)). Integration of the signals for the C(α)-H in the 
1H NMR 
spectrum shows that the racemic mixture ((R,R)-17 and (S,S)-17) and the meso complex (meso-
17) form in almost equivalent amounts (1 : 1.1), demonstrating the similar thermodynamic 
stability of these complexes.  
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Figure 2.29. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) for complex 17 in CDCl3. 
 
Although the analogous silver and copper complexes, 18 and 19, could theoretically also form 
as a mixture of diastereoisomers, only one isomer is formed in the reactions for their synthesis. 
The 1H NMR spectrum shows only one doublet for the Cα-H in both cases, and the 
31P{1H} 
NMR spectrum shows only a single sharp peak. This difference can be attributed to the different 
structure of complexes 18 and 19 compared to the gold derivative, 17. Complex 17 will have a 
linear coordination about the gold atom and no additional coordination of the C≡N to the gold 
occurs, as shown by the infrared absorption frequency (Table 2.4). Complexes 18 and 19, 
however will not adopt a linear geometry and additional stabilisation by coordination of the 
C≡N will be favourable. Again, this is clearly observed by the significantly lower infrared 
absorption frequency of the C≡N in these complexes. 
 
Table 2.4. Infrared absorption frequencies for bis-ylide complexes 
Complex ν(C≡N) (cm-1) 
17 2210 
18 2168 
19 2166 
 
a) 
b) 
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The molecular structure of complex 18 was determined by single crystal X-ray diffraction 
analysis (Figure 2.30). The silver atom has a distorted tetrahedral geometry due to the 
additional bonding of the C≡N groups, resulting in a polymeric structure. The two silver-carbon 
bonds are very similar in length (Ag(1)-C(1) 2.394(3) Å and Ag(1)-C(21) 2.333(3) Å). Close 
examination shows that the favoured diastereoisomer is the mixture of enantiomers. The meso 
complex would not have the required geometry to form such a polymeric structure and hence 
is less thermodynamically stable and does not form. Based on the IR data, complex 19 is 
presumed to have an analogous structure. 
 
 
Figure 2.30. Molecular structure of 18 determined by single crystal X-ray diffraction. Phenyl hydrogen atoms, 
anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Ag(1)-C(1) 
2.394(3), Ag(1)-C(21) 2.333(3), Ag(1)-N(1) 2.341(2), Ag(1)-N(2) 2.337(2), C(1)-C(2) 1.421(4), C(2)-N(1) 
1.150(4), P(1)-C(1) 1.736(3), C(21)-C(22) 1.417(4), C(22)-N(2) 1.156(4), P(2)-C(21) 1.751(3), C(21)-Ag(1)-C(1) 
110.93(9), N(1)-Ag(1)-C(1) 104.33(9), N(2)-Ag(1)-C(1) 114.05(9), C(21)-Ag(1)-N(1) 118.88(9), C(21)-Ag(1)-
N(2) 114.62(9), N(2)-Ag(1)-N(1) 92.68(9).
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2.4. Synthesis of Polynuclear Yldiide Complexes 
2.4.1. Anionic Complexes 
Reaction of the phosphonium triflate salt, 2, with two molar equivalents of [Au(C6F5)(tht)] in 
the presence of excess caesium carbonate led successfully to the formation of anionic dinuclear 
gold derivative Cs[20] with caesium as the cation (Scheme 2.23). In dichloromethane this 
reaction led to a mixture of Cs[20] and the neutral mononuclear complex 5, however in acetone 
the reaction was clean and complex Cs[20] was obtained as the only product in a yield of 91%.  
The analogous complex NBu4[20] with a tetrabutylammonium cation was prepared from the 
free ylide, 3, with two molar equivalents of [Au(C6F5)(tht)] using NBu4(acac) as the base and 
was again obtained in a good yield, 90%. The dichloro complex 21 could also be prepared by 
this route using [AuCl(tht)] in place of [Au(C6F5)(tht)], and was obtained in an excellent yield 
of 95%. 
 
 
Scheme 2.23. Synthesis of anionic complexes 20-21. 
 
The successful deprotonation of the ylide can be confirmed by the lack of the Cα-H signal in 
the 1H NMR spectra of complexes 20-21, and the presence of the tetrabutylammonium cation 
in complexes NBu4[20] and 21 can also clearly be seen by the signals corresponding to the 
butyl chains (Figure 2.31). Integration of these signals shows the presence of one 
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tetrabutylammonium group per ylide. The 19F NMR spectra of complexes Cs[20] and 
NBu4[20] show clearly the presence of one type of pentafluorophenyl group since the two 
pentafluorophenyl groups are equivalent in these complexes, and the presence of the Au-Cl 
bonds in complex 21 is confirmed by a strong absorption at 316 cm-1 in the IR spectrum. The 
C≡N absorption frequencies for 20-21, 2160 cm-1 and 2165 cm-1, respectively, are considerably 
lower than the gold(I) derivatives in which the ylide is mono-coordinate. This can be attributed 
to the strong electron withdrawing effect of the two Au-X groups at the ylide carbon which 
leads to a loss of electron density in the C≡N bond. The complexes were also successfully 
observed by high resolution mass spectrometry (ESI-QTOF) with peaks observed at 
m/z = 1028.0199 corresponding to [M]⁻ for complexes Cs[20] and NBu4[20] and 
m/z = 763.9656 corresponding to [M]⁻ for complex 17. The experimentally determined isotopic 
distribution patterns are in good agreement with the theoretical predictions (Figures 2.32-2.33).  
  
 
 
Figure 2.31. 1H NMR spectrum of complex 21 in CD2Cl2. 
 
CD2Cl2 
H2O 
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Figure 2.32. Calculated (a) and experimentally determined (b) isotopic distribution patterns for C32H15Au2F10NP 
[M]⁻ for complex Cs[20]. 
   
Figure 2.33. Calculated (a) and experimentally determined (b) isotopic distribution patterns for C20H15Au2Cl2NP 
[M]⁻ for complex 21. 
 
Anionic trinuclear derivatives of the bis-ylide gold complex 17 could also be prepared in a 
similar manner by double deprotonation of complex 17 using NBu4(acac) as a base, and 
subsequent coordination to Au(C6F5) or AuCl by displacement of tht from [Au(C6F5)(tht)] or 
[AuCl(tht)] to give complexes 22 and 23, respectively (Scheme 2.24). 
 
a) b) 
a) b) 
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Scheme 2.24. Synthesis of anionic complexes 22-23. 
 
Again, the successful deprotonation could be confirmed by the lack of a C(α)-H signal in the 
1H 
NMR spectrum and integration of the tetrabutylammonium and triphenylphosphine signals 
showed the presence of two ylide units per tetrabutylammonium cation (Figure 2.34). Only one 
peak at 29.17 ppm is observed in the 31P{1H} NMR spectrum of complex 23 showing that only 
one diastereoisomer has formed from the mixture of diastereoisomers of complex 17. This is 
likely to be because one diastereoisomer would have less steric hindrance between the 
relatively bulky triphenylphosphine groups and hence would be thermodynamically more 
stable.  
 
 
 
 
Figure 2.34. 1H NMR spectrum of complex 23 in CD2Cl2 
 
CD2Cl2 
H2O 
 2.4. Synthesis of Polynuclear Yldiide Complexes 
101 
Both complexes were identified by high resolution mass spectrometry (ESI-QTOF) with peaks 
observed at m/z = 1525.0710 corresponding to [M]⁻ for complex 22, and m/z = 1261.0241 
corresponding to [M]⁻ for complex 23 with isotopic distribution patterns in good agreement 
with the theoretical prediction (Figures 2.35-2.36). 
 
      
Figure 2.35. Calculated (a) and experimentally determined (b) isotopic distribution patterns for C52H30Au3F10N2P2 
[M]⁻ for complex 22. 
 
     
Figure 2.36. Calculated (a) and experimentally determined (b) isotopic distribution patterns for C46H30Au3Cl2N2P2 
[M]⁻ for complex 23. 
 
Complexes 20-23 were unstable in solution and over time all gradually formed the more 
thermodynamically stable tetranuclear complex, 24, by loss of NBu4[AuX2] (X = C6F5, Cl) 
(Scheme 2.25).  
a) b) 
a) b) 
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Scheme 2.25. Formation of tetranuclear complex 24 from complexes 20-23. 
 
2.4.2. Neutral Complexes 
The neutral tetrameric gold complex, 24, could also be prepared by reaction of complex 6 with 
a variety of different bases including n-BuLi, NBu4(acac) and Cs2CO3, in each case the chloride 
ligand was removed as the corresponding chloride salt LiCl, NBu4Cl or CsCl (Scheme 2.26). 
The yields in these reactions were only moderate (54-55%).  
 
The analogous silver tetramer, complex 25, could be prepared from the free ylide, 3, with 
0.5 equivalents of Ag2O. The Ag2O acts as a base, deprotonating the ylide and allowing 
coordination to silver, with complex 25 obtained in a yield of 86%.  Complex 25 could also be 
prepared from the commercially available phosphonium chloride salt, 1, with one equivalent 
of Ag2O. In this case, the precipitation of silver chloride drives the reaction and can readily be 
removed from the product by filtration of the reaction solution through a pad of celite. The 
final complex was obtained in a slightly lower yield of 78%. Reaction of complex 25 with 
[AuCl(tht)] led to the formation of complex 24, by a transmetallation reaction driven by the 
precipitation of silver chloride. This method gave complex 24 by a very clean reaction and in 
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an excellent yield of 92%. Both complexes 24 and 25 were obtained as white solids and were 
highly stable under ambient conditions. 
 
 
Scheme 2.26. Synthesis of tetranuclear complex 24 and 25. 
 
The infrared absorption frequencies for the C≡N bond for complexes 24 and 25, 2154 cm-1 and 
2110 cm-1, respectively, are considerably lower than the values for the phosphonium salts or 
the monocoordinated ylide complexes. This can again be attributed to the presence of two 
electron withdrawing metal atoms at the ylide carbon atom resulting in a reduction of electron 
density in the C≡N triple bond. 
 
Two different isomers of 24 were characterised by single crystal X-ray diffraction 
(Figure 2.37).  One of the isomers, 24a, crystallises in a tetragonal crystal system with only one 
quarter of the molecule observed in the asymmetric unit (Figure 2.37(a)). The other, 24b, is 
monoclinic and the entire molecule is observed in the asymmetric unit (Figure 2.37(b)). Isomer 
24a features alternating upwards facing CN and PPh3 groups. Linear coordination is observed 
about the gold centres and aurophilic interactions are present with Au-Au distances of 
3.0710(5) and 3.0711(5) Å. Isomer 24b has two adjacent upwards facing CN groups. The 
coordination about the gold centres is almost linear in every case and again aurophilic 
interactions are present between all of the gold atoms. 
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Figure 2.37. Molecular structure of isomers 24a and 24b determined by single crystal X-ray diffraction. Phenyl 
hydrogen atoms, anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°] 
24a: Au(1)-C(1) 2.090(9), Au(1A)-C(1) 2.099(10), P(1)-C(1) 1.765(11), C(1)-C(2) 1.410(16), C(2)-N(1) 
1.159(14), Au(1)-Au(1A) 3.0710(5), Au(1)-Au(1C) 3.0711(5), C(1)-Au(1A)-C(1A) 172.5(3), C(1)-C(2)-N(1) 
178.1(11); 24b: Au(1)-C(1) 2.140(10), Au(1)-C(61) 2.129(10), Au(2)-C(1) 2.125(9), Au(2)-C(21) 2.127(11), 
Au(3)-C(21) 2.115(9), Au(3)-C(41) 2.110(9), Au(4)-C(41) 2.120(10), Au(4)-C(61) 2.136(10), Au(1)-Au(2) 
2.9706(8), Au(2)-Au(3) 2.9708(8), Au(3)-Au(4) 3.0362(9), Au(4)-Au(1) 2.9775(8), P(1)-C(1) 1.727(10), 
C(1)-C(2) 1.427(15), C(2)-N(1) 1.153(15), P(2)-C(21) 1.745(10), C(21)-C(22) 1.433(14), C(22)-N(2) 1.150(14), 
P(3)-C(41) 1.741(10), C(41)-C(42) 1.432(15), C(42)-N(3) 1.152(15), P(4)-C(61) 1.729(9), 
C(61)-C(62) 1.427(13), C(62)-N(4) 1.155(14), C(1)-Au(1)-C(61) 174.8(4), C(21)-Au(2)-C(1) 178.0(4), 
C(41)-Au(3)-C(21) 176.1(4), C(61)-Au(4)-C(41) 171.9(4), C(1)-C(2)-N(1) 178.5(13), 
C(21)-C(22)-N(2) 178.2(10), C(41)-C(42)-N(3) 179.2(12), C(61)-C(62)-N(4) 179.3(12). 
 
Complex 25 was also characterised by single crystal X-ray diffraction (Figure 2.38). In this 
case only one isomer was observed which has a tetragonal structure with one quarter of the 
molecule in the asymmetric unit. Similarly to the gold derivative 24a, a linear coordination is 
observed about the silver centres and metallophilic interactions are observed between the silver 
atoms. No coordination of the nitrile group to silver is observed. 
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Figure 2.38. Molecular structure of 25 determined by single crystal X-ray diffraction. Phenyl hydrogen atoms, 
anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Ag(1)-C(1) 
2.147(15), Ag(1A)-C(1) 2.147(15), P(1)-C(1) 1.720(18), C(1)-C(2) 1.43(3), C(2)-N(1) 1.13(2), Ag(1)-Ag(1A) 
2.9201(18), Ag(1)-Ag(1C) 2.9202(18), C(1)-Ag(1A)-C(1A) 179.6(7), C(1)-C(2), N(1) 174.4(19). 
 
2.4.3. Cationic Complexes 
Dinuclear cationic gold phosphine derivatives 26 and 27 with bridging ylide ligands were 
prepared from the phosphonium triflate salt, 2, using acac as the base in both cases 
(Scheme 2.27). In the synthesis of complex 27 the tetrabutylammonium chloride formed in the 
reaction was readily removed by washing the reaction mixture with water. Both complexes 
were obtained cleanly and in good yields of 89% and 90%, respectively. 
 
Scheme 2.27. Synthesis of cationic gold phosphine complexes 26 and 27. 
The lack of Cα-H signal in the 
1H NMR spectra of both complexes indicates successful 
deprotonation of the phosphonium salt. For complex 27 phosphorus-phosphorus coupling 
between the ylide phosphorus atom and the triphenylphosphine ligands can clearly be seen in 
the 31P{1H} NMR spectrum. A doublet at 37.27 ppm corresponding to the triphenylphosphine 
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ligands and a triplet at 34.27 ppm (3JPP = 6.3 Hz) for the ylide phosphorus atom are observed 
since both AuPPh3 groups are equivalent (Figure 2.39). 
 
Figure 2.39. 31P{1H} NMR spectrum for complex 26 in CD2Cl2. 
For complex 27, the flexibility of the phosphine at room temperature causes the ferrocene C-H 
signals to be observed as broad singlets in the 1H NMR spectrum (Figure 2.40(a)) whilst in the 
31P{1H} NMR spectrum, the phosphine is observed as a broad signal and the signal for the 
ylide phosphorus atom appears as a pseudo-triplet due to coupling with the two phosphorus 
atoms of the dppf ligand (Figure 2.40(b)).  
 
 
Figure 2.40. 1H NMR spectrum for complex 27 in CD2Cl2 at room temperature (a), 31P{1H} NMR spectrum for 
complex 27 in CD2Cl2 at room temperature (b). 
a) 
b) 
dppf C-H 
CD2Cl2 H2O 
dppf P 
ylide P 
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At -80 °C each of the ferrocene C-H signals can be observed as a separate singlet in the 
1H NMR spectrum (Figure 2.41(a)) and three multiplets are observed in the 31P{1H} NMR 
spectrum due to the inequivalence of the two phosphorus atoms in the dppf ligand at this 
temperature (Figure 2.41(b)). 
 
 
Figure 2.41. 1H NMR spectrum for complex 27 in CD2Cl2 at -80 °C (a), 31P{1H} NMR spectrum for complex 27 
in CD2Cl2 at -80 °C (b). 
 
The molecular structures of both complexes were determined by single crystal X-ray 
diffraction (Figure 2.42). For complex 26 both gold atoms have an almost linear coordination. 
The slight distortion from 180° is due to the sterically bulky triphenylphosphine groups. The 
Au(2)-C(1)-Au(1) angle of 90.7(3)° is reduced significantly from that typical of a tetrahedron 
(109.5°) due to the presence of an aurophilic interaction which causes the two gold atoms to 
be closer in proximity. A gold-gold distance Au(1)-Au(2) of 2.9829(4) Å is observed. For 
complex 27, again an almost linear coordination is observed about each gold centre with angles 
C(1)-Au(1)-P(2) 171.2(5)° and C(1)-Au(2)-P(3) 173.9(5)°. One of the gold carbon bonds is 
slightly longer than the other: Au(1)-C(1) 2.142(16) Å and Au(2)-C(1) 2.192(18) Å. This is 
likely due to steric hindrance. An aurophilic interaction is observed between the gold centres 
with a distance Au(1)-Au(2) 2.8423(13) Å. 
 
a) 
b) 
dppf C-H 
CD2Cl2 
H2O 
ylide P 
dppf P 
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Figure 2.42. Molecular structures of 26 and 27 determined by single crystal X-ray diffraction. Phenyl hydrogen 
atoms, anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°] 26: 
Au(1)-C(1) 2.096(7), Au(1)-P(1) 2.268(2), Au(1)-Au(2) 2.9829(4), Au(2)-C(1) 2.095(9), Au(2)-P(2) 2.257(2), 
C(1)-C(2) 1.434(11), C(2)-N(1) 1.149(11), P(3)-C(1) 1.764(8), C(1)-Au(1)-P(1) 173.2(2), 
C(1)-Au(2)-P(2) 178.6(2), Au(2)-C(1)-Au(1) 90.7(3); 27: Au(1)-C(1) 2.142(16), Au(1)-P(2) 2.247(6), 
Au(1)-Au(2) 2.8423(13), Au(2)-C(1) 2.192(18), Au(2)-P(3) 2.237(5), C(1)-C(2) 1.38(3), C(2)-N(1) 1.22(3), 
C(1)-P(1) 1.732(18), C(1)-Au(1)-P(2) 171.2(5), C(1)-Au(2)-P(3) 173.9(5), Au(2)-C(1)-Au(1) 81.9(6). 
 
Although complex 27 with the flexible diphosphine, dppf, forms readily and in high yield, the 
analogous reaction with a more rigid diphosphine, XantPhos, led to a mixture of products 
(Scheme 2.28). These can be seen in the 31P{1H} NMR spectrum (Figure 2.43). 
 
 
Scheme 2.28. Synthesis of XantPhos derivatives 28 and 29. 
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Figure 2.43. 31P{1H} NMR spectrum showing mixture of products 28 and 29. 
 
It is likely that the geometry and rigidity of the XantPhos ligand means that despite the 
stoichiometry of the reaction, formation of dinuclear complex 28 with a bridging ylide ligand 
is less favourable. Attempts to grow crystals from the reaction mixture for X-ray diffraction 
studies led to the formation of crystals of pentanuclear derivative 30, the formation of which 
can be explained by reaction of complex 29 with [Au2Cl2(XantPhos)] (Scheme 2.29).  
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Scheme 2.29. Formation of 30. 
 
This complex was not detected by NMR of the reaction mixture and formed in too small a 
quantity to enable NMR or IR analysis, however the molecular structure was determined by 
single crystal X-ray diffraction (Figure 2.44). This complex has two asymmetric carbon atoms 
and hence could exist as different diastereoisomers, however only this meso isomer 
crystallised. Aurophilic interactions are present linking the five gold atoms in a chain and hence 
providing stability to this structure with distances Au(1)-Au(2) 2.9197(8) Å and 
Au(2)-C(1) 2.104(18) Å. The three central gold atoms are in a linear arrangement with the 
Au(2)-Au(1)-Au(2A) angle of 180°. There is a linear coordination of the two ylide ligands 
about the central gold atom, however the other two gold atoms have a coordination somewhat 
distorted form linearity with angles C(1)-Au(2)-P(2) 167.8(5)° and 
P(3)-Au(3)-Cl(1) 166.71(16)°. This is likely to be due to the steric repulsion between the bulky 
phosphine groups and the phosphonium of the ylide.  
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Figure 2.44. Molecular structure of 30 determined by single crystal X-ray diffraction. Phenyl hydrogen atoms, 
anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: 
Au(1)-C(1) 2.079(17), Au(1)-Au(2) 2.9197(8), Au(2)-C(1) 2.104(18), Au(2)-P(2) 2.254(5), 
Au(2)-Au(3) 3.0286(11), Au(3)-P(3) 2.231(6), Au(3)-Cl(1) 2.365(4), P(1)-C(1) 1.774(17), C(1)-C(2) 1.42(2), 
C(2)-N(1) 1.13(2), C(1)-Au(1)-C(1A) 179.998(1), C(1)-Au(2)-P(2) 167.8(5), P(3)-Au(3)-Cl(1) 166.71(16), 
Au(2)-Au(1)-Au(2A) 180.0, C(1)-C(2)-N(1) 177(2). 
 
Both complexes 28 and 29 could be prepared cleanly by alternative routes (Scheme 2.30). 
Reaction of the free ylide with [Au2Cl2(XantPhos)] and NBu4(acac) in the presence of silver 
triflate led to the formation of 28 in a yield of 90%. The acac acts as a base to deprotonate the 
ylide, and the precipitation of silver chloride will drive the reaction. Complex 29 was prepared 
from the bis-ylide complex 17 by reaction with two equivalents of NBu4(acac) and one of 
[Au2Cl2(XantPhos)]. In this case, the addition of a silver salt was not required and the 
tetrabutylammonium chloride which forms in the reaction was readily removed by washing the 
reaction solution with water, with the final product obtained in a good yield of 74%. A similar 
triphenylphoshine gold derivative, complex 31 was also prepared from complex 17 by reaction 
with two equivalents of [Au(acac)PPh3] and was obtained in a yield of 88%. 
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Scheme 2.30. Synthesis of complexes 28, 29 and 31. 
 
Complexes 29 and 31 both have two asymmetric carbon atoms and hence could exist as a 
mixture of diastereoisomers. The 31P{1H} NMR spectrum of complex 29 shows two doublets 
at 31.30 ppm and 29.29 ppm with 3JPP = 5.5 Hz due to the ylide phosphorus atom and the 
XantPhos phosphorus atom, respectively (Figure 2.45(a)) indicating that only one 
diastereoisomer formed in this case. In the 31P{1H} NMR spectrum of complex 31, however, 
four doublets are observed (Figure 2.45(b)) indicating that a mixture of diastereoisomers has 
formed. As with complex 17 these would be the racemic mixture of (R,R)-31 and (S,S)-31, and 
the non-optically active meso complex. This was further proven by high temperature NMR 
studies in DMSO (Figure 2.46). Upon heating, no change in the integral of the peaks was 
observed, eliminating the possiblity of rotamers. At 90 °C the complex started to decompose. 
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Figure 2.45. 31P{1H} NMR spectra for complex 29 (a) and 31 (b) in CDCl3 at room temperature. 
 
 
Figure 2.46. Variable temperature 31P{1H} NMR spectra for complex in DMSO. 
 
The molecular structures of the two XantPhos derivatives, 28 and 29 were successfully 
determined by single crystal X-ray diffraction (Figure 2.47). The structure of complex 28 is 
very similar to that of the dppf derivative, 27. The coordination about the gold atoms is slightly 
distorted from linearity with angles C(1)-Au(1)-P(2) 165.98(9)° and 
C(1)-Au(2)-P(3) 171.77(9), due to the rigidity of the XantPhos ligand. A strong aurophilic 
interaction is observed with a gold-gold distance Au(1)-Au(2) 2.7512(12) Å. For the trinuclear 
a) 
b) 
RT 
30 °C 
50 °C 
70 °C 
90 °C 
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derivative, 29, aurophilic interactions are observed between the outer gold atoms with the 
central gold atom with distances Au(1)-Au(3) 2.9395(12) Å and Au(2)-Au(3) 2.9517(10) Å. 
The coordination about the central gold atom is close to linear with angle 
C(1)-Au(3)-C(3) 175.5(3)°, however the coordination about the other gold atoms is more 
distorted with angles C(1)-Au(1)-P(3) 168.2(2)° and C(3)-Au(2)-P(4) 170.2(2)°. Again, this is 
due to the rigidity of the XantPhos ligand. 
 
 
Figure 2.47. Molecular structures of 28 and 29 determined by single crystal X-ray diffraction. Hydrogen atoms, 
anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°] 28: 
Au(1)-C(1) 2.117(3), Au(1)-P(2) 2.2571(11), Au(1)-Au(2) 2.7512(12), Au(2)-C(1) 2.143(3), 
Au(2)-P(3) 2.2523(11), P(1)-C(1) 1.754(3), C(1)-C(2) 1.424(5), C(2)-N(1) 1.154(5), C(1)-Au(1)-P(2) 165.98(9), 
C(1)-Au(2)-P(3) 171.77(9), C(1)-C(2)-N(1) 179.5(4), Au(1)-C(1)-Au(2) 80.45(11); 29: Au(1)-C(1) 2.111(8), 
Au(1)-P(3) 2.263(2), Au(1)-Au(3) 2.9395(12), Au(2)-C(3) 2.099(7), Au(2)-P(4) 2.261(2), Au(2)-Au(3) 
2.9517(10), Au(3)-C(1) 2.099(8), Au(3)-C(3) 2.096(8), P(1)-C(1) 1.769(8), C(1)-C(2) 1.427(12), C(2)-N(1) 
1.151(11), P(2)-C(3) 1.752(8), C(3)-C(4) 1.438(11), C(4)-N(2) 1.156(11), C(1)-Au(1)-P(3) 168.2(2), 
C(3)-Au(2)-P(4) 170.2(2), C(1)-Au(3)-C(3) 175.5(3), C(1)-C(2)-N(1) 178.5(9), C(3)-C(4)-N(2) 176.8(8), 
Au(1)-C(1)-Au(3) 88.5(3), Au(2)-C(1)-Au(3) 89.4(3). 
 
The molecular structure of the meso diastereoisomer of complex 31 was also determined by 
single crystal X-ray diffraction (Figure 2.48). The large triphenylphosphine groups are directed 
in opposite directions to minimise repulsions. An almost linear coordination is observed about 
each of the gold centres with a slight distortion observed for the outer gold atoms (angles 
C(1)-Au(2)-P(2) 172.2(2)° and C(39)-Au(3)-P(4) 174.5(2)°), due to the steric repulsions of the 
bulky phosphine groups. Aurophilic interactions are present between the gold atoms with 
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distances Au(1)-Au(2) 2.9723(5) Å and Au(1)-Au(3) 3.0501(5) Å and an angle 
Au(2)-Au(1)-Au(3) 169.063(13)°. 
 
 
Figure 2.48. Molecular structures 31 determined by single crystal X-ray diffraction. Hydrogen atoms, anions and 
solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 2.097(7), 
Au(1)-C(39) 2.110(7), Au(1)-Au(2) 2.9723(5), Au(1)-Au(3) 3.0501(5), Au(2)-C(1) 2.096(7), 
Au(2)-P(2) 2.265(2), Au(3)-C(39) 2.089(7), Au(3)-P(4) 2.270(2), P(1)-C(1) 1.762(7), C(1)-C(2) 1.476(10), 
C(2)-N(1) 1.075(10), P(3)-C(39) 1.739(7), C(39)-C(40) 1.449(11), C(40)-N(2) 1.155(10), 
C(1)-Au(1)-C(39) 177.0(3), C(1)-Au(2)-P(2) 172.2(2), C(39)-Au(3)-P(4) 174.5(2), 
Au(2)-Au(1)-Au(3) 169.063(13), C(1)-C(2)-N(1) 175.5(7), C(39)-C(40)-N(2) 177.1(8), Au(2)-C(1)-Au(1) 
90.3(3), Au(3)-C(39)-Au(1) 93.2(3). 
 
2.4.4. Heterometallic Complexes with N Coordination 
Trinuclear complexes 32-34 were prepared from complex 22 by reaction with a gold, silver or 
copper precursor bearing a triphenylphosphine group and a labile ligand (Scheme 2.31). For 
the gold derivative, 32a, the precursor [Au(OTf)(PPh3)] was prepared in situ by reaction of 
[AuCl(PPh3)] and AgOTf, driven by the precipitation of silver chloride. Complex 32a was 
obtained in a yield of 87%. This same complex but with one tetrafluoroborate and one triflate 
anion be prepared from the phosphonium triflate salt directly by reaction with the oxonium 
[O(AuPPh3)3]BF4 which can deprotonate the phosphonium salt twice and allow the possibility 
for coordination of the ylide to three AuPPh3 groups. The yield of complex 32b by this route 
was slightly lower, 73%. Complexes 33 and 34 were both obtained in excellent yields of 98% 
and 99%, respectively.  
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Scheme 2.31. Synthesis of complexes 32-34. 
 
Table 2.5. Infrared absorption frequencies for complexes 32-34 
Complex ν(C≡N) (cm-1) 
26 2173 
32 2171 
33 2160 
34 2166 
 
The additional coordination through the nitrogen atom results in a reduction in the C≡N 
absorption frequency in the infrared spectrum of complexes 32-34 compared to complex 26. 
For the gold derivative, 32, the difference is only slight since the gold-nitrogen bond is 
relatively weak. For complexes 33 and 34 the stronger coordination to silver or copper results 
in a more significant difference. 
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Figure 2.49. 31P{1H} NMR spectra in CDCl3 for complex 32 at room temperature (a), complex 33 at -50 °C (b) 
and complex 34 at -50 °C (c). 
b) 
107Ag-P 
109Ag-P 
a) 
c) 
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The 31P{1H} NMR spectra of complexes 32-34 each show an additional peak compared to 
complex 26 as a result of the additional triphenylphosphine group, and for all three complexes 
at room temperature the doublet and triplet peaks observed for complex 26 are still present but 
appear at different chemical shifts (Figure 2.49). No coupling to the additional 
triphenylphosphine group is observed. For complex 33 the 31P{1H} spectrum at -50 °C shows 
two doublets at 13.37 ppm due to the phosphorus-silver coupling with 1J109Ag-P = 786.5 Hz and 
1J107Ag-P = 683.5 Hz. At this temperature, the doublet and triplet peaks for the AuPPh3 and ylide 
phosphorus atom are observed as more complex multiplets.  
 
Polynuclear derivatives 35-37 were prepared by reaction of complex 26 with [Au(tmbn)2]SbF6 
(tmbn = 2,4,6-trimethoxybenzonitrile), AgOTf or [Cu(NCMe)4]PF6 (Scheme 2.32). Although 
complex 35 formed, separation from the trimethoxybenzonitrile was not possible. Complexes 
36 and 37, however were obtained cleanly in yields of 73% and 84%, respectively. Successful 
reaction was observed by a colour change. The starting complex, 26, is a white solid however 
35 and 37 were pale yellow solids and 36 was a pale orange solid.  
 
Infrared absorption frequencies for the C≡N bond indicate successful coordination of the 
nitrogen atom to the metal centres since they appear at lower values than that of complex 26 as 
a result of a loss of electron density from the triple bond (Table 2.6). 
 
Table 2.6. Infrared absorption frequencies for complexes 35-37 
Complex ν(C≡N) (cm-1) 
35 2172 
36 2166 
37 2167 
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Scheme 2.32. Synthesis of complexes 35-37. 
 
The 31P{1H} NMR spectra for complexes 35-37 show peaks analogous to those for complex 
26, however they appear at different chemical shifts when measured in the same solvent, 
another an indication of successful coordination of the nitrile group (Figure 2.50). 
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Figure 2.50. 31P{1H} NMR spectra for complex 26 (a), complex 35 (b), complex 36 (c) and complex 37 (d) in 
CDCl3 at room temperature. 
 
 
a) 
b) 
c) 
d) 
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2.5. Luminescence 
Polynuclear complexes 36 and 37 were luminescent at 77 K. The excitation and emission 
maxima and emission lifetimes are shown in Table 2.7. 
 
Table 2.7. Excitation and emission maxima for complexes 36 and 37. 
Complex Excitation λmax (nm) Emission λmax (nm) τ0 (μs) 
36 296, 339 668, 539 440 
37 357 523 1666 
 
Complex 36 has two excitation bands and two emission bands (Figure 2.51). Excitation at 
296 nm results in a weak emission at 668 nm (Figure 2.51(a)). Taking into account the low 
energy emission for this band and the large Stokes shift, the origin of the emission likely to be 
due to metal interactions and could be a metal-centred or cluster-centred. The other excitation 
band at 339 nm has a corresponding emission band at 539 nm (Figure 2.51(b)) and can be 
assigned to a metal to ligand charge transfer (MLCT) from the silver to the nitrile groups. The 
lifetime of this emission indicates phosphorescence. 
 
 
Figure 2.51. Excitation and emission spectra for complex 36 at 77 K. 
 
Complex 37 has only one excitation and one emission band (Figure 2.52). Excitation at 357 nm 
results in an emission at 523 nm. This is assigned to a metal to ligand charge transfer transition 
from the copper to the nitrile ligands. The long lifetime indicates phosphorescence. 
 
(a) (b) 
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Figure 2.52. Excitation and emission spectra for complex 37 at 77 K. 
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2.6. Biological Activity 
The biological activity of several of the ylide complexes was studied by MTT assay for lung 
carcinoma cell line A549. This cell line was chosen since in is one which shows cisplatin 
resistance and hence there is a need to look for alternative treatments. 
 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium 
reduction assay is a well-known method for testing the anti-proliferative activity of compounds, 
first described by Mosmann in 1983.173 It is a quantitative colorimetric assay based on the 
cleavage of the yellow, water-soluble tetrazolium salt, MTT, to form dark blue/purple, 
water-insoluble formazan crystals (Scheme 2.33). 
 
 
Scheme 2.33. Reduction of MTT to formazan by mitochondrial reductase. 
 
This reaction occurs only in the presence of living cells since it is caused by the mitochondrial 
reductase enzyme, succinate hydrogenase. The resulting formazan crystals can be solubilised 
in DMSO and the optical density of the resulting solution measured with a spectrophotometer. 
The absorbance of the solution is directly proportional to the concentration of formazan, which 
is directly proportional to the number of metabolically active cells. This technique therefore 
allows the determination of the number of living cells after a certain incubation time with a 
complex, and if measurements with various concentrations of complex are taken, a curve of 
cell viability against concentration may be drawn, allowing determination of the half maximal 
inhibitory concentration (IC50) of the complex. A schematic representation of the technique is 
shown in Scheme 2.34. 
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Scheme 2.34. Schematic representation MTT assay method. 
 
The calculated IC50 values for the bis-ylide complexes 17-19 and tetramers 24 and 25 after 24 h 
incubation with A549 cells is shown in Table 2.8. The bis-ylide complexes were chosen as 
suitable candidates due to their similarity to bis-NHC complexes which are known to show 
good anticancer activity. Only the silver derivative, 18, showed activity at the concentrations 
tested (<50 μM) but was not particularly active with an IC50 of 48.39 ± 2.66 μM. The tetrameric 
complexes 24 and 25 were also tested. Unfortunately, the gold complex precipitated in the cell 
culture medium and consequently did not show anticancer activity. The silver derivative, 25, 
however, did show a reasonable activity with an IC50 value of 19.09 ± 1.25 μM. 
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Table 2.8. IC50 values for Complexes 17-19 and 24-25 after 24 h Incubation with A549 Cells 
Complex IC50 (μM) Complex IC50 (μM) 
 
>50 
 
>50 
 
48.39 ± 2.66 
 
19.09 ± 1.25 
 
>50 
 
Since the presence of a phosphine ligand can improve the lipophilicity of a complex and often 
results in an increased anticancer activity, the activity of triphenylphosphine derivatives 12, 13 
and 26 was tested along with JohnPhos derivative, 11. The anticancer activity of NHC 
derivatives 9 and 10 was also tested. The calculated IC50 values are shown in Table 2.9. 
 
Table 2.9. IC50 values for Complexes 9-13 and 26 after 24 h Incubation with A549 Cells 
Complex IC50 (μM) Complex IC50 (μM) 
 
15.43 ± 0.73 
 
4.40 ± 0.73 
 
10.26 ± 0.90 
 
3.83 ± 0.69 
 
12.18 ± 1.22 
 
5.38 ± 0.76 
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The mononuclear gold complexes 9-11 all showed good anticancer activities with IC50 values 
in the range 10-15 μM, the best of these being complex 10 bearing the IPr NHC ligand. A 
significant improvement in activity is observed upon changing from a mononuclear to a 
dinuclear gold complex, comparing the two gold phosphine derivatives 11 and 26 with IC50 
values of 12.18 μM and 5.38 μM, respectively. This can readily be seen in the graph of cell 
viability against concentration where complex 26 has a steeper curve indicating greater 
antiproliferative activity at lower concentrations (Figure 2.53). Since the mononuclear gold 
triphenylphosphine derivative, 15, could not be isolated and tested, it cannot be concluded 
whether this improvement in activity is due to changing the phosphine group from JohnPhos 
to triphenylphosphine or due to the additional gold atom.  
 
 
Figure 2.53. Graph of cell viability (% of control) against concentration (μM) for complexes 11 and 26 (Each 
point is the average of eight measurements, where error bars represent the standard deviation. Curve generated by 
a sigmoidal non-linear regression 4-parameter logistic analysis). 
 
The silver and copper triphenylphosphine derivatives, 12 and 13 also showed excellent activity 
in A549 cells with incredibly low IC50 values of 4.40 and 3.83 μM, respectively. The graph of 
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cell viability against concentration for the three triphenylphosphine complexes 12, 13 and 26 
shows that they all have very similar curves (Figure 2.54). The copper complex, 13, has the 
steepest curve and hence the highest activity, however the differences are not significant within 
error. It should also be noted that in these studies the complexes were incubated with the cancer 
cells for just 24 h and show IC50 values far superior to cis-platin when measured under the same 
conditions which has an IC50 value of 114 μM. 
 
Figure 2.54. Graph of cell viability (% of control) against concentration (μM) for complexes 12, 13 and 26 (Each 
point is the average of eight measurements, where error bars represent the standard deviation. Curve generated by 
a sigmoidal non-linear regression 4-parameter logistic analysis). 
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2.7. Conclusions 
The coordination chemistry of the cyano-stabilised ylide, 
triphenylphosphoniumcyanomethylide with gold has been thoroughly explored. Several 
mononuclear gold(I) and gold(III) derivatives have been prepared and structurally 
characterised. The synthesis of cationic mononuclear gold(I) derivatives of 
triphenylphosphoniumcyanomethylide requires the presence of a bulky ligand such as a IPr or 
JohnPhos at the gold centre. When a small NHC ligand or PPh3 was used, further deprotonation 
of the ylide occurred leading to the formation of dinuclear complexes. Mononuclear silver and 
copper derivatives were also prepared. In these complexes additional coordination of the C≡N 
nitrogen atom to the metal is observed, stabilising the structure. This additional C≡N 
coordination is not observed in any of the gold complexes. This difference in coordination 
between gold and the other coinage metals influenced the outcome of the synthesis of the 
bis-ylide complexes. For the bis-ylide gold derivative, two diastereoisomers of the product 
formed, however with silver and copper the formation of only one diastereoisomer was 
observed. This is because the stabilising effect of the additional coordination of the nitrogen to 
the metal centre would only be possible in one of the diastereoisomers. The silver derivative 
was structurally characterised showing the favoured diastereoisomer to be the racemic mixture 
of enantiomers rather than the meso complex. A polymeric structure was observed in the solid 
state. 
 
Polynuclear derivatives of the cyano-stabilised phosphonium yldiide species were also 
prepared. The negatively charged complexes were found to be unstable in solution and over 
time formed the more stable neutral tetranuclear complex. Gold and silver tetranuclear species 
with bridging yldiide ligands could also be synthesised by different routes and two different 
conformers were structurally characterised. The cationic derivatives were highly stable and 
many examples with different structural frameworks were prepared and characterised. 
Additional coordination through the nitrogen of the C≡N was also achieved, resulting in some 
polynuclear heterometallic derivatives. Two of these were found to be luminescent. 
 
 2.7. Conclusions 
129 
The anticancer activity of several of the complexes in A549 cells was tested. The metal 
triphenylphosphine derivatives were found to be the most active with very low IC50 values. 
Amongst them the copper and silver complexes were slightly more active than the gold species. 
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2.8. Experimental 
 
To a solution of [Ph3PCH2CN]Cl (0.6756 g, 2.0 mmol) in CH2Cl2 (10 ml) was added AgOTf 
(0.5139 g, 2.0 mmol) and the mixture stirred for 1 h at room temperature with the exclusion of 
light. AgCl was removed by filtration through celite and the pale yellow filtrate concentrated 
under reduced pressure to approximately 1 ml. The product was precipitated with n-hexane, 
collected by vacuum filtration and dried to give [Ph3PCH2CN]OTf as a white solid 
(0.8632 g, 96 %).  
IR (cm-1): ν(C≡N) 2250; ν(OTf) 1281 (SO3), 1226 (CF3), 1151 (CF3), 1028 (SO3).  
1H NMR (300 MHz, CDCl3) δ 8.02 – 7.57 (m, 15H, Ph), 5.05 (d, 2JHP = 15.1 Hz, 2H, CH2). 
31P{1H} NMR  (121 MHz, CDCl3) δ 21.53. (s, PPh3).  
19F NMR (282 MHz, CDCl3) δ -78.45 (s, OTf). 
13C APT (75 MHz, CDCl3) δ 136.30 (d, 4JCP = 3.2 Hz, p-PPh3), 133.98 (d, 3JCP = 10.8 Hz, m-
PPh3), 130.89 (d, 
2JCP = 13.4 Hz, o-PPh3), 115.83 (d, 
1JCP = 89.0 Hz, ipso-PPh3), 111.54 (d, 
2JCP = 9.5 Hz, C≡N), 15.43 (d, 1JCP = 56.7 Hz, CH2). 
 
 
To a solution of [Ph3PCH2CN]Cl (0.6756 g, 2.0 mmol) in H2O (20 ml) was added NaOH (25% 
soln) solution. A white precipitate immediately formed and addition was continued until the 
reaction mixture was alkaline. The solid was collected by vacuum filtration, dissolved in 
CH2Cl2 (10 ml) and dried over Na2SO4. The solution was concentrated to approximately 1 ml 
and Et2O (10 ml) added to precipitate a white solid which was collected and vacuum dried to 
give the crude product. NMR showed the presence of Ph3PO. The crude product was dissolved 
in toluene, filtered through celite and the solution concentrated under reduced pressure to 
approximately 1 ml. Et2O was added to precipitate the pure product as a white solid which was 
collected and vacuum dried.  
IR (cm-1): ν(C≡N) 2136.  
1H NMR (400 MHz, CD2Cl2) δ 7.77 – 7.39 (m, 15H, PPh3), 1.56 (d, 2JHP = 7.3 Hz, 1H, CH) 
31P{1H} NMR (162 MHz, CD2Cl2) δ 23.29 (PPh3). 
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13C APT (75 MHz, CD2Cl2) δ 133.30 (d, 3JCP = 10.0 Hz, m-PPh3), 133.13 (d, 4JCP = 2.9 Hz, 
p-PPh3), 129.59 (d, 
2JCP = 12.3 Hz, o-PPh3), 128.05 (d, 
1JCP = 91.6 Hz, ipso-PPh3), -2.02 (d, 
1JCP = 135.6 Hz, CH). 
 
 
To a solution of [Ph3PCH2CN]Cl (0.0676 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
[Au(C6F5)(tht)] (0.0904 g, 0.2 mmol) and the mixture stirred for 30 min at room temperature. 
The colourless solution was concentrated under reduced pressure to approximately 1 ml and n-
n-pentane (10 ml) added to precipitate a white solid which was collected and vacuum dried to 
give the product (0.1150 g, 81%).  
IR (cm-1) ν(C≡N) 2255; ν(C6F5) 1500, 951, 801; ν(Au-Cl) 316.  
1H NMR (300 MHz, CD2Cl2) δ 8.02 – 7.63 (m, 15H, Ph), 5.06 (d, 3JHP = 14.5 Hz, 2H, CH2).  
31P{1H} NMR (121 MHz, CD2Cl2) δ 20.76 (s, PPh3).  
19F NMR (282 MHz, CD2Cl2) δ -115.89 – -116.13 (m, 2F, o-C6F5), -162.60 (t, 3JFF = 20.1 Hz, 
1F, p-C6F5), -163.99 – -164.36 (m, 2F, m-C6F5).  
13C APT (75 MHz, CD2Cl2) δ 137.16 (d, 4JCP = 3.1 Hz, p-PPh3), 134.43 (d, 3JCP = 10.9 Hz, m-
PPh3), 131.50 (d, 
2JCP = 13.4 Hz, o-PPh3), 115.67 (d, 
1JCP = 89.0 Hz, ipso-PPh3), 111.36 (d, 
2JCP = 9.2 Hz, C≡N), 17.63 (d, 1JCP = 56.4 Hz, CH). 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au(C6F5)(tht)] (0.0452 
g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
concentrated under reduced pressure to approximately 1 ml and n-pentane added to precipitate 
a white solid which was collected and vacuum dried to give the product (0.0658 g, 99%).  
HRMS (ESI-QTOF) m/z: [M+Na]+ Calcd for C26H16AuF5NNaP 688.0498; Found 688.0483. 
IR (cm-1): ν(C≡N) 2201, ν(C6F5) 1499, 953, 797.  
1H NMR (300 MHz, CD2Cl2) δ 8.07 – 7.53 (m, 15H, PPh3), 3.33 (d, 2JHP = 12.5 Hz, 1H, CH).  
31P{1H} NMR  (121 MHz, CD2Cl2) δ 27.28 (s, PPh3).  
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19F NMR (282 MHz, CD2Cl2) δ -116.57 – -116.99 (m, 2F, o-C6F5), -161.40 (t, 3JFF = 20.0 Hz, 
1F, p-C6F5), -163.64 – -164.18 (m, 2F, m-C6F5).  
13C APT (75 MHz, CD2Cl2) δ 135.04 (d, 4JCP = 3.0 Hz, p-PPh3), 134.15 (d, 3JCP = 9.9 Hz, m-
PPh3), 130.42 (d, 
2JCP = 12.6 Hz, o-PPh3), 122.91 (d, 
1JCP = 88.5 Hz, ipso-PPh3), 119.76 (d, 
2JCP = 6.9 Hz, C≡N), 11.22 (d, 1JCP = 51.6 Hz, CH). 
 
 
To a solution of 3 (0.0904 g, 0.3 mmol) in CH2Cl2 (5 ml) was added [AuCl(tht)] (0.0962 g, 0.3 
mmol) and the solution stirred for 1 h. The solution was filtered through celite, concentrated 
under reduced pressure to approximately 1 ml and Et2O added to precipitate a white solid which 
was collected and vacuum dried to give the product (0.1330 g, 83%). Spectral data are in 
agreement with previously reported values. 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au(C6F5)3(tht)] (0.0786 
g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
concentrated under reduced pressure to approximately 1 ml and n-pentane added to precipitate 
a white solid which was collected and vacuum dried to give the product (0.0959 g, 96%). 
IR (cm-1): ν(C≡N) 2227, ν(C6F5) 1478, 968, 805, 791. 
1H NMR (300 MHz, CD2Cl2) δ 7.79 – 7.35 (m, 15H, PPh3), 2.36 (d, 2JHP = 4.5 Hz, 1H, CH).  
31P{1H} NMR (121 MHz, CD2Cl2) δ 24.48 (s, PPh3).  
19F NMR (282 MHz, CD2Cl2) δ -122.08 – -122.46 (m, 2F, o-C6F5), -123.05 – -123.54 (m, 4F, 
o-C6F5), -158.63 (t, 
3JFF = 19.8 Hz, 1F, p-C6F5), -158.65 (t, 3JFF = 19.8 Hz, 2F, p-C6F5), -162.17 
– -162.57 (m, 4F, m-C6F5), -162.96 – -163.34 (m, 2F, m-C6F5). 
13C APT (75 MHz, CD2Cl2) δ 134.30 (d, 4JCP = 3.0 Hz, p-PPh3), 133.27 (d, 3JCP = 10.5 Hz, m-
PPh3), 130.06 (d, 
2JCP = 12.8 Hz, o-Ph3), 124.33 (d, 
1JCP = 93.5 Hz, ipso-PPh3), 6.60 (d, 
1JCP = 
130.9 Hz, CH). 
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Method 1: To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [AuCl3(tht)] 
(0.0783 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
concentrated under reduced pressure to approximately 1 ml and n-pentane added to precipitate 
a yellow solid which was collected and vacuum dried to give the product (0.0544 g, 90%). 
Method 2: To a solution of 2 (0.0534 g, 0.1 mmol) in CH2Cl2 (5 ml) was added an equimolar 
amount of a standardised Cl2 solution in CCl4. The solution immediately became yellow and 
was stirred for 1 h at room temperature. The solution was concentrated under reduced pressure 
to approximately 1 ml and Et2O (10 ml) added to precipitate a yellow solid (0.0580 g, 96%) 
IR (cm-1) ν(C≡N) 2228, ν(Au-Cl) 360, 342, 315. 
1H NMR (300 MHz, CD2Cl2) δ 8.25 – 7.38 (m, 15H, PPh3), 5.09 (d, 2JHP = 13.1 Hz, 1H, CH). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 24.87 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 136.43 (d, 4JCP = 3.1 Hz, p-PPh3), 135.23 (d, 3JCP = 10.1 Hz, m-
PPh3), 130.85 (d, 
2JCP = 13.1 Hz, o-PPh3), 118.33 (d, 
1JCP = 88.0 Hz, ipso-PPh3), 114.98 (d, 
2JCP = 6.6 Hz, C≡N), 16.42 (d, 1JCP = 51.6 Hz, CH). 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added 
chloro-gold-1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene [AuCl(IMes)] (0.0537 g, 0.1 
mmol) and AgSbF6 (0.0343 g, 0.1 mmol) and the mixture stirred for 1 h with the exclusion of 
light. The solution was filtered through celite, the filtrate concentrated under reduced pressure 
to approximately 1 ml and Et2O (10 ml) added to precipitate a white solid which was collected 
and vacuum dried to give the product (0.0861 g, 83%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C41H40AuN3P 802.2620, Found 802.2648. 
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IR (cm-1) ν(C≡N) 2211. 
1H NMR (400 MHz, CD2Cl2) δ 7.86 – 7.74 (m, 3H, PPh3), 7.61 – 7.50 (m, 6H, PPh3), 7.48 – 
7.34 (m, 6H, PPh3), 7.17 (s, 2H, CH (imidazole)), 7.05 – 6.95 (m, 4H, CHAR), 3.05 (d, , 2JHP = 
13.5 Hz, 1H, CH), 2.36 (s, 6H, CH3), 1.97 (s, 6H, CH3), 1.94 (s, 6H, CH3). 
31P{1H} NMR (162 MHz, CD2Cl2) δ 28.10 (s, PPh3) 
13C APT (75 MHz, CD2Cl2) δ 181.47 (s, C (NHC)),  140.63 (s, p-CAR), 135.38 (d, 4JCP  = 3.0 
Hz, p-PPh3), 134.81, (s, ipso-C
AR), 135.20 (s, o-C (AR)), 133.56 (d, 3JCP = 9.9 Hz, m-PPh3), 
130.62 (d, 2JCP = 12.7 Hz, o-PPh3), 130.00 (s, m-CH (AR)), 129.98 (s, m-CH (AR)), 123.68 (s, 
CH (imidazole)), 121.86 (d, 1JCP = 88.6 Hz, ipso-PPh3) 118.46 (d, 
2JCP = 7.8 Hz, C≡N), 21.50 
(s, CH3), 18.03 (s CH3), 18.00 (s, CH3), 10.68 (d, , 
1JCP  = 51.5 Hz, CH). 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added chloro-gold-1,3-bis(2,6-
diisopropylphenyl)imidazol-2-ylidine [AuCl(IPr)] (0.0621 g, 0.1 mmol) and AgSbF6 (0.0343 
g, 0.1 mmol) and the mixture stirred for 1 h with the exclusion of light. The solution was filtered 
through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.1021 g, 91%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C47H52AuN3P 886.3559, Found 886.2598. 
IR (cm-1) ν(C≡N) 2214 
1H NMR (400 MHz, CD2Cl2) δ 7.79 – 7.69 (m, 3H, CHAR), 7.63 (t, 3JHH = 7.8 Hz, 2H, CHAR), 
7.47 (m, 6H, CHAR + PPh3), 7.39 – 7.30 (m, 10H, PPh3), 7.27 (s, 2H, CH (imidazole)), 3.04 (d, 
2JHP = 14.3 Hz, 1H, CH), 2.45 (septuplet, 
3JHH = 6.9 Hz, 4H, CH(CH3)2), 1.13 (d, 
3JHH = 6.9 
Hz, 6H, CH(CH3)2), 1.07 (d, 
3JHH = 6.9 Hz, 6H, CH(CH3)2). 
31P{1H} NMR (162 MHz, CD2Cl2) δ 28.72 (s, PPh3) 
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13C APT (75 MHz, CD2Cl2) δ 183.11 (s, C (NHC)), 146.30 (s ipso-C (AR)), 135.41 (d, 
4JCP = 3.1 Hz, p-PPh3), 134.10 (s, o-C
AR), 133.47 (d, 3JCP  = 9.9 Hz, m-PPh3), 131.63 (s, p-CH 
(AR)), 130.71 (d, 2JCP = 12.7 Hz, o-PPh3), 124.93 (s, m-CH (AR)), 124.77 (s, CH (imidazole)), 
121.37 (d, 1JCP = 88.6 Hz, ipso-PPh3), 118.06 (d, 
2JCP = 6.9 Hz, C≡N), 29.37 (s, CH(CH3)2), 
25.01 (s, CH(CH3)2), 24.90 (s, CH(CH3)2), 24.19 (s, CH(CH3)2), 24.15 (s, CH(CH3)2), 10.56 
(d, 1JCP = 51.7 Hz, CH). 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [AuCl(JohnPhos)] (0.0531 
g, 0.1 mmol) and AgSbF6 (0.0343 g, 0.1 mmol) and the mixture stirred for 1 h with the 
exclusion of light. The solution was filtered through celite, the filtrate concentrated under 
reduced pressure to approximately 1 ml and Et2O (10 ml) added to precipitate a white solid 
which was collected and vacuum dried to give the product (0.0950 g, 92%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C40H43AuNP2 796.2531, Found 796.2550. 
IR (cm-1) ν(C≡N) 2200 
1H NMR (300 MHz, CD2Cl2) δ 7.87 – 7.80 (m, 4H, ), 7.77 – 7.51 (m, 16H), 7.40 – 7.35 (m, 
1H, ), 7.29 – 7.25 (m, 2H, ), 7.23 – 7.13 (m, 1H), 2.08 (dd, 2JHP = 12.2, 3JHP = 7.5 Hz, 1H, CH), 
1.35 (d, 3JHP = 15.7 Hz, 9H, 
tBu), 0.97 (d, 3JHP = 15.7 Hz, 9H, 
tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 64.31 (d, 3JPP = 8.4 Hz, P (JohnPhos)), 26.94 (d, 3JPP = 
8.4 Hz, P (ylide)). 
13C APT (75 MHz, CD2Cl2) δ 149.25 (d, 2JCP = 14.0 Hz, C (JohnPhos)), 144.98 (d, 3JCP = 6.3 
Hz, C (JohnPhos)), 135.65 (d, 4JCP = 3.0 Hz, p-PPh3), 134.66 (d, 
4JCP = 2.3 Hz, CH (JohnPhos)), 
133.73 (d, 3JCP = 9.7 Hz, m-PPh3), 131.72 (d, 
4JCP = 2.4 Hz, CH (JohnPhos)), 130.73 (d, 
2JCP = 
12.6 Hz, o-PPh3), 130.27 (s, CH (JohnPhos)), 129.73 (s, CH (JohnPhos)), 128.97 (s, CH 
(JohnPhos)), 128.14 (d, 3JCP = 6.7 Hz, CH (JohnPhos)), 127.77 (s, CH JohnPhos), 126.36 (d, 
1JCP = 43.8 Hz, C (JohnPhos)), 121.80 (d, 
1JCP = 88.3 Hz, ipso-PPh3), 38.13 (d, 
1JCP = 23.2 Hz, 
C (tBu)), 37.83 (d, 1JCP = 22.8 Hz, C (
tBu)), 31.31 (d, 2JCP = 6.5 Hz, CH3 (
tBu)), 30.59 (d, 2JCP 
= 6.3 Hz, CH3 (
tBu)), 17.53 (dd, 1JCP = 68.6, 
2JCP 53.7 Hz, CH). 
 Chapter 2 – Ylide Gold Complexes 
136 
 
 
To a solution of 3 (0.0602 g, 0.2 mmol) in CH2Cl2 (5 ml) was added [Ag(OTf)(PPh3)] (0.1038 
g, 0.2 mmol) and the mixture stirred for 1 h with the exclusion of light. The solution was filtered 
through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.1461 g, 89%). 
IR (cm-1) ν(C≡N) 2188 
1H NMR (300 MHz, CD2Cl2) δ 7.80 – 7.17 (m, 30H, 2 x PPh3), 2.86 (d, 2JHP = 4.3 Hz, 1H, 
CH). 
31P{1H} NMR (121 MHz, CD2Cl2, 298 K) δ 25.92 (s, PPh3 (ylide)), 12.48 (s, br, Ag-PPh3). 
31P{1H} NMR (121 MHz, CD2Cl2, 203 K) δ 25.83 (s, PPh3 (ylide)), 11.81 (dd, 1J109Ag-P = 628.2 
Hz, 1J107Ag-P 544.1 Hz). 
13C APT (75 MHz, CD2Cl2) δ 134.56 (d, 4JCP = 2.9 Hz, p-PPh3 (ylide)), 134.26 (d, 2JCP = 15.9 
Hz, o-PPh3), 133.39 (d, 
3JCP = 9.9 Hz, m-PPh3 (ylide)), 131.65 (s, p-PPh3, 130.34 (d, 
2JCP = 
12.5 Hz, o-PPh3 (ylide)), 129.77 (d, 
3JCP = 10.2 Hz, m-PPh3), 124.50 (d, 
1JCP = 90.6 Hz, ipso-
PPh3 (ylide)), 1.17 (d, 
1JCP = 83.2 Hz, CH). 
 
 
To a solution of 3 (0.0602 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Cu(NO3)(PPh3)2] (0.1303 
g, 0.1 mmol) and the mixture stirred for 1 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.1585 g, 
83%). 
IR (cm-1) ν(C≡N) 2153. 
1H NMR (300 MHz, CD2Cl2) δ 7.69 – 7.11 (m, 45H, 3 x PPh3), 1.78 (d, 2JHP = 5.9 Hz, 1H, 
CH). 
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31P{1H} NMR (121 MHz, CD2Cl2) δ 23.12 (s, PPh3 (ylide)), -1.36 (s, br, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 134.15 (d, 2JCP = 14.8 Hz, o-PPh3), 133.59 (d, 4JCP = 3.0 Hz, 
p-PPh3 (ylide)), 133.24 (d, 
3JCP = 10.3 Hz, m-PPh3 (ylide)), 132.67 (d, 
1JCP = 31.8 Hz, 
ipso-PPh3), 130.71 (s, p-PPh3), 129.81 (d, 
2JCP = 12.5 Hz, o-PPh3 (ylide)), 129.31 (d, 
3JCP = 9.3 
Hz, m-PPh3), 126.66 (d, 
1JCP = 92.5 Hz, ipso-PPh3 (ylide)), 1.21 (s, CH). 
 
 
To a solution of complex 6 (0.0534g, 0.1 mmol) in CH2Cl2 (5 ml) was added AgOTf 
(0.0257 g, 0.1 mmol) and PPh3 (0.0262 g, 0.1 mmol) and the mixture stirred for 3 h with the 
exclusion of light. The solution was filtered through celite, the filtrate concentrated under 
reduced pressure to approximately 1 ml and n-pentane added to precipitate a white solid. A 
mixture of 15, 2 and 26 was obtained. The peaks corresponding to 15 in the NMR spectra could 
be identified. 
1H NMR (400 MHz, CDCl3) δ 7.86 – 7.13 (m, 2 x PPh3), 4.32 (dd, 2JHP = 13.0 Hz, 3JHP = 8.6 
Hz, 1H, CH). 
31P{1H} NMR  (162 MHz, CDCl3) δ 38.72 (d, 3JPP = 10.6 Hz, PPh3), 27.92 (d, 3JPP = 10.6 Hz, 
PPh3 (ylide)). 
 
 
[Au2Cl2(dppe)] (0.0432 g, 0.05 mmol), AgOTf (0.0257 g, 0.1 mmol) and 3 (0.0301 g, 0.1 
mmol) were dissolved in CH2Cl2 (5 ml) and the mixture stirred for 4 h with the exclusion of 
light. The solution was filtered through celite, the filtrate concentrated under reduced pressure 
to approximately 1 ml and Et2O (10 ml) added to precipitate a white solid which was collected 
and vacuum dried. A mixture of diastereoisomers of 16 and [Au(dppe)2](OTf) was obtained. 
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Method 1: To a solution of [AuCl(tht)] (0.0321 g, 0.1 mmol) in CH2Cl2 (5 ml) was added 
[Ag(OTf)(tht)] (0.0345 g, 0.1 mmol) and the mixture stirred for 1 h with the exclusion of light. 
Precipitated silver chloride was removed by filtration through celite and to the filtrate was 
added a solution of 3 (0.0602 g, 0.2 mmol) in CH2Cl2 (5 ml) and the mixture stirred for 1 h. 
The solution was concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) 
added to precipitate a white solid which was collected and vacuum dried to give the product 
(0.0718 g, 76%).  
Method 2: To a solution of 18 (0.0430 g, 0.05 mmol) in CH2Cl2 (3 ml) was added [AuCl(tht)] 
(0.0161 g, 0.05 mmol) and the mixture stirred for 15 min with the exclusion of light. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.0443 g, 93%) 
IR (cm-1) ν(C≡N) 2210 
1H NMR (400 MHz, CD2Cl2) δ 8.66 – 6.85 (m, 30H, PPh3), 3.38 (d, 2JHP = 12.8 Hz, 1H, CH), 
3.37 (d, 2JHP = 12.8 Hz, 1H, CH (diastereoisomer)). 
31P{1H} NMR  (162 MHz, CD2Cl2) δ 26.69 (s, PPh3), 26.64 (s, PPh3 (diastereoisomer)). 
13C APT (75 MHz, CD2Cl2) δ 135.51 (d, 4JCP = 2.8 Hz, p-PPh3), 133.77 (d, 3JCP = 10.0 Hz, m-
PPh3), 130.77 (d, 
2JCP = 12.8 Hz, o-PPh3), 121.76 (d, 
1JCP = 88.6 Hz, ipso-PPh3), 118.46 (d, 
2JCP = 9.2 Hz, C≡N), 9.94 (d, 1JCP = 52.1 Hz, CH). 
 
 
3 (0.0602 g, 0.2mmol) and AgOTf (0.0257 g, 0.1 mmol) were mixed in CH2Cl2 (5 ml) and the 
mixture stirred for 3 h with the exclusion of light. The solution was concentrated under reduced 
pressure to approximately 1 ml and Et2O (10 ml) added to precipitate a white solid which was 
collected and vacuum dried to give the product (0.0768 g, 89%). 
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IR (cm-1) ν(C≡N) 2168 
1H NMR (400 MHz, CD2Cl2) δ 8.12 – 7.28 (m, 30H, PPh3), 2.76 (d, 2JHP = 8.7 Hz, 1H, CH). 
31P{1H} NMR  (162 MHz, CD2Cl2) δ 26.58 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 135.17 (d, 4JCP = 3.1 Hz, p-PPh3), 133.35 (d, 3JCP = 9.8 Hz, m-
PPh3), 130.72 (d, 
2J = 12.6 Hz, o-PPh3), 123.25 (d, 
1JCP = 89.7 Hz, ipso-PPh3), 0.82 (d, 
1JCP = 
66.6 Hz, CH). 
 
 
3 (0.0602 g, 0.2 mmol) and [Cu(NCMe)4]PF6 (0.0373 g, 0.1 mmol) were mixed in CH2Cl2 
(5 ml) and the mixture stirred for 3 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0600 g, 
74%). 
IR (cm-1) ν(C≡N) 2166 
1H NMR (300 MHz, CD2Cl2) δ 7.97 – 6.89 (m, 30H, PPh3), 2.10 (d, 2JHP = 4.0 Hz, 2H, CH). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 24.43 (s, PPh3). 
13C NMR (75 MHz, CD2Cl2) δ 134.16 (d, 4JCP = 3.0 Hz, p-PPh3), 133.37 (d, 3JCP = 10.4 Hz, 
m-PPh3), 130.07 (d, 
2JCP = 12.6 Hz, o-PPh3), 125.38 (d, 
1JCP = 93.1 Hz, ipso-PPh3), 1.83 (d, 
1JCP = 130.9 Hz, CH). 
 
 
To a solution of 2 (0.0451 g, 0.1 mmol) in acetone (5 ml) was added [Au(C6F5)(tht)] 
(0.0904 g, 0.2 mmol) and Cs2CO3 (excess) and the mixture stirred for 3 h. The mixture was 
filtered through celite, the filtrate concentrated under reduced pressure to approximately 1 ml 
and n-hexane added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.1056 g, 91%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C32H15Au2F10NP 1028.0199, Found 1028.0199 
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IR (cm-1) ν(C≡N) 2165, ν(C6F5) 1503, 951, 794. 
1H NMR (400 MHz, Acetone) δ 8.28 – 8.18 (m, 6H, PPh3), 7.73 – 7.63 (m, 3H, PPh3), 7.59 – 
7.54 (m, 6H, PPh3). 
31P{1H} NMR  (162 MHz, Acetone) δ 32.37 (s, PPh3). 
19F NMR (376 MHz, Acetone) δ -116.81 – -117.03 (m, 4F, o-C6F5), -166.23 (t, 3JFF = 19.8 
Hz, 2F, p-C6F5), -166.42 – -166.84 (m, 4F, m-C6F5). 
13C APT (101 MHz, Acetone) δ 134.75 (d, 3JCP = 8.9 Hz, m-PPh3), 133.22 (d, 4JCP = 2.8 Hz, 
p-PPh3), 130.46 (d, 
1JCP = 86.8 Hz, ipso-PPh3), 129.49 (d, 
2JCP = 11.6 Hz, o-PPh3), 127.65 (s, 
C≡N). 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) and [Au(C6F5)(tht)] (0.0904 g, 0.2 mmol) in CH2Cl2 
(5 ml) was added NBu4(acac) (0.0342 g, 0.1 mmol) and the mixture stirred for 3 h. The solution 
was filtered through celite, the filtrate concentrated under reduced pressure to approximately 1 
ml and n-hexane added to precipitate a white solid which was collected and vacuum dried to 
give the product (0.1243 g, 98%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C32H15Au2F10NP 1028.0199, Found 1028.0199 
1H NMR (400 MHz, CD2Cl2) δ 8.45 – 7.30 (m, 15H, PPh3), 3.17 – 3.04 (m, 8H, CH2), 1.67 – 
1.49 (m, 8H, CH2), 1.39 (h, 
3JHH = 7.4 Hz, 8H, CH2), 0.96 (t, 
3JHH = 7.3 Hz, 12H, CH3). 
31P{1H} NMR  (162 MHz, CD2Cl2) δ 32.08 (s, PPh3). 
19F NMR (376 MHz, CD2Cl2) δ -115.46 – -115.70 (m, 4F, o-C6F5), -162.92 (t, 3JFF = 20.1 Hz, 
2F, p-C6F5), -163.91 – -164.12 (m, 4F, m-C6F5). 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) and [AuCl(tht)] (0.0641 g, 0.2 mmol) in CH2Cl2 (5 ml) 
was added NBu4(acac) (0.0342 g, 0.1 mmol) and the mixture stirred for 3 h. The solution was 
filtered through celite, the filtrate concentrated under reduced pressure to approximately 1 ml 
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and Et2O added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.0961 g, 95%) 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C20H15Au2Cl2NP 763.9656, Found 763.9643. 
IR (cm-1) ν(C≡N) 2160. 
1H NMR (300 MHz, CD2Cl2) δ 8.25 – 7.28 (m, 15H, PPh3), 3.39 – 3.07 (m, 8H, CH2), 1.85 – 
1.63 (m, 8H, CH2), 1.46 (h, 
3JHH = 7.3 Hz, 8H, CH2), 1.02 (t, 
3JHH = 7.3 Hz, 12H, CH3). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 28.95 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 134.37 (d, 3JCP = 9.0 Hz, m-PPh3), 133.38 (d, 4JCP = 2.8 Hz, p-
PPh3), 129.48 (d, 
2JCP = 11.9 Hz, o-PPh3), 128.21 (d, 
1JCP = 87.2 Hz, ipso-PPh3), 125.94 (s, 
C≡N), 59.72 (s, CH2), 24.64 (s, CH2), 20.42 (s, CH2) 14.08 (s, CH3). 
 
 
To a solution of 17 (0.0660 g, 0.07 mmol) in CH2Cl2 (5 ml) was added [Au(C6F5)(tht)] (0.0474 
g, 0.14 mmol) and NBu4(acac) (0.0628 g, 0.14 mmol) and the mixture stirred for 2 h. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and n-hexane added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.0936 g, 38%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C52H30Au3F10N2P2 1526.0716, Found 1525.0710. 
IR (cm-1) ν(C≡N) 2153. 
 
 
To a solution of 17 (0.2071 g, 0.2 mmol) in THF (5 ml) was added [AuCl(tht)] (0.1282 g, 0.4 
mmol) and NBu4(acac) (0.3206 g, 0.4 mmol) and the mixture stirred for 2 h. The solution was 
cooled to 0 °C and a white precipitate formed which was collected by filtration, washed with 
Et2O and vacuum dried to give the product (0.0761 g, 13%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C46H30Au3Cl2N2P2 1261.0252, Found 1261.0241. 
 Chapter 2 – Ylide Gold Complexes 
142 
IR (cm-1) ν(C≡N) 2154 
1H NMR (300 MHz, CD2Cl2) δ 7.98 – 7.26 (m, 30H, Ph), 3.38 – 3.21 (m, 8H, CH2), 1.80-1.69 
(m, 8H, CH2), 1.54 – 1.39 (m, 8H, CH2), 1.01 (t, 3JHH = 7.3 Hz, 12H, CH3). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 29.17 (s, PPh3). 
 
 
To a solution of 25 (0.2041 g, 0.125 mmol) in CH2Cl2 (10 ml) was added [AuCl(tht)] (0.1603 
g, 0.5 mmol) and the mixture stirred for 2 h with the exclusion of light. The solution was filtered 
through celite to give a yellow filtrate. The filtrate was concentrated under reduced pressure to 
approximately 1 ml and Et2O (10 ml) added to precipitate a pale-yellow solid which was 
collected and vacuum dried to give the product (0.2284 g, 92%). 
MS (ESI+) m/z: 1988.8 [M]+, 1791.3 [M-Au]+, 1293.9 [M-{Au2 C(PPh3)(C≡N)]+ 
IR (cm-1) ν(C≡N) 2154 
1H NMR (300 MHz, CD2Cl2) δ 7.81 – 7.42 (m, Ph). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 28.92 (s, PPh3) 
13C APT (75 MHz, CD2Cl2) δ 134.13 (d, 3JCP = 9.0 Hz, m-PPh3), 132.76 (s, p-PPh3), 129.37 
(d, 2JHP = 12.4 Hz, o-PPh3), 129.04 (d, 
1JCP = 85.9 Hz, ipso-PPh3), 127.03 (s, C≡N). 
 
 
Method 1: To a solution of 3 (0.3013 g, 1.0 mmol) in CH2Cl2 (10 ml) was added Ag2O (0.1159 
g, 0.5 mmol) and the mixture stirred for 12 h with the exclusion of light. The resulting pale-
yellow solution was filtered through celite and the filtrate concentrated under reduced pressure 
to approximately 1 ml. Et2O (10 ml) was added to precipitate a white solid which was collected 
and vacuum dried to give the product (0.3506 g, 86%). 
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Method 2: To a solution of 1 (0.3378 g, 1.0 mmol) in CH2Cl2 (10 ml) was added Ag2O (0.2317 
g, 1.0 mmol) and the mixture stirred for 12 h with the exclusion of light. The solution was 
filtered through celite and the resulting pale-yellow filtrate concentrated under reduced 
pressure to approximately 1 ml. Et2O (10 ml) was added to precipitate a white solid which was 
collected and vacuum dried to give the product (0.3179 g, 78%). 
MS (MALDI) m/z: 1740 [M+Ag]+, 1331 [M-{AgC(PPh3)(C≡N)}+Ag]+, 816 
[M-2{AgC(PPh3)(C≡N)}]+, 408 [M-3{AgC(PPh3)(C≡N)}]+. 
IR (cm-1) ν(C≡N) 2109 
1H NMR (300 MHz, CD2Cl2) δ 8.33 – 6.82 (m, PPh3). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 29.52 (m, PPh3). 
13C NMR (75 MHz, CD2Cl2) δ 133.29 (d, 3JCP = 8.9 Hz, m-PPh3), 132.72 (d, 4JCP = 2.7 Hz, p-
PPh3), 130.81 (d, 
1JCP = 87.3 Hz, ipso-PPh3), 129.62 (d, 
2JHP = 11.7 Hz, o-PPh3). 
 
 
To a solution of 2 (0.2257 g, 0.5 mmol) in CH2Cl2 (10 ml) was added [Au(acac)(PPh3)] (0.5594 
g, 1.0 mmol) and the mixture stirred for 4 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.6093 g, 
89%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C56H45Au2NP3 1218.2090, Found 1218.2033. 
IR (cm-1) ν(C≡N) 2168, ν(OTf) 1271 (SO3), 1222 (CF3), 1156 (CF3), 1029 (SO3). 
1H NMR (400 MHz, CDCl3)  δ 8.23 – 6.51 (m, PPh3). 
31P{1H} NMR  (162 MHz, CDCl3) δ 37.21 (d, 3JPP = 6.5 Hz, Au-PPh3), 33.82 (t, 3JPP = 6.5 Hz, 
C-PPh3). 
19F NMR (376 MHz, CDCl3) δ -77.97 (OTf). 
13C APT (101 MHz, CDCl3) δ 169.94 (s, C-C≡N), 133.97 (s, p-Ph3P-C), 133.68 (d, 3JCP = 14.0 
Hz, m-Ph3P-Au), 133.10 (d, 
3JCP = 9.5 Hz, m-Ph3P-C), 132.23 (s, p-Ph3P-Au), 129.66 (d, 
2JCP 
= 12.2 Hz, o-Ph3P-C), 129.48 (d, 
2JCP = 11.8 Hz, o-Ph3P-Au), 128.29 (d, 
1JCP = 57.8 Hz, ipso-
Ph3P-Au), 126.58 (d, 
1JCP = 88.6 Hz, ipso-Ph3P-C), 124.28 (s, C≡N). 
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To a solution of 2 (0.451 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au2Cl2(dppf)] (0.1019 g, 
0.1 mmol) and NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 4 hours. The bright 
orange solution was concentrated under reduced pressure to approximately 1 ml and Et2O (10 
ml) was added to precipitate a bright orange solid which was collected and vacuum dried to 
give the product (0.1285 g, 90%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C54H43Au2FeNP3 1248.1285, Found 1248.1223. 
IR (cm-1) ν(C≡N) 2173 
1H NMR (300 MHz, CD2Cl2) δ 8.21 – 7.88 (m, 6H, Ph), 7.83 - 7.77 (m, 3H, Ph), 7.66 – 7.50 
(m, 17H, Ph), 7.47 – 7.41 (m, 5H, Ph), 7.37 – 7.00 (m, 4H, Ph), 5.05 – 3.60 (m, 10H, Cp). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 33.12 (t, 3JPP = 5.4 Hz, PPh3), 31.67 (m, dppf). 
 
 
 
To a solution of 3 (0.0301 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au2Cl2(XantPhos)] 
(0.1043 g, 0.1 mmol), AgOTf (0.0514 g, 0.2 mmol) and NBu4(acac) (0.0342 g, 0.1 mmol) and 
the mixture stirred for 2 h. The solution was filtered through celite, the filtrate concentrated 
under reduced pressure to approximately 1 ml and Et2O (10 ml) added to precipitate a white 
solid which was collected and vacuum dried to give the product (0.1280 g, 90%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C59H47Au2NOP3 1272.2196, Found 1272.2193. 
IR (cm-1) ν(C≡N) 2175. 
1H NMR (300 MHz,) δ 8.05 – 7.89 (m, 6H, XantPhos), 7.82 – 7.69 (m, 2H, XantPhos), 7.66 
– 7.03 (m, 27H, Ph), 6.97 - 6.91 (m, 4H, XantPhos), 6.53 – 6.45 (m, 2H, XantPhos), 1.90 (s, 
3H, Me), 1.53 (s, 3H, Me). 
31P{1H} NMR  (121 MHz, CD2Cl2) δ 35.14 (s, XantPhos), 32.85 (s, PPh3). 
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To a solution of 17 (0.1035 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au2Cl2(XantPhos)] 
(0.1043 g, 0.1 mmol) and NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 1 h. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.1439 g, 74%). 
IR (cm-1) ν(C≡N) 2160. 
1H NMR (300 MHz, CD2Cl2) δ 8.20 – 6.25 (m, 56H, XantPhos +Ph), 1.70 (s, 3H, Me), 1.27 
(s, 3H, Me). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 31.18 (d, 3JPP = 5.5 Hz, PPh3), 29.18 (d, 3JPP = 5.4 Hz, 
XantPhos). 
 
 
To a solution of 17 (0.1035 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au(acac)(PPh3)] (0.1118 
g, 0.2 mmol) and the mixture stirred for 4 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O added to precipitate a 
white solid which was collected and vacuum dried to give the product (0.1641 g, 88%). 
MS (ESI+) m/z: 1715.1 [M]+. 
IR (cm-1) ν(C≡N) 2161 
1H NMR (400 MHz, CDCl3)  δ 8.15 – 6.80 (m, Ph). 
31P{1H} NMR (162 MHz, CDCl3) δ 36.37 (d, 3JPP = 7.5 Hz), 36.20 (d, 3JPP = 6.8 Hz), 32.24 
(d, 3JPP = 6.5 Hz), 30.89 (d, 
3JPP = 7.4 Hz). 
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Method 1: To a solution of [AuCl(PPh3)] (0.0495 g, 0.1 mmol) in CH2Cl2 (5 ml) was added 
AgOTf (0.0257 g, 0.1 mmol) and the mixture stirred for 1 h with the exclusion of light. 26 
(0.1368 g, 0.1 mmol) was added and the mixture stirred for a further 2 h. The solution was 
filtered through celite, the filtrate concentrated under reduced pressure to approximately 1 ml 
and Et2O added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.1719 g, 87%). 
Method 2: To a solution of 2 (0.0451 g, 0.1 mmol) in CH2Cl2 (20 ml) was added 
[O{Au(PPh3)}3]BF4 (0.1481 g, 0.1 mmol) and the mixture stirred for 4 h at room temperature. 
The solution was concentrated under reduced pressure to approximately 2 ml and Et2O added 
to precipitate a white solid which was collected and vacuum dried to give the product (0.1402 
g, 73 %). 
IR (cm-1) ν(C≡N) 2171 
1H NMR (400 MHz, CDCl3) δ 7.95 – 7.05 (m, Ph). 
31P{1H} NMR (162 MHz, CDCl3) δ 36.51 (d, 3JPP = 7.3 Hz, Au-PPh3), 33.26 (t, 3JPP = 7.3 Hz, 
C-PPh3), 29.08 (s, N-Au-PPh3). 
19F NMR (376 MHz, CDCl3) δ -77.83 (s, OTf), -153.30 (s, BF4). 
13C APT (101MHz, CDCl3) δ 134.70 (d, 4JCP = 2.7, p-Ph3P-C), 134.09 (d, 3JCP = 13.6, m-
Ph3P-C), 133.73 (d, 
3JCP = 6.9, m-Ph3P-Au), 133.16 (d, 
3JCP = 9.9, m-Ph3P-N), 132.58 (d, 
4JCP 
= 2.5, p-Ph3P-N), 132.44 (s, p-Ph3P-Au), 130.16 (d, 
2JCP = 12.5, o-Ph3P-N), 129.64 (d, 
2JCP = 
12.1, o-Ph3P-Au), 129.57 (d, 
2JCP = 12.4, o-Ph3P-C), 127.83 (d, 
1JCP = 59.0, ipso-Ph3PAu-N), 
126.94, (d, 1JCP = 66.3, ipso-Ph3PAu-C), 125.06 (d, 
1JCP = 89.4, ipso-Ph3P-C). 
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To a solution of 26 (0.0684 g, 0.05 mmol) in CH2Cl2 (5 ml) was added [Ag(OTf)(PPh3)] 
(0.0260 g, 0.05 mmol) and the mixture stirred for 1 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0925 g, 
98%). 
IR (cm-1) ν(C≡N) 2160 
1H NMR (300 MHz, CDCl3) δ 8.61 – 6.67 (m, Ph). 
31P{1H} NMR (121 MHz, CDCl3) δ 36.93 (d, 3JPP = 6.6 Hz, Au-PPh3), 33.62 (t, 3JPP = 6.7 Hz, 
C-PPh3), 11.51 (s, Ag-PPh3). 
 
 
To a solution of 26 (0.0684 g, 0.05 mmol) in CH2Cl2 (5 ml) was added [Cu(NO3)(PPh3)2] 
(0.0325 g, 0.05 mmol) and the mixture stirred for 1 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and n-hexane added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0825 g, 
99%). 
IR (cm-1) ν(C≡N) 2166 
1H NMR (300 MHz, CDCl3) δ 8.15 – 6.90 (m, Ph). 
31P{1H} NMR (121 MHz, CDCl3) δ 37.08 (d, 3JPP = 6.4 Hz, Au-PPh3), 33.66 (t, 3JPP = 6.4 Hz, 
C-PPh3), -0.35 (s, Cu-PPh3). 
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To a solution of 26 (0.0684 g, 0.05 mmol) in CH2Cl2 (10 ml) was added [Au(tmbn)2]SbF6 
(0.0205 g, 0.025 mmol) and the mixture stirred for 2 h. The solution was filtered through celite, 
the resulting yellow filtrate concentrated under reduced pressure to approximately 1 ml and 
Et2O added to precipitate a pale yellow solid which was collected and vacuum dried. A mixture 
of the product and tmbn was obtained 
IR (cm-1) ν(C≡N) 2172 
1H NMR (300 MHz, CDCl3) δ 8.15 – 6.85 (m, Ph). 
31P{1H} NMR (121 MHz, CDCl3) δ 36.48 (d, 3JPP = 7.2 Hz, Au-PPh3), 33.16 (t, 3JPP = 7.2 Hz, 
C-PPh3). 
 
 
To a solution of 26 (0.8207 g, 0.6 mmol) in acetone (20 ml) was added AgOTf (0.0771 g, 0.3 
mmol) and the mixture stirred for 3 h at room temperature with the exclusion of light. The 
mixture was filtered through celite and the resulting pale yellow solution concentrated to 
dryness under reduced pressure to give 36 as a pale orange solid (0.6594 g, 73 %). 
IR (cm-1) ν(C≡N) 2166 
1H NMR (300 MHz, Acetone) δ 7.32 – 8.09 (m, Ph).  
31P{1H} NMR (121 MHz, Acetone) δ 37.39 (d, 3JPP = 6.1, AuPPh3), 33.83 (t, 3JPP = 6.1, PPh3).  
19F NMR (376 MHz, Acetone) δ -77.70 (s, OTf).  
13C APT (101 MHz, CDCl3) 134.15 (s, p-Ph3P-C), 133.64 (d, 
3JCP = 14.2 Hz, m-Ph3P-Au), 
133.06 (d, 3JCP = 9.6 Hz, m-Ph3P-C), 132.22 (s, p-Ph3P-Au), 129.77 (d, 
2JCP = 12.3 Hz, o-Ph3P-
C), 129.47 (d, 2JCP = 12.1 Hz, o-Ph3P-Au), 128.10 (d, 
1JCP = 58.2 Hz, ipso-Ph3P-Au), 126.02 
(d, 1JCP = 88.9 Hz, ipso-Ph3P-C), 125.05 (s, C≡N). 
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To a solution of 26 (0.2734 g, 0.2 mmol) in acetonitrile (20 ml) was added [Cu(NCMe)4]BF4 
(0.0315 g, 0.1 mmol) and the mixture stirred for 3 h at room temperature. The mixture was 
filtered through celite and the resulting yellow solution concentrated to dryness under reduced 
pressure to give 33 as a pale yellow solid (0.2415 g, 84 %). 
IR (cm-1) ν(C≡N) 2167 
1H NMR (400 MHz, CDCl3) δ 7.11 – 7.80 (m, Ph).  
31P{1H} NMR (162 MHz, CDCl3) δ 36.84 (d, 3JPP = 6.8, AuPPh3), 33.22 (t, 3JPP = 6.8, PPh3).  
19F NMR (376 MHz, CDCl3) δ -77.76 (s, OTf), -153.82 (s, BF4). 
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Chapter 3 – Allenyl Gold Complexes 
3.1. Introduction 
Allenes are well known within organic chemistry. They are valuable building blocks for the 
synthesis of more complex molecular targets and can participate in a variety of different types 
of reaction including nucleophilic and electrophilic additions174, cycloadditions175, cyclisations 
as well as various palladium-176 and gold-catalysed reactions177. Their potential application in 
natural product synthesis178, pharmaceutical chemistry179 and materials science has resulted in 
the recent development of new synthetic methodologies. The allene moiety has now been found 
in over 150 natural products and their intrinsic axial chirality means allenes are of great utility 
in organic chemistry due to their unique structure and reactivity. In the past few decades there 
has been a huge increase in interest in allene chemistry and many research groups have now 
focussed their attention on the synthesis and application of these highly versatile compounds, 
which for many years were considered only chemical curiosities. 
 
In organometallic chemistry, allenes are somewhat less common. π-Bound metal allene 
complexes have been reported as catalytic intermediates and many examples of isolable 
complexes in which the allene is π-bound to the metal have been reported and structurally 
characterised.180 σ-Bound η1-allenyl transition metal complexes, however, are considerably 
rarer and only known for a few transition metals. Challenging syntheses along with little known 
application have resulted in a lack of interest in such complexes until recently. Their chemical 
potential as well as the useful bonding information they can provide has only started to be 
realised in the last two decades and the diverse chemistry and versatility of these cumulated 
ligands is now gaining more interest.181 They do, however, still remain somewhat elusive 
species in organometallic chemistry. 
 
3.1.1. Allenes – Structure and Axial Chirality 
The symmetry and isomerism of allenes has fascinated chemists for many years. The allene 
unit is comprised of three carbon atoms with two adjacent C=C double bonds and a C-C-C 
bond angle of 180°. The central carbon atom is therefore sp hybridised while the terminal C 
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atoms are sp2 hybridised. The two adjacent π-orbitals formed as a result of the overlap of the 
p-orbitals are orthogonal and consequently the substituents at the terminal carbon atoms are 
also orthogonal, resulting in axial chirality when different substituents are present at the 
terminal carbon atoms. (Figure 3.1).  
 
 
Figure 3.1. Allene orbitals and enantiomers where A > B. 
 
3.1.2. History 
The correct structure of allenes and higher cumulenes as well as their axial chirality was 
predicted by Van’t Hoff in 1875182 only very shortly after the tetrahedral geometry of carbon 
was first suggested and at a time when some of the most significant developments in organic 
chemistry were made. Van’t Hoff used tetrahedrons to model the bonding in organic molecules, 
considering the carbon atom to be at the centre of each tetrahedron. Allenes were therefore 
comprised of three tetrahedrons (Figure 3.2). 
 
 
Figure 3.2. Van’t Hoff’s tetrahedron model for an allene. 
 
Although several experimental investigations were made in the following years, many chemists 
doubted the existence of such allene bond systems, considering them to be highly unstable. The 
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first documented synthesis of an allene was the synthesis of “glutinic acid” reported in 1887 
by Burton and Pechmann,183 however their aim was actually to disprove the existence of such 
compounds and the lack of analytical tools at the time meant that it was almost impossible to 
distinguish between allenes and alkynes. Burton and Pechmann initially proposed an alkyne 
structure for “glutinic acid” and it was not until the introduction of IR spectroscopy and the 
discovery of the characteristic allene C=C=C vibration at around 1950 cm-1 that allenes could 
readily be identified. The revised structure for “glutinic acid” was published by Jones and 
co-workers in 1954 (Figure 3.3).184 
 
 
Figure 3.3. “Glutinic acid” proposed alkyne and revised allene structure. 
 
Many problems with the incorrect characterisation of allenic natural products were encountered 
at the beginning of the twentieth century (Figure 3.4). In 1906 Semmler proposed an allene 
structure for carlina oxide, a furan derivative extracted from the roots of Carlina acualis,185 
however this was later revised with the help of Raman spectroscopy and is actually the isomeric 
alkyne (Figure 3.4(a)).186 Another case is pyrethrolone which was reported by Staudinger and 
Ruzicka to have an allene structure.187 This incorrect assignment was based on the cleavage of 
the natural product by ozonolysis but later spectroscopic investigations revealed the correct 
structure to be a conjugated diene (Figure 3.4(b)).188 Similarly, for many well-known natural 
products which do have an allene structure, the correct determination of the allene was made 
long after their original isolation, for example the carotinoid peridinin which was first isolated 
in 1890189 but not correctly characterised until 1971,190 some 81 years later! The huge number 
of naturally occurring allenes shows that they represent an important structural class of 
compounds and can no longer be considered mere curiosities.  
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Figure 3.4. Incorrectly assigned allene natural products and the corrected structures. 
 
The first π-bound metal-allene complex was reported in 1967 by Pettit with the preparation of 
a tetramethylallene iron complex by reaction of tetramethylallene with Fe2(CO)9. The authors 
reported the formation of two different complexes in the reaction, one being 2,4-dimethyl-1,3-
pentadiene iron tricarbonyl and the other the iron-allene complex (Scheme 3.1). The complexes 
were characterised by NMR spectroscopy and it was suggested that in in solution at room 
temperature the Fe(CO)4 unit of the allene complex is rapidly moving between the two allene 
double bonds.191  
 
 
Scheme 3.1. Synthesis of first π-bound metal-allene complex. 
 
Many examples of π-bound metal-allene complexes have subsequently been isolated and 
structurally characterised by single crystal X-ray diffraction. One of the earliest examples is 
the bis(triphenylphosphino)palladium π-allene complex reported by Okamoto and co-workers 
in 1974 (Figure 3.5).192 The structure clearly shows that one of the allene π-bonds coordinates 
to palladium resulting in the allene being significantly distorted from linearity with the 
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C(1)-C(8)-C(15) bond angle of 148.3(8)°. The C(1)-C(8) bond is lengthened slightly to 
1.401(11) Å compared to free allene (1.31 Å) due to a loss of electron density to palladium. 
The uncoordinated C-C allene bond, C(8)-C(15), has a bond distance typical for that of an 
allene at 1.304(12) Å. 
 
 
Figure 3.5. Molecular structure of Pd(η2-CH2=C=CH2)(PPh3)2 determined by single crystal X-ray diffraction. 
Triphenylphosphine hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: Pd(1)-C(1) 
2.118(9), Pd(1)-C(2) 2.067(8), Pd(1)-P(1) 2.314(2), Pd(1)-P(2) 2.324(2), C(1)-C(8) 1.401(11), C(8)-C(15) 
1.304(12), C(1)-C(8)-C(15) 148.3(8). 
 
Gold(I) π-allene complexes were reported in 2010 by the group of Widenhoefer193 and were 
prepared by a procedure previously used for the synthesis of gold(I) π-alkene, π-diene and 
π-alkyne complexes (see Chapter 1). Chloride abstraction from [AuCl(JohnPhos)] with 
AgSbF6 and subsequent addition of allene allowed the isolation of a series of gold(I) π-allene 
complexes (Scheme 3.2).112 
 
 
Scheme 3.2. Synthesis of gold(I) π-allene complexes. 
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Three examples were successfully characterised by single crystal X-ray diffraction 
(Figure 3.6). In each case the gold is coordinated to the less hindered double bond of the allene. 
The C-C bond distances for the double bond bound to gold are slightly longer than the 
uncoordinated allene bond. 
 
Figure 3.6. Molecular structures of [Au(η2-CH2=C=CMe2)(JohnPhos)]+ (a), [Au(η2-CH2=C=CHEt)(JohnPhos)]+ 
(b) and [Au(η2-CHnPr=C=CHnPr)(JohnPhos)]+ (c) determined by single crystal X-ray diffraction. JohnPhos 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°] a: Au(1)-C(1) 2.191(5), 
Au(1)-C(2) 2.306(5), Au(1)-P(1) 2.309(1), C(1)-C(2) 1.340(7), C(2)-C(3) 1.311(7), C(1)-C(2)-C(3) 165.0(5). b: 
Au(1)-C(1) 2.208(4), Au(1)-C(2) 2.238(4), Au(1)-P(1) 2.298(1), C(1)-C(2) 1.348(6), C(2)-C(3) 1.310(6), 
C1-C2-C3=166.4(4). c: Au(1)-C(1) 2.269(2), Au(1)-C(2) 2.219(2), Au(1)-P(1) 2.2953(6), C(1)-C(2) 1.329(4), 
C(2)-C(3) 1.314(4), C(1)-C(2)-C(3) 164.2(3). 
 
The first σ-η1-allenyl transition metal complex was the rhenium complex reported by the group 
of Stone in 1966.194 This was prepared by reaction of hexafluorobut-2-yne with [Re(CO)5]⁻ 
and was believed to proceed via addition of the rhenium anion to the acetylene followed by 
elimination of fluoride (Scheme 3.3).195 The allene structure of the product was established by 
1H and 19F NMR spectrometry and IR spectroscopy. 
 
 
Scheme 3.3. Synthesis of the first σ-η1-allenyl transition metal complex. 
 
In 1968 Jolly and Pettit reported the synthesis of a propargyl iron complex by reaction of 
Na[Fe(CO)2Cp] with propargyl bromide (Scheme 3.4).
196 One year later it was pointed out by 
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Johnson that the large coupling constant reported for the protons of the propargyl ligand 
(6.5 Hz) could only be derived from an allene π-interaction and the complex was indeed an 
allenyl iron complex. The C=C=C stretching frequency in the IR spectrum was obscured by 
the C≡O signal making the characterisation difficult. In the same paper Johnson reported the 
synthesis of an allenyl cobalt complex by reaction of bis(dimethylglyoximato)pyridine 
cobalt(I) anion with propargyl bromide.197 
 
 
Scheme 3.4. Synthesis of σ-η1-allenyl iron complex. 
 
The first allenyl metal complex to be characterised by single crystal X-ray diffraction was the 
tris(trifluoromethyl)allenyl manganese derivative reported in 1978 (Figure 3.7). The allenyl 
structure of the ligand can clearly be seen by the C=C bond distances of C(5)-C(6)1.2907(2) Å 
and C(6)-C(7) 1.2530(2) Å. The C(5)-C(6)-C(7) bond angle is only slightly distorted from 
linearity at 176.723(10)°. 
 
 
Figure 3.7. Molecular structures of [Mn(η1-C(CF3)=C=C(CF3)2)(CO)4(PPh3)] determined by single crystal X-ray 
diffraction. Hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: 
Mn(1)-P(1) 2.3192(4), Mn(1)-C(5) 2.1102(4), C(5)-C(6) 1.2907(2), C(6)-C(7) 1.2530(2), C(5)-C(6)-C(7) 
176.723(10). 
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Allenyl complexes of several transition metals have now been successfully isolated and 
structurally characterised by single crystal X-ray diffraction, including: tungsten,198-200 
ruthenium,201-211 osmium,202,212,213 iridium,214 platinum,215,216 chromium,217,218 rhodium,219-221 
zirconium,222-226 hafnium227-229 and palladium.230-233 However, although allenyl complexes of 
the coinage metals have been suggested as intermediates in various reactions, no examples 
have previously been isolated or characterised. 
 
3.1.3. Tautomerism in Allenyl Metal Complexes 
One important aspect of η1-allenyl metal complexes which has attracted attention is their 
tautomeric behaviour with η1-propargyl complexes. Such allene-propargyl tautomerism 
processes are very common in organic chemistry and can be reversible,234,235 however the 
analogous rearrangements in transition metal complexes are quite rare.236 The first evidence of 
propargyl-allenyl tautomerism in a complex was found with complexes of tungsten. Addition 
of propargyl bromide to [W(CO)3Cp]ˉ initially gave the η1-propargyl complex, however, on 
heating the η1-allenyl complex was produced. When the deuterium labelled BrCH2C≡CD was 
used, [W(CO)3Cp(CH2C≡CD)] formed which then gave [W(CO)3Cp(CD=C=CH2)] 
exclusively (Scheme 3.5), ruling out a 1,3-hydrogen shift mechanism. The tautomerism was 
also found to be an intramolecular process since addition of [W(CO)3Cp]ˉ had no effect on the 
rate. A 1,3-metal migration was suggested.237-239 
 
 
Scheme 3.5. Synthesis and isomerisation of propargyl tungsten complex. 
 
The first reversible example of such a tautomerism process in metal complexes was reported 
in 1995 for complexes of platinum. The complex [Pt(η1-CH2C≡CPh)Cl(PPh3)2] underwent 
slow tautomerisation upon heating to yield an equilibrium mixture of the η1-allenyl and 
η1-propargyl species. The pure η1-allenyl tautomer gave the same equilibrium mixture upon 
dissolution, showing that the tautomerisation is reversible (Scheme 3.6). A 5-coordinate 
intermediate was suggested.240-242 
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Scheme 3.6. Reversible propargyl-allenyl tautomerisation of [Pt(η1-CH2C≡CPh)X(PPh3)2] and proposed 
5-coordinate intermediate. 
 
3.1.4. Triphenylpropargyl Phosphonium Bromide 
Triphenylpropargyl phosphonium bromide (Figure 3.8. (a)) is a functionalised phosphonium 
salt which can readily isomerise into the allenyl (Figure 3.8. (b)) or α-alkynyl (Figure 3.8 (c)) 
phosphonium salts and therefore has the potential for some very interesting chemistry. 
 
 
Figure 3.8. Isomeric structures of propargyl (a), allenyl (b) and α-alkynyl (c) phosphonium bromide salts. 
 
In 1977 Schweizer reported that treatment of the propargyl phosphonium salt with potassium 
tert-butoxide gives the allenyl isomer, whereas heating in phenol leads to the α-alkynyl 
species.118 Bagdasaryan and co-workers, however, found a solvent dependence for the 
propargylic rearrangement with a mixture of the α-alkynyl and allenyl isomers found in 
solution in chloroform and a mixture of the propargyl and α-alkynyl isomers in solution in 
acetonitrile.119 More recently Hill and co-workers reported a rhodium catalysed version of this 
rearrangement in which addition of [RhCl(CO)(PPh3)2] to the propargyl phosphonium salt 
resulted in the formation of the allenyl isomer, with the reaction proceeding via an η2-allenyl  
phosphonium complex (Scheme 3.7).243  
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Scheme 3.7. Rhodium catalysed formation of allenylphoshonium salt. 
 
Computational studies of the relative energies of the different isomeric forms of this 
phosphonium salt found that the propargyl isomer is the least favourable in the gas phase, 
tetrahydrofuran solution and chloroform solution. In THF the allenyl isomer is slightly lower 
in energy that the alkynyl isomer, however, in chloroform the alkynyl isomer is favoured 
(Figure 3.9).244 It is therefore not surprising that such propargylic rearrangements occur. 
 
 
Figure 3.9. Relative energies (ΔG, kJ/mol) of the isomeric cations a+ - c+.  
 
Triphenylpropargylphosphonium bromide has successfully been used to prepare η2-allenyl 
complexes of ruthenuium, platinum, rhodium and iridium. A vinyl ruthenium complex was 
also reported by reaction of [RuClH(CO)(PPh3)3] with triphenylpropargyl phosphonium 
bromide and NH4PF6 as a result of addition of ruthenium hydride across the alkyne bond.
245 
As with all phosphonium salts bearing protons at the α-carbon, 
triphenylpropargylphosphonium bromide is the precursor to a phosphonium ylide which, 
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similarly to the phosphonium salt, has several isomers. There therefore exists the possibility 
for a variety of different ylide metal complexes (Figure 3.10). 
 
 
Figure 3.10. Possible structures for ylide metal complexes derived from triphenylpropargylphosphonium 
bromide. 
 
The propargyl isomer could be deprotonated and subsequently coordinate to a metal atom at 
the α-carbon to give isomer a or the γ-carbon to give a linear coordination of the metal to the 
alkyne group, isomer b. Similarly, the allenyl isomer could be deprotonated at either the α- or 
γ-carbon and coordinate a metal atom to give isomers c or d, respectively. The α-alkynyl isomer 
has only one potential site for deprotonation, the γ-carbon, which after coordination to a metal 
atom would give isomer e. No examples of any such σ-coordination complexes of this ylide 
have previously been reported. Since triphenylpropargyl phosphonium bromide will readily 
isomerise to the allenyl isomer it is a promising candidate for the potential formation of allenyl 
metal complexes. 
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3.2. Propargyl Phosphonium Salts 
3.2.1. Triphenylpropargylphosphonium bromide isomerism in solution 
The solvent dependence of the isomeric form of triphenylpropargylphosphonium bromide in 
solution over time was studied by NMR spectroscopy. The results are shown in Table 3.1. 
 
Table 3.1. Percentage of isomers a, b and c of triphenylpropargylphosphonium bromide 
present after 1 h, 10 h and 24 h in solution in various solvents 
Solvent 
 
1 h 
a : b : c 
 
10 h 
a : b : c 
24 h 
a : b : c 
Acetone-d6  100 : 0 : 0 0 : 100 : 0  0 : 84 : 16  
Acetonitrile-d3  100 : 0 : 0 100 : 0 : 0   100 : 0 : 0  
Chloroform-d 100 : 0 : 0 29 : 71 : 0  0 : 98 : 2 
Dichloromethane-d2 100 : 0 : 0 16 : 84 : 0 0 : 97 : 3  
DMSO-d6 100 : 0 : 0 100 : 0 : 0 89 : 11 : 0  
Methanol-d4 100 : 0 : 0 Addition product formed 
 
 
In all solvents after 1 h only the propargyl isomer a (Figure 3.8) was observed. After 10 h in 
solution significant amounts of the allenyl isomer b were observed in chloroform and 
dichloromethane solutions and in acetone complete conversion to the allenyl isomer had 
occurred. In DMSO and acetonitrile, however, no isomerism was observed after 10 h. After 24 
h in solution in acetone, chloroform and dichloromethane no propargyl isomer remained. In 
acetone 16% of the α-alkynyl isomer c was observed, whereas in chloroform and 
dichloromethane only trace amounts were present. This shows the solvent can have a huge 
effect on the tautomer present in solution and consequently on the reactivity. 
 
3.2.2. Triphenylpropargylphosphonium triflate 
The reaction of triphenylpropargylphosphonium bromide with silver triflate was carried out in 
order to change the coordinating bromide anion for the far less coordinating triflate anion. 
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Reaction of triphenylpropargylphosphonium bromide, 38a, with a stoichiometric amount of 
silver triflate in dichloromethane gave triphenylpropargylphosphonium triflate, 39a, in a yield 
of 93%. Heating a dichloromethane solution of the salt to 40 °C for 10 min resulted in complete 
conversion into the allene isomer, 39b (Scheme 3.8). 
 
 
Scheme 3.8. Synthesis of propargyl and allenyl phosphonium triflate salts. 
 
The infrared absorption frequencies for the bromide salt 38a and the triflate salts 39a and 39b 
are shown in Table 3.2. The strong absorption band at 1909 cm-1 present only in salt 39b clearly 
shows the presence of the allene isomer. 
 
Table 3.2. Infrared absorption frequencies 
Phosphonium Salt ν (cm-1) 
38a 3148 C≡CH, 2111 C≡C 
39a 3261 C≡CH 
39b 3055 C=CH2, 1909 C=C=C 
 
 
The isomers 39a and 39b could readily be identified by 1H NMR spectroscopy (Figure 3.11). 
In the 1H NMR spectrum of isomer 39a the propargyl C-H appears as a doublet of triplets at 
2.30  ppm with coupling constants of 4JHP = 6.8 Hz and 
4JHH = 2.5 Hz. This shift is characteristic 
for a shielded proton next to a C≡C triple bond. In the allenyl isomer, 39b, however, the C-H 
appears at a much higher chemical shift, 6.96 ppm. The C-H proton will be deshielded as a 
result of being next to a C=C double bond and in close proximity to the positively charged 
phosphorus atom of the triphenylphosphine group. Again, the signal is observed as a doublet 
of triplets but with higher coupling constants compared to the propargyl isomer, 4JHP = 7.8 Hz 
and 4JHH 6.6 Hz. The enhanced HH coupling is a result of the allenyl π-bonds. 
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Figure 3.11. 1H NMR spectra of 39a (a) and 39b (b) in CDCl3 at room temperature. 
 
The molecular structures of both salts 39a and 39b were obtained by single crystal X-ray 
diffraction (Figure 3.12). Suitable crystals were grown by slow diffusion of n-hexane into a 
solution of the complex in dichloromethane. For salt 39a the bond length C(2)-C(3) 1.176(8) Å 
is typical of that for a C≡C triple bond, cf. 1.20 Å in ethyne,246 highlighting the presence of the 
alkyne isomer. The C(1)-C(2)-C(3) bond angle is very close to linear at 177.5(6)°. For complex 
39b the bond distances C(7)-C(8) and C(8)-C(9) are 1.257(4) and 1.250(4) Å, respectively. 
These distances are characteristic for C-C double bonds. The bond angle C(7)-C(8)-C(9) is 
almost linear at 178.1(3)° as would be expected for an allene.  
 
a) 
b) 
CDCl3 
H2O 
CDCl3 
H2O 
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Figure 3.12. Molecular structures of 39a (a) and 39b (b) determined by single crystal X-ray diffraction. Selected 
bond lengths [Å] and angles [°] 39a: P(1)-C(1) 1.819(6), C(1)-C(2) 1.459(8), C(2)-C(3) 1.176(8), C(1)-C(2)-C(3) 
177.5(6). 39b: P(1)-C(7) 1.769(3), C(7)-C(8) 1.257(4), C(8)-C(9) 1.250(4), C(9)-C(8)-C(7) 178.1(3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) b) 
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3.3. Allenyl Gold Complexes from Triphenylpropargylphosphonium 
Salts 
3.3.1. Synthesis of Allenyl Gold Complexes 
Reaction of triphenylpropargylphosphonium bromide with [AuX(tht)] (X = Cl, C6F5) in 
dichloromethane in the presence of caesium carbonate led to the formation of the 
unprecedented allenyl gold complexes 40 and 41 in good yields of 63% and 85%, respectively 
(Scheme 3.9). Reaction of the phosphonium triflate salt with [Au(acac)(PPh3)] gave the allenyl 
gold phosphine complex 42, however the yield was only moderate, 50%. A more effective 
synthetic route was the reaction of complex 41 with [Au(PPh3)2]OTf which gave complex 42 
in a yield of 60%. The driving force in this reaction is the formation of the stable 
[Au(C6F5)(PPh3)] which can readily be separated due to its high solubility in organic solvents.  
 
 
Scheme 3.9. Synthesis of complexes 40-42. 
 
The IR spectra of complexes 40-42 clearly show the presence of the allene by the characteristic 
C=C=C absorption at around 1900 cm-1 (Table 3.3). 
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Table 3.3. Infrared absorption frequencies 
Complex ν(C=CH2) (cm-1) ν(C=C=C) (cm-1) 
40 3068 1906 
41 3055 1901 
42 3054 1911 
 
In the 1H NMR spectra of complexes 40 and 41 the allene CH2 protons are observed as 
a doublet with coupling constant 4JHP = 16.0 Hz due to coupling with the PPh3 group. Despite 
the presence of the second phosphorus atom in complex 42, the CH2 protons are still observed 
as a doublet with 4JHP = 15.6 Hz due to coupling only with the ylide PPh3. The 
13C APT spectra 
show the characteristic signals for the allene carbon atoms with signals at 83.8, 216.5 and 
65.6 ppm for complex 40. Not all of the quaternary carbon signals are observed in the 13C APT 
spectra of complexes 41 and 42, with resonances at 215.9 and 64.0 ppm for complex 41 and 
66.5 ppm for complex 42.  
 
The molecular structures of complexes 40-42 were determined by single crystal X-ray 
diffraction (Figure 3.13). The expected linear coordination about the gold centres can clearly 
be seen with angles of 179.66(10)° (40), 175.24(9)° (41), 177.7(3)° (42), the slight distortion 
is due to the steric hindrance between the bulky triphenylphosphine group of the allenyl unit 
and the other ligand at gold. The Au-C distances are within values found for Au-C σ-bonds. 
The similarity of the bond lengths C(1)-C(2) and C(2)-C(3), 1.296(5) and 1.304(5) Å for 40, 
1.304(4) and 1.300(4) Å for 41 and 1.293(16) and 1.290(19) Å for 42, highlights the presence 
of the allenyl isomer. These are also comparable to the carbon-carbon bond length in ethene, 
1.34 Å.  
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Figure 3.13. Molecular structures of 40-42 determined by single crystal X-ray diffraction. Phenyl hydrogen 
atoms, anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°] 40: Au(1)-
C(1) 2.032(4), Au(1)-Br(1) 2.3980(4), C(1)-P(1) 1.769(3), C(1)-C(2) 1.296(5), C(2)-C(3) 1.304(5), C(1)-Au(1)-
Br(1) 179.66(10), C(1)-C(2)-C(3) 178.6(4). 41: Au(1)-C(1) 2.055(2), Au(1)-C(11) 2.036(2), C(1)-P(1) 1.770(2), 
C(1)-C(2) 1.304(4), C(2)-C(3) 1.300(4), C(11)-Au(1)-C(1) 175.24(9), C(3)-C(2)-C(1) 178.4(3). 42: Au(1)-C(1) 
2.063(11), Au(1)-P(1) 2.265(3), C(1)-P(2) 1.758(11), C(1)-C(2) 1.293(16), C(2)-C(3) 1.290(19), C(1)-Au(1)-P(1) 
177.7(3), C(3)-C(2)-C(1) 178.6(14). 
 
With the aim of obtaining allenyl gold(III) complexes which are unknown in the literature, the 
reaction of triphenylpropargylphosphonium bromide with the gold(III) derivative 
[Au(C6F5)3(tht)] was carried out in dichloromethane (Scheme 3.10). This reaction resulted in 
the formation of phosphonium aurate salt 43a in which the alkyne triple bond is maintained. 
Attempts to coordinate the Au(C6F5)3 unit by a reaction with excess caesium carbonate, a 
method analogous to that for the preparation of allenyl gold(I) complexes, led only to 
isomerisation to the allene isomer salt 43b. Reaction of 43a with the stronger base, sodium 
hydride, resulted in deprotonation, isomerisation to the allenyl isomer and coordination of the 
Au(C6F5)3 unit to the γ-carbon atom to give chiral allenyl gold(III) complex 44 in a yield of 
65%. Complex 44 could also be prepared by the synthetically simpler route in which 
triphenylpropargylphosphonium triflate is reacted with [Au(C6F5)3(tht)] in the presence of 
excess caesium carbonate. In this case an intermediate phosphonium aurate salt analogous to 
53 is not produced since the triflate ion is too weakly coordinating to bind to the gold centre.  
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Scheme 3.10. Synthesis of allenyl gold(III) derivatives. 
 
The 1H NMR spectrum of complex 44 confirms the coordination of the gold(III) centre to the 
γ-carbon atom as the protons of the outer allenyl carbon atoms each appear as a doublet of 
doublets coupling themselves and also to the phosphorus atom, with 4JHP = 12.8 Hz, 
4JHH = 6.0 Hz (Au-CH) and 
2JHP = 14.0 Hz, 
4JHH = 6.0 Hz (CH(PPh3)). In the 
13C APT spectrum 
the allenic carbon atoms (Ph3P)HC=C=CH(AuR3) appear at 86.4, 205.6 and 65.6, respectively, 
downshielded compared with those of the gold(I) species. An absorption at 1907 cm-1 is 
observed in the IR spectrum due to the C=C=C fragment. 
 
The formation of complex 44 by deprotonation of the γ-carbon atom is unusual since the proton 
at the α-carbon of the phosphonium salt would be more acidic as a negative charge here would 
be stabilised by the positively charged phosphorus of the triphenylphosphine group. It is likely 
that the triphenylphosphine and tris-pentafluorophenyl gold(III) groups are too sterically bulky 
to be in close proximity resulting in regioselectivity in the coordination to the γ-carbon. 
 
The molecular structure of 44 was unambiguously determined by single crystal X-ray 
diffraction methods (Figure 3.14). Complex 44 is an axially chiral allenyl derivative which 
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crystallises in the space group P21/c with both the (S) and (R) enantiomers in the asymmetric 
unit. The bond distances C(1)-C(2) of 1.276(7) Å and C(2)-C(3) of 1.322(9) Å for the (S) 
enantiomer and C(67)-C(68) of 1.276(9) Å and 1.322(9) Å for the (R) enantiomer are typical 
of those for carbon-carbon double bonds. The Au-C bond distances to the carbon atoms of the 
pentafluorophenyl moieties and to the carbon atom of the allenyl ligand are very similar. A 
square planar coordination is observed about the gold(III) centres. 
 
      
Figure 3.14. Molecular structures of both enantiomers of complex 44 determined by single crystal X-ray 
diffraction. Phenyl hydrogen atoms and solvent molecules are omitted for clarity. Selected bond lengths [Å] and 
angles [°]: Au(1)-C(1) 2.076(7), Au(1)-C(41) 2.056(6), Au(1)-C(51) 2.070(6), Au(1)-C(61) 2.063(6), C(1)-C(2) 
1.276(9), C(2)-C(3) 1.322(9), C(3)-P(1) 1.769(6), Au(2)-C(67) 2.055(7), Au(2)-C(101) 2.063(6), Au(2)-C(111) 
2.064(6), Au(2)-C(121) 2.062(6), C(67)-C(68) 1.276(9), C(68)-C(69) 1.322(9), C(69)-P(2) 1.757(7), C(51)-
Au(1)-C(1) 176.7(2), C(41)-Au(1)-C(61) 177.9(2), C(1)-C(2)-C(3) 176.3(7), C(67)-Au(2)-C(111) 175.7(3), 
C(121)-Au(2)-C(101) 177.4(2), C(67)-C(68)-C(69) 177.8(7). 
 
The stability of the allenyl gold complexes at different temperatures was determined by 
variable temperature NMR experiments (Figure 3.15-16). No dynamic NMR effects were 
observed at low or high temperature indicating a high thermal stability for the complexes. This 
is likely to be due to the electron-withdrawing phosphonium group.  
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Figure 3.15. 1H NMR spectra for complex 40 in THF at different temperatures. 
 
Figure 3.16. 31P{1H} NMR spectra for complex 40 in THF at different temperatures. 
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A protodeauration experiment was carried out with complex 36 by addition of a stoichiometric 
amount of a solution of HCl in diethyl ether to a solution of the complex in deuterated 
chloroform at room temperature (Scheme 3.11). NMR experiments showed the formation of 
[AuCl(PPh3)] and the phosphonium salt after 12 hours (Figure 3.17). This process could be 
relevant in a catalytic cycle as the key step for the release of a catalyst.  
 
 
Scheme 3.11. Protodeauration of complex 42.  
 
 
Figure 3.17. 31P{1H} NMR spectra for complex 42 (a) and complex 42 12 h after addition of HCl (b). 
 
3.3.2. Influence of Steric and Electronic Properties 
In order to determine if the regioselectivity found in the allenyl gold complexes was due to 
steric effects or the oxidation state of gold, additional gold(I) complexes were prepared in 
which the gold bears a sterically bulky NHC ligand (Scheme 3.12). 
a) 
b) 
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Scheme 3.12. Synthesis of allenyl gold(I) NHC complexes. 
 
Reaction of the phosphonium triflate salt with [AuCl(NHC)] (NHC = IMes, IPr) in the presence 
of Cs2CO3 gave allenyl gold(I) complexes 45 and 46. Despite the huge steric bulk of the NHC 
ligand, coordination at the α-carbon of the allenyl ligand still occurs. 
 
Table 3.4. Selected Infrared Absorption Frequencies for Complexes 45 and 46 
Complex ν(C=CH2) (cm-1) ν(C=C=C) (cm-1) 
45 3062 1910 
46 - 1908 
 
Selected IR absorption frequencies for complexes 45 and 46 are shown in Table 3.4. For both 
complexes a characteristic allene C=C=C absorption at around 1900 cm-1 is observed. In the 
1H NMR spectra the allenyl CH2 protons are observed as a doublet at 4.08 ppm with 
4JHP = 16.1 Hz for 45 and at 3.99 ppm with 
4JHP = 15.8 Hz for 39. Not all of the allenyl carbons 
are observed in the 13C APT spectra with signals at 216.7 and 65.0 ppm for complex 45 and a 
signal at 64.6 ppm for complex 46. 
 
The molecular structures of 45 and 46 were determined by single crystal X-ray diffraction 
analysis (Figure 3.18). In both cases a linear coordination is observed about gold with angles 
177.66(13)° (45) and 177.66(9)° (46), the slight distortion due to the steric bulk of the NHC 
ligands and the triphenylphosphine group. In both cases the allenyl C-C bond distances are 
similar with distances of 1.305(5) and 1.297(5) Å for 45 and 1.309(3) and 1.298(4) Å for 46, 
comparable to the C-C bond distances in ethene. The C=C=C bond angles are almost linear at 
178.3(4)° for 45 and 179.1(3)° for 46. 
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Figure 3.18. Molecular structures of complexes 45 and 46 determined by single crystal X-ray diffraction. Phenyl 
hydrogen atoms, anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°] 
45: Au(1)-C(1) 2.015(4), Au(1)-C(22) 2.048(4), P(1)-C(22) 1.776(3), C(22)-C(23) 1.305(5), C(23)-C(24) 
1.297(5), C(1)-Au(1)-C(22) 177.66(13), C(24)-C(23)-C(22) 178.3(4). 46: Au(1)-C(37) 2.017(2), Au(1)-C(1) 
2.051(2), C(1)-P(1) 1.775(2), C(1)-C(2) 1.309(3), C(2)-C(3) 1.298(4), C(37)-Au(1)-C(1) 177.66(9), C(3)-C(2)-
C(1) 179.1(3). 
 
When a bulky phosphine gold(I) precursor was used, a different reactivity was observed. 
Reaction of the phosphonium triflate salt, 39a, with [AuCl(JohnPhos)] in the presence of 
caesium carbonate gave two products, 47 and 48 (Scheme 3.13).  
 
The expected allenyl gold(I) complex, 47, in which the gold is bound to the α-carbon of the 
allenyl ligand is observed by NMR spectroscopy by the presence of a doublet of doublets at 
4.29 ppm in the 1H NMR spectrum with 4JHP = 16.1 Hz and 
5JHP = 3.8 Hz due to the allenyl 
CH2 coupling with the triphenylphosphine and the JohnPhos phosphorus atoms. The 
31P{1H} NMR spectrum shows two doublets at 63.84 ppm (JohnPhos) and 18.84 ppm (PPh3) 
with 3JPP = 2.0 Hz. However, an additional doublet at 62.65 ppm and triplet at 18.95 ppm with 
4JPP = 6.5 Hz are also observed in the 
31P{1H} NMR spectrum due to the presence of complex 
48 in which two gold phosphine units are bound to the γ-carbon atom of the allenyl ligand 
(Figure 3.19). It is likely that this complex forms due to the favourable Au···Au interactions.  
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Scheme 3.13. Synthesis of complexes 47 and 48.  
 
 
 
 
 
Figure 3.19. 31P{1H NMR spectrum of reaction mixture from the formation of complexes 47 and 48 in CD2Cl2. 
 
The molecular structure of the dinuclear complex, 48, was determined by single crystal X-ray 
diffraction (Figure 3.20). The coordination about each gold atom is slightly distorted from 
linearity due to the presence of the bulky phosphine groups, with angles C(1)-Au(1)-P(2) 
174.22(10)° and C(1)-Au(2)-P(3) 173.95(10)°. One of the allene bonds is slightly shorter than 
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the other with distances C(1)-C(2) 1.251(5) Å and C(2)-C(3) 1.364(5) Å, however both are still 
comparable to the typical distance for a carbon-carbon double bond. The C=C=C angle is 
practically linear at 178.7(4)°. 
 
Figure 3.20. Molecular structures of complex 48 determined by single crystal X-ray diffraction. Phenyl hydrogen 
atoms and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 
2.052(3), Au(1)-P(2) 2.2780(9), Au(1)-Au(2) 3.1487(2), Au(2)-C(1) 2.038(4), Au(2)-P(3) 2.2891(9), C(1)-C(2) 
1.251(5), C(2)-C(3) 1.364(5), C(3)-P(1) 1.721(4), C(1)-Au(1)-P(2) 174.22(10), C(1)-Au(2)-P(3) 173.95(10), 
C(1)-C(2)-C(3) 178.7(4). 
 
When the even more sterically demanding phosphine, 1-[2-[bis(tert-butyl)phosphino]phenyl]-
3,5-diphenyl-1H-pyrazole (TrippyPhos), is used, only one product, 49, is formed in which one 
gold phosphine unit is bound to the α-carbon of the allenyl ligand (Scheme 3.14). In this case 
the steric bulk of the phosphine is so great that the formation of a dinuclear species would not 
be possible. Despite the hindrance of the PPh3 group coordination at the α-carbon is still 
preferable. 
 
Scheme 3.14. Synthesis of complex 49. 
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The allenyl CH2 protons of complex 41 are observed in the 
1H NMR spectrum as a doublet of 
doublets at 4.23 ppm (4JHP = 16.0 Hz, 
5JHP = 4.1 Hz) due to coupling with both the ylide and 
the TrippyPhos phosphorus atoms (Figure 3.21(a)). The 31P{1H} NMR spectrum presents two 
doublets at 60.76 ppm and 19.39 ppm (3JPP = 1.6 Hz) due to the TrippyPhos and ylide 
phosphorus atoms, respectively (Figure 3.21(b)). 
 
 
 
 
 
 
 
 
Figure 3.21. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) of complex 49 in CD2Cl2 at room temperature. 
 
In an attempt to prepare a further gold(III) derivative, phosphonium aurate salts 50a and 51a 
were prepared (Scheme 3.15). Reaction with caesium carbonate led only to isomerisation to 
the allene in both cases to give salts 50b and 51b and no coordination of the allenyl group to 
gold was observed. Use of a stronger base led to decomposition. 
H2O 
CD2Cl2 
a) 
b) 
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Scheme 3.15. Synthesis of salts 50a-b and 51a-b.  
 
The oxidation of complex 40 with Cl2 to give a gold(III) derivative was attempted (Scheme 
3.16).  
 
 
Scheme 3.16. Oxidation of complex 40. 
 
A mixture of products was obtained due to the mixture of halide ligands. In the 31P{1H} NMR 
spectrum two groups of signals are clearly observed (Figure 3.22). The signals at around 21 
ppm are assigned to complex 52 with coordination to gold through the α-carbon atom of the 
allenyl ligand. Different derivatives are possible with different mixtures of Br and Cl. The 
signals at around 7 ppm indicate a different coordination and are proposed to be a result of the 
formation of complex 53 with coordination through the γ-carbon of the allenyl ligand to gold. 
Again, different derivatives are possible due to the mixture of Cl and Br.  
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Figure 3.22. 31P{1H} NMR spectrum from the reaction mixture from the oxidation of 40. 
 
Crystals were obtained from the reaction mixture and measured by single crystal X-ray 
diffraction. The molecular structure of a derivative of complex 52 was found in which two 
bromide ligands and one chloride ligand are bound to gold (Figure 3.23). A square-planar 
coordination is observed about the gold(III) centre. The carbon-carbon bond distance in the 
allenyl ligand are clearly double bonds with distances C(1)-C(2) 1.276(15) Å and C(2)-C(3) 
1.328(16) Å. The C=C=C bond angle is almost linear, C(1)-C(2)-C(3) 179.1(12)°. 
 
 
Figure 3.23. Molecular structures of complex 52 determined by single crystal X-ray diffraction. Phenyl hydrogen 
atoms and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-Br(1) 
2.3709(14), Au(1)-Br(2) 2.3752(15), Au(1)-Cl(1) 2.391(2), Au(1)-C(1) 2.034(10), P(1)-C(1) 1.801(10), C(1)-
C(2) 1.276(15), C(2)-C(3) 1.328(16), Br(1)-Au(1)-Br(2) 175.24(5), C(1)-Au(1)-Cl(1) 175.4(3), C(1)-C(2)-C(3) 
179.1(12). 
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The oxidation of complex 45 with Cl2 was also attempted (Scheme 3.17). In this case only two 
signals were observed in the 31P{1H} NMR spectrum, assigned to the products 54 and 55 
(Figure 3.24(b)). Three doublets are observed in the 1H NMR spectrum, these are assigned to 
the CH2 group of the allenyl ligand in complex 54, and the two separate protons of the allenyl 
ligand in complex 55 (Figure 3.24(a)). 
  
 
Scheme 3.17. Oxidation of complex 45. 
 
 
 
 
 
 
Figure 3.24. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) for the reaction mixture from the oxidation 
of complex 45 in CD2Cl2. 
CD2Cl2 
H2O 
a) 
b) 
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To prepare a more stable gold(III) derivative, a gold(III) precursor bearing a tridentate 
2,6-bis(benzimidazol-2′-yl)pyridine ligand was used. Reaction of this precursor with 
triphenylpropargylphosphonium triflate in the presence of triethylamine led to a mixture of 
products (Scheme 3.18). One of these crystallised from the mixture and was characterised by 
single crystal X-ray diffraction as complex 56.  
 
 
Scheme 3.18. Synthesis of complex 56. 
 
 
Figure 3.25. Molecular structures of complex 56 determined by single crystal X-ray diffraction. Phenyl hydrogen 
atoms and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 
2.065(10), Au(1)-N(1) 2.026(9), Au(1)-N(3) 2.038(9), Au(1)-N(4) 2.017(8), Au(2)-C(3) 2.055(11), Au(2)-N(6) 
2.016(10), Au(2)-N(8) 2.053(9), Au(2)-N(9) 1.988(10), Au(3)-C(3) 2.016(11), Au(3)-Br(1) 2.3853(16), P(1)-C(1) 
1.774(11), C(1)-C(2) 1.338(15), C(2)-C(3) 1.219(15), C(1)-Au(1)-N(3) 172.9(4), N(1)-Au(1)-N(4) 158.8(4), 
C(3)-Au(2)-N(8) 173.2(4), N(6)-Au(2)-N(9) 159.4(4), C(3)-Au(3)-Br(1) 177.5(4), C(1)-C(2)-C(3) 172.2(10). 
 
The molecular structure of complex 56 is shown in Figure 3.25. A distorted square planar 
coordination is observed about the gold(III) centres, Au(1) and Au(2), and a linear coordination 
about the gold(I) centre with angle C(3)-Au(3)-Br(1) 177.5(4)°. One of the allene bonds is 
longer than the other with distances C(1)-C(2) 1.338(15) Å and C(2)-C(3) 1.219(15) Å. The 
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C=C=C bond is also slightly distorted from linearity with an angle C(1)-C(2)-C(3) of 
172.2(10)°. This is due to the steric repulsion between the bulky ligands. 
 
In complex 56 the allenyl ligand is fully aurated. Two gold(III) units are bound, one at the 
α-carbon and one at the γ-carbon atom. An additional gold(I) is also bound at the γ-carbon 
atom. The formation of this complex can be proposed to proceed via initial formation of the 
mononuclear allenyl gold(III) complex with coordination at the γ-carbon of the allenyl ligand. 
In the presence of excess base further deprotonation will occur however due to the bulkiness 
of the gold(III) precursor, coordination of a second unit at the γ-carbon is unfavourable and 
hence coordination at the α-carbon occurs. Additional base finally results in further 
deprotonation at the γ-carbon. It is likely that the reduction to gold(I) occurs in the work-up as 
a result of washing with water and due to the smaller size of the Au-Br, this can successfully 
coordinate to the γ-carbon (Scheme 3.19). 
 
Scheme 3.19. Formation of complex 56. 
 
To fully aurate the allenyl ligand with gold(I), reaction of triphenylpropargylphosphonium 
triflate with 1.5 equivalents of [O(Au(PPh3))3]BF4 was carried out (Scheme 3.20). The 
tetranuclear derivative, 57, formed and was successfully characterised by single crystal X-ray 
diffraction. 
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Scheme 3.20. Synthesis of complex 57. 
 
 
Figure 3.26. Molecular structures of complex 57 determined by single crystal X-ray diffraction (Phenyl rings, 
anoins and solvent molecules are omitted for clarity.). Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 
2.122(14), Au(1)-P(2) 2.280(5), Au(1)-Au(2) 2.8994(10), Au(2)-C(1) 2.099(14), Au(2)-P(3) 2.267(4), Au(3)-C(3) 
2.068(13), Au(3)-P(4) 2.273(4), Au(3)-Au(4) 2.9176(9), Au(4)-C(3) 2.070(14), Au(4)-P(5) 2.261(4), P(1)-C(1) 
1.756(14), C(1)-C(2) 1.398(19), C(2)-C(3) 1.251(19), C(1)-Au(1)-P(2) 177.1(4), C(1)-Au(2)-P(3) 177.2(4), C(3)-
Au(3)-P(4) 175.5(4), C(3)-Au(4)-P(5) 178.4(4), C(1)-C(2)-C(3) 174.1(15). 
 
The molecular structure of complex 57 is shown in Figure 3.26. The coordination about each 
of the gold centres is linear and aurophilic interactions are observed with distances Au(1)-Au(2) 
2.8994(10) Å and Au(3)-Au(4) 2.9176(9) Å. The C=C=C bond angle is slightly distorted from 
linearity with an angle C(1)-C(2)-C(3) 174.1(15)°. One of the allenyl carbon-carbon bonds is 
considerably shorter than the other with distances C(1)-C(2) 1.398(19) Å and C(2)-C(3) 
1.251(19) Å.  
 
To observe whether two gold(I) atoms would preferentially bind to the γ-carbon atom of the 
allenyl ligand with an aurophilic interaction, or bind one at each carbon atom, the reaction of 
39a with two equivalents of [Au(acac)(PPh3)] was carried out (Scheme 3.21). Initial NMR 
 Chapter 3 – Allenyl Gold Complexes 
184 
studies after 10 min reaction time showed the presence of mononuclear complex 42 and 
unreacted starting material. However, after 10 h reaction time complex 42 was no longer 
observed. Two new doublets are observed in the 1H NMR spectrum and are assigned to 
complexes 58 and 59 (Figure 3.27(a)). 31P{1H} NMR studies show the presence of significant 
amounts of triphenylphosphine oxide. The other signals can be assigned to complexes 58 and 
59 (Figure 3.27(b)). 
 
 
Scheme 3.21. Synthesis of complexes 58 and 59. 
 
 
 
 
 
 
 
Figure 3.27. 1H NMR spectrum (a) and 31P{1H} NMR spectrum of complexes 58 and 59 in CD2Cl2 at room 
temperature.
Ph3PO 
CD2Cl2 
H2O 
Hacac 
Hacac 
Hacac 
a) 
b) 
 3.4. Propargyl Functionalised 1,1-Bis(diphenylphosphino)methane Derivatives 
185 
3.4. Propargyl Functionalised 1,1-Bis(diphenylphosphino)methane 
Derivatives 
Following the success with the triphenylpropargylphosphonium salts, attempts were made to 
prepare an analogous propargyl functionalised phosphonium salt from a diphosphine, hence 
providing an additional coordination site. 
 
 
Figure 3.28. Diphosphine derived propargyl phosphonium salt. 
 
Reaction of 1,1-bis(diphenylphosphino)methane with propargyl bromide in acetonitrile did 
give the expected phosphonium salt, 60, however the same reaction in chloroform led to the 
formation of an unusual cyclic diphosphole 61 (Scheme 3.22). 
 
 
Scheme 3.22. Synthesis of salts 60 and 61. 
 
Both salts could readily be identified by NMR spectroscopy. The 1H NMR spectrum of salt 60 
shows a doublet of triplets at 2.11 ppm (4JHP = 6.9 Hz and 
4JHH = 2.7 Hz) for the propargyl CH, 
a doublet of doublets at 4.73 ppm (2JHP = 15.5 Hz and 
4JHH = 2.8 Hz) for the propargyl CH2 
and a further doublet of doublets at 4.47 ppm (2JHP = 14.8 Hz and 
2JHP = 1.5 Hz) for the dppm 
CH2 (Figure 3.29(a)). Two doublets are observed in the 
31P{1H} NMR spectrum at 25.94 ppm 
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for the phosphonium P and at -25.94 ppm for the phosphine P with 2JPP = 59.1 Hz (Figure 
3.29(b)).  
 
 
 
 
Figure 3.29. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) for salt 60 in CDCl3. 
 
For salt 61 four non-aromatic proton signals are observed in the 1H NMR spectrum (Figure 
3.30(a)). The proton at C(1) is observed as a triplet of doublets at 2.01 ppm (2JHP = 6.4 Hz, 
5JHH = 1.1 Hz) due to coupling with the phosphorus atoms and the trans proton at C(4). The 
protons at C(2) are observed as a doublet of doublets at 4.31 ppm due to coupling with the 
nearest phosphorus atom and the trans proton at C(4). The protons at C(4) are each observed 
as a doublet due to coupling with the nearest phosphorus atom. The trans proton appears at 
7.03 ppm with 3JHP = 36.2 Hz whereas the cis proton appears at 5.86 ppm with a smaller 
coupling constant of 3JHP = 17.3 Hz. The 
31P{1H} NMR spectrum is a second order spectrum 
for an AB spin system (Figure 3.30(b)). The calculated chemical shifts are 32.28 and 31.64 
ppm with 2JPP = 61.9 Hz. 
 
 
 
a) 
b) 
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Figure 3.30. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) for salt 61 in CDCl3. 
 
The stability of propargylphosphonium salt 60 in solution was studied by NMR spectroscopy. 
In acetonitrile no isomerisation was observed after 24 h, however in solution in chloroform 
considerable amounts of salt 61 were observed after 24 h (Figure 3.31). The mechanism for the 
formation of salt 61 was suggested to proceed via first isomerisation of the propargyl unit into 
the allene and subsequent cyclisation to give 61 (Scheme 3.23). 
 
 
 
Figure 3.31. 31P{1H} NMR spectrum of salt 60 after 24 h in CDCl3. 
a) 
b) 
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Scheme 3.23. Suggested formation of salt 61. 
 
Reaction of salt 60 with [AuCl(tht)] in dichloromethane led to the formation of complex 62 
(Scheme 3.24). Coordination of the phosphine to gold could be confirmed by a change in 
chemical shift in the 31P{1H} NMR spectrum of the phosphine P signal from -25.94 to 19.71 
ppm. The phosphonium P signal at 23.90 ppm remains at a very similar chemical shift to that 
of salt 60 (Figure 3.32). No tautomerisation of the propargyl unit is observed.  
 
 
Scheme 3.24. Synthesis of complex 62. 
 
 
 
Figure 3.32. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) for complex 62. 
 
a) 
b) 
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Crystals of complex 62 were grown in chloroform and measured by single crystal X-ray 
diffraction. The molecular structure determined was actually that of complex 62 following the 
addition of HCl to the alkyne triple bond (Scheme 3.25). This reaction is likely to have occurred 
upon crystallisation due to significant amounts of HCl in the chloroform used to grow the 
crystals. 
 
 
Scheme 3.25. Addition of HCl to complex 62. 
 
The molecular structure is shown in Figure 3.33. The coordination of the phosphine to the gold 
can clearly be seen. 
 
 
Figure 3.33. Molecular structure of the complex formed upon addition of HCl to 62 determined by single crystal 
X-ray diffraction. Phenyl hydrogen atoms, anions and solvent molecules are omitted for clarity. Selected bond 
lengths [Å] and angles [°]: Au(1)-P(1) 2.2331(19), Au(1)-Br(1) 2.3858(12), P(1)-C(13) 1.836(7), P(2)-C(13) 
1.801(7), P(2)-C(25) 1.818(8), C(25)-C(26) 1.490(10), C(26)-Cl(1) 1.727(8), C(26)-C(27) 1.333(12), P(1)-Au(1)-
Br(1) 174.93(6). 
 
In order to prepare further derivatives from complex 62, attempts were made to change the 
chloride anion for a less coordinating triflate anion. Reaction of complex 62 with a 
stoichiometric amount of silver triflate led to rapid decomposition. An alternative route 
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involving changing the anion before the coordination to gold, i.e. by reaction of salt 60 with 
silver triflate led to a mixture of products, likely due to coordination of the silver to the free 
phosphine group (Scheme 3.26). 
 
 
Scheme 3.26. Attempts to exchange the halide anion for triflate. 
 
Attempts were also made to prepare coordination complexes from salt 61, however these 
proved unsuccessful (Scheme 3.27). 61 slowly isomerises to 63 in solution. This reaction alos 
occurs more rapidly in the presence of a base. The formation of 63 could readily be identified 
by NMR spectroscopy due to the loss of the vinylic CH signals and the presence of a new CH3 
signal. The 31P{1H} NMR spectrum shows two doublets. Salt 63 was found to be unstable 
towards hydrolysis, readily forming the hydrolysis products 64a and 64b which could be 
identified by mass spectrometry.  
 
 
Scheme 3.27. Reactions of salt 61. 
 
Reaction of salt 61 with silver triflate did successfully give the salt 61-OTf following the 
precipitation of silver bromide (Scheme 3.28). Attempts to grow crystals of this salt were made 
but the crystals obtained were actually of the triflate derivative of complex 64a This is because 
over time in solution salt 61-OTf isomerises to the methyl derivative 63-OTf and this then 
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undergoes hydrolysis. The molecular structure determined by single crystal X-ray diffraction 
is shown in Figure 3.34.  
 
 
Scheme 3.28. Reactions of salt 61. 
 
 
Figure 3.34. Molecular structure of 64a-OTf determined by single crystal X-ray diffraction. Phenyl hydrogen 
atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: P(1)-O(1) 1.4860(13), P(1)-C(13) 
1.8019(18), C(13)-C(14) 1.335(2), C(14)-C(15) 1.511(2), C(14)-P(2) 1.8264(17), P(2)-C(16) 1.7820(19). 
 
Reaction of salt 61 with [Au(C6F5)(tht)] gave the aurate salt 65. This could readily be identified 
by NMR studies with the diphosphole unit observed in the 1H and 31P{1H} NMR spectra. The 
19F NMR spectrum clearly shows the presence of the C6F5 ligand. Attempts to coordinate gold 
to the ylide-type carbon of diphosphole unit by abstraction of the bromide ligand with silver 
triflate to form complex 66, gave a mixture of products.  
 
Scheme 3.29. Synthesis of 65 and attempted synthesis of 66.  
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3.5. Propargyl Functionalised Ammonium Salt Derivatives 
To compare the difference in reactivity between propargyl functionalised phosphonium salts 
and ammonium salts, a series of propargyl functionalised ammonium salts were prepared by 
reaction of amines with propargyl bromide. In all cases the ammonium salts formed cleanly as 
highly insoluble solids, soluble only in DMSO and acetonitrile. The more soluble triflate salts 
were prepared by reaction of the ammonium bromide salts with silver triflate in acetonitrile 
(Scheme 3.30).  
 
Scheme 3.30. Synthesis of salts 67-74. 
 
Reaction of the ammonium salts, 71-74 with [Au(acac)(PPh3)] in dichloromethane gave 
complexes 75-78 in good yields 68-90% (Scheme 3.31). The loss of the propargyl CH signal 
in the 1H NMR spectra confirms coordination of the gold at the terminal C of the propargyl 
unit. Only one signal at around 40 ppm is observed in the 31P{1H} NMR spectrum in each case.  
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Scheme 3.31. Synthesis of complexes 75-78. 
 
Table 3.5. Selected 1H NMR and 31P{1H} NMR Peaks for Complexes 75-78 in CH2Cl2. 
Complex 1H NMR Cα-H (ppm) 31P{1H} NMR (ppm) 
75 3.99 41.17 
76 4.10 41.22 
77 4.27 41.23 
78 4.45 41.25 
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Figure 3.35. 1H NMR spectrum of 71 in CD3CN (a) and 75 in CD2Cl2 (b) at room temperature. 
 
Table 3.6. Selected Infrared Absorption Frequencies for Complexes 75-78. 
Complex ν(C≡C) (cm-1) 
75 2146 
76 2144 
77 2142 
78 2141 
 
Complexes 75-78 display an absorption band in the IR spectrum at around 2140 cm-1 
corresponding to the C≡C stretch. No allene band is observed indicating that no tautomerisation 
to the allene occurred in any case. This is not surprising since in order to tautomerise 
CD3CN 
H2O 
CD2Cl2 
H2O 
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deprotonation at the propargyl CH2 would have to occur, forming a nitrogen ylide. Nitrogen 
ylides are far less stable than their phosphorus analogues since a π-bond cannot form between 
the ammonium nitrogen atom and the carbon, and stabilisation occurs only through electrostatic 
interactions. 
 
Complex 78 was characterised by single crystal X-ray diffraction (Figure 3.36). 
 
 
Figure 3.36. Molecular structure of 78 determined by single crystal X-ray diffraction. Phenyl hydrogen atoms, 
anions and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(3) 
1.990(16), Au(1)-P(1) 2.275(4), Au(2)-C(24) 2.000(17), Au(2)-P(2) 2.264(4), Au(3)-P(3) 2.271(4), Au(3)-C(63) 
2.02(2), Au(4)-C(66) 1.977(17), Au(4)-P(4) 2.274(4), N(1)-C(1) 1.501(18), N(1)-C(22) 1.505(18), N(1)-C(61) 
1.521(18), N(1)-C(64) 1.520(18), C(1)-C(2) 1.46(2), C(2)-C(3) 1.22(2), C(22)-C(23) 1.43(2), C(23)-C(24) 
1.20(2), C(61)-C(62) 1.45(2), C(62)-C(63) 1.18(2), C(64)-C(65) 1.45(2), C(65)-C(66) 1.22(2), C(3)-Au(1)-P(1) 
170.7(5), C(24)-Au(2)-P(2) 173.6(4), C(63)-Au(3)-P(3) 169.8(4), C(66)-Au(4)-P(4) 176.0(5), C(1)-C(2)-C(3) 
179.4(16), C(22)-C(23)-C(24) 175.8(16), C(61)-C(62)-C(63) 176.3(16), C(64)-C(65)-C(66) 173.7(15). 
 
A distorted linear coordination is observed about each gold atom with angles C(3)-Au(1)-P(1) 
170.7(5)°, C(24)-Au(2)-P(2) 173.6(4)°, C(63)-Au(3)-P(3) 169.8(4)° and C(66)-Au(4)-P(4) 
176.0(5)°. This distortion is likely to be due to steric hindrance between the bulky 
triphenylphosphine ligands. The propargyl units are maintained as evidenced by the carbon-
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carbon bond lengths C(1)-C(2) 1.46(2) Å and C(2)-C(3) 1.22(2) Å, typical values for a single 
and triple bond, respectively. The C-C≡C bond angles are practically linear in each case.  
 
The molecules of 78 are linked by intermolecular aurophilic interactions creating a polymeric 
structure (Figure 3.37) with distances Au(1)-Au(4A) 3.5056(11) Å and Au(2)-Au(3) 
3.1888(9) Å. 
 
Figure 3.37. Intramolecular aurophilic interactions in the structure of 78. 
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3.6. Propargyl Functionalised Sulfonium Salt Derivatives 
A propargyl functionalised sulfonium salt was prepared by reaction of dimethylsulfide with 
propargyl bromide. The sulfonium bromide salt 79 was highly insoluble and was therefore 
reacted with silver triflate in acetonitrile to give the sulfonium triflate salt 80 (Scheme 3.32). 
 
 
Scheme 3.32. Synthesis of salt 79 and 80. 
 
As with the phosphonium salt 38, the solvent dependence of the isomeric form of 80 in solution 
was studied by NMR spectroscopy. In all solvents after 24 h only the propargyl tautomer was 
observed with no formation of the allene derivative. Refluxing the salt in acetonitrile for 
1 week, however, did lead to some conversion to the allene tautomer (Figure 3.38).  
 
 
  
 
 
Figure 3.38. 1H NMR spectrum of salt 80 after 1 week at reflux in CD3CN. 
 
Reaction of salt 80 with [Au(acac)(PPh3)] in dichloromethane led to the formation of a mixture 
of complexes 81 and 82 (Scheme 3.33). 
CD3CN 
H2O 
Me 
Me 
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Scheme 3.33. Synthesis of complexes 81 and 82. 
 
The propargyl CH2 in complex 81 appears as a singlet at 4.26 ppm in the 
1H NMR spectrum. 
The allenyl CH2 in complex 82 appears as a doublet at 5.04 ppm (
5JHP = 4.0 Hz) due to coupling 
with the triphenylphosphine group. A singlet for each complex is observed in the 31P{1H} NMR 
spectrum of the mixture. A small peak at 44.93 ppm is also observed due to the formation of 
small amounts of [Au(PPh3)2]
+.  
 
 
 
 
 
Figure 3.39. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) of complexes 81 and 82 in CD2Cl2. 
 
 
 
CD2Cl2 
H2O 
Me 
Me 
[Au(PPh3)2]+ 
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3.7. Biological Activity 
Since propargyl gold phosphine complexes are known to exhibit anticancer activity, the activity 
of the propargyl ammonium salt derivatives, 75-78 was studied in cancer cell line A549. The 
activity of the corresponding ammonium salts 71-74 was also tested. The MTT assay was used 
as described in Chapter 2. The calculated IC50 values are shown in Table 3.7. 
 
Table 3.7. IC50 values for Salts 71-74 and Complexes 75-78 after 24 h Incubation with A549 
Cells 
Complex IC50 (μM) Complex IC50 (μM) 
 
>50 
 
14.85 ± 1.96 
 
>50 
 
15.38 ± 1.28 
 
>50 
 
5.24 ± 0.64 
 
>50 
 
>50 
 
None of the ammonium salts showed any anticancer activity towards A549 cells. Complexes 
75 and 76 bearing one -AuPPh3 unit showed very similar activities with IC50 values of 14.85 μM 
and 15.38 μM, respectively. Complex 77 with an additional -AuPPh3 unit showed a 
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significantly improved anticancer activity with an incredibly low IC50 value of 5.24 μM. The 
graph of cell viability (% of control) against concentration for complexes 75-77 clearly shows 
an improvement in activity at low concentrations (Figure 3.40). Complex 78 bearing four 
AuPPh3 units was expected to show a high anticancer activity, however this complex had 
limited solubility in the cell culture medium and precipitated during the experiment and hence 
did not show anticancer activity. 
 
 
Figure 3.40. Graph of cell viability (% of control) against concentration (μM) for complexes 75-77 (Each point 
is the average of eight measurements, where error bars represent the standard deviation. Curve generated by a 
sigmoidal non-linear regression 4-parameter logistic analysis). 
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3.8. Conclusions 
In this chapter the coordination chemistry of propargyl functionalised phosphonium, 
ammonium and sulfonium salts with gold has been explored. 
 
The tautomeric behaviour of triphenylpropargylphosphonium bromide in solution in different 
solvents has been studied. The results show that in all solvents except acetonitrile 
tautomerisation to the allenyl isomer occurs at room temperature. Heating a solution of the 
phosphonium salt increased the rate of this process with full tautomerisation to the allenyl form 
observed after 10 min at 40 °C. 
 
Triphenylpropargylphosphonium bromide has successfully been used to prepare the first 
examples of allenyl gold complexes, with the structures unambiguously determined by single 
crystal X-ray diffraction. Stability experiments found the complexes to be highly stable in 
solution. An interesting regioselectivity was observed between gold(I) and gold(III), with 
gold(I) binding preferentially to the α-carbon of the allenyl ligand, despite the presence of 
sterically bulky ligands. Gold(III), however, was found to bind to the γ-carbon of the allenyl 
ligand. When two gold(I) atoms were present, coordination at the γ-carbon was preferable due 
to the possibility of the formation of a stabilising aurophilic interaction. 
 
A propargyl functionalised derivative of dppm has also been prepared. In all solvents other 
than acetonitrile a cyclisation was observed forming a cyclic diphosphole species. This was 
presumed to proceed via the allenyl intermediate and hence did not occur in acetonitrile where 
the propargyl-allenyl tautomerism is disfavoured. Attempts were made to prepare coordination 
complexes of both the cyclic and open derivatives, however this was complicated due to the 
instability of the ligand towards hydrolysis in solution. 
 
Several propargyl functionalised ammonium salts were prepared. No tautomerisation to the 
allenyl forms was observed in solution. Gold(I) triphenylphosphine derivatives were prepared 
with coordination to gold through the terminal alkyne carbon of the propargyl unit in each case.  
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A propargyl functionalised sulfonium salt was prepared. No tautomerisation to the allenyl form 
was observed in solution in any solvent at room temperature over time, however after reflux 
for 1 week a small amount of the allenyl tautomer was observed. Reaction of the propargyl 
sulfonium salt with [Au(acac)(PPh3)] led to a mixture of the propargyl and allenyl products 
which could readily be identified by NMR spectroscopy. 
 
The biological activity of the propargyl ammonium derivatives was studied. The ammonium 
salts were found to show no anticancer activity, however, the gold derivatives showed an 
excellent activity against A549 cells. The presence of more than one gold triphenylphosphine 
unit increased the activity. However, the tetranuclear derivative lacked solubility in the cell 
culture medium and hence showed no antiproliferative activity.  
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3.9. Experimental 
 
To a solution of [Ph3PCH2C≡CH]Br (0.0763 g, 0.2 mmol) in CH2Cl2 (20 ml) was added AgOTf 
(0.0514 g, 0.2 mmol) and the mixture stirred for 2 h at room temperature with the exclusion of 
light. The mixture was filtered through celite and the resulting colourless solution concentrated 
under reduced pressure to approximately 2 ml. The product was precipitated with n-hexane, 
collected by vacuum filtration and dried to give 39a as a white solid (0.0836 g, 93 %).  
IR (cm-1) ν(C≡C-H) 3261, ν(OTf) 1282 (SO3), 1246 (CF3), 1159 (CF3), 1029 (SO3).  
  
1H NMR (400 MHz, CDCl3) δ 2.24 (dt, 4JHP = 6.8 Hz and 4JHH = 2.8 Hz, 1H, CH), 4.48 (dd, 
2JHP = 15.2 Hz and 
4JHH = 2.8 Hz, 2H, CH2), 7.61 – 7.79 (m, 15H, Ph).  
31P{1H} NMR (162 MHz, CDCl3) δ 21.97 (s, PPh3).  
19F NMR (376 MHz, CDCl3) δ -78.24 (s, OTf). 
 
 
A solution of 39a (0.0100 g) in CDCl3 was heated to 40 °C for 10 min. NMR studies indicated 
full conversion to the product. Removal of solvent gave the product as a pale orange solid. 
IR (cm-1) ν(C=CH2) 3055, ν(C=C=C) 1909, ν(OTf) 1262 (SO3), 1222 (CF3), 1145 (CF3), 1029 
(SO3).  
1H NMR (400 MHz, CDCl3) δ 5.24 (dd, 2JHP = 12.8 Hz and 4JHH = 6.4 Hz, 2H, CH2), 6.90 (dt, 
4JHP = 8.0 Hz and 
4JHH = 6.4 Hz, 1H, CH), 7.57 – 7.79 (m, 15H, Ph).  
31P{1H} NMR (162 MHz, CDCl3) δ 18.62 (s, PPh3).  
19F NMR (376 MHz, CDCl3) δ -78.20 (s, OTf). 
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To a solution of 38a (0.0763 g, 0.2 mmol) in CH2Cl2 (20 ml) was added [AuCl(tht)] (0.0321 g, 
0.1 mmol) and the mixture stirred for 4 h at room temperature with excess Cs2CO3. The mixture 
was filtered through celite and the resulting orange solution concentrated under reduced 
pressure to approximately 2 ml. The product was precipitated with ethanol, collected by 
vacuum filtration and dried to give 9 as an orange solid (0.0364 g, 63 %). 
IR (cm-1) ν(C=CH2) 3068, ν(C=C=C) 1906.  
1H NMR (400 MHz, CDCl3) δ 7.54 – 7.76 (m, 15 H, Ph), 4.09 (d, 4JHP = 16.0 Hz, 2 H, CH2).  
31P{1H} NMR (162 MHz, CDCl3) δ 17.30 (s, PPh3).  
13C APT (76 MHz, CDCl3) δ 216.54 (s, C=C=C), 133.95 (d, 3JCP = 9.0 Hz, m-Ph3P), 133.72, 
(d, 4JCP = 2.9 Hz, p-Ph3P), 129.30 (d, 
2JCP = 12.4 Hz, o-Ph3P), 122.44 (d, 
1JCP = 89.1 Hz, ipso-
Ph3P), 83.88 (d, 
1JCP = 50.2 Hz, C(PPh3)), 65.63 (d, 
3JCP = 20.9 Hz, CH2). 
 
 
To a solution of [Ph3PCH2C≡CH]Br (0.0381 g, 0.1 mmol) in CH2Cl2 (20 ml) was added 
[Au(C6F5)(tht)] (0.0452 g, 0.1 mmol) and the mixture stirred for 3 h at room temperature with 
excess Cs2CO3. The mixture was filtered through celite and the resulting pale yellow solution 
concentrated under reduced pressure to approximately 2 ml. The product was precipitated with 
ethanol, collected by vacuum filtration and dried to give 41 as a pale yellow solid (0.0566 g, 
85 %).  
IR (cm-1) ν(C=CH2) 3055, ν(C=C=C) 1901, ν(C6F5) 1500, 953, 794.  
1H NMR (400 MHz, CDCl3) δ 4.12 (d, 4JHP = 16.0, 2 H, CH2), 7.39 – 7.83 (m, 15 H, Ph). 
31P{1H} NMR (162 MHz, CDCl3) δ 19.22 (s, PPh3).  
19F NMR (376 MHz, CDCl3) δ -115.77 – -115.92 (m, 2 F, o-C6F5), -161.14 (t, 3JFF = 20.3, 1 
F, p-C6F5), -163.28 – -163.43 (m, 2 F, m-C6F5). 
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13C APT (76 MHz, CDCl3) δ 215.98 (s, C=C=C), 134.22 (d, 3JCP = 9.0 Hz, m-Ph3P), 133.71 
(d, 4JCP = 2.9 Hz, p-Ph3P), 129.40 (d, 
2JCP = 12.3 Hz, o-Ph3P), 123.32 (d, 
1JCP = 88.5 Hz, i-
Ph3P), 64.00 (d, 
3JCP = 22.2 Hz, CH2). 
 
 
Method 1: [Ph3PCH2C≡CH]Br (0.0450 g, 0.1 mmol) and [Au(acac)(PPh3)] (0.0559 g, 0.1 
mmol) were stirred in CH2Cl2 (20 ml) for 1 h at room temperature. The mixture was filtered 
through celite and the resulting yellow solution concentrated under reduced pressure to 2 ml. 
The product was precipitated with n-hexane, collected by vacuum filtration and dried to give 
42 as an orange solid (0.0526 g, 58 %). 
Method 2: 41 (0.0664 g, 0.1 mmol) and [Au(PPh3)2]OTf (0.0870 g, 0.1 mmol) were stirred in 
CH2Cl2 (20 ml) for 30 min at room temperature. The mixture was filtered through celite and 
the resulting colourless solution concentrated under reduced pressure to approximately 2 ml. 
The product was precipitated with diethyl ether, collected by vacuum filtration and dried to 
give 42 as a white solid (0.0452 g, 50 %).  
IR (cm-1) ν(C=CH2) 3054, ν(C=C=C) 1911, (OTf) 1266 (SO3), 1225 (CF3), 1159 (CF3), 1030 
(SO3).  
1H NMR (400 MHz, CDCl3) δ 4.50 (d, 4JHP = 15.6 Hz, 2 H, CH2), 7.44 – 7.80 (m, 30 H, Ph). 
31P{1H} NMR (162 MHz, CDCl3) δ 19.85 (s, PPh3), 40.24 (s, AuPPh3).  
19F NMR (376 MHz, CDCl3) δ -77.98 (s, OTf).  
13C APT (76 MHz, CDCl3) δ 134.64 (d, 4JCP = 2.9 Hz, p-PPh3), 134.04 (d, 2JCP = 13.6 Hz, o-
PPh3), 133.91 (d, 
3JCP = 9.1 Hz, m-PPh3), 132.36 (d, 
4JCP = 2.5 Hz, p-PPh3), 130.00 (d, 
2JCP = 
12.4 Hz, o-Ph3P), 129.67 (d, 
3JCP = 11.5 Hz, m-Ph3P), 128.61 (d, 
1JCP = 57.1 Hz, ipso-Ph3P), 
122.04 (d, 1JCP = 90.6 Hz, i-Ph3P), 66.52 (d, 
3JCP = 21.1 Hz, CH2). 
 
 
[Ph3PCH2C≡CH]Br (0.1372 g, 0.36 mmol) and [Au(C6F5)3(tht)] (0.2839 g, 0.36 mmol) were 
stirred in CH2Cl2 (20 ml) overnight at room temperature. The colourless solution was 
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concentrated under reduced pressure to 2 ml. The product was precipitated with n-hexane, 
collected by vacuum filtration and dried to give 43a as a white solid (0.3782 g, 97 %).  
IR (cm-1) ν(C≡C-H) 3305, ν(C≡C) 2214, ν(C6F5) 1505, 963, 793.  
1H NMR (400 MHz, CDCl3) δ 7.67 – 7.92 (m, 15 H, Ph), 4.18 (dd, 2JHP = 14.8 Hz, 4JHH = 2.4 
Hz, 2 H, CH2), 2.37 (dt, 
4JHP = 6.8, 
4JHH = 2.4, 1 H, CH).  
31P{1H} NMR (162 MHz, CDCl3) δ 21.26 (s, PPh3).  
19F NMR (376 MHz, CDCl3) δ -120.93 – -121.04 (m, 4 F, o-C6F5), -121.78 – -121.88 (m, 2 F, 
o-C6F5), -158.82 (t, 
3JFF = 18.8, 1 F, p-C6F5), -159.91 (t, 
3JFF = 18.8, 2 F, p-C6F5), -162.31 – -
162.44 (m, 2 F, m-C6F5), -162.69 – -162.84 (m, 4 F, m-C6F5).  
13C APT (101 MHz, CDCl3) δ 136.33 (d, 4JCP = 2.9 Hz, p-PPh3), 133.62 (d, 3JCP = 10.1 Hz, 
m-PPh3), 130.93 (d, 
2JCP = 13.0 Hz, o-PPh3), 116.52 (d, 
1JCP = 88.0 Hz, i-Ph), 77.77 (d, 
3JCP = 
9.6 Hz, CH), 70.21 (d, 2JCP = 12.1 Hz, C≡CH), 17.84 (d, 1JCP = 58.4 Hz, CH2). 
 
 
43a (0.1079 g, 0.1 mmol) was stirred in CH2Cl2 (20 ml) for 2 h at room temperature with excess 
Cs2CO3. The mixture was filtered through celite and the resulting yellow solution concentrated 
under reduced pressure to 2 ml. The product was precipitated with n-hexane, collected by 
vacuum filtration and dried to give 43b as a pale orange solid (0.0486 g, 45 %).  
IR (cm-1) ν(C=CH2) 3063, ν(C=C=C) 1914, ν(C6F5) 1504, 963, 793.  
1H NMR (400 MHz, CDCl3) δ 7.52 – 7.89 (m, 15 H, Ph), 6.45 (dt, 2JHP = 8.4 Hz, 4JHH = 6.8 
Hz, 1 H, CH), 5.36 (dd, 4JHP = 12.8 Hz, 
4JHH = 6.8 Hz, 2 H, CH2).  
31P{1H} NMR (162 MHz, CDCl3) δ 18.29 (s, PPh3).  
19F NMR (376 MHz, CDCl3) δ -120.80 – -120.89 (m, 4 F, o-C6F5), -121.71 – -121.84 (m, 2 F, 
o-C6F5), -158.98 (t, 
3JFF = 20.1 Hz, 1 F, p-C6F5), -160.14 (t, 
3JFF = 19.7 Hz, 2 F, p-C6F5), -
162.42 – -162.56 (m, 2 F, m-C6F5), -162.87 – -163.03 (m, 4 F, m-C6F5). 
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Method 1: 43a (0.0810 g, 0.075 mmol) was stirred in Et2O (20 ml) for 2 h at room temperature 
with excess NaH. The mixture was filtered through celite and the resulting yellow solution 
concentrated under reduced pressure to 2 ml. The product was precipitated with n-hexane, 
collected by vacuum filtration and dried to give (±)-5 as an orange solid (0.0490 g, 65 %). 
Method 2: [Ph3PCH=C=CH2]OTf  (0.0901 g, 0.2 mmol) and [Au(C6F5)3(tht)] (0.1573 g, 0.2 
mmol) were stirred in CH2Cl2 (20 ml) for 30 min at room temperature with excess Cs2CO3. 
The mixture was filtered through celite and the resulting orange/brown solution concentrated 
under reduced pressure to 2 ml. The product was precipitated with n-hexane, collected by 
vacuum filtration and dried to give 44 as an orange solid (0.1013 g, 51 %).  
IR (cm-1) ν(C=C=C) 1907, ν(C6F5) 1504, 963, 793.  
1H NMR (400 MHz, CDCl3) δ 7.42 – 7.89 (m, 15 H, Ph), 5.84 (dd, 4JHP = 12.8 Hz, 4JHH = 6.0 
Hz, 1 H, Au-CH), 4.88 (dd, 2JHP = 14.0 Hz, 
4JHH = 6.0 Hz, 1 H, CH(PPh3)).  
31P{1H} NMR (162 MHz, CDCl3) δ 17.86 (s, PPh3).  
19F NMR (376 MHz, CDCl3) δ -121.41 – -121.75 (m, o-C6F5), -154.39 (t, 3JFF = 20.0 Hz, p-
C6F5), -155.74 (t, 
3JFF = 20.3 Hz, p-C6F5), -159.14 – -159.35 (m, m-C6F5), -160.36 – -160.47 
(m, m-C6F5).  
13C APT (75 MHz, CDCl3) δ 205.63 (s, C=C=C), 147.41 – 146.96 (m, C6F5), 144.39 – 143.88 
(m, C6F5), 140.24 – 139.86 (m, C6F5), 139.21 – 138.68 (m, C6F5), 136.98 – 136.61 (m, C6F5), 
135.64 – 135.34 (m, C6F5), 134.92 (d, 4JCP = 2.9 Hz, p-PPh3), 133.44 (d, 3JCP = 10.2 Hz, m-
PPh3), 130.15 (d, 
2JCP = 12.9 Hz, o-PPh3) 119.97 (d, 
1JCP = 91.3 Hz, i-PPh3), 86.41 (d, 
3JCP = 
15.1 Hz, Au-CH), 60.45 (d, 1JCP = 104.3 Hz, CH(PPh3)). 
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To a solution of 39a (0.0450 g, 0.1 mmol) was added [AuCl(IMes)] (0.0538 g, 0.1 mmol) and 
excess Cs2CO3 and the mixture stirred for 4 h at room temperature. The solution was filtered 
through celite and the yellow filtrate concentrated under reduced pressure to approximately 1 
ml. Et2O (10 ml) was added to precipitate the product which was collected by filtration and 
vacuum dried to give 45 as an orange solid (0.0491 g, 52%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C42H41AuN2P 801.2667, Found 801.2693. 
IR (cm-1) ν(C=C=C) 1911. 
1H NMR (300 MHz, CDCl3) δ 7.93 – 6.67 (m, 21H, PPh3, Mesityl-H, Imidazole C-H), 4.08 
(d, 4JHP = 16.0 Hz, 2H, CH2), 2.32 (s, 6H, Me), 1.96 (s, 12H, Me). 
31P{1H} NMR (121 MHz, CDCl3) δ 19.22. 
13C APT (75 MHz, CDCl3) δ 216.69 (d, 2JCP = 4.0 Hz, C=C=C), 184.51 (s, N-C-N IMes), 
139.70 (s, C4 Mes), 134.69 (s, C2/C6 Mes), 134.61 (s, C1 Mes), 134.05 (d, 4JCP = 3.0 Hz, p-
PPh3), 133.64 (d, 
2JCP = 9.1 Hz, o-PPh3), 129.54 (d, 
3JCP = 8.5 Hz, m-PPh3), 129.43 (s, CH 
Mes), 123.06 (s, CH imidazole), 122.28 (d, 1JCP = 89.0 Hz, i-PPh3), 65.01 (d, 
3JCP = 21.4 Hz, 
C=C=CH2), 21.32 (s, Me), 17.78 (s, Me). 
 
 
 
To a solution of 39a (0.0310 g, 0.069 mmol) was added [AuCl(IPr)] (0.0430 g, 0.069 mmol) 
and excess Cs2CO3 and the mixture stirred for 4 h at room temperature. The solution was 
filtered through celite and the yellow filtrate concentrated under reduced pressure to 
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approximately 1 ml. Et2O (10 ml) was added to precipitate the product which was collected by 
filtration and vacuum dried to give 46 as an orange solid (0.0363 g, 51%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C48H53AuN2P 885.3606; Found 885.3607. 
1H NMR (300 MHz, CD2Cl2) δ 7.82 – 6.81 (m, 23H, IPr + CH imidazole + PPh3), 4.01 (d, 
4JHP = 15.8 Hz, 2H, CH2), 2.50 (hept, 
3JHH = 6.8 Hz, 4H, CH 
iPr), 1.20 (d, 3JHH = 6.8 Hz, 12H, 
CH3 
iPr), 1.10 (d, 3JHH = 6.8 Hz, 12H, CH3 
iPr). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 19.82 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 146.38 (s, C2/C6 IPr), 134.36 (d, 4JCP = 3.0 Hz, p-PPh3), 134.02 
(d, 3JCP = 9.0 Hz, m-PPh3), 131.32 (s, C3/C5 IPr), 129.92 (d, 
2JCP = 12.4 Hz, o-PPh3), 124.74 
(s, CH imidazole), 122.43 (d, 1JCP = 89.2 Hz, i-PPh3), 64.60 (d, 
3JCP = 21.0 Hz, C=C=CH2), 
29.33 (s, CH iPr), 24.77 (s, CH3 
iPr), 24.17 (s, CH3 
iPr). 
 
 
To a solution of 39a (0.0451 g, 0.1 mmol) was added [AuCl(JohnPhos)] (0.0531 g, 0.1 mmol) 
and excess Cs2CO3 and the mixture stirred for 4 h at room temperature. The solution was 
filtered through celite and the filtrate concentrated under reduced pressure to approximately 1 
ml. Et2O (10 ml) was added to precipitate the product which was collected by filtration and 
vacuum dried to give a mixture of 47 and 48.  
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To a solution of 39a (0.0451 g, 0.1 mmol) was added [AuCl(TrippyPhos)] (0.0673 g, 0.1 mmol) 
and excess Cs2CO3 and the mixture stirred for 4 h at room temperature. The solution was 
filtered through celite and the filtrate concentrated under reduced pressure to approximately 1 
ml. Et2O (10 ml) was added to precipitate the product which was collected by filtration and 
vacuum dried to give a mixture of 49 as an orange solid.  
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C50H50AuN2P2 937.3109; Found 937.3085. 
1H NMR (400 MHz, CD2Cl2) δ 7.99 – 6.95 (m, 30H, TrippyPhos + PPh3), 4.23 (dd, 4JHP = 
16.0 Hz, 5JHP = 4.1 Hz, 2H, CH2), 1.09 (d, 
3JHP = 15.7 Hz, 9H, CH3 
tBu), 1.02 (d, 3JHP = 15.7 
Hz, 9H, CH3 
tBu).  
31P{1H} NMR (162 MHz, CD2Cl2) δ 60.76 (d, 3JPP = 1.7 Hz, TrippyPhos), 19.39 (d, 3JPP = 1.7 
Hz, PPh3). 
 
 
To a solution of 38a (0.1906 g, 0.5 mmol) in EtOH (10 ml) was added KAuCl4 (0.1889 g, 0.5 
mmol). A bright orange solid precipitated which was collected and vacuum dried to give the 
product (0.2610 g, 82%). 
1H NMR (300 MHz, CDCl3) δ 8.06 – 7.58 (m, 15H, PPh3), 4.35 (dd, 2JHP = 15.0 Hz, CH2, 
4JHH = 2.8 Hz, 2H), 2.39 (dt, 
4JHP = 6.7 Hz, 
4JHH 2.8 Hz, 1H, CH). 
31P{1H} NMR (121 MHz, CDCl3) δ 21.33 (s, PPh3). 
13C APT (75 MHz, CDCl3) δ 136.28 (d, 4JCP = 3.1 Hz, p-PPh3), 133.88 (d, 3JCP = 10.1 Hz, m-
PPh3), 130.98 (d, 
2JCP = 13.0 Hz, o-PPh3), 116.67 (d, 
1JCP = 87.9 Hz, i-PPh3), 77.87 (d, 
3JCP = 
9.6 Hz, CH2), 18.21 (d, 
1JCP = 58.0 Hz, CH). 
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To a solution of 38a (0.0763 g, 0.2 mmol) in EtOH (10 ml) was added AuBr3 (0.0873 g, 0.2 
mmol). A bright orange solid precipitate which was collected and vacuum dried to give the 
product (0.0874 g, 53%). 
1H NMR (400 MHz, CDCl3) δ 8.21 – 7.54 (m, 15H, PPh3), 4.42 (dd, 2JHP = 15.0 Hz, 4JHH = 
2.8 Hz, 2H, CH2), 2.39 (dt, 
4JHP = 6.6 Hz, 
4JHH = 2.8 Hz, 1H, CH). 
31P{1H} NMR (162 MHz, CDCl3) δ 21.42. 
 
 
To a solution of 51a (10 mg) in CD2Cl2 (1 ml) was added Cs2CO3 and the solution stirred for 
1 h. The solution was filtered through celite and NMR spectrum of the filtrate was recorded. 
1H NMR (400 MHz, CD2Cl2) δ 8.25 – 7.44 (m, 15H, PPh3), 6.50 (dt, 2JHP = 8.2 Hz, 4JHH = 6.6 
Hz, 1H, CH), 5.40 (dd, 4JHP = 12.7 Hz, 
4JHH 6.6 Hz, 2H, CH2). 
31P{1H} NMR (162 MHz, CD2Cl2) δ 18.20 (s, PPh3) 
 
 
To a solution of 40 (0.0057 g, 0.01 mmol) in CD2Cl2 (1 ml) was added Cl2 (0.5M soln in CCl4, 
20 μl) and the solution stirred for 1 h. NMR spectra of the solution were recorded. 
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To a solution of 46 (0.0056 g) in CD2Cl2 (1 ml) was added Cl2 (0.5 M soln in CCl4, 11.8 μl) 
and the solution stirred for 1 h. NMR spectra of the solution were recorded. 
 
 
To a solution of 39a (0.0451 g, 0.1 mmol) in CH2Cl2 (10 ml) was added [O(AuPPh3)3]BF4 
(0.2222 g, 0.15 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.1296 g, 
55%). 
1H NMR (400 MHz, CDCl3) δ 7.98 – 7.23 (m, PPh3). 
31P{1H} NMR (162 MHz, CDCl3) δ 37.86 (s, C=C=C(AuPPh3)2), 32.10 (s, Ph3PAu-
C(PPh3)=C=C), 18.52 (s, Ph3PC). 
 
 
To a solution of 39a (0.0045 g, 0.01 mmol) in CD2Cl2 (1 ml) was added [Au(acac)(PPh3)] 
(0.0112 g, 0.02 mmol) and the solution stirred for 10 h. NMR spectra of the solution were 
recorded. 
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To a solution of dppm (1.92 g, 5.0 mmol) in acetonitrile (20 ml) was added propargyl bromide 
(1.08 ml, 80% soln in toluene, 10 mmol) and the solution stirred for 2 days at room temperature. 
The solution was concentrated to dryness under reduced pressure and the crude solid 
recrystallised CH2Cl2/Et2O to give a pale orange solid which was vacuum dried to give the 
product (1.9379 g, 77%). 
1H NMR (300 MHz, CD2Cl2) δ 7.96 – 7.19 (m, 20H, Ph), 4.76 (dd, 2JHP = 15.6 Hz, 4JHH = 2.8 
Hz, 2H, CH2C≡CH), 4.43 (dd, 2JHP = 14.8 Hz, 2JHP = 1.4 Hz, 2H, CH2), 2.24 (dt, 4JHP = 6.9 Hz, 
4JHH = 2.8 Hz, 1H, C≡CH). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 25.57 (d, 2JPP = 59.6 Hz, PPh2CH2C≡CH), -26.58 (d, 2JPP 
= 59.7 Hz, PPh2). 
 
 
To a solution of dppm (5.77 g, 15.0 mmol) in CHCl3 (30 ml) was added propargyl bromide 
(1.62 ml, 80% soln toluene, 15 mmol) and the solution stirred for 4 days at room temperature. 
The solution was concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) 
was added to precipitate a beige solid which was collected and vacuum dried to give the product 
(5.29 g, 70%). 
1H NMR (400 MHz, CDCl3) δ 7.91 – 7.41 (m, 20H, Ph), 7.03 (d, 3JHP = 36.3 Hz, 1H, C=CH2 
(trans)), 5.86 (d, 3JHP = 17.7 Hz, 1H, C=CH2 (cis)), 4.31 (dd, 
2JCP = 11.4 Hz, 
2JCP = 9.7 Hz, 
3H), 2.01 (ddd, 2JHP = 7.6 Hz, 
2JHP = 6.2 Hz, 
5JHH 1.3 Hz, 1H). 
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Triethylamine (1.39 ml, 10.0 mmol) and propargyl bromide (1.08 ml, 10 mmol) were mixed. 
A white solid formed which was collected, washed with Et2O and vacuum dried to give the 
product (2.1795 g, 99%). 
1H NMR (400 MHz, DMSO) δ 4.36 (d, 4JHH = 2.6 Hz, 2H, CH2C≡CH), 4.04 (t, 4JHH = 2.5 Hz, 
1H, C≡CH), 3.34 (q, 3JHH = 7.2 Hz, 6H, CH2), 1.22 (t, 3JHH = 7.2 Hz, 9H, CH3). 
 
 
N,N-Diisopropylethylamine (1.74 ml, 10 mmol) and propargyl bromide (1.08 ml, 10 mmol) 
were mixed. A white solid formed which was collected, washed with Et2O and vacuum dried 
to give the product (0.8802 g, 35%). 
1H NMR (400 MHz, DMSO) δ 4.41 (d, 4JHH = 2.6 Hz, 2H, CH2C≡CH), 4.06 (hept, 3JHH = 6.6 
Hz, 2H, CH iPr), 4.01 (t, 4JHH = 2.6 Hz, 1H, C≡CH), 3.44 (q, 3JHH = 7.2 Hz, 2H, CH2 Et), 1.42 
(t, 3JHH = 6.5 Hz, 12H, CH3 
iPr), 1.30 (t, 3JHH = 7.2 Hz, 3H, CH3 Et). 
 
 
3-Dimethylamino-1-propyne (1.08 ml, 10 mmol) and propargyl bromide (1.08 ml, 10 mmol) 
were mixed. A white solid formed which was collected, washed with Et2O and vacuum dried 
to give the product (2.0008 g, 99%).  
1H NMR (400 MHz, DMSO) δ 4.50 (d, 4JHH = 2.5 Hz, 2H, CH2), 4.13 (t, 4JHH = 2.5 Hz, 1H, 
CH), 3.18 (s, 3H, Me). 
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Tripropargylamine (1.42 ml. 10 mmol) and propargyl bromide (1.08 ml, 10 mmol) were mixed. 
After 3 h a white solid formed which was collected, washed with Et2O and vacuum dried to 
give the product (0.5920 g, 22%). 
1H NMR (400 MHz, DMSO) δ 4.53 (d, 4JHH = 2.6 Hz, 2H, CH2), 4.21 (t, 4JHH = 2.6 Hz, 1H, 
CH). 
 
 
To a solution of 67 (0.2202 g, 1.0 mmol) in acetonitrile (10 ml) was added AgOTf (0.2569 g, 
1.0 mmol) and the solution stirred for 30 min. The solution was filtered through celite, the 
filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.2555 g, 
88%). 
1H NMR (400 MHz, CD3CN) δ 4.02 (d, 4JHH = 2.6 Hz, 1H, CH2), 3.32 (q, 3JHH = 7.3 Hz, 6H, 
CH2 Et), 3.14 (t, 
4JHH = 2.6 Hz, 1H, CH), 1.26 (t, 
3JHH = 7.3 Hz, 9H, CH3 Et). 
19F NMR (376 MHz, CD3CN) δ -79.30 (OTf) 
 
 
To a solution of 68 (0.2482 g, 1.0 mmol) in acetonitrile (10 ml) was added AgOTf (0.2569 g, 
1.0 mmol) and the solution stirred for 30 min. The solution was filtered through celite, the 
filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.2793 g, 
88%). 
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1H NMR (400 MHz, CD3CN) δ 4.10 – 4.09 (m, 2H, CH2C≡CH), 4.05 (hept, 3JHH = 6.7 Hz, 
2H, CH iPr), 3.43 (q, 3JHH = 7.3 Hz, 2H, CH2 Et), 3.14 (t, 
4JHH = 2.6 Hz, 1H, C≡CH), 1.48 (d, 
3JHH = 6.7 Hz, 6H, CH3 
iPr), 1.45 (d, 3JHH = 6.7 Hz, 6H, CH3 
iPr), 1.35 (t, 3JHH = 7.3 Hz, 3H, 
CH3 Et). 
19F NMR (376 MHz, CD3CN) δ -79.30 (OTf). 
 
 
To a solution of 69 (0.2021 g, 1.0 mmol) in acetonitrile (10 ml) was added AgOTf (0.2569 g, 
1.0 mmol) and the solution stirred for 30 min. The solution was filtered through celite, the 
filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.2297 g, 
85%). 
1H NMR (400 MHz, CD3CN) δ 4.24 (d, 4JHH = 2.5 Hz, 2H, CH2), 3.26 (t, 4JHH = 2.5 Hz, 1H, 
CH), 3.17 (s, 3H, Me). 
19F NMR (376 MHz, CD3CN) δ -79.32 (OTf) 
 
 
To a solution of 70 (0.2501 g, 1.0 mmol) in acetonitrile (10 ml) was added AgOTf (0.2569 g, 
1.0 mmol) and the solution stirred for 30 min. The solution was filtered through celite, the 
filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.2986 g, 
94%). 
1H NMR (400 MHz, CD3CN) δ 4.41 (d, 4JHH = 2.6 Hz, 2H, CH2), 3.32 (t, 4JHH = 2.6 Hz, 1H, 
CH). 
19F NMR (376 MHz, CD3CN) δ -79.32 (OTf). 
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71 (0.0289 g, 0.1 mmol) and [Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) were mixed in CH2Cl2 (5 
ml) and the solution stirred for 1 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0535 g, 
72%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C27H32AuNP 598.1932; Found 598.1945. 
1H NMR (300 MHz, CD2Cl2) δ 7.78 – 7.18 (m, 15H, PPh3), 3.99 (s, 2H, CH2C≡C), 3.40 (q, 
3JHH = 7.3 Hz, 6H, CH2 Et), 1.35 (t, 
3JHH = 7.3 Hz, 9H, CH3 Et). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 41.17 (s, PPh3) 
13C APT (75 MHz, CD2Cl2) δ 134.76 (d, 2JCP = 13.7 Hz, o-PPh3), 132.42 (d, 4JCP = 2.3 Hz, p-
PPh3), 129.87 (d, 
3JCP = 11.3 Hz, m-PPh3), 129.82 (d, 
1JCP = 56.3 Hz, i-PPh3), 53.20 (CH2 Et) 
, 50.35 (s, CH2C≡C), 8.20 (s, CH3 Et). 
 
 
72 (0.0317 g, 0.1 mmol) and [Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) were mixed in CH2Cl2 (5 
ml) and the solution stirred for 1 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0621 g, 
80%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C29H36AuNP 636.2245; Found 626.2277. 
1H NMR (300 MHz, CD2Cl2) δ 7.86 – 7.14 (m, 15H, PPh3), 4.19 – 4.11 (m, 2H, CH iPr), 4.10 
(s, 2H, CH2C≡C), 3.48 (q, J = 7.3 Hz, 2H, CH2 Et), 1.60 (d, 3JHH = 6.8 Hz, 6H, iPr), 1.56 (d, 
3JHH = 6.8 Hz, 6H, CH3 
iPr), 1.44 (t, 3JHH = 7.3 Hz, 3H, CH3). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 41.22 (s, PPh3) 
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13C APT (75 MHz, CD2Cl2) δ 134.76 (d, 2JCP = 13.5 Hz, o-PPh3), 132.42 (s, p-PPh3), 129.87 
(d, 3JCP = 11.4 Hz, m-PPh3), 63.62 (s, CH 
iPr), 52.94 (s, CH2 Et), 49.56 (s, CH2C≡C), 19.21 
(CH3 
iPr), 19.03 (CH3 
iPr), 10.78 (CH3 Et). 
 
 
73 (0.0271 g, 0.1 mmol) and [Au(acac)(PPh3)] (0.1119 g, 0.2 mmol) were mixed in CH2Cl2 (5 
ml) and the solution stirred for 1 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0707 g, 
68%). 
HRMS (ESI-QTOF) m/z: [M]+ Calcd for C44H40Au2NP2 1038.1962; Found 1038.1999. 
1H NMR (300 MHz, CD2Cl2) δ 7.58 – 7.47 (m, 15H, PPh3), 4.27 (s, 2H, CH2), 3.24 (s, 3H, 
Me). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 41.23 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 134.80 (d, 2JCP = 13.6 Hz, o-PPh3), 132.39 (s, p-PPh3), 129.86 
(d, 3JCP = 11.2 Hz, m-PPh3), 56.10 (s, CH2), 49.86 (s, Me). 
 
 
 
74 (0.0160 g, 0.05 mmol) and [Au(acac)(PPh3)] (0.1119 g, 0.2 mmol) were mixed in CH2Cl2 
(5 ml) and the solution stirred for 1 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
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precipitate a white solid which was collected and vacuum dried to give the product (0.0970 g, 
90%). 
1H NMR (300 MHz, CD2Cl2) δ 7.55 – 7.50 (m, 15H, PPh3), 4.45 (s, 2H, CH2). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 41.25 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 138.13 (d, 2JCP = 141.6 Hz, C≡C-Au), 134.80 (d, 2JCP = 13.9 
Hz, o-PPh3), 132.38 (d, 
4JCP = 2.5 Hz, p-PPh3), 129.87 (d, 
1JCP = 56.9 Hz, i-PPh3), 129.86 (d, 
3JCP = 11.4 Hz, m-PPh3), 88.63 (d, 
3JCP = 27.0 Hz, CH2C≡C), 49.69 (s, CH2). 
 
 
Dimethyl sulfide (0.73 ml, 10 mmol) and propargyl bromide (1.08 ml, 10 mmol) were mixed. 
A solid formed which was washed with Et2O and vacuum dried to give the product (0.4686 g, 
26%). 
1H NMR (400 MHz, CD3CN) δ 4.54 (d, 4JHH = 2.6 Hz, 2H, CH2), 3.13 (t, 4JHH = 2.6 Hz, 1H, 
CH), 2.96 (s, 6H, Me). 
 
 
To a solution of 79 (0.1811 g, 1.0 mmol) in acetonitrile (10 ml) was added AgOTf (0.2569 g, 
1.0 mmol) and the mixture stirred for 30 min. The solution was filtered through celite, the 
filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.2275 g, 
91%). 
 
1H NMR (400 MHz, CD2Cl2) δ 4.35 (d, 4JHH = 2.6 Hz, 2H, CH2), 2.97 (s, 6H, Me), 2.86 (t, 
4JHH = 2.6 Hz, 1H, CH). 
19F NMR (376 MHz, CD2Cl2) δ -78.97 (OTf). 
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80 (0.0250 g, 0.1 mmol) and [Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) were mixed in CH2Cl2 (5 
ml) and the solution stirred for 1 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the a mixture of 81 and 
82 (0.0420 g, 59%). 
1H NMR (300 MHz, CD2Cl2) δ 7.60 – 7.48 (m, PPh3), 5.04 (d, 5JHP = 4.0 Hz, CH2 82), 4.26 
(s, CH2 81), 2.95 (s, Me, 82), 2.94 (s, Me, 81). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 41.10 (s, PPh3), 40.45 (s, PPh3). 
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Chapter 4 – NHC Gold Complexes 
4.1. Introduction 
N-Heterocyclic carbenes (NHCs) have made a huge impact on organometallic chemistry in 
recent years. They make attractive ligands due to their strong σ-donor capacity and the fact that 
a broad variety of substituents can be introduced at the nitrogen atoms, allowing both the steric 
and electronic properties to be fine-tuned. NHC gold complexes have received considerable 
attention due to their numerous and varied applications. 
 
4.1.1. Basic Concepts 
NHCs are defined as heterocyclic species containing a carbene carbon atom and at least one 
nitrogen atom in the ring structure.247 Classical NHCs feature a five-membered heterocycle and 
are derived from imidazolium, dihydroimidazolium, benzimidazolium or triazolium salts. 
Examples in which the carbene centre is stabilised by one nitrogen and one alternative 
heteroatom such as sulfur or oxygen are also known and prepared from thiazolium or 
oxazolium salts (Figure 4.1). 
 
 
Figure 4.1. Classical NHCs. 
 
NHCs have some unusual electronic properties which can explain their remarkable stability 
compared to typical free carbenes. They exhibit a singlet ground state electron configuration 
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where the HOMO is best described as a formally sp2-hybridised lone pair and the LUMO an 
occupied p orbital at the carbon atom. The nitrogen atoms provide stabilisation through their 
σ-electron withdrawing and π-electron donating properties, lowering the energy of the 
occupied σ-orbital and donating electron density into the empty p orbital (Figure 4.2). The 
cyclic structure of NHCs also favours the singlet state by forcing the carbene carbon into a bent 
sp2-like arrangement.  
 
Figure 4.2. NHC orbitals. 
 
The C-N bonds in NHCs have partial double bond character as evidenced by the bond distances 
found in the molecular structures determined by single crystal X-ray diffraction (Figure 4.3). 
The C-N bond in the NHC 1,3-bis(1-adamantyl)imidazol-2-ylidene was found to have a 
distance of 1.37 Å (Figure 4.3 (a)), compared to 1.33 Å for the parent imidazolium salt248 
(Figure 4.3 (b)) and 1.49 Å for the saturated derivative249 (Figure 4.3 (c)). 
 
     
Figure 4.3. Molecular structures of 1,3-bis(1-adamantyl)imidazol-2-ylidene (a), 1,3-bis(1-
adamantyl)imidazolium tetraphenylborate (b) and 1,3-bis(1-adamantyl)-2,3-dihydro-1H-imidazole (c) 
determined by single crystal X-ray diffraction. Adamantyl hydrogen atoms are omitted for clarity. Selected bond 
lengths [Å] and angles [°] a: C(1)-N(1) 1.367(2), C(1)-N(2) 1.373(2), N(1)-C(1)-N(2) 102.2(2). b: C(1)-N(1) 
1.328(4), C(1)-N(2) 1.331(3), N(1)-C(1)-N(2) 109.7(3). c: C(1)-N(1) 1.4851(47), C(1)-N(2) 1.4875(45), N(1)-
C(1)-N(2) 104.3(3).  
a) b) c) 
 4.1. Introduction  
223 
While most conventional carbenes are electrophilic, the lone pair in the plane of the ring results 
in NHCs being highly nucleophilic. They are incredibly strong σ-donors and will readily bind 
to a wide range of metallic and non-metallic species, however they exhibit only very weak 
π-accepting properties. The coordination chemistry of NHCs is therefore more comparable to 
that of P, N or O donating ligands than to Schrock or Fischer carbenes and they were initially 
considered mimics of phosphines as ligands in organometallic complexes.250 In general, 
however, NHCs are more electron-donating than phosphines, resulting in metal-ligand bonds 
that are more thermally and chemically inert towards cleavage. Some exceptions do arise due 
to steric constraints. For example, a study of the relative bond dissociation energies for NHC 
ruthenium(II) complexes found a linear decrease in metal-ligand bond strength with increasing 
bulkiness of the NHC, however, for all but the bulkiest adamantyl NHC, the metal-ligand bond 
dissociation energies for the NHC complexes were greater than that of the analogous complex 
with the most Lewis basic phosphine tested, PCy3 (Figure 4.4).
251 The high stability of NHC 
complexes has led NHCs to become ever more popular ligands in organometallic chemistry. 
 
 
Figure 4.4. Relative bond dissociation energy (kcal/mol) vs steric paramerter (% buried volume) for complexes 
[RuClCp*(L)] (IAd = 1,3-bis(adamantyl)imidazol-2-ylidene, IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-
ylidene, SIPr = 1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene, IMes = 1,3-bis(2,4,6-trimethylphenyl)-
imidazol-2-ylidene, SIMes = 1,3-bis(2,4,6-trimethylphenyl)-imidazolin-2-ylidene, ITol = 1,3-bis(4-
methylphenyl)imidazol-2-ylidene). 
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4.1.2. History 
The existence of NHCs was first suggested by Ronald Breslow in 1958 when he proposed that 
benzoin-type condensations catalysed by vitamin B1 dependant enzymes proceed via the 
formation of a catalytically active NHC by deprotonation of an azolium salt (Scheme 4.1).252 
The NHC subsequently reacts with an aldehyde to form a so-called “Breslow Intermediate”. 
The first isolation of such a species was not achieved until 2012.253 
 
 
Scheme 4.1. Breslow’s proposal for the mechanism of the benzoin condensation. 
 
In the years following Breslow’s proposal it was suggested that NHCs exist only as highly 
reactive intermediates and are not isolable due to their tendency to dimerise.254 In 1968, 
however, a breakthrough was made with the first successful isolation of NHC coordination 
complexes, achieved separately by Wanzlick and Öfele. Wanzlick prepared a bis-NHC 
mercury(II) complex by reaction of an imidazolium salt with [Hg(OAc)2] (Scheme 4.2(a)).
255 
The structure was confirmed by 1H NMR spectroscopy. In the same year Öfele isolated the 
first NHC chromium(0) complex  (Scheme 4.2(b)), although he was actually trying to prepare 
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dihydro-complexes by heating heterocyclic salts of chromium.256 Again, the structure of the 
NHC product was confirmed by 1H NMR spectroscopy.  
 
 
Scheme 4.2. Synthesis of the first NHC transition metal complexes by Wanzlick and Öfele. 
 
The first NHC gold(I) complex was reported by Lappert and co-workers in 1974, prepared by 
cleavage of an enetetramine. Heating a toluene solution of tetramethylenetetramine with 
[AuCl(PPh3)] led to precipitation of the bis-NHC gold(I) chloride complex, and subsequent 
anion metathesis with sodium tetrafluoroborate afforded the more thermally stable bis-NHC 
gold(I) tetrafluoroborate complex (Scheme 4.3). The complexes were characterised by 
elemental analysis and 1H NMR spectroscopy.257 Although of historical importance, this 
methodology for the preparation of NHC complexes by the cleavage of enetetramines has very 
limited scope in terms of ligand diversity and has therefore been little used for the preparation 
of further NHC gold complexes.258 
 
 
Scheme 4.3. Synthesis of the first NHC gold(I) complex 
 
In 1989 Burini and co-workers reported the synthesis of bis-NHC gold(I) complexes by 
reaction of N-methyl or benzyl imidazole with n-butyllithium, followed by addition of 
[AuCl(PPh3)] and HCl (Scheme 4.4). The initial product was proposed to be an unusual cyclic 
NHC trimer complex  based on mass spectrometry data, although the authors did not rule out 
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the possibility that larger oligomeric structures could form. Treatment with hydrochloric acid 
led to the formation of the bis-NHC gold(I) complex which was successfully characterised by 
single crystal X-ray diffraction.72 
 
 
 
 
Scheme 4.4. Synthesis of a bis-NHC gold(I) complex by Burini. Molecular structure determined by single crystal 
X-ray diffraction. Hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 
2.01(1), Au(1)-C(11) 2.02(1), C(1)-N(1) 1.42(1), C(1)-N(2) 1.28(2), C(11)-N(3) 1.34(1), C(11)-N(4) 1.37(1), 
C(1)-Au(1)-C(11) 175.18(41). 
 
One of the key moments in the history of NHC chemistry came in 1991 with the successful 
isolation of a free NHC by Arduengo and co-workers. The carbene was prepared by reaction 
of 1,3-bis(1-adamantyl)imidazolium chloride with sodium hydride in THF with catalytic 
amounts of DMSO (Scheme 4.5).248 DMSO reacts with the sodium hydride to form the dimsyl 
anion which, according to Arduengo, is a better base for imidazolium salts than the sodium 
hydride itself. The side products formed in the reaction, hydrogen gas and sodium chloride, are 
readily removable and concentration of the THF filtrate allowed isolation of the product as 
colourless crystals. The NHC was found to be indefinitely stable under inert atmosphere and 
also had a high thermal stability, melting without decomposition at 240 °C.  
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Scheme 4.5. Preparation of the first stable free NHC, 1,3-bis(1-adamantyl)imidazol-2-ylidene. 
 
Arduengo’s work showed how readily accessible NHCs were and his report led to a renewed 
interest in NHC chemistry. The relatively simple syntheses and the high stability of their 
corresponding metal complexes have made NHCs attractive ligands in organometallic 
chemistry. Various synthetic methods for NHC complexes are known, however most 
commonly deprotonation of an azolium salt is used, either with an external base or a metal 
complex bearing a basic ligand.247 The coordination chemistry of NHCs is now a well-
developed field and NHC complexes have been described for all transition metals259 as well as 
many main group260 and f-block metals.261 In recent years there has been a growing interest in 
NHC gold complexes due to their numerous applications in catalysis, medicine and 
luminescence. 
 
4.1.3. Applications of NHC Gold Complexes 
4.1.3.1. Homogeneous Gold Catalysis 
NHC gold(I) complexes are considered powerful tools in organic synthesis due to their use in 
homogeneous gold catalysis. The strong σ-donor ability of the NHC ligands results in these 
complexes being more electron rich than many other homogeneous gold catalysts and hence 
they have a unique catalytic activity.  
 
The first reported use of an NHC gold complex in a catalytic reaction was in 2003 with the 
gold catalysed hydration of 3-hexyne described by Herrmann and co-workers (Scheme 4.6), 
showing that NHC gold(I) complexes were able catalyse the addition of water to non-activated 
alkynes.262 
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Scheme 4.6. Gold catalysed hydration of 3-hexyne with NHC gold(I) catalyst. 
 
Since then, NHC gold complexes have successfully been employed in a wide variety of organic 
transformations including enyne cycloisomerisations,263 alkyne hydrations,262 propargylic ester 
rearrangement,264 alkene activation,265 alkane C-H bond activation266 and cross-coupling 
reactions.267 However, the importance of NHC gold complexes in catalysis comes not only 
from their high selectivity in directed organic synthetic strategies but also their ability to 
stabilise reactive intermediates in catalytic reactions. Recently several otherwise highly 
unstable intermediates have been isolated as a result of the stabilisation imparted by the NHC 
ligand, including vinyl gold derivatives,79,80,268 gold(I) hydrides75 and gold(I) and gold(III) 
intermediates in gold-only photoredox catalysis,269 thus providing chemists with a better 
understanding of the key steps in reaction mechanisms. 
 
4.1.3.2. Biological Applications 
NHC gold complexes have also been found to have important biological applications. The 
strong gold-carbon bond in NHC gold(I) complexes causes them to be inert towards 
biologically important thiol groups, making them relatively stable in vivo, and hence they have 
potential medical applications.270  
 
In 2004 the first report of the antimicrobial activity of NHC gold complexes was published by 
Çetinkaya and co-workers. A series of bis-NHC gold complexes were found to be effective 
against a variety of Gram-positive and Gram-negative bacteria (Figure 4.5). Variation of the 
substituent at the nitrogen atom was found to cause a significant difference in the antimicrobial 
activity. The complex bearing a p-methoxybenzyl group was active against all strains 
investigated with the exception of E.Coli. The complex bearing a p-dimethylaminobenzyl 
group, however, only showed activity against E.Coli  and was the only complex active against 
this Gram-negative strain.271 
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Figure 4.5. Cationic bis-NHC gold(I) complexes with antimicrobial activity. 
 
A similar effect was noted by Özdemir in a study of the antibacterial and antifungal properties 
of a series of chloro NHC gold(I) complexes (Figure 4.6). Complexes bearing methoxy 
substituents were found to inhibit the growth of Gram-positive bacteria while having no effect 
on Gram-negative bacteria or fungi. However, the incorporation of a pentamethylbenzyl 
substituent at the nitrogen atom of the NHC resulted in no antimicrobial activity but good 
inhibition of fungi was observed.272 
 
 
Figure 4.6. Chloro NHC gold(I) complexes with antimicrobial and antifungal activity. 
 
Significant contributions to the study of the anticancer activity of NHC gold(I) complexes have 
been made by the group of Berners-Price.273 A series of neutral chloro- and 2’,3’,4’,6’-tetra-O-
acetyl-β-D-glucopyranosyl-1-thiolato-NHC gold(I) complexes were reported (Figure 4.7) in 
which variation of the alkyl substituents at the NHC ligand allowed modulation of the lipophilic 
properties of the resultant complexes.274 The complexes were found to target the mitochondria, 
an important feature since carcinoma cells have an elevated mitochondrial membrane potential 
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compared to normal human epithelial cells275 and exploitation of this phenomenon could allow 
delivery of the complex to the cancer cells selectively. The same group went on to report a 
series of homoleptic bis-NHC gold(I) complexes with potent anti-cancer activity which could 
selectively induce apoptosis in cancer cells, leaving normal cells unaffected.120,276 
 
 
Figure 4.7. NHC gold(I) complexes with antitumoural activity. 
 
Ott and co-workers reported how the antiproliferative effects of NHC gold complexes were 
greater for cationic complexes compared to the neutral complexes. The introduction of a 
positive charge was found to increase cellular uptake and generally improve the cytotoxic 
properties.277  
 
The importance of the metal on the mechanism of the anticancer activity of NHC complexes 
has also been studied. Mao and co-workers reported a study of the antiproliferative activities 
of two cationic bis-NHC gold(I) complexes and their silver analogues (Figure 4.8). The 
complexes were tested in five different cell lines with the bis-NHC gold(I) complexes showing 
greater antiproliferative activity and selectivity than the corresponding silver complexes. The 
similarity in structure of the complexes confirms that the metal plays a role in the mode of 
action of the complexes.278 
 
 
Figure 4.8. Bis-NHC silver(I) and gold(I) complexes reported by Mao and co-workers. 
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Although many studies of the biological activity of NHC gold(I) complexes have been carried 
out, gold(III) has been far less explored. Generally NHC gold(III) complexes are unstable in 
biological environments since gold(III) is readily reduced to gold(I) or gold(0) by cellular 
thiol-containing compounds.279-281 Che and co-workers were able to overcome this problem by 
use of a strongly chelating scaffold to stabilise the gold(III) complex. The 2,6-diphenylpyridine 
NHC gold(III) derivative (Figure 4.9), the synthesis of which was reported by the group of 
Yam,282 was found to show antiproliferative effects against a series of human cancer cell 
lines.283  
 
 
Figure 4.9. NHC gold(III) complex with anticancer activity. 
 
More recently modifications to the NHC have been made to incorporate a photoaffinity unit 
and a clickable alkyne moiety. This allowed the target intracellular proteins to be identified 
since the complex can covalently bind to the protein through the photoaffinity unit and then a 
copper catalysed click reaction can be carried out to attach a dye molecule to allow detection 
(Scheme 4.7).284 
 
 
Scheme 4.7. Procedure for the identification of cellular targets of the NHC gold(III) complex. 
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4.1.3.3. Luminescence 
Luminescent NHC gold complexes were first reported in 1999 by Lin and co-workers. A series 
of gold(I) complexes bearing a benzimidazol-2-ylidene ligand were found to exhibit long-lived 
luminescence at room temperature, both in the solid state and in acetonitrile solutions (Figure 
4.10). Multiple emissions were observed for different substituents at the NHC nitrogen atoms 
and with different ligands at the gold.285  
 
 
Figure 4.10. First examples of luminescent NHC gold(I) complexes. 
 
More recently, Casini and coworkers reported fluorescent NHC gold(I) complexes 
functionalised with a fluorescent anthracenyl ligand (Figure 4.11(a)). These were found to have 
low-energy excitation and emission bands at suitable wavelengths for use in cellular 
distribution studies using fluorescence confocal microscopy whilst also exhibiting 
cytotoxicity.286 
 
    
Figure 4.11. Luminescent NHC gold(I) complexes. (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene, 
SIPr = 1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene, IMes = 1,3-bis(2,4,6-trimethylphenyl)-imidazol-2-
ylidene, SIMes = 1,3-bis(2,4,6-trimethylphenyl)-imidazolin-2-ylidene, IAMe = 1-acridinyl-3-methylimidazol-2-
ylidene, IABn = 1-acridinyl-3-benzylimidazol-2-ylidene, IAPic = 1-acridinyl-3-(2-picolyl)imidazole-2-ylidene. 
 
NHC ligands have also been found to stabilise three coordinate gold complexes incorporating 
a nido-carborane diphosphine (Figure 4.11(b)). The resultant complexes were brightly 
luminescent with incredibly high quantum yields, giving them the potential for future practical 
a) b) 
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applications such as in OLEDs. The emission of the NHC gold complexes could be changed 
by simple alterations to the structure of the NHC ligand and hence ligand design could 
potentially allow the luminescent properties to be fine-tuned for specific applications.287 
 
4.1.4. Synthetic Methods for the Preparation of NHC Gold Complexes 
The standard methods for the preparation of NHC gold complexes have several disadvantages. 
Reaction of a free NHC with a gold(I) source was reported almost simultaneously by the groups 
of Roesky and Nolan in 2005 (Scheme 4.8). It was noted that reaction with AuCl led to poor 
yields and gave complex mixtures of mono- and bis-carbene species as well as metallic gold.288 
Ligand displacement from a gold(I) precursor bearing a labile ligand was more successful. 
Nolan carried out the reaction of the free NHC with [AuCl(SMe2)] in THF to form the 
[AuCl(NHC)] complexes in moderate yields. The method was not general, however, and a 
mixture of products was obtained with the NHC IMes.288 Roesky described the formation of 
two [AuCl(NHC)] complexes by reaction of the free NHC with [AuCl(CO)] obtaining the 
complexes in yields of 67 and 83%.289 This methodology requires glovebox techniques and 
anhydrous solvents due to the instability of the free NHC. Often disproportionation and 
decomposition processes compete, leading to poor yields.  
  
 
Scheme 4.8. Synthesis of [AuCl(NHC)] complexes via free NHCs. 
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The most popular method for the preparation of NHC gold(I) complexes is the in situ 
preparation of the NHC silver or copper complex and subsequent transmetallation with gold, 
which is far more versatile, generally does not require the exclusion of air or moisture and 
results in high yields (Scheme 4.9). This method was first introduced in 1998 by Lin where the 
synthesis of both mono- and bis-NHC gold(I) complexes was achieved depending on whether 
a halide or non-coordinating anion was present in the starting imidazolium salt.290 Later an 
analogous method was reported in which silver(I) oxide was substituted for copper(I) oxide to 
give an NHC copper(I) complex which could then undergo transmetallation with gold.291  
 
 
Scheme 4.9. General synthesis of NHC gold(I) complexes via transmetallation (X = halide, Y = non-coordinating 
anion). 
 
Although successful and high yielding, this method results in a full equivalent of silver or 
copper to be consumed in the reaction, making this process costly, and the final products may 
be contaminated with unwanted silver or copper species which is particularly undesirable in 
the preparation of catalysts or catalyst precursors. 
 
More recently, several alternative methods have been reported. Hashmi and co-workers 
described a modular template synthesis of unsymmetrical NHC gold, palladium and platinum 
complexes starting from metal salts, isonitriles and amines with tethered acetal or etal moieties, 
or with β-chloroammonium salts in the presence of a base (Scheme 4.10).292-295 However, 
reaction times were long and in many cases only moderate yields of the final products were 
obtained.  
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Scheme 4.10. Modular template synthesis for unsymmetrical NHC gold(I) complexes. 
 
Alternative methods starting from imidazolium salts have also been described. In 2012, Zhu 
and co-workers demonstrated the successful preparation of a series of [AuCl(NHC)] by heating 
the tetrachloroaurate salts, [Na][AuCl4].2H2O or [K][AuCl4].2H2O with imidazolium salts, 
NHC.HCl, in 3-chloropyrdine for 24 h in the presence of potassium carbonate (Scheme 
4.11(a)).296 Although several complexes were prepared in good yields, this method was not 
suitable for the synthesis of bulky NHC gold complexes. Taton, Vignolle and co-workers 
reported the synthesis of bulky NHC gold complexes by heating imidazolium hydrogen 
carbonates in the presence of [AuCl(SMe2)] in good yields (Scheme 4.11(b)).
297 In 2013, a 
method reported both by our group and the group of Nolan showed that [AuX(NHC)] 
complexes could be prepared in excellent yields by reaction of a gold source such as 
[AuCl(tht)] or [AuCl(SMe2)] and the imidazolium salt in the presence of a weak base, without 
the need for inert atmosphere or dry solvents (Scheme 4.11(c)).298,299 This method, however, is 
limited to NHCs with bulky groups at the nitrogen atoms and decomposition to metallic gold 
is observed when sterically smaller NHCs are employed. 
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Scheme 4.11. Improved methods for the synthesis of NHC gold(I) complexes. 
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4.2. Synthesis of NHC Gold Complexes using 
Tetrabutylammonium Acetylacetonate 
Tetrabutylammonium acetylacetonate, NBu4(acac), is a reagent which has previously been 
used in gold chemistry for the synthesis of a variety of gold(I) complexes in which the acac 
ligand is bound to gold.300 However, this reagent also has the potential to deprotonate an 
imidazolium chloride salt to form an NHC with concurrent formation of NBu4Cl. In the 
presence of a gold(I) precursor possessing a labile ligand this would lead to formation of the 
NHC-gold complex. 
 
4.2.1. Synthesis of Tetrabutylammonium Acetylacetonate 
Until now, the main method for the preparation of NBu4(acac) has been the reaction of 
tetrabutylammonium chloride or bromide with thallium acetylacetonate (Scheme 4.12).301 
Although effective and high yielding, this method requires use of an expensive and toxic 
thallium compound and is therefore not desirable. 
 
 
Scheme 4.12. Synthesis of tetrabutylammonium acetylacetonate with thallium acetylacetonate. 
 
NBu4(acac) can readily be prepared by a more economical and sustainable thallium-free 
method. The reaction of tetrabutylammonium hydroxide hydrate with acetylacetone in ethanol 
at room temperature leads to the formation of NBu4(acac) in a very high yield, 95% (Scheme 
4.13). Excess water is removed by drying a dichloromethane solution of the product over 
sodium sulfate, and recrystallisation with diethyl ether gives the pure product as a white 
crystalline solid. NBu4(acac) is air stable and may readily be handled under ambient conditions.  
 
 
Scheme 4.13. Thallium-free synthesis of tetrabutylammonium acetylacetonate. 
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4.2.2. Synthesis of NHC Gold Complexes using Tetrabutylammonium Acetylacetonate 
The one-pot reaction of an imidazolium chloride salt with [AuCl(tht)] and NBu4(acac) led to 
the formation of [AuCl(NHC)] complexes in 1 h (Scheme 4.14). Reactions were carried out at 
room temperature under air and anhydrous solvents were not required. Filtration of the reaction 
solution through a pad of silica led to removal of the NBu4Cl formed as a side product, and 
subsequent precipitation from dichloromethane solution by addition of diethyl ether allowed 
the NHC gold complexes to be obtained cleanly.  
 
 
Scheme 4.14. Synthesis of [AuCl(NHC)].  
 
The method was tested with a range of commercially available imidazolium chloride salts and 
found to be successful in both those with bulky groups at the nitrogen atoms as well as the 
more challenging, sterically smaller imidazolium salts (Table 4.1). In all cases the yields were 
high, although for complexes 87, 88 and 90 slightly lower yields are observed due to some 
decomposition of the product on the silica. NMR studies show full conversion of the starting 
materials to products therefore it is likely that on a larger scale almost quantitative yields would 
be obtained.  
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Table 4.1. Scope of the new procedure for the synthesis of [AuCl(NHC)] complexes. 
Complex Yield (%) Complex Yield (%) 
 
95 
 
98 
 
94 
 
96 
 
64 
 
67 
 
87 
 
60 
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Figure 4.12. 1H NMR spectrum of starting imidazolium salt (a), reaction mixture after 10 min (b) and isolated 
product (c). 
 
The 1H NMR spectrum of the reaction mixture for the IPr derivative taken after 10 min reaction 
time shows the presence of the [AuCl(NHC)] complex along with the side products tht, Hacac 
and NBu4Cl (Figure 4.12(b)) which are readily removed in the work-up. Four signals are 
observed for Hacac due to the keto and enol forms. No imidazolium salt is present and no other 
products are formed. 
 
CD2Cl2 
H2O 
NBu4Cl 
tht 
Hacac 
CD2Cl2 
a) 
b) 
c) 
 4.2. Synthesis of NHC Gold Complexes using Tetrabutylammonium Acetylacetonate  
241 
When [Au(C6F5)(tht)], rather than [AuCl(tht)], is used as the gold(I) precursor, the 
[Au(C6F5)(NHC)] complexes are obtained with good to excellent yields (Scheme 4.15). Again, 
a simple filtration through silica and subsequent precipitation from dichloromethane allows the 
complexes to be obtained cleanly and the method is successful for both the bulky and smaller 
NHCs (Table 4.2). 
 
 
Scheme 4.15. Synthesis of [Au(C6F5)(NHC)] 
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Table 4.2. Scope of the new procedure for the synthesis of [Au(C6F5)(NHC)] complexes. 
Complex Yield (%) Complex Yield (%) 
 
73 
 
80 
 
86 
 
56 
 
61 
 
91 
 
76 
 
52 
 
 
The molecular structures of complexes 92, 93, 95 and 98 were determined by single crystal X-
ray diffraction (Figure 4.13). All four complexes have the expected linear geometry around the 
gold centre with angles ranging from 173.66(12)° for complex 95 to 177.30(12)° for complex 
92. The shortest Au-C distances for the NHC carbon are 2.013(3) Å for 98, 2.017(3) Å for 95 
and 2.018(5) Å for 93, which correspond to the alkyl substituted NHC ligands, and the longest 
was 2.035(2) Å for complex 92 with an aryl substituent. These distances are longer than those 
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found in [AuCl(NHC)] complexes,274 probably because of the higher trans influence of the 
pentafluorophenyl group compared to the chloride ligand.  
 
 
Figure 4.13. Molecular structures of complexes 92, 93, 95 and 98. Hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å] and angles [°] 92: Au(1)-C(1) 2.013(3), Au(1)-C(22) 2.041(3), N(1)-C(1)                     
1.358(4), N(2)-C(1) 1.352(4), C(1)-Au(1)-C(22) 177.30(12). 93: Au(1)-C(1) 2.018(5), Au(1)-C(6)                    
2.024(6), N(1)-C(1) 1.354(7), N(2)-C(1) 1.337(6), C(1)-Au(1)-C(6) 174.21(17). 95: Au(1)-C(1)                    
2.017(3), Au(1)-C(10) 2.040(3), N(1)-C(1) 1.359(4), N(2)-C(1) 1.357(4), C(1)-Au(1)-C(10) 173.66(12). 98: 
Au(1)-C(1) 2.035(2), Au(1)-C(24) 2.041(2), N(1)-C(1) 1.361(3), N(2)-C(1) 1.366(3), C(1)-Au(1)-C(24) 
177.22(9). 
 
The smaller NHC ligand in complex 93 allows the presence of intramolecular contacts. The 
molecules are associated in trimers through weak Au···Au interactions of 3.648 Å. There are 
also several F···H contacts between the molecules in the range 2.550-2.820 Å. The 
pentafluorophenyl and imidazolium rings are located in parallel fashion with π-stacking 
interactions between one of the carbons of the imidazolium moiety and two carbons of the 
pentafluorophenyl ring (Figure 4.14). 
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Figure 4.14. Association of molecules of 93 in trimers through weak intramolecular Au···Au contacts and 
secondary bonds [Å]. 
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4.3. Synthesis of Propargyl Functionalised Imidazolium Salts 
With the aim of subsequently preparing propargyl functionalised NHC gold complexes using 
the new NBu4(acac) method, a series of propargyl functionalised imidazolium salts (99-102) 
were prepared (Scheme 4.16).  
 
The methyl and benzyl derivatives, 99 and 100, were prepared by reaction of 1-methyl- or 
1-benzylimidazole with propargyl bromide in acetone at room temperature, similar to a 
previously reported procedure.302 1,3-dipropargylimidazolium bromide, 101, was prepared by 
heating an acetonitrile solution of imidazole to reflux with and excess of propargyl bromide, a 
modification to another previously reported procedure.303-305 The pyridyl derivative, 102, 
described for the first time, was prepared similarly by reaction of 1-(2-pyridyl)imidazole with 
propargyl bromide at reflux in acetonitrile. All of the imidazolium salts, apart from the methyl 
derivative, were white solids at room temperature and were insoluble in all common organic 
solvents but soluble in water and alcohols. The methyl derivative was a pale yellow ionic liquid, 
immiscible with organic solvents but miscible with water and alcohols. 
 
 
Scheme 4.16. Synthesis of propargyl functionalised imidazolium salts 99-102. 
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Formation of the imidazolium salts could readily be confirmed by the presence of a signal at a 
high chemical shift (⁓10 ppm) in the 1H NMR spectrum, corresponding to the proton at the 
N-C2-N carbon atom. Additionally, a doublet and triplet are observed, corresponding to the 
CH2 and CH of the propargyl group, respectively (Figure 4.15).  
 
 
 
 
 
 
Figure 4.15. 1H NMR spectrum of imidazolium salt 102 in DMSO. 
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4.4. Synthesis of Propargyl Functionalised NHC Gold Complexes 
4.4.1. Synthesis of Bromo Derivatives 
Addition of a stoichiometric amount of [AuCl(tht)] to imidazolium bromide salts 99-102 in 
dichloromethane led to solutions of the [imidazolium][AuBrCl] salts. Subsequent addition of 
the NBu4(acac) gave the [AuBr(NHC)] complexes 103-106 with reaction times of just 1 h, 
similarly to with the commercial imidazolium chloride salts (Scheme 4.17). The complexes 
could be separated from the NBu4Cl formed in the reaction by filtration through silica and were 
obtained in good yields (73-82%). 
 
 
Scheme 4.17. Synthesis of [AuBr(NHC)] complexes 103-106. 
 
The successful formation of the NHC could be confirmed by the disappearance of the 
imidazolium C2-H signal in the 1H NMR spectrum. In the 13C APT spectra the carbene carbon 
signal appears at a much higher chemical shift (⁓170 ppm) compared to the starting 
imidazolium salts (Figure 4.16).  
 
 
  
Figure 4.16. 13C NMR spectrum of complex 103 in DMSO . 
 
DMSO 
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The molecular structures of complexes 103-106 were determined by single crystal X-ray 
diffraction. Suitable crystals were obtained by the slow diffusion of pentane into solutions of 
the complexes in dichloromethane. In all of the complexes the carbon-carbon triple bond of the 
propargyl unit is maintained and no interaction with the gold centre is observed. 
 
Complex 103 with the smallest substituent on the NHC, a methyl group, has a structure in 
which intermolecular aurophilic interactions are present, with Au···Au distances of 3.324(1) Å 
(Figure 4.17). The propargyl substituent is orientated perpendicular to the coplanar Br-Au-
NHC unit. The Au-C bond distance is 1.985(5) Å, which is the shortest described for an NHC-
Au-Br complex and indicates a strong bond, as expected for strong σ-donor NHCs. The Au-Br 
distance of 2.4038(15) Å is longer that that reported by Meyer and co-workers with an aryl 
substituted carbene (2.3904(4) Å).306 The C-C distances within the propargyl unit are C(5)-
C(6) 1.472(6) Å and C(6)-C(7) 1.183(7) Å, which correspond to single and triple bonds, 
respectively. The gold centre is in a linear geometry with a C(1)-Au(1)-Br(1) angle of 
174.35(12)°. 
 
 
Figure 4.17. Molecular structure of complex 103. Selected bond lengths [Å] and angles [°]: Au(1)-C(1) 1.985(5), 
Au(1)-Br(1) 2.4038(15), N(1)-C(1) 1.353(6), N(2)-C(1) 1.342(6), C(5)-C(6) 1.472(6), C(6)-C(7) 1.183(7), 
C(1)-Au(1)-Br(1) 174.35(12). 
 
The structures of complexes 104-106 (Figure 4.18) show patterns similar to those found in 103 
with the exception of the aurophilic interactions. The increase in steric demand of the 
substituents on the nitrogen atom of the imidazole ring causes the disappearance of this 
intermolecular contact. As expected when changing to substituents with a weaker donor 
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capacity the Au-Ccarbene bond distances are slightly longer in these complexes following the 
order Me < CH2C≡CH < CH2Ph ≈ Py, although values for Py and CH2Ph are similar within the 
errors and the differences may not be significant. Additionally, a concurrent decrease in the 
Au-Br distance is observed with increasing Au-Ccarbene bond distance. 
 
 
Figure 4.18. Molecular structures of complexes 104-106. Selected bond lengths [Å] and angles [°] 104: 
Au(1)−C(1) 2.004(5), Au(1)− Br(1) 2.3927(7), N(1)−C(1) 1.341(6), N(2)−C(1) 1.327(6), C(4)− C(5) 1.453(7), 
C(5)−C(6) 1.179(7), C(1)−Au(1)−Br(1) 177.78(12); 105: Au(1)−C(1) 1.994(4), Au(1)−Br(1) 2.4057(4), 
N(1)−C(1) 1.337(5), N(2)−C(1) 1.346(5), C(5)−C(6) 1.176(7), C(8)−C(9) 1.172(6), C(1)−Au(1)−Br(1) 
177.23(12); 106: Au(1)− C(1) 1.988(10), Au(1)−Br(1) 2.3967(10), N(1)−C(1) 1.347(12), N(2)−C(1) 1.354(11), 
C(4)−C(5) 1.478(13), C(5)−C(6) 1.191(15), C(8)−C(9) 1.172(6), C(1)−Au(1)−Br(1) 174.6(2). 
 
4.4.2. Synthesis of Bis-NHC Complexes 
When the reaction of the imidazolium bromide salts, [AuCl(tht)] and NBu4(acac) was carried 
out in THF, rather than dichloromethane, a white precipitate was observed in all cases except 
for with the benzyl derivative 100 (Scheme 4.18). This was identified as the bis-carbene species 
[Au(NHC)2]Br, and its formation is likely favoured in this case because of its insolubility in 
THF. Complexes 107, 108 and 110 could be formed in excellent yields (82-95%) by reaction 
of 2 equivalents of the imidazolium salt with 1 equivalent of [AuCl(tht)] and 2 equivalents of 
NBu4(acac) in THF with precipitation of the product (Scheme 4.18(b)). Due to its solubility in 
THF, bis-carbene species 109 was prepared by reaction in dichloromethane followed by 
washing water to remove NBu4Cl, however, 109 also exhibits some water solubility and hence 
was only isolated in moderate yield (63%).  
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As with the bromo derivatives, the successful formation of the NHC could be confirmed by the 
disappearance of the imidazolium C2-H signal in the 1H NMR spectrum and the high chemical 
shift of the C2 carbon signal in the 13C APT spectrum. For these bis-carbene species the carbene 
carbon signal was observed at a higher chemical shift than for the bromo derivatives (180-185 
ppm), due to the greater trans influence of the NHC.  
 
 
Scheme 4.18. Formation of [Au(NHC)2]Br complexes. 
 
The molecular structures of 109 and 110 were obtained by single crystal X-Ray diffraction. 
Complex 109 presents an almost ideal linear geometry with a C(1)-Au(1)-C(10) angle of 
178.6(5)° (Figure 4.19). The Au-C bond lengths are 2.011(13) Å and 2.015(12) Å, which as 
expected, are longer than in the [AuBr(NHC)] complexes. The molecules are associated in 
dimers with some secondary π-π stacking contacts, resulting in a long Au···Au interaction of 
3.797 Å between the gold centres. The distance between the centroids of the imidazolyl rings 
is 3.848 Å, although there are shorter contacts between the carbene carbon and the nitrogen 
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atom of the other molecule. Additionally, a weak Au-C interaction of 3.243 Å is observed with 
the alkyne carbon. The bromide anions form hydrogen bonds in an octahedral fashion with the 
protons of the propargyl units, most of which are above the sum of the van der Waals radii, the 
shortest value being 2.487 Å. 
 
Figure 4.19. Molecular structure of complex 109, and associated dimers through different secondary interactions. 
Selected bond lengths [Å] and angles [°]: Au(1)-C(10) 2.011(13), Au(1)-C(1) 2.015(12), N(1)-C(1) 1.342(15), 
N(2)-C(1) 1.353(15), N(3)-C(10) 1.368(16), N(4)-C(10) 1.351(17), C(4)-C(5) 1.469(18), C(5)-C(6) 1.185(19), 
C(7)-C(8) 1.457(17), C(8)-C(9) 1.182(19), C(13)-C(14) 1.489(18), C(14)-C(15) 1.18(2), C(16)-C(17) 1.466(19); 
C(10)-Au(1)-C(1) 178.6(5). 
 
The structure of complex 110 is shown in Figure 4.20. The molecule lies in a two-fold axis and 
therefore only half corresponds to the asymmetric unit. The Au-C distance of 2.21(8) Å is 
slightly longer than that found in complex 109, as expected for a weaker σ-donor carbene. The 
bromide makes a weak hydrogen bonds of 2.522 and 2.594 Å with the alkyne protons, giving 
rise to a supramolecular structure with formation of squares (Figure 4.21). 
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Figure 4.20. Molecular structure of complex 110. Selected bond lengths (Å) and angles (°): Au(1)-C(1) 2.021(8), 
C(5)-C(6) 1.176(14), C(5)-C(4) 1.463(15); C(1)#1-Au(1)-C(1) 179.997(1). Symmetry transformations used to 
generate equivalent atoms: (#1) −𝑥 +  1
2
 , −𝑦 +  1
2
 , −𝑧. 
 
Figure 4.21. Formation of a supramolecular structure by Br···H interactions in complex 110. 
 
4.4.3. Synthesis of Pentafluorophenyl Derivatives 
Reaction of the imidazolium salts 99-102 with [Au(C6F5)(tht)] gave the 
[imidazolium][AuBr(C6F5)] salts and subsequent addition of NBu4(acac) led to the formation 
of the [Au(C6F5)(NHC)] complexes 111-114 (Scheme 4.19(a)). 
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Scheme 4.19. Formation of complexes 29-32 and their equilibrium in water. 
 
Initial NMR studies of the reaction showed the formation of small amounts of NBu4[Au(C6F5)2] 
(Figure 4.22(a)), and washing the reaction mixture with water led to an increase in the ratio of 
this product compared to the desired [Au(C6F5)(NHC)] (Figure 4.22(b)). This can be explained 
by the equilibrium shown in Scheme 4.19(b). Since the bis-carbene species are soluble in water, 
washing the reaction mixture with water would result in removal of this product, forcing the 
equilibrium to produce more with concurrent formation of NBu4[Au(C6F5)2]. 
 
 
 
Figure 4.22. 19F NMR of initial reaction mixture (a) and after washing with water (b). 
a) 
b) 
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Before washing with water, the equilibrium lies far towards the side of the desired product 
[Au(C6F5)(NHC)]. These complexes could therefore be obtained cleanly and in high yields by 
using an alternative purification method. Simply filtering the reaction mixture through silica 
led to removal of NBu4Br and any of the by-products formed as a result of the equilibrium of 
the products, thus leaving the desired complexes 111-114 in good yields (76-87%) 
 
The molecular structure of 113 was obtained by single crystal X-ray diffraction (Figure 4.23). 
The gold centre is linearly coordinated with a C(1)-Au(1)-C(10) angle of 175.79(19)°, to two 
different carbon donor ligands. The Ccarbene-Au distance is 2.022(5) Å while the 
Cpentafluorphenyl-Au distance is 2.048(5) Å. The molecules of 113 are associated in dimers with a 
weak intermolecular Au···Au interaction of 3.3506(8) Å, together with some slipped π-π 
stacking interactions between the imidazolyl and the pentafluorophenyl rings, the shortest 
contacts are 3.388 Å and 3.420 Å. 
 
 
Figure 4.23. Molecular structure of complex 113. Selected bond lengths (Å) and angles (°): Au(1)-C(1) 2.022(5), 
Au(1)-C(10) 2.048(5), Au(1)-Au(1)#1 3.3506(8), N(1)-C(1) 1.353(7), C(4)-C(5) 1.462(7), C(5)-C(6) 1.181(8), 
C(7)-C(8) 1.455(8), C(8)-C(9) 1.184(8); C(1)-Au(1)-C(10) 175.79(19). 
 
4.4.4. Synthesis of NHC Gold Phosphine Derivatives 
The synthesis of triphenylphosphine derivatives [Au(NHC)(PPh3)]
+ from the imidazolium salts 
99-102 was attempted. Since the desired complexes are cationic, the anion of the imidazolium 
salts was changed for a non-coordinating tetrafluoroborate anion by a metathesis reaction with 
sodium tetrafluoroborate in methanol, followed by recrystallisation in dichloromethane. The 
resulting imidazolium tetrafluoroborate salts, 115-118, were then reacted with [AuCl(PPh3)] 
and NBu4(acac) in dichloromethane (Scheme 4.20). 
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Scheme 4.20. Attempted synthesis of [Au(NHC)(PPh3)]BF4 
 
Reaction of the imidazolium tetrafluoroborate salts, 115-118, with [AuCl(PPh3)] and 
NBu4(acac) followed by washing with water to remove NBu4Cl, gave a white solid in each 
case. 31P{1H} NMR studies in CD2Cl2 at room temperature showed a broad peak at around 
39 ppm (Figure 4.24(a)) and lowering the temperature to -80 °C allowed observation of three 
different phosphorus containing products, believed to be the desired [Au(NHC)(PPh3)]
+, 
[Au(PPh3)2]
+ and a tricoordinate species (Figure 4.24(b)). 
 
 
 
 
Figure 4.24. 31P{1H} NMR spectrum of the reaction of 115 with [AuCl(PPh3)] and NBu4(acac) in CD2Cl2 at room 
temperature (a) and -80 °C (b). 
 
This indicates the presence of an equilibrium in solution at room temperature (Scheme 4.21). 
 
[Au(PPh3)2]+ 
a) 
b) 
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Scheme 4.21. Proposed equilibrium of [Au(NHC)(PPh3)]BF4 present in solution. 
 
It should be noted, however, that the same equilibrium was not observed when the analogous 
reaction was carried out with the commercially available 
1,3-bis(2,6- diisopropylphenyl)imidazolium tetrafluoroborate salt. Reaction with NBu4(acac) 
and [AuCl(PPh3)] gave [Au(IPr)(PPh3)] as the unique product (Scheme 4.22), observed as a 
sharp peak at 40.04 ppm in the 31P{1H} NMR spectrum at room temperature (Figure 4.25). 
This product has previously been reported and structurally characterised by the group of Nolan, 
although it was prepared by an alternative method.307  
 
 
Scheme 4.22. Reaction of 1,3-bis(2,6-diisopropylphenyl)imidazolium tetrafluoroborate with [AuCl(PPh3)] and 
NBu4(acac). 
 
Figure 4.25. 31P{1H} NMR spectrum of [Au(IPr)(PPh3)]BF4 prepared by NBu4(acac) method, in CD2Cl2 at room 
temperature. 
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To determine if the equilibrium was due to steric or electronic effects, the method was tested 
with a series of different gold(I) phosphine precursors of different steric and electronic 
requirements (Scheme 4.23). With the more σ-donating but sterically smaller phosphines, PiPr3 
and PPh2Me the same effect was observed and broad peaks were observed in the 
31P{1H} NMR 
spectra of the reactions corresponding to the presence of equilibria in solution at room 
temperature. However, increasing the steric bulk of the phosphine did allow a clean reaction to 
occur to give a unique product. With JohnPhos, CyJohnPhos and TrippyPhos only one sharp 
peak was observed in the 31P{1H} NMR spectrum corresponding to the desired 
[Au(NHC)(PR3)]BF4 product. 
 
 
Scheme 4.23. Synthesis of [Au(NHC)(PR3)]BF4 
 
The isolated [Au(NHC)(PR3)]BF4 complexes are shown in Table 4.3. In all cases the NBu4Cl 
formed in the reaction was removed by washing with water and a dichloromethane solution of 
the product was dried over sodium sulfate to remove excess water. All products were obtained 
in moderate-good yields as air stable white solids.  
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Table 4.3. NHC Gold Phosphine Derivatives 
Complex R 
31P{1H} NMR 
(ppm) 
Yield  
(%) 
 
 
 
123 Me 63.66 69 
124 Bn 63.78 76 
125 CH2C≡CH 63.58 63 
126 Py 63.42 65 
 
 
 
127 Me 43.75 70 
128 Bn 43.97 54 
129 CH2C≡CH 43.62 77 
130 Py 43.16 71 
 
 
 
131 Me 60.09 67 
132 Bn 60.06 75 
133 CH2C≡CH 59.97 74 
134 Py 59.58 66 
 
Complexes 123-134 were characterised by NMR spectroscopy. Successful formation of the 
NHC is observed by the disappearance of the imidazolium C2-H signal in the 1H NMR 
spectrum. As with the previous complexes, the propargyl unit of the NHC ligand is observed 
as a doublet and a triplet (Figure 4.26(a)). A single sharp peak is observed in the 31P{1H} NMR 
spectrum in each case (Figure 4.26(b)). This signal appears at a higher chemical shift than that 
of the corresponding [AuCl(PR’3)] complex due to the greater trans influence of the NHC 
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compared to the chloride ligand. In the 13C APT spectra the carbene C2 signal appears as a 
doublet at around 190 ppm (Figure 4.26(c)). This chemical shift is typical for an NHC carbon 
signal and the doublet is due to coupling with the phosphine ligand, further evidence that both 
ligands are bound to the gold centre. 
 
 
 
 
 
 
 
 
 
 
Figure 4.26. 1H NMR spectrum (a) 31P{1H} NMR spectrum (b) and 13C APT spectrum (c) of complex 126 in 
CD2Cl2 at room temperature. 
 
CD2Cl2 
H2O 
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For complexes 131-134, bearing the very bulky TrippyPhos ligand, an ABX spin pattern is 
observed for the protons of the propargyl unit in the 1H NMR spectrum (Figure 4.27). 
 
 
 
 
 
 
Figure 4.27. 1H NMR spectrum for complex 133 in CD2Cl2 at room temperature. 
 
For complex 132, the CH2 of the benzyl group is also observed as an AB spin pattern in the 
1H 
NMR spectrum (Figure 4.28). In this case the product was obtained as a mixture of 132 and the 
bis-NHC species, 108. This could be due to increased steric hindrance between the bulky 
phosphine and the benzyl group, compared to the smaller NHCs. 
 
 
 
 
 
 
Figure 4.28. 1H NMR spectrum of complex 132 in CD2Cl2 at room temperature. 
 
CH2Ph CH2C≡C 
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Complexes 123-134 were characterised by high resolution mass spectrometry. In all cases the 
molecular ion pear [M]+ was observed (Table 4.4). 
 
Table 4.4. HRMS (ESI-TOF) Calculated and Found m/z Values 
Complex Peak m/z Calculated m/z Found 
 
  
123 [M]+ 615.2198 615.2213 
124 [M]+ 691.2511 691.2520 
125 [M]+ 639.2179 639.2198 
126 [M]+ 678.2307 678.2306 
 
  
127 [M]+ 667.2511 667.2546 
128 [M]+ 743.2824 743.2858 
129 [M]+ 691.2511 691.2487 
130 [M]+ 730.2620 730.2599 
 
  
131  [M]+ 757.2729 757.2658 
132 [M]+ 833.3042 833.3049 
133 [M]+ 781.2729 781.2739 
134 [M]+ 820.2838 820.2802 
 
The JohnPhos derivatives 124-126 were characterised by single crystal X-ray diffraction. The 
molecular structures are shown in Figure 4.29. In all cases a distorted linear coordination about 
the gold atom can be observed with angles 175.76(17)° for 124, 176.2(2)° for 125 and  
173.40(13)° for 126. The distortion is a result of the bulky JohnPhos ligand. In all cases the 
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propargyl unit is maintained and typical bond distances for carbon-carbon single and triple 
bonds are observed. The biphenyl group of the JohnPhos is orientated over the gold centre in 
each case and no interaction of the gold centre with the alkyne of the propargyl side arm is 
observed in any of the complexes. 
 
 
Figure 4.29. Molecular structures of complex 124-126. Selected bond lengths (Å) and angles (°) 124: 
Au(1)-P(1) 2.2966(15), Au(1)-C(1) 2.039(6), N(1)-C(1) 1.348(7), N(2)-C(1) 1.343(8), C(4)-C(5) 1.468(9), 
C(5)-C(6) 1.174(11), C(1)-Au(1)-P(1) 175.76(17), C(4)-C(5)-C(6) 175.9(7); 125: Au(1)-P(1) 2.2991(16), 
Au(1)-C(1) 2.031(7), N(1)-C(1) 1.371(10), N(2)-C(1) 1.345(9), C(2)-C(3) 1.465(12), C(3)-C(4) 1.174(13), 
C(7)-C(8) 1.469(12), C(8)-C(9) 1.167(12), C(1)-Au(1)-P(1) 176.2(2), C(2)-C(3)-C(4) 175.0(9), 
C(7)-C(8)-C(9) 174.0(8); 126: Au(1)-P(1) 2.2953(14), Au(1)-C(1) 2.036(4), N(1)-C(1) 1.368(6), 
N(2)-C(1) 1.334(6), C(4)-C(5) 1.467(7), C(5)-C(6) 1.166(7), C(1)-Au(1)-P(2) 173.40(13), 
C(4)-C(5)-C(6) 179.2(6). 
 
The CyJohnPhos derivatives, 127-130, were also characterised by single crystal X-ray 
diffraction. The molecular structures are shown in Figure 4.30. Again, a distorted linear 
coordination about the gold centre is observed in each case. The biphenyl ligand lies over the 
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gold centre and the propargyl side arms are maintained. No interaction of the gold centre with 
the alkyne of the propargyl unit is observed. The Au-Ccarbene bond distances are very similar to 
those for the JohnPhos, indicating a very similar σ-donor capacity between JohnPhos and 
CyJohnPhos. 
 
 
Figure 4.30. Molecular structures of complex 127-130. Selected bond lengths (Å) and angles (°) 127: 
Au(1)-C(1) 2.032(3), Au(1)-P(1) 2.2817(7), N(1)-C(1) 1.358(3), N(2)-C(1) 1.342(3), C(4)-C(5) 1.468(4), 
C(5)-C(6) 1.174(4), C(1)-Au(1)-P(1) 176.89(8), C(6)-C(5)-C(4) 179.3(3); 128: Au(1)-C(1) 2.064(7), 
Au(1)-P(1) 2.287(2), N(1)-C(1) 1.330(10), N(2)-C(1) 1.331(10), C(4)-C(5) 1.452(14), C(5)-C(6) 1.184(15), 
C(1)-Au(1)-P(1) 170.6(2), C(6)-C(5)-C(4) 177.9(11); 129: Au(1)-C(1) 2.032(5), Au(1)-P(1) 2.2774(13), 
N(1)-C(1) 1.345(6), N(2)-C(1) 1.346(6), C(4)-C(5) 1.456(9), C(5)-C(6) 1.159(9), C(7)-C(8) 1.457(8), 
C(8)-C(9) 1.175(9), C(1)-Au(1)-P(1) 176.37(14), C(6)-C(5)-C(4) 178.4(7), C(9)-C(8)-C(7) 178.9(6); 130: 
Au(1)-C(1) 2.033(3), Au(1)-P(1) 2.2692(8), N(1)-C(1) 1.359(3), N(2)-C(1) 1.344(3), C(4)-C(5) 1.441(4), 
C(5)-C(6) 1.188(5), C(1)-Au(1)-P(1) 173.03(8), C(6)-C(5)-C(4) 178.3(4). 
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4.4.5. Gold(III) Derivatives 
Attempts to form gold(III) derivatives from the imidazolium salts directly by addition of 
NBu4(acac) and AuCl3(tht) were unsuccessful and reduction to gold(I) was observed. However, 
the gold(III) derivatives could readily be prepared by oxidation of the NHC gold(I) complexes 
with Cl2. Addition of an excess of Cl2 solution in CCl4 to a solution of the NHC gold bromide 
complexes, 103 and 106, led to the formation of the gold(III) derivatives [AuCl3(NHC)], 135  
and 136 (Scheme 4.24). 
 
 
 
Scheme 4.24. Synthesis of NHC gold(III) complexes 135-136. 
 
Complexes 135 and 136 were characterised by single crystal X-ray diffraction. Suitable crystals 
were grown by slow diffusion of pentane into a solution of the complex in dichloromethane. 
The molecular structures are shown in Figure 4.31. The presence of three chloride ligands at 
the gold centre can readily be observed and square planar coordination is observed about the 
gold centre in both cases. The propargyl unit shows typical distances for a carbon-carbon single 
and triple bond and the C-C≡C bond angles are practically linear. 
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Figure 4.31. Molecular structures of complex 135 and 136. Selected bond lengths (Å) and angles (°) 135: 
Au(1)-C(1) 2.008(19), Au(1)-Cl(2) 2.324(5), Au(1)-Cl(3) 2.346(4), Au(1)-Cl(1) 2.352(4), N(1)-C(1)                     
1.30(3), N(2)-C(1) 1.37(3), C(4)-C(5) 1.43(4), C(5)-C(6) 1.11(4), C(1)-Au(1)-Cl(2) 179.0(5), 
Cl(3)-Au(1)-Cl(1) 176.92(14), C(6)-C(5)-C(4) 174(3); 136: Au(1)-C(1) 1.993(3), Au(1)-Cl(3) 2.2802(9), Au(1)-
Cl(1) 2.2827(9), Au(1)-Cl(2) 2.3166(9), N(1)-C(1) 1.338(5), N(2)-C(1) 1.343(4), C(4)-C(5) 1.458(5), C(5)-C(6) 
1.181(6), Cl(3)-Au(1)-Cl(1) 176.30(3), C(1)-Au(1)-Cl(2) 179.20(10), C(6)-C(5)-C(4) 176.4(4). 
 
4.4.6. Di-NHC Complexes 
Since polynuclear gold complexes are of interest due to their potential luminescence and 
enhanced biological activity, attempts were made to prepare propargyl-functionalised NHC 
derivatives bearing more than one NHC which could hence coordinate more than one gold 
centre. 
 
Two imidazolium salts bridged by a dimethylpyridine unit were prepared by reaction of 
2,6-bis(bromomethyl)pyridine with imidazole or benzimidazole in the presence of NaOH, and 
subsequent alkylation with propargyl bromide to give 137 and 138 (Scheme 4.25). 
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Scheme 4.25. Synthesis of di-imidazolium salts 137 and 138. 
 
The di-NHC gold bromide derivatives, 139 and 140, were prepared by reaction of the 
imidazolium salts with [AuCl(tht)] in acetone with excess Cs2CO3 (Scheme 4.26). The poor 
solubility of the products led to low yields in these reactions. 
 
 
Scheme 4.26. Synthesis of di-NHC gold bromide complexes 139-140. 
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Successful formation of the NHC could be confirmed by the disappearance of the imidazolium 
C-H signal in the 1H NMR spectrum. The propargyl side arms are maintained in both cases and 
observed as a doublet and triplet in the 1H NMR spectrum (Figure 4.32). 
 
 
 
 
 
 
 
 
Figure 4.32. 1H NMR spectrum for salt 139 (a) and complex 141 (b) in DMSO at room temperature. 
 
Complex 139 was characterised by single crystal X-ray diffraction. The molecular structure is 
shown in Figure 4.33. The two NHC-Au-Br units are angled in opposite directions, bringing 
the gold centres in close proximity, however the Au-Au distance, 4.414 Å, is too long to be 
considered an aurophilic interaction. A linear coordination is observed about each gold(I) 
centre with angles C(1)-Au(1)-Br(1) 177.2(6)° and C(14)-Au(2)-Br(2) 177.9(5)°. The 
propargyl units can readily be observed by the carbon-carbon bond lengths which show typical 
distances for a single and triple bond. 
 
H2O 
DMSO 
H2O 
DMSO 
CH2Cl2 
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Figure 4.33. Molecular structures of complex 139. Selected bond lengths (Å) and angles (°): 
Au(1)-C(1) 2.005(17), Au(1)-Br(1) 2.400(2), Au(2)-C(14) 2.023(17), Au(2)-Br(2) 2.393(2), N(1)-C(1) 1.34(2), 
N(2)-C(1) 1.32(2), N(4)-C(14) 1.31(2), N(5)-C(14) 1.32(2), C(4)-C(5) 1.46(3), C(5)-C(6) 1.14(3), 
C(17)-C(18) 1.46(2), C(18)-C(19) 1.17(2), C(1)-Au(1)-Br(1) 177.2(6), C(14)-Au(2)-Br(2) 177.9(5), 
C(6)-C(5)-C(4) 175(2), C(19)-C(18)-C(17) 173(2). 
 
Attempts were also made to prepare NHC gold phosphine derivatives from imidazolium salts 
137 and 139. Initially the BF4 salts, 141 and 142, were prepared by reaction with NaBF4 in 
methanol. Addition of two equivalents of [Au(acac)(PPh3)] led to the formation of the 
[Au2(NHC)2(PPh3)2](BF4)2 complexes, 143 and 144 (Scheme 4.27), which similarly to the 
mononuclear [Au(NHC)(PPh3)]BF4 complexes presented equilibria in solution with broad 
31P{1H} NMR spectra observed at room temperature (Figure 4.34).  
 
 
Scheme 4.27. Synthesis of complexes 143-144. 
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Figure 4.34. 31P{1H} NMR spectrum of complex 144 in DMSO at room temperature. 
 
Crystals of complex 144 were grown and measured by single crystal X-ray diffraction, showing 
that in the solid state the [Au2(NHC)2(PPh3)2](BF4)2 complex does exist (Figure 4.35). 
Similarly to complex 139, the gold triphenylphosphine units are angled in opposite directions. 
This minimises the steric repulsions between the bulky triphenylphosphine groups. A linear 
coordination is observed about each gold centre. No tautomerisation of the propargyl side arms 
is observed. 
 
 
Figure 4.35. Molecular structures of complex 144 (PPh3 phenyl rings are omitted for clarity). Selected bond 
lengths (Å) and angles (°): Au(1)-C(1) 2.045(7), Au(1)-P(1) 2.280(2), Au(2)-C(18) 2.043(8), Au(2)-P(2) 2.274(2), 
N(1)-C(1) 1.349(9), N(2)-C(1) 1.327(10), N(4)-C(18) 1.333(10), N(5)-C(18) 1.343(10), C(8)-C(9) 1.438(11), 
C(9)-C(10) 1.183(11), C(25)-C(26) 1.482(11), C(26)-C(27) 1.179(11), C(1)-Au(1)-P(1) 172.0(2), C(18)-Au(2)-
P(2) 173.3(2), C(10)-C(9)-C(8) 173.2(9), C(27)-C(26)-C(25) 172.8(10). 
 
When the bulky JohnPhos phosphine was used the equilibrium in solution was not observed. 
Complexes 145 and 146 were prepared by reaction of imidazolium salts 141 and 142 with two 
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equivalents of [AuCl(JohnPhos)] and two equivalents of NBu4(acac). Successful formation of 
the di-NHC is observed by the loss of the imidazolium C-H signal in the 1H NMR spectrum. 
The propargyl CH2 and CH protons are still observed as a singlet and triplet (Figure 4.36(a)). 
A single sharp peak is observed in the 31P{1H} spectrum (Figure 4.36(b)).  
 
 
Scheme 4.28 Synthesis of complexes 145 and 146. 
 
 
 
 
 
Figure 4.36. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) of 145 in CD2Cl2 at room temperature.
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4.5. Functionalisation of the Propargyl Unit 
4.5.1. Dinuclear NHC Gold JohnPhos Derivatives 
Attempts were made to coordinate and additional -AuJohnPhos unit to the propargyl side arm 
of complexes 123 and 124. Reaction of imidazolium salt 99 with 2 equivalents of 
[AuCl(JohnPhos)] and 2 equivalents of NBu4(acac) led only to the formation of mononuclear 
complex 123 and unreacted starting material even after 24 h reaction time, suggesting 
NBu4(acac) is not a strong enough base to deprotonate the propargyl CH (Scheme 4.29(a)). 
When the reaction is carried out in methanol using potassium hydroxide as the base, the desired 
dinuclear complexes form (Scheme 4.29(b)). 
 
 
Scheme 4.29. Synthesis of complexes 147 and 148. 
 
1H NMR spectroscopy confirms the deprotonation of the alkyne C-H. The propargyl CH2 is 
observed as a doublet at 4.67 ppm (4JHP = 1.6 Hz) due to weak coupling with the JohnPhos 
phosphorus atom (Figure 4.37(a)). Two peaks are observed in the 31P{1H} NMR spectrum at 
similar chemical shifts since the two phosphorus atoms are in similar chemical environments, 
both bound to a gold atom bearing a carbon ligand (Figure 4.37(b)).  
 
 
 Chapter 4 – NHC Gold Complexes 
272 
 
 
Figure 4.37. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) of complex 147 in CD2Cl2 at room 
temperature. 
 
The identity of the products is also confirmed by HRMS(ESI-QTOF) with the molecular ion 
peaks [M]+ observed as the most intense peaks (Table 4.5). 
 
Table 4.5. HRMS (ESI-TOF) Calculated and Found m/z Values 
Complex Peak m/z Calculated m/z Found 
147 [M]+ 1109.3636 1109.3650 
148 [M]+ 1185.3949 1185.3899 
 
 
 
 
 
CD2Cl2 
Me 
H2O tBu 
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4.5.2. Formation of Trimers 
Reaction of the bromo NHC gold complexes 103, 104 and 106 with HNiPr2 in the presence of 
CuI as a catalyst led to the elimination of both the alkyne proton and the bromide ligand bound 
to gold to afford the sparingly soluble trimeric complexes 149-151 (Scheme 4.30). 
 
 
Scheme 4.30. Synthesis of trimers 149-151. 
 
The elimination of the alkyne proton was confirmed by 1H NMR spectroscopy (Figure 4.38). 
The propargyl CH2, which in the starting complexes, 103-106, was observed as a doublet, is 
now observed as a singlet and the triplet corresponding to the alkyne CH is no longer present. 
 
The trimeric nature of the products was confirmed by HRMS(ESI-QTOF) with spectra showing 
the molecular ion peaks [M+Na]+ as the most intense peaks (Table 4.6). 
 
Table 4.6. HRMS (ESI-TOF) Calculated and Found m/z Values 
Complex Peak m/z Calculated m/z Found 
149 [M+3MeOH+Na]+ 1067.1503 1067.1523 
150 [M+Na]+ 1199.1655 1199.1721 
151 [M+Na]+ 1160.1043 1160.1031 
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Figure 4.38. 1H NMR spectrum of starting complex 103 (a) and trimer product 149 (b) in DMSO at room 
temperature. 
 
The IR spectra of complexes 149-151 lack the C≡C-H vibration present in the starting 
complexes at around 3260 cm-1 (Figure 4.39), while the -C≡C- vibration mode at around 
2160 cm-1 is maintained (Figure 4.40). 
 
H2O 
DMSO 
H2O DMSO 
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Figure 4.39. IR Spectrum of complex 104. 
 
 
 
Figure 4.40. IR Spectrum of complex 150. 
C≡C-H 
stretch 
-C≡C- 
stretch 
-C≡C- 
stretch 
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4.5.3. Propargyl-Allenyl Tautomerism 
Reaction of the imidazolium salts 99 and 100 with Ag2O gave the bis-NHC silver bromide 
derivatives 152 and 153 in which the propargyl side arm has tautomerised to the allenyl form 
(Scheme 4.31). 
 
Scheme 4.31. Synthesis of bis-NHC silver complexes 152 and 153. 
 
The allenyl unit is readily observed in the 1H NMR spectrum by the presence of a triplet at a 
high chemical shift (7.35 ppm for 152 and 7.56 ppm for 153) corresponding to the CH and a 
doublet at around 5.6 ppm (5.68 ppm for 152 and 5.57 ppm for 153 with coupling constant 
4JHH = 6.4 Hz in both cases) corresponding to the CH2 (Figure 4.41). 
 
 
Figure 4.41. 1H NMR spectrum of complex 152 in CD2Cl2 at room temperature. 
 
The molecular structure of complex 153 was determined by single crystal X-ray diffraction 
(Figure 4.42). 
 
H2O 
CD2Cl2 
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Figure 4.42. Molecular structure of complex 153. Selected bond lengths (Å) and angles (°): Ag(1)-C(1) 2.062(10), 
Ag(1)-C(14) 2.156(9), C(4)-C(5) 1.362(13), C(5)-C(6) 1.303(16), C(17)-C(18) 1.226(13), C(18)-C(19) 1.308(17), 
C(1)-Ag(1)-C(14) 168.24(10), C(6)-C(5)-C(4) 175.6(12), C(17)-C(18)-C(19) 178.2(14). 
 
A distorted linear coordination is observed about the silver with C(1)-Ag(1)-C(14) angle of 
168.24(10)°. The allenyl nature of the side arm can be seen by the similarity of the carbon bond 
distances C(4)-C(5) 1.362(13) Å and C(5)-C(6) 1.303(16) Å indicating two carbon-carbon 
double bonds. 
 
Reaction of complexes 152 and 153 with two equivalents of [AuCl(tht)] led to the formation 
of the allenyl functionalised NHC gold complexes 154 and 155 in excellent yields (99%) 
(Scheme 4.32). 
 
 
Scheme 4.32. Synthesis of complexes 154-155. 
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As with complexes 152-153, the allenyl side arm can clearly be seen in the 1H NMR spectra 
by the presence of a triplet at around 7.5 ppm due to the CH and a doublet at around 5.6 ppm 
due to the CH2 (Figure 4.43).  
 
 
 
 
Figure 4.43. 1H NMR spectrum of complex 154 in CDCl3 at room temperature. 
 
The molecular structure of complex 155 was determined by single crystal X-ray diffraction 
(Figure 4.44). The presence of the bromide anion can clearly be seen and a linear coordination 
about the gold centre is observed. The similarity of the C-C bond distances C(4)-C(5) 1.284(19) 
Å and C(5)-C(6) 1.352(18) Å highlights the presence of the allenyl unit. The C=C=C angle is 
practically linear. 
 
Figure 4.44. Molecular structure of complex 155. Selected bond lengths (Å) and angles (°): Au(1)-C(1) 2.019(12), 
Au(1)-Br(1) 2.339(2), N(1)- C(1) 1.321(17), N(2)-C(1) 1.322(17), C(4)-C(5) 1.284(19), C(5)-C(6) 1.352(18), 
C(1)-Au(1)-Br(1) 178.3(3), C(4)-C(5)-C(6) 177.8(15).
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4.6. Biological Activity 
The biological activity of the imidazolium salts 99-102, bromo NHC gold(I) bromide 
derivatives 103-106, bis-NHC gold(I) complexes 107-110 and phosphine derivatives 123-134 
was studied by MTT assay for lung carcinoma cell line A549. A technique analogous to that 
described in Chapter 2 was used. The calculated IC50 values for the imidazolium salts and NHC 
complexes after 24 h incubation with A549 cells are shown in Table 4.7. 
 
Table 4.7. IC50 Values for Imidazolium Salts and NHC Gold Complexes after 24 h Incubation 
with A549 Cells 
Complex IC50 (μM) Complex IC50 (μM) 
  
99 >100 103 39.44 ± 10.48 
100 >100 104 2.93 ± 1.73 
101 >100 105 >100 
102 >100 106 79.11 ± 11.32 
  
107 32.00 ± 8.33 123 4.69 ± 0.18 
108 1.50 ± 0.30 124 5.01 ± 0.67 
109 27.80 ± 2.10 125 4.74 ± 0.47 
110 23.84 ± 3.51 126 5.96 ± 0.86 
 
 
127 4.78 ± 0.13 131 8.59 ± 0.93 
128 1.84 ± 0.46 132 4.09 ± 1.09 
129 5.64 ± 0.18 133 5.67 ± 0.29 
130 4.86 ± 0.44 134 5.90 ± 0.58 
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As expected, the imidazolium salts did not show anti-proliferative activity, with IC50 values 
>100 µM in all cases. The NHC gold complexes, however, were active.  
 
The [Au(NHC)Br] complexes, 103-106 showed only moderate activity, probably due to their 
instability in the cell culture medium. The bis-propargyl derivative, 105, decomposed and 
hence showed no antiproliferative activity. The benzyl derivative, 104, was the most stable of 
these complexes and showed excellent activity with an IC50 value of 2.93 ± 1.73 µM.  
 
All of the cationic NHC gold complexes all showed good stability in the cell culture medium. 
The [Au(NHC)2]Br complexes showed moderate antiproliferative activity, apart from the 
benzyl derivative, 108, which again showed excellent activity with a very low IC50 value of 
1.50 ± 0.30 µM. This is very promising since this complex is also water soluble and hence 
could be used to develop new anticancer treatments.  
 
The NHC gold phosphine derivatives showed excellent antiproliferative activity with 
IC50 <10 µM in all cases. No significant differences were observed upon changing the 
phosphine, probably due to the similar steric and electronic properties of the phosphines used. 
Changing the substituent on the nitrogen of the NHC also had little effect on the 
antiproliferative activity of the complex, although in all of the complexes tested the benzyl 
derivatives were generally the most active, probably due to their greater solubility.  
 
A graph of cell viability (% of control) against concentration of complex for the derivatives of 
the methyl NHC is shown in Figure 4.45. The higher activity of the [Au(NHC)(Phosphine)]+ 
derivatives can clearly be seen by the steeper slopes of the corresponding curves. 
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Figure 4.45. Cell viability (% of control) vs Concentration (µM) for complexes of the methyl functionalised NHC 
(Each point is the average of eight measurements, where error bars represent the standard deviation. Curve 
generated by a sigmoidal non-linear regression 4-parameter logistic analysis). 
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4.7. Luminescence 
The NHC gold phosphine derivatives, 123-134, all exhibited luminescence in the solid state 
both at room temperature and at 77 K.  
 
The excitation and emission maxima for the JohnPhos derivatives, 123-126, and free JohnPhos 
are shown in Table 4.8. 
 
Table 4.8. Excitation and Emission Maxima for Complexes 123-126 and JohnPhos 
Complex 
Temperature 
(K) 
Excitation 
λmax (nm) 
Emission 
λmax (nm) 
τ0 (μs) 
 
123 298 286 546 107.1 
 77 290, 332 552, 444 2282.3 
124 298 296 501 204.7 
 77 290. 323 502, 442 2091.2 
125 298 277 551 83.0 
 77 287 547 1740.6 
126 298 303 548  
 77 297, 364 542, 457 1592.8 
 
    
JohnPhos (free ligand) 298 371 527  
 
 
The non-coordinated JohnPhos ligand does exhibit luminescence at room temperature with an 
excitation at 371 cm-1 and emission at 527 cm-1 (Figure 4.46). This is due to intraligand π-π* 
transitions within the biphenyl group.  
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Figure 4.46. Excitation and emission maxima for JohnPhos at room temperature. 
 
The emission due to the intraligand transition in the phosphine is not observed in complexes 
123-126 at room temperature. One excitation band and one emission band are observed in each 
case but there is a much larger Stokes shift compared to the bands for the free ligand and the 
wavelength of the emission varies upon changing the NHC ligand (Figure 4.47). The long 
lifetimes indicate that this is a phosphorescent emission and it can therefore be assigned to a 
ligand to metal to ligand charge transfer (LMLCT).  
 
At 77 K an additional, less intense excitation band and emission band are observed. This band 
is due to intraligand transitions within the JohnPhos and the wavelength of emission is modified 
with respect to the free ligand due to coordination to the metal (Figure 4.48) 
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Figure 4.47. Emission bands for complexes 123-126 at room temperature. 
 
 
Figure 4.48. Excitation and emission bands for complex 123 at 77 K. 
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The excitation and emission maxima for the CyJohnPhos derivatives, 127-130, and free 
CyJohnPhos are shown in Table 4.9. 
 
Table 4.9. Excitation and Emission Maxima for Complexes 127-130 and CyJohnPhos 
Complex 
Temperature 
(K) 
Excitation 
λmax (nm) 
Emission 
λmax (nm) 
τ0 (μs) 
 
127 298 281, 344 472, 373 293.7 
 77 283, 346 492, 466 4606.4 
128 298 318, 358 480 152.8 
 77 310, 345 465 2081.9 
129 298 297 497 211.3 
 77 291 496 3597.2 
130 298 303, 388 549, 455 443.2 
 77 289, 392 528, 480 2399.0 
 
    
CyJohnPhos (free ligand) 298 362 492  
 
Similarly to Johnphos, CyJohnPhos is luminescent at room temperature with an excitation band 
at 362 cm-1 and an emission band at 492 cm-1 as a result of intraligand π-π* transitions within 
the biphenyl group. Complexes 127, 128 and 130 exhibit two excitation and two emission 
bands at room temperature and at 77 K. The high energy excitation band and corresponding 
emission are assigned to a ligand to metal to ligand charge transfer (LMLCT) due to the large 
Stokes shift and the long lifetimes which indicate phosphorescence. The other band is an 
intraligand charge transfer in the CyJohnPhos ligand, modified due to coordination to the gold 
centre. In complex 129 this intraligand charge transfer band is not observed at room 
temperature or at 77 K.  
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The excitation and emission maxima for the CyJohnPhos derivatives, 131-134, and free 
TrippyPhos are shown in Table 4.10. 
 
Table 4.10. Excitation and Emission Maxima for Complexes 131-134 and TrippyPhos 
Complex 
Temperature 
(K) 
Excitation 
λmax (nm) 
Emission 
λmax (nm) 
τ0 (μs) 
 
131 298 385 465 303.2 
 77 315, 392 522, 460 8371.3 
132 298 381 468 195.0 
 77 310, 365 535, 459 9091.8 
133 298 386 464 190.7 
 77 307,377 489,456 4887.8 
134 298 388 468 103.7 
 77 308 494, 465 4808.7 
 
    
TrippyPhos (free ligand) 298 391 526  
 
The TrippyPhos ligand is intensely luminescent at room temperature with and excitation band 
at 391 cm-1 and an emission band at 526 cm-1 as a result of intraligand π-π* transitions. 
Complexes 131-134 have one excitation and one emission band at room temperature. The 
emission band does not change upon changing the NHC ligand, however the lifetimes suggest 
that this is a phosphorescent emission and therefore cannot be assigned to an intraligand 
transition. This band is assigned to a ligand to metal charge transfer (LMCT) from the 
phosphine ligand to the gold. At 77 K and addition excitation and emission band are observed 
with a larger Stokes shift. This band is assigned to ligand to metal to ligand charge transfer 
(LMLCT) similar to complexes 123-130.  
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4.8. Conclusions 
A new thallium-free synthesis for tetrabutylammonium acetylacetonate starting from relatively 
cheap precursors has been described. This reagent has been shown to be effective in the 
formation of NHCs from their corresponding imidazolium salts with reactions carried out at 
room temperature, in air and with reaction times of just 1 hour. The method was tested with 
several commercially available imidazolium salts and was shown to be incredibly versatile, 
allowing NHC gold complexes to be prepared both with very bulky NHCs as well as smaller 
NHCs bearing a simple alkyl chains at the nitrogen atoms. The synthesis of pentafluorophenyl 
gold derivatives from the imidazolium salts was also possible and several examples were 
characterised by single crystal X-ray diffraction. 
 
Propargyl functionalised imidazolium salts were prepared by the alkylation of imidazoles with 
propargyl bromide. Bromo-, pentafluorophenyl- and bis-NHC gold complexes derived from 
these imidazolium salts were prepared using the tetrabutylammonium acetylacetonate method 
and structurally characterised. In all cases the propargyl side arms were maintained. Cationic 
gold phosphine derivatives could also be prepared; however, a bulky phosphine was required 
for a clean reaction. With smaller phosphines an equilibrium was observed in solution, although 
it is possible that the [Au(NHC)(PR3)]
+ complexes do exist in the solid state. The NHC 
complexes bearing the bulky phosphines were characterised by single crystal X-ray diffraction.  
 
Attempts to prepare NHC gold(III) derivatives from [AuCl3(tht)] were unsuccessful and 
resulted in the reduction to gold(I). However, the [AuCl3(NHC)] derivatives were accessible 
by the oxidation of the [AuBr(NHC)] complexes with Cl2 and two examples were characterised 
by single crystal X-ray diffraction. Three chloride ligands were coordinated to the gold(III) 
centre and no mixture of chloride and bromide was observed. This is due to the large excess of 
chlorine used in the oxidation reaction. 
 
Dinuclear NHC gold complexes derived from a di-imidazolium salt were prepared and 
characterised. In all cases the propargyl side arm was maintained. As with the mononuclear 
NHC gold complexes, the triphenylphosphine derivatives were found to exist in equilibrium in 
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solution. One example was characterised by single crystal X-ray diffraction, showing that these 
complexes can exist in the solid state.  
 
Studies into the possible functionalisation of the propargyl side arm were also carried out. 
Tetrabutlyammonium acetylacetonate was found to be too weak a base to deprotonate the 
alkyne CH, however, the use of potassium hydroxide was successful and allowed dinuclear 
gold JohnPhos derivatives to be prepared. Reaction of the NHC gold bromo complexes with 
diisopropylamine resulted in the formation of highly insoluble trimeric species. All were 
characterised by high resolution mass spectrometry and one example was sufficiently soluble 
to be characterised by NMR spectroscopy. Infrared spectra of the complexes suggest that the 
triple bond is maintained. 
 
The use of silver oxide to prepare NHC complexes from the imidazolium salts successfully 
gave the bis-NHC silver derivatives, however in this case a tautomerism of the propargyl unit 
occurred. The presence of the allenyl unit could be observed in the 1H NMR spectrum as well 
as in the molecular structure determined by single crystal X-ray diffraction. Transmetallation 
with [AuCl(tht)] allowed the allenyl functionalised NHC gold complexes to be accessed. One 
example was successfully characterised by single crystal X-ray diffraction. The allenyl unit 
could readily be seen by the similarity of the carbon-carbon bond lengths in the molecular 
structure. 
 
The antiproliferative activity of the complexes against lung cancer cell line A549 was tested 
by MTT assay. The imidazolium salts showed no activity. Some of the [AuBr(NHC)] 
complexes were unstable in the cell culture medium used for the study and hence showed poor 
activities, however, the cationic complexes were all highly stable and showed antiproliferative 
activity. The phosphine derivatives were the most active with very low IC50 values.  
 
The NHC gold phosphine derivatives were also found to be luminescent in the solid state, both 
at room temperature and at 77 K. In all cases emission bands assigned to ligand to metal to 
ligand charge transfer transitions were observed. For the JohnPhos and CyJohnPhos 
derivatives, emission bands assigned to intraligand ππ* transitions were also observed. 
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4.9. Experimental 
 
To a solution of tetrabutylammonium hydroxide 30-hydrate (1.600 g, 2.0 mmol) in ethanol (10 
ml) was added acetylacetone (0.2 ml, 2 mmol) and the solution stirred for 8 h. Solvent was 
removed in vacuo to leave a pale yellow residue which was dissolved in CH2Cl2 (10 ml) and 
dried over Na2SO4. The solution was concentrated to minimum volume and diethyl ether (10 
ml) was added to precipitate an off-white solid which was collected and vacuum dried to give 
the product (0.649 g, 95%).  
Spectral data are in agreement with values previously reported in the literature. 
 
 
1,3-Bis(2,6-diisopropylphenyl)imidazolium chloride (0.0850 g, 0.2 mmol) and [AuCl(tht)] 
(0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.1182 g, 95%).  
Spectral data are in agreement with values previously reported in the literature. 
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1,3-Bis(2,4,6-trimethylphenyl)imidazolinium chloride (0.1023 g, 0.3 mmol) and [AuCl(tht)] 
(0.0962 g, 0.3 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.1025 g, 0.3 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.1582 g, 98%).  
Spectral data are in agreement with values previously reported in the literature. 
 
 
1,3-dimethylimidazolium chloride (0.0397 g, 0.3 mmol) and [AuCl(tht)] (0.0962 g, 0.3 mmol) 
were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). NBu4(acac) (0.1025 
g, 0.3 mmol) was added and the mixture stirred for 1 h. The solution was filtered through a 
plug of silica and the colourless filtrate evaporated to minimum volume. Pentane was added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.1582 g, 
98%).  
Spectral data are in agreement with values previously reported in the literature. 
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1-ethyl-3-methylimidazolium chloride (0.0440 g, 0.3 mmol) and [AuCl(tht)] (0.0962 g, 0.3 
mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). NBu4(acac) 
(0.1025 g, 0.3 mmol) was added and the mixture stirred for 1 h. The solution was filtered 
through a plug of silica and the colourless filtrate evaporated to minimum volume. Pentane was 
added to precipitate a white solid which was collected and vacuum dried to give the product 
(0.0987 g, 96%).  
Spectral data are in agreement with values previously reported in the literature. 
 
 
1,3-diisopropyl imidazolium chloride (0.0377 g, 0.2 mmol) and [AuCl(tht)] (0.0641 g, 
0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.0649 g, 64%).  
Spectral data are in agreement with values previously reported in the literature. 
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1,3-dicyclohexyl imidazolium chloride (0.0806 g, 0.3 mmol) and [AuCl(tht)] (0.0962 g, 
0.3 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.1025 g, 0.3 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.0931 g, 67%).  
Spectral data are in agreement with values previously reported in the literature. 
 
 
1-octyl-3-methylimidazolium chloride (0.0692 g, 0.3 mmol) and [AuCl(tht)] (0.0962 g, 
0.3 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.1025 g, 0.3 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.1112 g, 87%).  
1H NMR (400 MHz, CDCl3) δ 6.93 (d, J = 1.9 Hz, 1H, CH imidazole), 6.92 (d, J = 1.9 Hz, 
1H, CH imidazole), 4.13 (t, J = 7.3 Hz, 2H, CH2CH2(CH2)5CH3), 3.82 (s, 3H, Me), 1.88 – 1.74 
(m, 2H, CH2CH2(CH2)5CH3), 1.27 (m, 10H, CH2CH2(CH2)5CH3), 0.86 (t, J = 6.9 Hz, 3H, 
CH2CH2(CH2)5CH3).  
13C NMR (101 MHz, CDCl3) δ 170.88 (s, N-C-N), 121.81 (s, CH imidazole), 120.56 (s, CH 
imidazole), 51.53 (s, CH2CH2(CH2)5CH3), 38.37 (s, Me), 31.78 (s, CH2CH2(CH2)5CH3), 31.18 
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(s, CH2CH2(CH2)5CH3), 29.15 (s, CH2CH2(CH2)5CH3), 26.48 (s, CH2CH2(CH2)5CH3), 22.67 
(s, CH2CH2(CH2)5CH3), 14.15 (s, CH2CH2(CH2)5CH3). 
 
 
1,3-bis(1-adamantyl)imidazolium chloride (0.1119 g, 0.3 mmol) and [AuCl(tht)] (0.0962 g, 
0.3 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.1025 g, 0.3 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.1027 g, 60%).  
Spectral data are in agreement with values previously reported in the literature 
 
 
1,3-Bis(2,6-diisopropylphenyl)imidazolium chloride (0.0850 g, 0.2 mmol) and [Au(C6F5)(tht)] 
(0.0904 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
The solution was concentrated to dryness under reduced pressure to give a white solid which 
was washed several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) 
(0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. The solution was filtered 
through a plug of silica and the colourless filtrate evaporated to minimum volume. Pentane was 
added to precipitate a white solid which was collected and vacuum dried to give the product 
(0.1098 g, 73%).  
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1H NMR (300 MHz, CDCl3) δ 7.49 (t, J = 7.8 Hz, 2H, p-C6H3), 7.29 (d, J = 7.8 Hz, 4H, 
m-C6H3), 7.20 (s, 2H, CH imidazole), 2.62 (sept, J = 6.9 Hz, 4H, CHMe2), 1.36 (d, J = 6.9 Hz, 
6H, CHMe2), 1.24 (d, J = 6.9 Hz, 6H, CHMe2).  
19F NMR (376 MHz, CDCl3) δ -115.28 – -116.84 (m, o-C6F5), -161.20 (t, J = 20.0 Hz, p-C6F5), 
-162.46 – -165.76 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 192.15 (s, N-C-N, (observed by HMBC)), 145.93 (s, i-C6H3), 
134.25 (s, o-C6H3), 130.61 (s, p-C6H3), 124.16 (s, m-C6H3), 123.14 (s, CH imidazole), 29.02 
(s, CHMe2), 24.48 (s, Me), 24.17 (s, Me). 
 
 
1,3-Bis(2,4,6-trimethylphenyl)imidazolinium chloride (0.1023 g, 0.3 mmol) and 
[Au(C6F5)(tht)] (0.1357 g, 0.3 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). The solution was concentrated to dryness under reduced pressure to give a 
white solid which was washed several times with hexane. The solid was dissolved in CH2Cl2 
(10 ml), NBu4(acac) (0.1025 g, 0.3 mmol) was added and the mixture stirred for 1 h. The 
solution was filtered through a plug of silica and the colourless filtrate evaporated to minimum 
volume. Pentane was added to precipitate a white solid which was collected and vacuum dried 
to give the product (0.1604 g, 80%).  
1H NMR (300 MHz, CDCl3) δ 7.12 (s, 2H, CH imidazole), 7.02 (s, 4H, C6H2), 2.35 (s, 6H, 
p-Me), 2.17 (s, 12H, o-Me).  
19F NMR (376 MHz, CDCl3) δ -115.94 – -116.11 (m, o-C6F5), -160.84 (t, J = 20.0 Hz, p-C6F5), 
-163.56 – -163.83 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 190.50 (s, N-C-N, (observed by HMBC)) 139.63 (s, CH 
aromatic), 134.97 (s, CH aromatic), 134.88 (s, CH aromatic), 129.44 (s, CH aromatic), 122.30 
(s, CH imidazole), 21.31 (s, CH3), 18.00 (s, CH3). 
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1,3-dimethylimidazolium chloride (0.0397 g, 0.3 mmol) and [Au(C6F5)(tht)] (0.1357 g, 0.3 
mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). The solution 
was concentrated to dryness under reduced pressure to give a white solid which was washed 
several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) (0.1025 g, 
0.3 mmol) was added and the mixture stirred for 1 h. The solution was filtered through a plug 
of silica and the colourless filtrate evaporated to minimum volume. Pentane was added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.1184 g, 
86%).  
1H NMR (300 MHz, CDCl3) δ 6.92 (s, 2H, CH imidazole), 3.90 (s, 6H, Me).  
19F NMR (282 MHz, CDCl3) δ -115.96 – -117.07 (m, o-C6F5), -159.98 (t, J = 20.0 Hz, p-C6F5), 
-162.13 – -164.49 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 188.59 (s, N-C-N, (observed by HMBC)), 121.86 (s, CH 
imidazole), 37.91 (s, Me). 
 
 
1-ethyl-3-methylimidazolium chloride (0.0440 g, 0.3 mmol) and [Au(C6F5)(tht)] (0.1357 g, 0.3 
mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). The solution 
was concentrated to dryness under reduced pressure to give a white solid which was washed 
several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) (0.1025 g, 
0.3 mmol) was added and the mixture stirred for 1 h. The solution was filtered through a plug 
of silica and the colourless filtrate evaporated to minimum volume. Pentane was added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0797 g, 
56%).  
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1H NMR (300 MHz, CDCl3) δ 6.96 (d, J = 1.9 Hz, 1H, CH imidazole), 6.92 (d, J = 1.9 Hz, 
1H, CH imidazole), 4.28 (q, J = 7.3 Hz, 2H, CH2), 3.91 (s, 3H, Me), 1.53 (t, J = 7.3 Hz, 3H, 
CH2CH3).  
19F NMR (282 MHz, CDCl3) δ -115.07 – -117.62 (m, o-C6F5), -159.97 (t, J = 19.9 Hz, p-
C6F5), -161.74 – -165.12 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 187.85 (s, N-C-N, (observed by HMBC)), 121.77 (s, CH 
imidazole), 120.09 (s, CH imidazole), 46.24 (s, CH2), 38.05 (s, Me), 16.83 (s, CH3). 
 
 
1,3-diisopropyl imidazolium chloride (0.0566 g, 0.3 mmol) and [Au(C6F5)(tht)] (0.1357 g, 0.3 
mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). The solution 
was concentrated to dryness under reduced pressure to give a white solid which was washed 
several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) (0.1025 g, 
0.3 mmol) was added and the mixture stirred for 1 h. The solution was filtered through a plug 
of silica and the colourless filtrate evaporated to minimum volume. Pentane was added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0940 g, 
61%).  
1H NMR (300 MHz, CDCl3) δ 6.99 (s, 2H, CH imidazole), 5.06 (hept, J = 6.8 Hz, 2H, 
CHMe2), 1.54 (d, J = 6.8 Hz, 12H, CHMe2).  
19F NMR (282 MHz, CDCl3) δ -115.88 – -116.74 (m, o-C6F5), -160.10 (t, J = 19.9 Hz, p-
C6F5), -162.78 – -163.64 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 185.72(s, n N-C-N, (observed by HMBC)) 116.88 (s, CH 
imidazole), 53.47 (s, CHMe2), 23.72 (s, Me). 
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1,3-dicyclohexyl imidazolium chloride (0.0537 g, 0.2 mmol) and [Au(C6F5)(tht)] (0.0904 g, 
0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). The 
solution was concentrated to dryness under reduced pressure to give a white solid which was 
washed several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) 
(0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. The solution was filtered 
through a plug of silica and the colourless filtrate evaporated to minimum volume. Pentane was 
added to precipitate a white solid which was collected and vacuum dried to give the product 
(0.1083 g, 91%).  
1H NMR (300 MHz, CDCl3) δ 6.95 (s, 2H, CH imidazole), 4.58 (tt, J = 12.2, 3.6 Hz, 2H, CH 
(Cy)), 2.27 – 2.11 (m, 4H, Cy), 1.98 – 1.85 (m, 4H, Cy), 1.74 (ddd, J = 24.4, 12.2, 3.6 Hz, 6H, 
Cy), 1.60 – 1.39 (m, 4H, Cy), 1.24 (qt, J = 12.2, 3.6 Hz, 2H, Cy).  
19F NMR (282 MHz, CDCl3) δ -115.08 – -117.34 (m, o-C6F5), -160.20 (t, J = 20.0 Hz, p-
C6F5), -162.06 – -166.57 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 185.99 (s, N-C-N, (observed by HMBC)), 117.26 (s, CH 
imidazole), 61.21 (s, CH (Cy)), 34.54 (s, Cy), 25.69 (s, Cy), 25.32 (s, Cy). 
 
 
1-octyl-3-methylimidazolium chloride (0.0462 g, 0.2 mmol) and [Au(C6F5)(tht)] (0.0904 g, 0.2 
mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). The solution 
was concentrated to dryness under reduced pressure to give a white solid which was washed 
several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) (0.0683 g, 
 Chapter 4 – NHC Gold Complexes 
298 
0.2 mmol) was added and the mixture stirred for 1 h. The solution was filtered through a plug 
of silica and the colourless filtrate evaporated to minimum volume. Pentane was added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0854 g, 
76%).  
1H NMR (300 MHz, CDCl3) δ 6.94 (d, J = 1.9 Hz, 1H, CH imidazole), 6.91 (d, J = 1.8 Hz, 
1H, CH imidazole), 4.21 (t, J = 7.2 Hz, 2H, CH2CH2(CH2)5CH3), 3.91 (s, 3H, Me), 1.98 – 1.79 
(m, 2H, CH2CH2(CH2)5CH3), 1.38 – 1.21 (m, 10H, CH2CH2(CH2)5CH3), 0.86 (t, J = 6.8 Hz, 
3H, CH2CH2(CH2)5CH3).  
19F NMR (282 MHz, CDCl3) δ -114.78 – -118.16 (m, o-C6F5), -160.08 (t, J = 19.9 Hz, p-
C6F5), -162.36 – -164.72 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 188.17 (s, N-C-N, (observed by HMBC)), 121.63 (s, CH 
imidazole), 120.63 (s, CH imidazole), 51.26 (s, CH2CH2(CH2)5CH3), 38.04 (s, Me), 31.86 (s, 
CH2CH2(CH2)5CH3), 31.45 (s, CH2CH2(CH2)5CH3), 29.22 (s, CH2CH2(CH2)5CH3), 29.14 (s, 
CH2CH2(CH2)5CH3),  26.52 (s, CH2CH2(CH2)5CH3), 22.74 (s, CH2CH2(CH2)5CH3), 14.19 (s, 
CH2CH2(CH2)5CH3). 
 
 
1,3-bis(1-adamantyl)imidazolium chloride (0.0746 g, 0.2 mmol) and [Au(C6F5)(tht)] (0.0904 
g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). The 
solution was concentrated to dryness under reduced pressure to give a white solid which was 
washed several times with hexane. The solid was dissolved in CH2Cl2 (10 ml), NBu4(acac) 
(0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. The solution was filtered 
through a plug of silica and the colourless filtrate evaporated to minimum volume. Pentane was 
added to precipitate a white solid which was collected and vacuum dried to give the product 
(0.0728 g, 52%).  
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1H NMR (300 MHz, CDCl3) δ 7.11 (s, 2H, CH imidazole), 2.61 (m, 12H, CH2 adamantyl), 
2.29 (s, 6H, CH adamantyl), 1.80 (m, 12H, CH2 adamantyl).  
19F NMR (282 MHz, CDCl3) δ -114.12 – -115.46 (m, o-C6F5), -160.46 (t, J = 20.0 Hz, p-
C6F5), -162.64 – -164.07 (m, m-C6F5).  
13C NMR (75 MHz, CDCl3) δ 185.48 (s, N-C-N, (observed by HMBC)), 115.52 (s, CH 
imidazole), 59.37 (s, N-C adamantyl), 44.58 (s, CH2 adamantyl), 35.94 (s, CH2 adamantyl), 
30.20 (s, CH adamantyl). 
 
 
Propargyl bromide (2.99 g, 20.09 mmol, 80 wt% solution in toluene) was added drop wise 
to N-methylimidazole (1.5 g, 18.27 mmol) under nitrogen atmosphere at room temperature and 
stirred until a significant increase in the viscosity occurred. The solution was subsequently 
diluted with 25 ml of acetone and stirred overnight. The obtained white solid was collected by 
filtration, washed three times with 25 ml acetone and dried under vacuum to give the product 
(2.44 g, 66%). 
Spectral data are in agreement with values previously reported in the literature.302 
 
 
Propargyl bromide (6.05 g, 40.66 mmol, 80 wt% solution in toluene) was added drop wise to 
a solution of N-benzylimidazole (5 g, 40.26 mmol) and acetone (10 ml) under nitrogen 
atmosphere and stirred at room temperature for 24 h. The solvent was decanted, the raw product 
was washed with ethyl acetate (100 ml) and acetone (100 ml) and dried under vacuum to give 
a white solid (7.54 g, 86%). 
Spectral data are in agreement with values previously reported in the literature.302  
 
 Chapter 4 – NHC Gold Complexes 
300 
 
To a solution of imidazole (0.2723 g, 4.0 mmol) in acetonitrile (30 ml) was added 
propargylbromide (0.86 ml, 8.0 mmol, 80% wt solution in toluene) and the mixture heated to 
reflux for 24h. After cooling to room temperature, solvent was removed in vacuo to leave an 
oily solid which was recrystallized acetonitrile/Et2O, washed with further Et2O and vacuum 
dried to give the product as a beige solid (0.2851 g, 32%).  
Spectral data are in agreement with values previously reported in the literature.303-305 
 
 
To a solution of 1-pyridylimidazole (0.7259 g, 5.0 mmol) in acetonitrile (50 ml) was added 
propargylbromide (1.1 ml, 10.0 mmol, 80% wt solution in toluene) and the mixture heated to 
reflux for 24h. A pale yellow precipitate formed which was collected by vacuum filtration, 
washed with Et2O and vacuum dried to give the product (0.9504 g, 72%). 
1H NMR (300 MHz, DMSO) δ 10.20 (s, 1H, N-CH-N, imidazole), 8.65 (dd, 3JHH = 4.8, 4JHH 
= 1.0 Hz, 1H, Py), 8.60 (m, 1H, CH), 8.27 – 8.18 (m, 1H, Py), 8.16 – 8.05 (m, 2H, Py and CH), 
7.72 – 7.60 (m, 1H, Py), 5.35 (d, 4JHH = 2.6 Hz, 2H, CH2), 3.92 (t, 4JHH = 2.6 Hz, 1H, C≡CH). 
13C APT (75 MHz, DMSO) δ 149.25 (s, CH (Py)), 146.29 (s, ipso-Py), 140.63 (s, CH (Py)), 
135.13 (s, N-C-N), 125.39 (s, CH (Py)), 123.38 (s, CH), 119.74 (s, CH), 114.49 (s, CH (Py)), 
79.30 (s, C≡CH), 75.85 (s, C≡CH), 39.24 (s, CH2-C≡CH). 
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1-Methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0402 g, 0.2 mmol) and 
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. 
The solution was filtered through a plug of silica and the colourless filtrate evaporated to 
minimum volume. Pentane was added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.0646 g, 82%).  
IR (cm-1) ν(C≡C-H) 3240, ν(C≡C) 2125. 
1H NMR (400 MHz, DMSO) δ 7.53 (d, 3JHH = 1.9 Hz, 1H, CH), 7.48 (d, 3JHH = 1.9 Hz, 1H, 
CH), 5.00 (d, 4JHH = 2.5 Hz, 2H, CH2), 3.76 (s, 3H, CH3), 3.59 (t, 
4JHH = 2.5 Hz, 1H, C≡CH). 
13C APT (75 MHz, DMSO) δ 172.52 (s, N-C-N), 123.16 (s, CH), 121.35 (s, CH), 78.21 (s, 
C≡CH), 77.30 (s, C≡CH), 39.88 (s, CH2) 37.79 (s, CH3). 
 
 
1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0554 g, 0.2 mmol) and 
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. 
The solution was filtered through a plug of silica and the colourless filtrate evaporated to 
minimum volume. Pentane was added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.0696 g, 74%).  
IR (cm-1) ν(C≡C-H) 3262, ν(C≡C) 2131. 
1H NMR (300 MHz, DMSO) δ 7.60 (d, 3JHH = 2.0 Hz, 1H, CH), 7.57 (d, 3JHH = 2.0 Hz, 1H, 
CH), 7.42 – 7.27 (m, 5H, Ph), 5.36 (s, 2H, CH2-Ph), 5.03 (d, 4JHH = 2.5 Hz, 2H, CH2-C≡CH), 
3.60 (t, 4JHH = 2.5 Hz, 1H, C≡CH).  
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13C APT (75 MHz, DMSO) δ 172.55 (s, N-C-N), 136.44 (s, ipso-Ph), 128.78 (s, m-Ph), 128.18 
(s, p-Ph), 127.65 (s, o-Ph), 122.10 (s, CH), 121.87 (s, CH), 78.02 (s, C≡CH), 77.39 (s, C≡CH), 
53.85 (s, CH2-Ph), 40.03 (s, CH2-C≡CH). 
 
 
1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0450 g, 0.2 mmol) and [AuCl(tht)] 
(0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. The solution was 
filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.0616 g, 73%).  
1H NMR (300 MHz, CD2Cl2) δ 7.29 (s, 2H, CH), 5.04 (d, 4JHH = 2.6 Hz, 4H, CH2), 2.63 (t, 
4JHH = 2.6 Hz, 1H, C≡CH).  
13C APT (75 MHz, CD2Cl2) δ 175.44 (s, N-C-N), 121.09 (s, CH), 76.22 (s, C≡CH), 41.48 (s, 
CH2-C≡CH). 
 
 
1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0528 g, 0.2 mmol) and 
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). NBu4(acac) (0.0683 g, 0.2 mmol) was added and the mixture stirred for 1 h. 
The solution was filtered through a plug of silica and the colourless filtrate evaporated to 
minimum volume. Pentane was added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.0718 g, 78%). 
IR (cm-1) ν(C≡C-H) 3260, ν(C≡C) 2160.  
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1H NMR (300 MHz, DMSO) δ 8.63 (m, 1H, Py), 8.20 (dd, 3JHH = 7.1, 4JHH = 1.0 Hz, 1H, Py), 
8.17 – 8.09 (m, 1H, Py), 8.03 (d, 3JHH = 2.1 Hz, 1H, CH), 7.82 (d, 3JHH = 2.1 Hz, 1H, CH), 7.61 
(m, 1H, Py), 5.17 (d, 4JHH = 2.5 Hz, 2H, CH2), 3.69 (t, 
4JHH = 2.5 Hz, 1H, C≡CH).  
13C APT (75 MHz, DMSO) δ 171.96 (s, N-C-N), 150.28 (s, ipso-Py), 149.17 (s, CH (Py)), 
139.61 (s, CH (Py)), 124.75 (s, CH (Py)), 122.43 (s, CH), 121.50 (s, CH), 118.07 (s, CH (Py)), 
77.87 (s, C≡CH), 77.80 (s, C≡CH), 40.91 (s, CH2-C≡CH). 
 
 
1-Methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0804 g, 0.4 mmol) and 
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in THF (10 ml) until a colourless solution formed 
(5 min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred. After 
approximately 30 min a white precipitate formed. The mixture was left stirring for 12 h and 
then the precipitate collected by vacuum filtration and dried to give the product (0.0848 g, 
82%).  
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C14H16AuN4 437.1035; Found 437.1049. 
1H NMR (300 MHz, DMSO) δ 7.60 (d, 3JHH = 1.8 Hz, 1H, CH imidazole), 7.55 (d, 3JHH = 1.8 
Hz, 1H, CH imidazole), 5.13 (d, 4JHH = 2.5 Hz, 2H, CH2), 3.90 (s, 3H, Me), 3.65 (t, 
4JHH = 2.5 
Hz, 1H, C≡CH).  
13C APT (75 MHz, DMSO) δ 183.28 (s, N-C-N), 123.51 (s, CH), 122.05 (s, CH), 78.60 (s, 
C≡CH), 77.45 (s, C≡CH), 39.69 (s, CH2-C≡CH), 37.75 (s, CH3).  
 
 
1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.1109 g, 0.4 mmol) and 
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
 Chapter 4 – NHC Gold Complexes 
304 
formed (5 min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred for 1 h. 
The solution was washed with H2O (3 x 25 ml) and dried over Na2SO4. The solution was 
evaporated to minimum volume under reduced pressure and pentane added to precipitate a 
white solid which was collected and vacuum dried to give the product (0.0803 g, 63%).  
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C26H24AuN4 589.1661; Found 589.1634. 
1H NMR (300 MHz, DMSO) δ 7.70 (s, 1H, CH), 7.66 (s, 1H, CH), 7.34 (m, 5H, Ph), 5.44 (s, 
2H, CH2-Ph), 5.13 (d, 
4JHH = 1.9 Hz, 2H, CH2-C≡CH), 3.64 (s, 1H, C≡CH).  
13C APT (75 MHz, DMSO) δ 182.89 (s, N-C-N), 136.68 (s, ipso-Ph), 128.79 (s, m-Ph), 128.15 
(s, p-Ph), 127.63 (s, o-Ph), 122.75 (s, CH), 122.49 (s, CH), 78.36 (s, C≡CH), 77.54 (s, C≡CH), 
53.82 (s, CH2-Ph), 39.96 (s, CH2-C≡CH).  
 
 
1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0900 g, 0.4 mmol) and [AuCl(tht)] 
(0.0641 g, 0.2 mmol) were mixed in THF (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred. After approximately 30 
min a white precipitate formed. The mixture was left stirring for 12 h and then the precipitate 
collected by vacuum filtration and dried to give the product (0.1074 g, 95%).  
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C18H16AuN4 485.1035; Found 485.1044. 
1H NMR (300 MHz, DMSO) δ 7.68 (s, 1H, CH), 5.20 (d, 4JHH = 2.5 Hz, 2H, CH2), 3.66 (t, 
4JHH = 2.5 Hz, 1H, C≡CH).  
13C APT (75 MHz, DMSO) δ 183.12 (s, N-C-N), 122.32 (s, CH), 78.27 (s, C≡CH), 77.64 (s, 
C≡CH), 40.13 (s, CH2-C≡CH).  
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1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.1056 g, 0.4 mmol) and 
[AuCl(tht)] (0.0641 g, 0.2 mmol) were mixed in THF (10 ml) until a colourless solution formed 
(5 min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred. After 
approximately 30 min a white precipitate formed. The mixture was left stirring for 12 h and 
then the precipitate collected by vacuum filtration and dried to give the product (0.1159 g, 
90%).  
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C22H18AuN6 563.1253; Found 563.1247. 
1H NMR (300 MHz, DMSO) δ 8.54 (m, 1H, Py), 8.15 (d, 3JHH = 2.0 Hz, 1H, CH), 8.13 (d, 
3JHH = 5.3 Hz, 1H, Py), 8.01 (m, 1H, Py), 7.91 (d, 
3JHH = 2.0 Hz, 1H, CH), 7.59 (m, 1H, Py), 
5.27 (d, 4JHH = 2.4 Hz, 2H, CH2), 3.69 (t, 
4JHH = 2.4 Hz, 1H, C≡CH).  
13C APT (75 MHz, DMSO) δ 181.34 (s, N-C-N), 150.01 (s, ipso-Py), 148.95 (s, CH (Py)), 
139.67 (s, CH (Py)), 124.65 (s, CH (Py)), 123.10 (s, CH), 121.71 (s, CH), 117.53 (s, CH (Py)), 
77.96 (s, C≡CH), 77.83 (s, C≡CH), 40.87 (s, CH2-C≡CH).  
 
 
1-Methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0804 g, 0.4 mmol) and 
[Au(C6F5(tht)] (0.1809 g, 0.4 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred for 1 h. 
The solution was filtered through a plug of silica and the colourless filtrate evaporated to 
minimum volume. Pentane was added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.1466 g, 76%).  
1H NMR (300 MHz, CD2Cl2) δ 7.23 (d, 3JHH = 1.9 Hz, 1H, CH), 7.02 (d, 3JHH = 1.9 Hz, 1H, 
CH), 5.09 (d, 4JHH = 2.6 Hz, 2H, CH2), 3.90 (s, 3H, CH3), 2.61 (t, 
4JHH = 2.6 Hz, 1H, C≡CH). 
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19F NMR (377 MHz, CD2Cl2) δ -116.54 – -116.86 (m, 2F, o-C6F5), -160.80 (t, 3JFF = 19.8 Hz, 
1F, p-C6F5), -163.61 – -163.89 (m, 2F, m-C6F5).  
13C APT (75 MHz, CD2Cl2) δ 188.06 (s, N-C-N), 122.90 (s, CH), 120.73 (s, CH), 76.90 (s, 
C≡CH), 75.73 (s, C≡CH), 40.90 (s, CH2-C≡CH), 38.51 (s, CH3). 
 
 
1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.1109 g, 0.4 mmol) and 
[Au(C6F5(tht)] (0.1809 g, 0.4 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred for 1 h. 
The solution was filtered through a plug of silica and the colourless filtrate evaporated to 
minimum volume. Pentane was added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.1758 g, 78%).  
1H NMR (300 MHz, CD2Cl2) δ 7.49 – 7.32 (m, 5H, Ph), 7.25 (d, 3JHH = 1.9 Hz, 1H, CH), 7.03 
(d, 3JHH = 1.9 Hz, 1H, CH), 5.43 (s, 2H, CH2-Ph), 5.11 (d, 
4JHH = 2.6 Hz, 1H, CH2-C≡CH), 
2.61 (t, 3JHH = 2.6 Hz, 1H, C≡CH).  
19F NMR (282 MHz, CD2Cl2) δ -115.78 – -117.58 (m, 2F, o-C6F5), -160.81 (t, 3JFF = 19.8 Hz, 
1F, p-C6F5), -163.16 – -165.55 (m, 2F, m-C6F5).  
13C APT (75 MHz, CD2Cl2) δ 187.70 (s, N-C-N), 136.19 (s, ipso-Ph), 129.56 (s, m-Ph), 129.21 
(s, p-Ph), 128.75 (s, o-Ph), 121.64 (s, CH), 121.16 (s, CH), 76.76 (s, C≡CH), 75.89 (s, C≡CH), 
55.63 (s, CH2-Ph), 41.09 (s, CH2-C≡CH). 
 
 
1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.0900 g, 0.4 mmol) and [Au(C6F5(tht)] 
(0.1809 g, 0.4 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution formed (5 min). 
NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred for 1 h. The solution was 
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filtered through a plug of silica and the colourless filtrate evaporated to minimum volume. 
Pentane was added to precipitate a white solid which was collected and vacuum dried to give 
the product (0.1768 g, 87%).  
1H NMR (300 MHz, CD2Cl2) δ 7.29 (s, 2H, CH), 5.10 (d,4JHH = 2.6 Hz, 2H, CH2), 2.63 (t, 
4JHH = 2.6 Hz, 1H, C≡CH).  
19F NMR (376 MHz, CD2Cl2) δ -116.09 – -116.87 (m, 2F, o-C6F5), -160.34 (t, 3JFF = 19.8 Hz, 
1F, p-C6F5), -163.26 – -163.61 (m, 2F, m-C6F5).  
13C APT (75 MHz, CD2Cl2) δ 187.87 (s, N-C-N), 121.18 (s, CH), 76.55 (s, C≡CH), 76.03 (s, 
C≡CH), 41.19 (s, CH2-C≡CH). 
 
 
1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.1056 g, 0.4 mmol) and 
[Au(C6F5(tht)] (0.1809 g, 0.4 mmol) were mixed in CH2Cl2 (10 ml) until a colourless solution 
formed (5 min). NBu4(acac) (0.1366 g, 0.4 mmol) was added and the mixture stirred for 1 h. 
The solution was filtered through a plug of silica and the colourless filtrate evaporated to 
minimum volume. Pentane was added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.1911 g, 87%).  
1H NMR (300 MHz, CD2Cl2) δ 8.77 (d, 3JHH = 8.2 Hz, 1H, Py), 8.62 – 8.41 (m, 1H, Py), 8.01 
– 7.85 (m, 2H, Py and CH), 7.51 – 7.19 (m, 2H, Py and CH), 5.28 (d, 4JHH = 2.6 Hz, 2H, CH2), 
2.68 (t, 4JHH = 2.6 Hz, 1H, C≡CH).  
19F NMR (376 MHz, CD2Cl2) δ -116.43 – -116.65 (m, 2F, o-C6F5), -160.56 (t, 3JFF = 19.8 Hz, 
1F, p-C6F5), -163.56 – -163.82 (m, 2F, m-C6F5).  
13C APT (75 MHz, CD2Cl2) δ 186.66 (s, N-C-N), 149.29 (s, CH (Py)), 139.37 (s, CH (Py)), 
124.52 (s, CH (Py)), 121.22 (s, CH), 121.08(s, CH), 120.13(s, ipso-Py), 117.69 (s, CH (Py)), 
76.19 (s, C≡CH), 75.23(C≡CH), 42.00 (s, CH2-C≡CH).  
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1-Methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.2011, 1.0 mmol) and sodium 
tetrafluoroborate (0.1098 g, 1.0 mmol) were stirred in acetone (10 ml) for 24 h. A white 
precipitate formed which was removed by filtering the reaction mixture through celite. The 
filtrate was concentrated to dryness under reduced pressure to give the product.  
Spectral data are in agreement with values previously reported in the literature.308 
 
 
1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.5543 g, 2.0 mmol) and NaBF4 
(0.2196 g, 2.0 mmol) were dissolved in MeOH (10 ml) and the mixture stirred for 3 h. Solvent 
was removed under reduced pressure and the solid residue stirred in acetonitrile (20 ml) for 
24 h. The solution was filtered through celite, the filtrate concentrated under reduced pressure 
to approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.5624 g, 99%). 
 
 
1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.2251 g, 1.0 mmol) and NaBF4 
(0.1098 g, 2.0 mmol) were dissolved in MeOH (10 ml) and the mixture stirred for 3 h. Solvent 
was removed under reduced pressure and the solid residue stirred in acetonitrile (20 ml) for 
24 h. The solution was filtered through celite, the filtrate concentrated under reduced pressure 
to approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.2227 g, 96%). 
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1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium bromide (0.2641 g, 1.0 mmol) and NaBF4 
(0.1098 g, 2.0 mmol) were dissolved in MeOH (10 ml) and the mixture stirred for 3 h. Solvent 
was removed under reduced pressure and the solid residue stirred in acetonitrile (20 ml) for 
24 h. The solution was filtered through celite, the filtrate concentrated under reduced pressure 
to approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.2683 g, 99%). 
 
 
1-Methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0208 g, 0.1 mmol) and 
[Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) were mixed in CH2Cl2 (10 ml) and stirred for 2 h. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product.  
 
 
1-Benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0568 g, 0.2 mmol) and 
[Au(acac)(PPh3)] (0.1118 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) and stirred for 2 h. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product.  
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1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0463 g, 0.2 mmol) and 
[Au(acac)(PPh3)] (0.1118 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) and stirred for 2 h. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product.  
 
 
1-Pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0542 g, 0.2 mmol) and 
[Au(acac)(PPh3)] (0.1118 g, 0.2 mmol) were mixed in CH2Cl2 (10 ml) and stirred for 2 h. The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O added to precipitate a white solid which was collected and 
vacuum dried to give the product. 
 
 
To a solution of 1-methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0832 g, 
0.4 mmol) and [AuCl(JohnPhos)] (0.2123 g, 0.4 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.1366 g, 0.4 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
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approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1941 g, 69%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C27H35AuN2P 615.2198; Found 615.2213. 
1H NMR (300 MHz, CD2Cl2) δ 7.97 – 7.91 (m, 1H, JohnPhos), 7.68 – 7.47 (m, 2H, JohnPhos), 
7.40 – 7.21 (m, 6H, JohnPhos + CH imidazole), 7.15 (s, 1H, CH imidazole), 6.90 – 6.85 (m, 
1H, Johnphos), 4.71 (d, 4JHH = 2.6 Hz, 2H, CH2), 3.65 (s, 3H, Me), 2.66 (t, 
4JHH = 2.6 Hz, 1H, 
C≡CH), 1.46 (d, 3JHP = 15.4 Hz, 18H, tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 63.66 (s, JohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 187.7 (N-C-N, observed by HMBC), 149.68 (d, 2JCP = 14.1 Hz, 
C6 JohnPhos), 144.04 (d, 3JCP = 6.3 Hz, C7 JohnPhos), 135.01 (d, 
4JCP = 2.1 Hz, C4 JohnPhos), 
133.66 (d, 2JCP = 7.4 Hz, C2 JohnPhos), 131.68 (d, 
3JCP = 2.3 Hz, C5 JohnPhos), 130.03 (s, 
C9/C11 JohnPhos), 129.19 (s, C8/C12 JohnPhos), 128.13 (d, 3JCP = 6.6 Hz, C3 JohnPhos), 
127.80 (s, C10 JohnPhos), 125.97 (d, 1JCP = 43.5 Hz, C1 JohnPhos), 123.64 (d, 
4JCP = 3.1 Hz, 
CH imidazole), 121.66 (d, 4JCP = 2.9 Hz, CH imidazole), 76.30 (s, C≡C-H), 40.85 (s, CH2), 
38.68 (s, Me), 38.45 (d, 1JCP = 23.4 Hz, C-CH3 (
tBu)), 31.41 (d, 2JCP = 6.4 Hz, CH3 (
tBu)). 
 
 
To a solution of 1-benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.1136 g, 
0.4 mmol) and [AuCl(JohnPhos)] (0.2123 g, 0.4 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.1366 g, 0.4 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.2369 g, 76%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C33H39AuN2P 691.2511; Found 691.2520. 
1H NMR (300 MHz, CD2Cl2) δ 7.98 – 7.84 (m, 1H, JohnPhos), 7.65 – 7.49 (m, 2H, JohnPhos), 
7.44 – 7.04 (m, 12H, JohnPhos + Ph + CH imidazole), 7.00 – 6.94 (m, 1H, JohnPhos), 5.14 (s, 
2H, CH2Ph), 4.75 (d, 
4JHH = 2.6 Hz, 2H, CH2C≡CH), 2.69 (t, 4JHH = 2.6 Hz, 1H, C≡CH), 1.39 
(d, 3JHP = 15.5 Hz, 18H, 
tBu). 
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31P{1H} NMR (121 MHz, CD2Cl2) δ 63.76 (s, JohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 143.99 (d, 3JCP = 6.1 Hz, C7 JohnPhos), 135.44 (s, i-Ph), 134.98 
(d, 4JCP = 2.1 Hz, C4 JohnPhos), 133.71 (d, 
2JCP = 7.4 Hz, C2 JohnPhos), 131.73 (d, 3JCP = 
2.2 Hz, C5 JohnPhos), 130.12 (s, C9/C11 JohnPhos), 129.67 (s, Ph), 129.38 (s, C8/C12 
JohnPhos), 129.32 (s, Ph), 128.15 (d, 3JCP = 6.6 Hz, C3 JohnPhos), 127.90 (s, Ph), 127.81 (s, 
JohnPhos), 122.79 (d, 4JCP = 3.3 Hz, CH imidazole), 122.12 (d, 
4JCP = 2.7 Hz, CH imidazole), 
76.57 (s, C≡C-H), 55.44 (s, CH2Ph), 41.18 (s, CH2), 38.38 (d, 1JCP = 23.3 Hz, C-CH3 (tBu)), 
31.35 (d, 2JCP = 6.2 Hz, CH3 (
tBu)). 
 
 
To a solution of 1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0928 g, 0.4 
mmol) and [AuCl(JohnPhos)] (0.2123 g, 0.4 mmol) in CH2Cl2 (10 ml) was added NBu4(acac) 
(0.1366 g, 0.4 mmol) and the mixture stirred for 2 h. The solution washed with H2O (3 x 25 
ml), dried over Na2SO4 and then concentrated under reduced pressure to approximately 1 ml. 
Et2O (10 ml) was added to precipitate a white product which was collected and vacuum dried 
to give the product (0.1830 g, 63%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C29H35AuN2P 639.2179; Found 639.2198. 
1H NMR (300 MHz, CD2Cl2) δ 7.97 – 7.90 (m, 1H, JohnPhos), 7.64 – 7.56 (m, 2H, JohnPhos), 
7.42 – 7.19 (m, 7H, JohnPhos + CH imidazole), 6.94 – 6.89 (m, 1H, JohnPhos), 4.73 (d, 4JHH 
= 2.7 Hz, 4H, CH2), 2.69 (t, 
4JHH = 2.7 Hz, 2H, C≡CH), 1.47 (d, 3JHP = 15.5 Hz, 18H, tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 63.58 (s, JohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 188.25 (d, 2JCP = 113.6 Hz, N-C-N), 149.62 (d, 2JCP = 14.2 Hz, 
C6 JohnPhos), 143.99 (d, 3JCP = 6.2 Hz, C7 JohnPhos), 134.99 (d, 
4JCP = 2.2 Hz, C4 JohnPhos), 
133.67 (d, 2JCP = 7.5 Hz, C2 JohnPhos), 131.72 (d, 
3JCP = 2.4 Hz, C5 JohnPhos), 130.11 (s, 
C9/C11 JohnPhos), 129.36 (s, C8/C12 JohnPhos), 128.16 (d, 3JCP = 6.7 Hz, C3 JohnPhos), 
127.88 (s, C10 JohnPhos), 125.84 (d, 1JCP = 43.9 Hz, C1 JohnPhos), 122.14 (d, 
4JCP = 2.9 Hz, 
CH imidazole), 76.59 (s, C≡C-H), 41.22 (s, CH2), 38.46 (d, 1JCP = 23.5 Hz, C-CH3 (tBu)), 31.42 
(d, 2JCP = 6.4 Hz, CH3 (
tBu)). 
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To a solution of 1-pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.1084 g, 
0.4 mmol) and [AuCl(JohnPhos)] (0.2123 g, 0.4 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.1366 g, 0.4 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.199 g, 65%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C31H36AuN3P 678.2307; Found 678.2306. 
1H NMR (300 MHz, CD2Cl2) δ 8.57-8.55 (m, 1H, Py), 8.01 – 7.87 (m, 2H, JohnPhos + Py), 
7.83 – 7.73 (m, 2H, Py + CH imidazole), 7.64 – 7.44 (m, 4H, JohnPhos), 7.30 – 7.13 (m, 1H, 
Py), 7.11 – 6.91 (m, 4H, JohnPhos + CH imidazole), 6.88 – 6.75 (m, 1H, JohnPhos), 4.87 (d, 
4JHH = 2.6 Hz, 2H, CH2), 2.72 (t, 
4JHH = 2.6 Hz, 1H, C≡CH), 1.45 (d, 3JCP = 15.4 Hz, 18H, tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 63.42 (s, JohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 187.78 (d, 2JCP = 113.3 Hz, N-C-N), 150.68 (s, Py), 149.64 (d, 
2JCP = 14.2 Hz, C6 JohnPhos), 149.61 (s, Py), 143.74 (d, 
3JCP = 6.2 Hz, C7 JohnPhos), 139.87 
(s, Py), 134.81 (d, 4JCP = 2.2 Hz, C4 JohnPhos), 133.58 (d, 
2JCP = 7.5 Hz, C2 JohnPhos), 131.56 
(d, 3JCP = 2.3 Hz, C5 JohnPhos), 129.83 (s, C9/C11 JohnPhos), 129.05 (s, C8/C12 JohnPhos), 
128.04 (d, 3JCP = 6.6 Hz, C3 JohnPhos), 127.55, (s, C10 JohnPhos), 126.04 (d, 
1JCP = 43.7 Hz, 
C1 JohnPhos), 122.61 (d, 4JCP = 2.9 Hz, CH imidazole), 121.31 (d, 
4JCP = 2.8 Hz, CH 
imidazole), 117.34 (s, Py), 76.71 (s, C≡C-H), 41.95 (s, CH2), 38.23 (d, 1JCP = 23.5 Hz, C-CH3 
(tBu)), 31.20 (d, 2JCP  = 6.5 Hz, CH3 (
tBu)). 
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To a solution of 1-methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0416 g, 
0.2 mmol) and [AuCl(CyJohnPhos)] (0.1166 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1054 g, 69%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C31H39AuN2P 667.2511; Found 667.2546. 
1H NMR (300 MHz, CD2Cl2) δ 7.72 – 7.54 (m, 3H, CyJohnPhos), 7.40 – 7.23 (m, 6H, 
CyJohnPhos + CH imidazole), 7.17 – 7.16 (m, 1H, CyJohnPhos), 7.07 – 6.98 (m, 1H, 
CyJohnPhos), 4.72 (d, 4JHH = 2.6 Hz, 2H, CH2), 2.66 (t, 
4JHH = 2.6 Hz, 1H, C≡CH), 2.53 – 2.29 
(m, 2H, Cy), 2.12 – 2.05 (m, 2H, Cy), 1.97 – 1.66 (m, 8H, Cy), 1.55 – 1.08 (m, 10H, Cy). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 43.75 (s, CyJohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 188.84 (d, 2JCP = 119.2 Hz, N-C-N), 149.54 (d, 2JCP = 13.6 Hz, 
C6 CyJohnPhos), 143.12 (d, 3JCP = 6.0 Hz, C7 CyJohnPhos), 133.63 (d, 
4JCP = 3.3 Hz, C4 
CyJohnPhos), 132.97 (d, 2JCP = 7.5 Hz, C2 CyJohnPhos), 131.62 (d, 
3JCP = 2.3 Hz, C5 
JohnPhos), 130.19 (s, C9/C11 CyJohnPhos), 129.23 (s, C8/C12 CyJohnPhos), 128.72 (d, 3JCP 
= 7.2 Hz, C3 CyJohnPhos), 128.08 (s, C10 CyJohnPhos), 124.85 (d, 1JCP = 49.2 Hz, C1 
CyJohnPhos), 123.72 (d, 4JCP = 3.3 Hz, CH imidazole), 121.81 (d, 
4JCP = 3.1 Hz, CH 
imidazole), 76.77 (s, C≡C-H), 76.11 (s, C≡C-H), 40.81 (s, CH2), 38.65 (s, Me), 36.86 (d, 1JCP 
= 31.2 Hz, CH Cy), 31.66 (d, JCP = 4.2 Hz, CH2 Cy), 30.31 (s, CH2, Cy), 27.19 (d, JCP = 6.5 
Hz, CH2, Cy), 27.02 (d, JCP = 8.4 Hz, CH2 Cy), 26.38 (d, JCP = 1.5 Hz, CH2 Cy). 
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To a solution of 1-benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0568 g, 
0.2 mmol) and [AuCl(CyJohnPhos)] (0.1166 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1163 g, 70%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C37H43AuN2P 743.2824; Found 743.2858. 
1H NMR (300 MHz, CD2Cl2) δ 7.84 – 6.85 (m, 17H, CyJohnPhos + Ph + CH imidazole), 5.17 
(s, 2H, CH2Ph), 4.76 (d, 
4JHH = 2.6 Hz, 2H, CH2), 2.70 (t, 
4JHH = 2.6 Hz, 1H, C≡CH), 2.52 – 
1.56 (m, 12H, Cy), 1.55 – 0.98 (m, 8H, Cy). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 43.97 (s, CyJohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 188.75 (d, 2JCP = 118.8 Hz, N-C-N), 149.46 (d, 2JCP = 13.4 Hz, 
C6 CyJohnPhos), 142.97 (d, 3JCP = 6.0 Hz, C7 CyJohnPhos), 135.76 (s, i-Ph), 133.70 (d, 
4JCP 
= 3.7 Hz, C4 CyJohnPhos), 132.99 (d, 2JCP = 7.6 Hz, C2 CyJohnPhos), 131.66 (d, 
3JCP = 2.3 
Hz, C5 CyJohnPhos), 130.22 (s, C9/C11 CyJohnPhos), 129.57 (s, Ph), 129.38 (s, C8/C12 
CyJohnPhos), 129.24 (s, Ph), 128.73 (d, 3JCP = 7.4 Hz, C3 CyJohnPhos), 128.23 (s, Ph), 127.77 
(s, C10 CyJohnPhos), 124.73 (d, 1JCP = 49.3 Hz, C1 CyJohnPhos), 122.88 (d, 
4JCP = 3.2 Hz, 
CH imidazole), 122.30 (d, 4JCP = 3.0 Hz, CH imidazole), 76.67 (s, C≡C-H), 76.34 (s, C≡C-H), 
55.35 (s, CH2Ph), 41.11 (s, CH2), 36.89 (d, 
1JCP = 31.2 Hz, CH Cy), 31.65 (d, JCP = 4.1 Hz, 
CH2, Cy), 30.27 (s, CH2, Cy), 27.14 (d, JCP = 5.1 Hz, CH2, Cy), 26.97 (d, JCP = 7.1 Hz, CH2, 
Cy), 26.27 (d, JCP = 1.5 Hz, CH2, Cy). 
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To a solution of 1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0464 g, 
0.2 mmol) and [AuCl(CyJohnPhos)] (0.1166 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1199 g, 77%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C33H39AuN2P 691.2511; Found 691.2487. 
1H NMR (300 MHz, CD2Cl2) δ 7.71 – 7.55 (m, 3H, CyJohnPhos), 7.42 – 7.21 (m, 7H, 
CyJohnPhos + CH imidazole), 7.10 – 7.02 (m, 1H, CyJohnPhos), 4.74 (d, 4JHH = 2.6 Hz, 4H, 
CH2), 2.69 (t, 
4JHH = 2.6 Hz, 1H, C≡CH), 2.49 – 2.38 (m, 2H, Cy), 2.15 – 2.02 (m, 2H, Cy), 
1.95 – 1.67 (m, 10H, Cy), 1.56 – 1.09 (m, 8H, Cy). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 43.62 (s, CyJohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 188.92 (d, 2JCP = 118.3 Hz, N-C-N), 149.51 (d, 2JCP = 13.4 Hz, 
C6 CyJohnPhos), 143.08 (d, 3JCP = 6.1 Hz, C7 CyJohnPhos), 133.62 (d, 
4JCP = 3.4 Hz, C4 
CyJohnPhos), 132.99 (d, 2JCP = 7.5 Hz, C2 CyJohnPhos), 131.68 (d, 
3JCP = 2.3 Hz, C5 
CyJohnPhos), 130.28 (s, C9/C11 CyJohnPhos), 129.37 (s, C8/C12 CyJohnPhos), 128.76 (d, 
3JCP = 7.3 Hz, C3 CyJohnPhos), 128.17 (s, C10 CyJohnPhos), 124.69 (d, 
1JCP = 49.6 Hz, C1 
CyJohnPhos), 122.25 (d, 4JCP = 3.1 Hz, CH imidazole), 76.53 (s, C≡C-H), 76.43 (s, C≡C-H), 
41.23 (s, CH2), 36.86 (d, 
1JCP = 31.4 Hz, CH Cy), 31.65 (d, JCP = 4.1 Hz, CH2, Cy), 30.28 (s, 
CH2, Cy), 27.20 (d, JCP = 5.9 Hz, CH2, Cy), 27.02 (d, JCP = 7.8 Hz, CH2, Cy), 26.35 (d, JCP = 
1.4 Hz, CH2, Cy). 
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To a solution of 1-pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0542 g, 
0.2 mmol) and [AuCl(CyJohnPhos)] (0.1166 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1161 g, 71%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C35H40AuN3P 730.2620; Found 730.2599. 
1H NMR (300 MHz, CD2Cl2) δ 8.58 – 8.55 (m, 1H, Py), 7.98 – 7.87 (m, 1H, Py), 7.85 – 7.75 
(m, 2H, Py + CH imidazole), 7.69 – 7.45 (m, 5H, CyJohnPhos), 7.30 – 7.23 (m, 1H, 
CyJohnPhos), 7.15 – 6.98 (m, 4H, CyJohnPhos + Py + CH imidazole), 6.96 – 6.83 (m, 1H, 
CyJohnPhos), 4.90 (d, 4JHH = 2.6 Hz, 2H, CH2), 2.72 (t, 
4JHH = 2.6 Hz, 1H, C≡CH), 2.44 – 2.33 
(m, 2H, Cy), 2.17 – 0.89 (m, 20H, Cy). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 43.16 (s, CyJohnPhos). 
13C APT (75 MHz, CD2Cl2) δ 188.27 (d, 2JCP = 117.5 Hz, N-C-N), 149.68 (s, Py), 149.55 (d, 
2JCP = 13.3 Hz, C6 CyJohnPhos), 142.92 (d, 
3JCP = 6.0 Hz, C7 CyJohnPhos), 139.60 (s, Py), 
133.57 (d, 4JCP = 3.6 Hz, C4 CyJohnPhos), 132.94 (d, 
2JCP = 7.6 Hz, C2 CyJohnPhos), 131.59 
(d, 3JCP = 2.3 Hz, C5 CyJohnPhos), 129.99 (s, C9/C11 CyJohnPhos), 129.07 (s, C8/C12 
CyJohnPhos), 128.69 (d, 3JCP = 7.4 Hz, C3 CyJohnPhos), 127.89 (s, C10 CyJohnPhos), 125.08 
(s, Py), 124.42 (s, Py), 122.69 (d, 4JCP = 2.8 Hz, CH imidazole), 121.39 (d, 
4JCP = 3.0 Hz, CH 
imidazole), 117.32 (s, Py), 76.55 (s, C≡C-H), 76.43 (s, C≡C-H), 41.99 (s, CH2), 36.68 (d, 
1JCP = 31.5 Hz, CH Cy), 31.60 (d, JCP = 4.3 Hz, CH2, Cy), 30.03 (s, CH2, Cy), 27.17 (d, JCP = 
3.4 Hz, CH2, Cy), 26.99 (d, JCP = 5.4 H, CH2, Cy), 26.42 (d, JCP = 1.4 Hz, CH2, Cy). 
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To a solution of 1-methyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0416 g, 
0.2 mmol) and [AuCl(TrippyPhos)] (0.1346 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.0548 g, 67%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C36H41AuN4P 757.2729; Found 757.2658. 
1H NMR (300 MHz, CD2Cl2) δ 8.13 – 8.07 (m, 1H, TrippyPhos), 7.74 – 7.53 (m, 4H, 
TrippyPhos), 7.47 – 7.25 (m, 8H, TrippyPhos), 7.24 – 7.14 (m, 1H, TrippyPhos), 7.10 (s, 1H, 
CH imidazole), 6.93 (s, 1H, CH imidazole), 6.81 (s, 1H, TrippyPhos), 4.20 (ABX-system, 2H, 
Δδ = 0.38, JAB = 17.5 Hz, JAX = 2.6 Hz, JBX = 2.6 Hz, CH2), 3.16 (s, 3H, Me), 2.46 (t, 4JHH = 
2.6 Hz, 1H, C≡CH), 1.62 (d, 3JHP = 15.8 Hz, 9H, tBu), 1.51 (d, 3JHP = 15.7 Hz, 9H, tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 60.09 (s, TrippyPhos). 
13C APT (75 MHz, CD2Cl2) δ 136.47 (s, TrippyPhos), 133.36 (d, J = 2.0 Hz, TrippyPhos), 
132.35 (d, J = 5.1 Hz, TrippyPhos), 129.54 (s, TrippyPhos), 129.48 (s, TrippyPhos), 129.41 (s, 
TrippyPhos), 129.29 (s, TrippyPhos), 128.47 (s, TrippyPhos), 125.61 (s, TrippyPhos), 123.44 
(d, 4JCP = 3.2 Hz, CH imidazole), 121.58 (d, 
4JCP = 3.0 Hz, CH imidazole), 104.86, 76.10 (s, 
C≡C-H), 40.28 (s, CH2C≡CH), 37.98 (s, Me), 32.03 (d, 2JCP = 6.0 Hz, CH3 tBu), 31.61 (d, 2JCP 
= 6.0 Hz, CH3 
tBu). 
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To a solution of 1-benzyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0568 g, 
0.2 mmol) and [AuCl(TrippyPhos)] (0.1346 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1381 g, 75%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C42H45AuN4P 833.3042; Found 833.3049. 
31P{1H} NMR (121 MHz, CD2Cl2) δ 60.06 (s, TrippyPhos). 
 
 
To a solution of 1,3-bis(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0464 g, 
0.2 mmol) and [AuCl(TrippyPhos)] (0.1346 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1285 g, 74%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C38H41AuN4P 781.2729; Found 781.2739. 
1H NMR (300 MHz, CD2Cl2) δ 8.13 – 8.07 (m, 1H, TrippyPhos), 7.78 – 7.64 (m, 1H, 
TrippyPhos), 7.64 – 7.51 (m, 4H, TrippyPhos), 7.44 – 7.23 (m, 8H, TrippyPhos), 7.16 (s, 2H, 
CH imidazole), 6.85 (s, 1H, TrippyPhos), 4.20 (ABX-system, 2H, Δδ = 0.40, JAB = 17.5 Hz, 
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JAX = 2.6 Hz, JBX = 2.6 Hz, CH2), 2.48 (t, 
4JHH = 2.6 Hz, 1H, CH), 1.63 (d, 
3JHH = 15.9 Hz, 9H, 
CH3 
tBu), 1.51 (d, J = 15.7 Hz, 9H, CH3 
tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 59.97 (s, TrippyPhos). 
13C APT (75 MHz, CD2Cl2) δ 136.46 (s, TrippyPhos), 133.41 (s, TrippyPhos), 132.35 (d, J = 
5.1 Hz, TrippyPhos), 129.64 (s, TrippyPhos), 129.59 (s, TrippyPhos), 129.54 (s, TrippyPhos), 
129.51 (s, TrippyPhos), 129.46 (s, TrippyPhos), 129.40 (s, TrippyPhos), 128.53 (s, 
TrippyPhos), 125.60 (s, TrippyPhos), 121.98 (s, CH imidazole), 104.97 (s, TrippyPhos), 76.43 
(s, C≡C-H), 40.61 (s, CH2C≡CH), 32.02 (d, 2JCP = 6.8 Hz, CH3 tBu), 31.63 (d, 2JCP = 6.1 Hz, 
CH3 
tBu). 
 
 
To a solution 1-pyridyl-3-(2-propyn-1-yl)-1H-imidazol-3-ium tetrafluoroborate (0.0542 g, 
0.2 mmol) and [AuCl(TrippyPhos)] (0.1346 g, 0.2 mmol) in CH2Cl2 (10 ml) was added 
NBu4(acac) (0.0683 g, 0.2 mmol) and the mixture stirred for 2 h. The solution washed with 
H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under reduced pressure to 
approximately 1 ml. Et2O (10 ml) was added to precipitate a white product which was collected 
and vacuum dried to give the product (0.1198 g, 66%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C40H42AuN5P 820.2838; Found 820.2802. 
1H NMR (300 MHz, CD2Cl2) δ 8.23 – 8.20 (m, 1H, TrippyPhos), 8.13 – 8.07 (m, 1H, Py), 
7.69 – 7.46 (m, 7H, TrippyPhos), 7.37 – 7.17 (m, 7H, TrippyPhos), 7.08 – 6.98 (m, 4H, 
TrippyPhos), 6.62 (s, 1H, TrippyPhos), 4.17 (ABX-system,  2H, Δδ = 0.66, JAB = 17.6 Hz, JAX 
= 2.6 Hz, JBX = 2.6 Hz, CH2), 2.53 (t, 
4JHH = 2.6 Hz, 1H, CH), 1.61 (d, 
3JHP = 15.8 Hz, 9H, 
CH3 
tBu), 1.52 (d, 3JHP = 15.7 Hz, 9H, CH3 
tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 59.58 (s, TrippyPhos). 
13C APT (75 MHz, CD2Cl2) δ 149.29 (s, Py), 139.40 (s, Py), 136.42 (s, TrippyPhos), 133.27 
(d, J = 2.1 Hz, TrippyPhos), 132.24 (d, J = 5.0 Hz, TrippyPhos), 129.49 (s, TrippyPhos), 129.37 
(s, TrippyPhos), 129.20 (s, TrippyPhos), 128.39 (s, TrippyPhos), 125.51 (s, TrippyPhos), 
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124.61 (s, Py), 122.32 (d, 4JCP = 2.8 Hz, CH imidazole), 121.31 (d, 
4JCP = 2.9 Hz, CH 
imidazole), 116.85, 104.61 (s, TrippyPhos), 76.51 (s, C≡C-H), 41.14 (s, CH2C≡CH), 39.30 (d, 
1JCP = 9.8 Hz, C 
tBu), 38.99 (d, 1JCP = 10.4 Hz, C 
tBu), 31.91 (d, 2JCP = 6.8 Hz, CH3 
tBu), 31.40 
(d, 2JCP = 6.2 Hz, CH3 
tBu). 
 
 
To a solution of 103 (10 mg) in CH2Cl2 (1 ml) was added Cl2 (20 μl, 0.5 M soln in CCl4). The 
solution was layered with pentane and yellow crystals formed which were analysed by single 
crystal X-ray diffraction. 
 
 
To a solution of 106 (10 mg) in CH2Cl2 (1 ml) was added Cl2 (20 μl, 0.5 M soln in CCl4). The 
solution was layered with pentane and yellow crystals formed which were analysed by single 
crystal X-ray diffraction. 
 
 
To a solution of imidazole (0.4034 g, 6.0 mmol) in acetonitrile (15 ml) was added NaOH (25% 
soln, 3 ml) and the solution stirred for 10 min. 2,6-Bis(bromomethyl)pyridine (0.7948 g, 3.0 
mmol) was added and the solution stirred for 4 days. Solvent was removed under reduced 
pressure and the solid residue dissolved in chloroform (20 ml), washed with H2O (3 x 25 ml) 
and dried over Na2SO4. The solution was concentrated under reduced pressure to 
approximately 1 ml and Et2O (10 ml) added to precipitate a white solid (0.4067 g). The solid 
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was dissolved in acetonitrile (30 ml), propargyl bromide (0.36 ml, 3.4 mmol) was added and 
the solution heated to reflux for 20 h. A white precipitate formed which was collected by 
filtration, washed with Et2O and vacuum dried to give the product (0.6368 g, 44%). 
1H NMR (400 MHz, DMSO) δ 9.38 (s, 2H, N-CH-N imidazole), 7.98 (t, 3JHH = 7.8 Hz, 1H, 
C4H pyridine), 7.85 (t, 3JHH = 1.8 Hz, 2H, CH imidazole), 7.74 (t, 
3JHH = 1.8 Hz, 2H), CH 
imidazole, 7.50 (d, 3JHH = 7.8 Hz, 2H, CH pyridine), 5.60 (s, 4H, CH2), 5.29 (d, 
4JHH = 2.6 Hz, 
4H, CH2), 3.90 (t, 
4JHH = 2.6 Hz, 2H, C≡CH). 
 
 
To a solution of benzimidazole (0.7088 g, 6.0 mmol) in acetonitrile (15 ml) was added NaOH 
(25% soln, 3 ml) and the solution stirred for 10 min. 2,6-Bis(bromomethyl)pyridine (0.7948 g, 
3.0 mmol) was added and the solution stirred for 4 days. Solvent was removed under reduced 
pressure and the solid residue dissolved in chloroform (20 ml), washed with H2O (3 x 25 ml) 
and dried over Na2SO4. The solution was concentrated under reduced pressure to 
approximately 1 ml and Et2O (10 ml) added to precipitate a white solid (0.8472 g). The solid 
was dissolved in acetonitrile (30 ml), propargyl bromide (0.54 ml, 5.0 mmol) was added and 
the solution heated to reflux for 20 h. A white precipitate formed which was collected by 
filtration, washed with Et2O and vacuum dried to give the product (1.0350 g, 60%). 
1H NMR (400 MHz, DMSO) δ 9.94 (s, 2H, N-CH-N), 8.04 – 7.95 (m, 3H), 7.71 – 7.64 (m, 
4H, benzimidazole/Py), 7.62 – 7.54 (m, 2H, benzimidazole/Py), 7.47 – 7.43 (m, 2H, 
benzimidazole/Py), 5.87 (s, 4H, CH2), 5.52 (d, 
4JHH = 2.6 Hz, 4H, CH2), 3.92 (t, 
4JHH = 2.6 Hz, 
2H, C≡CH). 
 
 
To a solution of 137 (0.0239 g, 0.05 mmol) in acetone (5 ml) was added [AuCl(tht)] (0.0321 
g, 0.1 mmol) and excess Cs2CO3 and the mixture stirred for 2 h. The solution was filtered 
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through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.0174 g, 39%). 
1H NMR (400 MHz, DMSO) δ 7.87 (t, 3JHH = 7.8 Hz, 1H, C4H pyridine), 7.56 (d, 3JHH = 2.0 
Hz, 2H, CH imidazole), 7.51 (d, 3JHH = 2.0 Hz, 2H, CH imidazole), 7.25 (d, 
3JHH = 7.8 Hz, 2H, 
CH pyridine), 5.44 (s, 4H, CH2), 5.05 (d, 
4JHH = 2.6 Hz, 4H, CH2), 3.62 (t, 
4JHH = 2.5 Hz, 2H, 
C≡CH). 
 
 
To a solution of 138 (0.0239 g, 0.05 mmol) in acetone (5 ml) was added [AuCl(tht)] (0.0321 
g, 0.1 mmol) and excess Cs2CO3 and the mixture stirred for 2 h. The solution was filtered 
through celite, concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) 
added to precipitate a white solid which was collected and vacuum dried to give the product 
(0.0165 g, 34%). 
1H NMR (400 MHz, DMSO) δ 7.91 (t, 3JHH = 7.7 Hz, 1H, C4H pyridine), 7.79 (d, 3JHH = 8.2 
Hz, 2H, benzimidazole), 7.53 (d, J = 7.7 Hz, 2H, CH pyridine), 7.50 – 7.43 (m, 2H, 
benzimidazole), 7.38 (d, 3JHH = 8.2 Hz, 2H, benzimidazole), 7.29 – 7.25 (m, 2H, 
benzimidazole), 5.70 (s, 4H, CH2), 5.35 (d, 
4JHH = 2.6 Hz, 4H, CH2), 3.57 (t, 
4JHH = 2.5 Hz, 
2H, C≡CH). 
 
 
To a solution of 137 (0.7158 g, 1.5 mmol) was in MeOH (15 ml) was added NaBF4 (0.3294 g, 
3.0 mmol) and the solution stirred for 3 h. Solvent was removed under reduced pressure and 
the solid residue was dissolved in acetonitrile (50 ml), filtered through celite and the filtrate 
concentrated to dryness under reduced pressure to give a white solid which was washed with 
Et2O and vacuum dried to give the product (0.7193 g, 98%). 
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1H NMR (400 MHz, DMSO) δ 9.32 (s, 2H, N-CH-N), 7.98 (t, 3JHH = 7.8 Hz, 1H, C4H 
pyridine), 7.83 (t, 3JHH = 1.8 Hz, 2H, CH imidazole), 7.72 (t, 
3JHH = 1.8 Hz, 2H, CH imidazole), 
7.49 (d, 3JHH = 7.8 Hz, 2H, CH pyridine), 5.58 (s, 4H, CH2), 5.25 (d, 
4JHH = 2.6 Hz, 4H, CH2), 
3.88 (t, 4JHH = 2.6 Hz, 2H, C≡CH). 
19F NMR (376 MHz, DMSO) δ -148.21 (s, BF4) 
 
 
To a solution of 138 (1.1546 g, 2.0 mmol) was in MeOH (15 ml) was added NaBF4 (0.4392 g, 
4.0 mmol) and the solution stirred for 3 h. Solvent was removed under reduced pressure and 
the solid residue was dissolved in acetonitrile (50 ml), filtered through celite and the filtrate 
concentrated to dryness under reduced pressure to give a white solid which was washed with 
Et2O and vacuum dried to give the product (0.9835 g, 83%). 
 
 
To a solution of 141 (0.0246 g, 0.5 mmol) in CH2Cl2 (10 ml) was added [Au(acac)(PPh3)] 
(0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added 
to precipitate a white solid which was collected and vacuum dried to give the product (0.0577 g, 
82%). 
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To a solution of 142 (0.0296 g, 0.05 mmol) in CH2Cl2 (10 ml) was added [Au(acac)(PPh3)] 
(0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added 
to precipitate a white solid which was collected and vacuum dried to give the product (0.0648 g, 
86%). 
 
 
To a solution of 141 (0.0491 g, 0.1 mmol) in CH2Cl2 (10 ml) was added [AuCl(JohnPhos)] 
(0.1062 g, 0.2 mmol) and NBu4(acac) (0.0683 g, 0.2 mmol) and the solution stirred for 2 h. 
The solution washed with H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under 
reduced pressure to approximately 1 ml. Et2O (10 ml) was added to precipitate a white product 
which was collected and vacuum dried to give the product (0.1898 g, 62%). 
1H NMR (300 MHz, CD2Cl2) δ 7.97 – 6.99 (m, 23H, JohnPhos + Py + imidazole), 6.94 – 6.83 
(m, 2H, JohnPhos), 5.21 (s, 4H, CH2Py), 4.75 (d, 
4JHH = 2.6 Hz, 4H, CH2C≡C), 2.69 (t, 4JHH = 
2.6 Hz, 2H, C≡CH), 1.38 (d, 3JHP = 15.5 Hz, 36H). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 63.85 (s, JohnPhos). 
 
 
To a solution of 142 (0.0591 g, 0.1 mmol) in CH2Cl2 (10 ml) was added [AuCl(JohnPhos)] 
(0.1062 g, 0.2 mmol) and NBu4(acac) (0.0683 g, 0.2 mmol) and the solution stirred for 2 h. 
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The solution washed with H2O (3 x 25 ml), dried over Na2SO4 and then concentrated under 
reduced pressure to approximately 1 ml. Et2O (10 ml) was added to precipitate a white product 
which was collected and vacuum dried to give the product (0.2055 g, 65%). 
1H NMR (300 MHz, CD2Cl2) δ 7.96 – 7.48 (m, 6H, JohnPhos), 7.39 – 7.15 (m, 21H, JohnPhos 
+ Py + Benzimidazole), 6.72 – 6.64 (m, 2H, JohnPhos), 5.46 (s, 4H, CH2Py), 4.99 (d, 4JHH = 
2.6 Hz, 4H, CH2C≡C), 2.65 (t, 4JHH = 2.6 Hz, 2H, C≡CH), 1.39 (d, 3JHP = 15.6 Hz, 36H, tBu). 
31P{1H} NMR (121 MHz, CD2Cl2) δ 63.68 (s, JohnPhos). 
 
 
To a solution of 99 (0.0201 g, 0.1 mmol) in methanol (10 ml) was added [AuCl(JohnPhos)] 
(0.1062 g, 0.2 mmol) and excess potassium hydroxide and the solution stirred for 24 h. Solvent 
was removed under reduced pressure and the solid residue dissolved in CH2Cl2 (15 m). The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O (10 ml) added to precipitate a white solid which was collected 
and vacuum dried to give the product (0.0953 g, 80%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C47H61Au2N2P2 1109.3636; Found 1109.3650. 
1H NMR (400 MHz, CD2Cl2) δ 7.96 – 7.84 (m, 4H, JohnPhos), 7.63 – 7.13 (m, 16H, JohnPhos 
+ CH imidazole), 4.67 (d, 5JHP = 1.6 Hz, 2H, CH2), 3.65 (s, 3H, Me), 1.46 (d, 
3JHP = 15.4 Hz, 
18H, tBu), 1.37 (d, 3JHP = 15.0 Hz, 18H, 
tBu). 
31P{1H} NMR (162 MHz, CD2Cl2) δ 63.98 (s, JohnPhos), 63.86 (s, JohnPhos). 
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To a solution of 100 (0.0277 g, 0.1 mmol) in methanol (10 ml) was added [AuCl(JohnPhos)] 
(0.1062 g, 0.2 mmol) and excess potassium hydroxide and the solution stirred for 24 h. Solvent 
was removed under reduced pressure and the solid residue dissolved in CH2Cl2 (15 m). The 
solution was filtered through celite, the filtrate concentrated under reduced pressure to 
approximately 1 ml and Et2O (10 ml) added to precipitate a white solid which was collected 
and vacuum dried to give the product (0.0940 g, 74%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C53H65Au2N2P2 1185.3949; Found 1185.3899. 
1H NMR (400 MHz, CD2Cl2) δ 7.94 – 7.86 (m, 2H, JohnPhos), 7.63 – 7.12 (m, 22H, JohnPhos 
+ Ph + CH imidazole), 5.16 (s, 2H, CH2Ph), 4.72 (d, 
5JHP = 1.7 Hz, 2H, CH2C≡C), 1.39 (d, 3JHP 
= 15.0 Hz, 18H, tBu), 1.38 (d, 3JHP = 15.0 Hz, 18H, 
tBu). 
31P{1H} NMR (162 MHz, CD2Cl2) δ 63.97 (s, JohnPhos), 63.96 (s, JohnPhos). 
 
 
To a solution of 103 (0.0397 g, 0.1 mmol) in CH2Cl2 (5 ml) was added diisopropylamine 
(0.0350 ml, 0.25 mmol) and CuI (2 mg) and the mixture stirred for 2 h. A pale yellow 
precipitate formed which was collected by vacuum filtration, washed with distilled water 
(20 ml) and acetone (20 ml) and vacuum dried to give the product (0.0242 g, 77%). 
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HRMS (ESI-QTOF) m/z: [M + 3MeOH + Na]+ Calcd for C24H33Au3N6O3Na 1067.1503; 
Found 1067.1523.  
1H NMR (400 MHz, DMSO) δ 7.52 (s, 1H, CH), 7.45 (s, 1H, CH), 5.14 (s, 2H, CH2), 3.85 (s, 
3H, CH3).  
13C APT (75 MHz, DMSO) δ 182.74 (s, N-C-N), 122.45 (s, CH), 122.18 (s, CH), 102.90(s, 
C≡CH), 43.29 (s, CH2), 38.01 (s, CH3).  
 
 
To a solution of 104 (0.0473 g, 0.1 mmol) in CH2Cl2 (5 ml) was added diisopropylamine 
(0.0350 ml, 0.25 mmol) and CuI (2 mg) and the mixture stirred for 2 h. A white precipitate 
formed which was collected by vacuum filtration, washed with distilled water (20 ml) and 
acetone (20 ml) and vacuum dried to give the product (0.0255 g, 65%).  
HRMS (ESI-QTOF) m/z: [M + Na]+ Calcd for C39H33Au3N6Na 1199.1655; Found 
1199.1721. 
1H NMR (400 MHz, DMSO) δ 7.54-7.28 (m, 7H, 2CH + Ph), 5.30 (s, 2H, CH2), 5.17 (s, 2H, 
CH2).  
Compound too insoluble to obtain 13C NMR spectrum. 
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To a solution of 106 (0.0460 g, 0.1 mmol) in CH2Cl2 (5 ml) was added diisopropylamine 
(0.0350 ml, 0.25 mmol) and CuI (2 mg) and the mixture stirred for 2 h. A white precipitate 
formed which was collected by vacuum filtration, washed with distilled water (20 ml) and 
acetone (20 ml) and vacuum dried to give the product (0.0311 g, 82%).  
HRMS (ESI-QTOF) m/z: [M + Na]+ Calcd for C33H24Au3N9Na 1160.1043; Found 
1160.1031. 
Compound too insoluble to obtain NMR spectra.  
 
 
To a solution of 99 (0.0804 g, 0.4 mmol) in CH2Cl2/MeOH (5:1) (5 ml), was added Ag2O 
(0.0534 g, 0.23 mmol) and the mixture was stirred for 5 h protected from light. The solution 
was filtered through celite, the filtrate concentrated under reduced pressure to approximately 1 
ml and Et2O (10 ml) added to precipitate a white solid which was collected and vacuum dried 
to give the product (0.0575 g, 67%). 
1H NMR (300 MHz, CD2Cl2) δ 7.35 (t, 4JHH = 6.4 Hz, 1H, CH=C), 7.17 (d, 3JHH = 1.9 Hz, 
1H, CH imidazole), 7.05 (d, 3JHH = 1.9 Hz, 1H, CH imidazole), 5.68 (d, 
4JHH = 6.4 Hz, 2H, 
CH2), 3.87 (s, 3H, Me). 
13C APT (75 MHz, CD2Cl2) δ 123.35 (s, CH imidazole), 119.67 (s, CH imidazole), 101.26 (s, 
CH), 90.08 (s, CH2), 39.76 (s, Me). 
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To a solution of 100 (0.0554 g, 0.2 mmol) in CH2Cl2/MeOH (5:1) (5 ml), was added Ag2O 
(0.0267 g, 0.12 mmol) and the mixture was stirred for 5 h protected from light. The solution 
was filtered through celite, the filtrate concentrated under reduced pressure to approximately 1 
ml and Et2O (10 ml) added to precipitate a white solid which was collected and vacuum dried 
to give the product (0.0412 g, 71%). 
1H NMR (400 MHz, CDCl3) δ 5.87 (t, 4JHH = 6.4 Hz, 1H, CH), 5.59 – 5.26 (m, 5H, Ph), 5.19 
(d, 3JHH = 1.9 Hz, 1H, CH imidazole), 5.02 (d, 
3JHH = 1.9 Hz, 1H, CH imidazole), 3.72 (d, 
4JHH 
= 6.4 Hz, 2H, CH2=C), 3.38 (s, 2H, CH2Ph). 
 
 
To a solution of 152 (0.0428 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [AuCl(tht)] (0.0641 g, 
0.2 mmol) and the mixture stirred for 2 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0197 g, 
99%). 
1H NMR (400 MHz, CDCl3) δ 7.56 (t, 4JHH = 6.4 Hz, 1H, CH=C), 7.13 (d, 3JHH = 2.0 Hz, 1H, 
CH imidazole), 6.98 (d, 3JHH = 2.0 Hz, 1H, CH imidazole), 5.64 (d, 
4JHH = 6.4 Hz, 2H, CH2), 
3.86 (s, 3H, Me). 
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To a solution of 153 (0.0508 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [AuCl(tht)] (0.0641 g, 
0.2 mmol) and the mixture stirred for 2 h. The solution was filtered through celite, the filtrate 
concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added to 
precipitate a white solid which was collected and vacuum dried to give the product (0.0469 g, 
99%). 
1H NMR (400 MHz, CD2Cl2) δ 7.59 (t, 4JHH = 6.4 Hz, 1H, CH=C), 7.49 – 7.31 (m, 5H, Ph), 
7.16 (d, 3JHH = 2.1 Hz, 1H, CH imidazole), 6.97 (d, J = 2.1 Hz, 1H, CH imidazole), 5.66 (d, 
4JHH = 6.4 Hz, 2H, CH2=C), 5.39 (s, 2H, CH2Ph). 
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Chapter 5 – Propargyl Gold Complexes 
5.1. Introduction 
Propargyl gold complexes are those in which the gold centre is coordinated by one or more 
alkynyl type ligands of the form RnY-CH2C≡C⁻ where Y is a heteroatom (Figure 5.1). 
 
 
Figure 5.1. Propargyl gold complex general structure. 
 
Alkynyl gold(I) complexes have been known for many years, in fact, gold acetylide was one 
of the earliest examples of a gold complex with a gold-carbon bond, reported by Berthelot in 
1866,309 although this is generally not considered an organogold complex since acetylide is 
isoelectronic with cyanide (N≡C⁻) or carbon monoxide (CO) and interpreted as a pseudohalide 
ligand. Later, in the 1960s and 70s, alkynyl gold(I) complexes bearing a phosphine ligand were 
prepared by the groups of Coates and Parkin34,45 as well as by Mitchell and Stone.310 Such 
complexes tend to exhibit remarkable stability due to the high bond dissociation energies 
around the gold centre. Alkynyl ligands are strong σ- and π- donors and recent studies 
combining photoelectron spectroscopy and theoretical calculations found the gold-carbon bond 
in alkynyl gold complexes to be one of the strongest gold-ligand bonds known.311  
 
Alkynyl gold(I) complexes have been widely studied for their use in luminescence,312-316 
catalysis and materials science,317-321 however only recently have their potential biological 
applications begun to be realised. The high stability of these complexes under physiological 
conditions overcomes one of the main issues in the development of new metallodrugs: their 
tendency to decompose due to reaction with biologically occurring reducing agents such as 
thiols. Initial studies show promising results for the antiproliferative activity of alkynyl gold(I) 
phosphine complexes in a variety of different cancer cell lines and hence they could make 
excellent chemotherapeutic agents. Propargyl gold(I) complexes show the same high stability 
as the simpler alkynyl gold(I) complexes but the introduction of a heteroatom provides the 
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possibility to make changes to the molecular scaffold to give improved properties such as 
luminescence, solubility or even an additional coordination site for the synthesis of di- or 
polynuclear propargyl gold(I) complexes. The relatively simple syntheses of the propargyl 
functionalised ligands and their corresponding gold(I) phosphine derivatives means that such 
complexes have huge potential in the development of new gold-based cancer treatments.  
 
5.1.1. History of Gold in Medicine 
The use of gold in medicine is not new. The earliest medicinal use of gold is generally attributed 
to the ancient Chinese around 2500 BC where elemental gold was reportedly used by 
physicians and surgeons to treat a variety of different ailments. In 8th century Europe the 
alchemists attempted to prepare elixirs of life containing metallic gold in the form of a powder 
or flakes, which they believed would cure all diseases and confer eternal youth. By the 13th 
century it was known that gold could be dissolved in aqua regia and it became possible to 
prepare drinkable gold or aurum potabile, a mixture of gold dissolved in aqua regia and diluted 
with oil of rosemary or other essential oils which was recommended for the treatment of 
leprosy. Seventeenth century pharmacopoeias describe the use of gold for treatment of ailments 
caused by a decrease in the ‘vital spirits’ such as melancholy, fainting and fever, and in the 
early 19th century a mixture of gold chloride and sodium chloride, Na[AuCl4], was used to treat 
syphilis.322 Towards the end of the nineteenth century this same compound was prescribed as 
a treatment for chronic alcoholism. Despite the long history of the use of gold in medicine and 
the common belief that this metal possessed some form of healing properties, there was little 
or no biochemical basis for any of these historical treatments and it is unlikely that any of them 
were successful. 
 
The breakthrough for the use of gold in modern medicine came in 1890 with the discovery by 
German bacteriologist, Robert Koch, that potassium dicyanoaurate, K[Au(CN)2] is 
bacteriostatic towards tubercle bacillus, mycobacterium tuberculosis, the microorganism 
responsible for tuberculosis. He described it as the most effective of all known antiseptics with 
an activity in vitro at a dilution of one part in two million.323 The development of gold 
compounds for the treatment of tuberculosis soon followed. Although K[Au(CN)2] proved to 
some extent to be an effective treatment, there were many serious toxic side effects, leading 
scientists too look for alternatives. In 1913 Feldt confirmed that it was the gold, rather than the 
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cyanide, which caused K[Au(CN)2] to be toxic to mycobacteria and he introduced sodium 4-
amino-2-aurothiosalicylate (KrysolganTM) as an alternative.324 Gold(I) thiolates were found to 
be more stable in solution and far less toxic than K[Au(CN)2]. Other early examples include 
sodium aurothiosulfate (SanocrysinTM), sodium aurothiomalate (MyocrysinTM), sodium 
aurothiopropanol sulfonate (AllocrysineTM) and aurothioglucose (Solganol-B-OleosumTM) 
(Figure 5.2).  
 
 
Figure 5.2. Early gold based treatments. 
 
The incorrect but serendipitous assumption by Forestier in the early 1930s that tubercle bacillus 
was also linked to rheumatoid arthritis led to the administration of these gold-based treatments 
to patients with that disease. By the mid-1930s their use in the treatment of tuberculosis had 
stopped due to the lack of efficacy and numerous side effects, however, they were found to be 
very effective at slowing the progression of rheumatoid arthritis. Controlled trials by the 
Empire Rheumatism Council in 1960 confirmed these findings and since then, gold-based 
drugs have found use in both the treatment of rheumatoid arthritis as well as other rheumatic 
diseases such as juvenile rheumatoid arthritis and psoriatic arthritis.  
 
The early gold(I) thiolates sodium 4-amino-2-aurothiosalicylate, sodium aurothiomalate, 
sodium aurothiopropanol sulfonate and aurothioglucose are coordination polymers formed by 
the thiolate group bridging two gold(I) ions. Despite their polymeric structure, the functional 
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groups present in these derivatives result in the compounds being water soluble. Sodium 
aurothiosulfate, while also bearing thiolate-type sulfur atoms bound to the gold(I) which could 
potentially participate in bridges, is found to have a monomeric structure. All of these water-
soluble gold complexes have a low lipophilicity and are not well absorbed from the gut. 
Consequently, they have to be administered to patients by injection as an aqueous solution. In 
the 1970s and early 1980s Sutton and co-workers made another breakthrough with the 
development of auranofin, a gold phosphine compound, which could be administered orally to 
patients in the form of capsules and was approved for treatment in 1985. 
 
 
Figure 5.3. Structure of auranofin. 
 
Auranofin or [2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranosato-S-(triethylphosphine)gold] 
(RidauraTM) (Figure 5.3) is a monomeric thiolate gold complex with limited water solubility 
but it has a high lipophilicity due to the triethylphosphine ligand. The possibility for the oral 
administration of this drug initially made it more popular than the traditional injectable gold(I) 
thiolate compounds and only mild side effects were observed. However, it was later found that 
auranofin was somewhat less effective than the injectable gold-based drugs for the treatment 
of rheumatoid arthritis and although it is still in clinical use today, alternative more effective 
and better tolerated rheumatoid arthritis treatments such as methotrexate have become more 
popular. 
 
Rheumatoid arthritis is now known to be an autoimmune disorder which leads to an 
inflammation of the joints. Auranofin and other gold compounds halt or slow down the 
progression of this disease and reduce bone and cartilage damage by interfering with the body’s 
immune system, although their exact mode of action is not well understood. Auranofin also 
exhibits anti-cancer activity and it is often cited that early studies into the cytotoxicity of 
auranofin and other gold complexes initiated following the success of cisplatin and as part of 
an ongoing investigation into alternative metal-based drugs. However, this is not the only 
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reason that led scientists to study the anti-cancer activity of the anti-arthritic drug. In the 1970s 
and 80s studies were also being carried out into the potential use of the known anti-cancer 
drugs, 6-mercaptopurine and cyclophosphamide, for the treatment of rheumatoid arthritis due 
to their known immunosuppressive and anti-inflammatory actions.325 This work established an 
initial connection between the two diseases, and later, a long-term study into the mortality rates 
of patients suffering from rheumatoid arthritis and undergoing treatment with gold-based drugs 
found they had lower instances of malignant tumours than the rest of the population, leading 
scientists to believe there could be a connection between gold drugs and cancer.  
 
Cell growth inhibition studies in 1979 unexpectedly found auranofin to show potent anti-cancer 
activity against HeLa cells in vitro,326 prompting further studies with other cell lines. When 
compared to cisplatin, auranofin was found to show similar or greater cytotoxicity against a 
variety of different cell lines in vitro327,328 and good in vivo efficacy against P388 lymphocytic 
leukaemia cells implanted in mice.329 Subsequent screening of auranofin in various different 
cancer cell lines found a limited spectrum of anti-tumour activity but further studies into related 
gold-based anti-cancer treatments and their potential mode of action soon followed. In 1986 a 
comprehensive review of the anti-cancer properties of auranofin and structurally related 
analogues was published in which 62 different gold complexes were tested for in vitro 
cytotoxicity against B16 melanoma and P388 leukaemia cells, concluding that a wide variety 
of phosphine gold(I) thiolates display cytotoxicity.330 Many promising classes of gold(I) 
compounds with anti-cancer activity have now been described including in addition to 
auranofin analogues (phosphine gold(I) thiolates), gold(I) complexes with multiple phosphine 
ligands, gold(I) phosphole compounds, gold(I) carbene complexes, gold(I) thiourea complexes 
and, more recently, alkynyl and propargyl gold(I) complexes (Figure 5.4). 
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Figure 5.4. Gold(I) complexes with biological activity. 
 
5.1.2. Mechanism of Action of Anti-Cancer Gold(I) Complexes 
Many studies suggest that square planar anti-cancer metal complexes such as cis-platin and the 
iso-electronic gold(III) compounds exert cytotoxicity by targeting DNA, interfering with the 
transcription and replication processes and consequently leading to apoptosis of the cells. 
Gold(I) complexes, however, are believed to have a very different mode of action and their 
cytotoxicity most likely arises as a result of antimitochondrial action. Understanding the 
specific mode of action of auranofin and other antirheumatic and antitumoral gold(I) 
complexes has been of interest for many years, and while it is generally accepted that a single 
mode of action unlikely exists, the enzyme thioredoxin reductase (TrxR) does seem likely to 
be a main biological target. 
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TrxR is a homodimeric flavoprotein which helps to regulate the redox state of the cell by redox 
homeostasis, maintaining the correct balance between oxidised and reduced forms of 
intracellular thiol containing compounds, mainly the NADPH dependent reduction of 
thioredoxin disulfide (Trx). The crystal structure of TrxR was determined in 2007, allowing 
the mode of action of this enzyme to be established. Each monomer of TrxR features an 
NADPH binding site, an FAD unit and an active site featuring a cysteine residue (Cys497) 
adjacent to a selenocysteine residue (Cys498) and in close proximity to two further cysteine 
residues (Cys59 and Cys64) (Figure 5.5). Electrons are transferred from NADPH via FAD to 
the active site of TrxR which can then reduce a substrate.  
 
 
 
Figure 5.5. Ribbon representation of TrxR dimer (PDB entry 3ean) showing bound NADP⁺ (purple) and FAD 
(green). The figure was obtained using Chimera software. 
 
Cysteine is an amino acid bearing a thiol group and selenocysteine has the same structure but 
bears a more unusual selenol group (Figure 5.6).  
 
 
Figure 5.6. Structure of cysteine and selenocysteine residues. 
 Chapter 5 – Propargyl Gold Complexes 
340 
The active site of TrxR maintains the redox homeostasis of the cell by changing its own 
oxidation state. In the fully reduced form, the residues Cys497 and Sec498 are in their thiol 
and selenol forms respectively, however, upon the reduction of a substrate, such as the oxidised 
form of Trx, these residues couple forming a selenylsulfide bond (Scheme 5.1). The reduction 
of Trx is a process essential for life in all mammals since the reduced form of Trx acts as an 
antioxidant and is known to be involved in several vital redox processes within the cell. Studies 
have even found that mice which overexpress this enzyme are more resistant to inflammation.  
 
 
Scheme 5.1. Redox mechanism of TrxR active site. 
 
The selenol group in the reduced form of TrxR will readily bind metal ions. Selenol is a soft 
base and therefore an excellent nucleophile for gold(I), the softest of all acids. The binding of 
gold to the selenocysteine residue would block the activity of TrxR, resulting in mitochondrial 
damage, impairing the ability of the enzyme to maintain redox homeostasis and ultimately 
leading to cell death. The preferred binding of the gold complexes to the selenol group, rather 
than the thiol group has been confirmed by studies comparing the inhibition of TrxR and 
glutathione reductase (GR), an enzyme which is structurally and functionally closely related to 
TrxR but lacks the selenocysteine residue in the active site, in which a much higher affinity 
was found for TrxR. An overexpression of TrxR has been observed in many tumour cell lines 
and hence complexes which target this protein specifically could make excellent anti-cancer 
drugs with selectivity for tumour cells over healthy cells. Research into gold(I) based anti-
cancer compounds is therefore of interest. 
 
5.1.3. Alkynyl Gold(I) Phosphine Complexes with Anti-Cancer Activity 
One of the first examples of alkynyl gold(I) phosphine complexes with biological activity was 
the synthesis of gold(I) triphenylphosphine complexes with ethynyl steroid ligands, reported 
in 2006. The complexes were prepared from the corresponding alkynyl steroids with NaHMDS 
and [AuCl(PPh3)] in THF (Scheme 5.2), and initial reports found promising in vitro activities 
as potential cytostatics.331 
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Scheme 5.2. General method for the synthesis of ethynyl steroid gold(I) triphenylphosphine complexes. 
 
A dinuclear diethynylfluorene derivative of gold(I) was found to show significant biological 
activity both in vitro and in vivo. The complex was prepared from the diethynyl fluorene by 
reaction with [AuCl(PPh3)] in the presence of sodium hydroxide in methanol, resulting in the 
formation of an air-stable solid with high purity (Scheme 5.3). This complex showed excellent 
cytotoxicity against three different human cancer cell lines in vitro and good antitumour 
activity in vivo in a xenografted nude mice model. Limited adverse effects in vital organs were 
observed.332 
 
 
Scheme 5.3. Synthesis of a dinuclear diethynylfluorene gold(I) triphenylphosphine complex. 
 
In 2009 Mohr and co-workers prepared a series of propargyl gold(I) phosphine complexes from 
propargyl ethers and [AuCl(PPh3)] in the presence of KOH. The mononuclear complexes 
(Figure 5.7) exhibited excellent cytotoxicity in ovarian cancer cell lines CH1 and SK-OV-3 as 
well as colon cancer cell line SW480 and HeLa cells. Some efficacy against malaria strains 
was also exhibited.333 
 
 
Figure 5.7. Gold(I) phosphine complexes with propargyl ether ligands. 
 
Luminescent alkynyl gold(I) complexes containing the water-soluble PTA and DAPTA ligands 
(Figure 5.8) were reported in 2010. Cellular uptake of the complexes could be confirmed by 
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fluorescence microscopy. The complexes were found to show cytotoxicity to ovarian cancer 
cell lines while not showing any reactivity with DNA, as expected for gold(I) complexes. 
 
 
Figure 5.8. Structure of water soluble phosphines 1,3,5-triaza-7-phosphaadamantane (PTA) and 3,7-diacetyl-
1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (DAPTA). 
 
In 2012, complexes of gold(I) with propargyl functionalised anthraquinone fluorophores were 
prepared with a view to exploiting both the biological properties and the photophysical 
characteristics of the complexes. The ligands were prepared by reaction of the relevant 
hydroxyanthraquinones with propargyl bromide in the presence of potassium carbonate. The 
gold complexes were then prepared by reaction of the ligands with [AuCl(PPh3)] and potassium 
tert-butoxide in ethanol (Scheme 5.4). Cytotoxicity studies found the complexes to be active 
against MCF7 cancer cells (breast adenocarcinoma) and cellular uptake could be confirmed by 
live cell imaging studies.334 
 
 
Scheme 5.4. Synthesis of gold(I) triphenylphosphine complexes with propargyl functionalised anthraquinones. 
 5.1. Introduction 
343 
In the same year Ott and co-workers reported six different alkynyl gold(I) triphenylphosphine 
complexes with anti-proliferative activity (Figure 5.9(a)) which were also found to be potent 
inhibitors of TrxR.335 They went on to prepare a series of diphosphine derivatives (Figure 
5.9(b)), however these showed little TrxR inhibition and had limited biological application due 
to their poor water solubility and weak luminescence.336 Propynyloxycourmarin gold(I) 
derivatives with water soluble PTA and DAPTA phosphine ligands (Figure 5.9(c)) did show 
improved water solubility and very strong TrxR inhibition. They were also luminescent due to 
the chromophore unit; however only low cytotoxicity of the complexes was observed.337  
 
 
Figure 5.9. Alkynyl gold(I) triphenylphosphine derivatives with antiproliferative activity (a), diphosphine 
derivative (b) and propynyloxycourmarin gold(I) derivatives with water soluble phosphines (c). 
 
In 2015 two complexes were reported in which a gold(I) triphenylphosphine moiety was bound 
to a flavonoid group via a propargyl ether (Scheme 5.5). The flavonoids themselves were 
already known to have both in vitro and in vivo anticancer activities and the addition of the 
propargyl gold(I) phosphine unit was found to increase the cytotoxicity against human prostate 
cancer cells.338  
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Scheme 5.5. Synthesis of gold(I) triphenylphosphine complexes with propargyl ether functionalised flavonoid 
ligands. 
 
Very recently significant studies into 4-ethynylanisole gold(I) phosphine derivatives (Figure 
5.10) revealed that the nature of the phosphine had no major effect on the observed cytotoxicity 
of the complex, however, complexes containing phosphines which did not bear a heteroatom 
appeared to have higher TrxR inhibition. Some solubility issues were encountered for in vivo 
experiments however nanoformulation of the complex in peanut oil resulted in a formulation 
suitable for injection into mice. Although the low dosages used did not have any significant 
effects on the tumours being studied, the complexes were all well tolerated.339 
 
 
Figure 5.10. 4-Ethynylanisole gold(I) phosphine derivatives. 
 
The alkynyl gold(I) phosphine moiety has proven to be a useful organometallic pharmacore 
which can readily be incorporated into different biologically active groups or chromophore 
structures to potentially give complexes with anticancer activities and the possibility for the 
study of the mechanism of action by fluorescence microscopy studies.  
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5.2. Synthesis of Propargyl Functionalised Ligands 
Several different propargyl functionalised substrates with different heteroatoms were used for 
the preparation of the propargyl gold(I) phosphine complexes (Figure 5.11). Some of these 
were commercially available and others had to be prepared. 
 
 
Figure 5.11. Propargyl functionalised substrates used for the preparation of gold complexes. 
 
N-propargyl-di(2-picolyl)amine, 156, was chosen as a suitable substrate since the pyridyl 
groups could provide an additional coordination site allowing the subsequent preparation of 
polynuclear complexes which would be likely to exhibit luminescence. This ligand was 
prepared following a previously reported procedure by reaction of di-(2-picolyl)amine and 
propargyl bromide in THF in the presence of excess potassium carbonate (Scheme 5.6).340,341 
After stirring overnight under argon the product was obtained in an excellent yield of 96%.  
 
 
Scheme 5.6. Synthesis of N-propargyl-di(2-picolyl)amine 
 
The successful formation of the product could be confirmed by 1H NMR spectroscopy 
(Figure 5.12) in which the CH2 and CH of the propargyl unit are observed as a doublet and a 
triplet, respectively. The lack of NH signal confirms the successful deprotonation of the amine.  
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Figure 5.12. 1H NMR spectrum for N-propargyl-di-(2-picolyl)amine in CDCl3 at room temperature. 
 
The propargyl derivatives of indole and carbazole, 157 and 158, were again prepared by 
N-alkylation with propargyl bromide, but in these cases a stronger base was required to 
deprotonate the substrate. Potassium hydroxide in methanol was used and tetrabutylammonium 
bromide was employed as a phase transfer agent (Scheme 5.7). In both cases, following 
extraction into ethyl acetate and work-up the products were obtained cleanly and in good yields 
of 81% and 67%, respectively. The successful formation of the product could be confirmed by 
the lack of NH signal in the 1H NMR spectrum and the presence of a doublet and triplet 
corresponding to the CH2 and CH of the propargyl unit. 
 
 
Scheme 5.7. Synthesis of N-propargyl indole (a) and N-propargyl carbazole (b). 
 
CDCl3 
CH2 
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N-propargyl indole was selected as a suitable substrate for the preparation of biologically active 
gold(I) complexes since indole is a common structural motif in nature. Indole derivatives are 
found in many natural products and indole itself has been isolated from naturally occurring 
materials. Indole is also found in the liver, pancreas, brain and bile in the human body and 
hence derivatives of indole are likely to be biocompatible and potentially have some biological 
activity.342 N-propargyl carbazole was chosen since carbazole is a known fluorophore and it 
was therefore hoped that corresponding gold(I) derivatives could exhibit both biological 
activity and photophysical properties. The other propargyl functionalised substrates, 159-164, 
were commercially available and used as purchased 
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5.3. Synthesis of Propargyl Gold(I) Phosphine Complexes 
5.3.1. Derivatives with Nitrogen Substrates 
Propargyl gold(I) triphenylphosphine derivatives could be prepared by two different methods 
(Scheme 5.8). Addition of [Au(acac)(PPh3)] to a solution of the propargyl substrate in 
dichloromethane led to the formation of the products 165-168, which could be isolated by 
concentration of the reaction solution and precipitation with diethyl ether and were obtained in 
good yields (71-84%).  
 
 
Scheme 5.8. Synthesis of propargyl gold(I) triphenylphosphine derivatives with nitrogen based substrates. 
 
The products could also be prepared by the addition of [AuCl(PPh3)] and potassium hydroxide 
to a solution of the substrate in methanol. This method avoids the need to prepare the acac 
gold(I) precursor and the products are obtained with high purity since they precipitate from the 
reaction solution. Again, the yields were good (62-81%) and in both methods the reaction times 
were similar. The second method is perhaps preferable for the due to the ease of isolation of 
the final products. All of the products were obtained as air-stable white solids. 
 
Successful formation of products 165-168 could be confirmed by the disappearance of the 
propargyl C-H signal in the 1H NMR spectrum (e.g. Figure 5.13(a)). The propargyl CH2 signal 
is now observed as a singlet. In all cases the 31P{1H} NMR spectrum showed a single sharp 
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peak at around 42 ppm (e.g. Figure 5.13(b)), a typical value for a triphenylphosphine group 
bound to gold(I) with a trans carbon based ligand.  
 
 
 
Figure 5.13. 1H NMR spectrum (a) and 31P{1H} NMR spectrum of complex 165 in CD2Cl2 at room temperature. 
 
Table 5.1. 31P{1H} NMR signals (162 MHz) in CD2Cl2 at room temperature 
Complex 31P{1H} NMR (ppm) 
165 42.23 
166 42.14 
167 42.11 
168 41.74 
 
The infrared absorption spectra of complexes 165-168 lack the C≡C-H stretch at around 
3300 cm-1 present in the substrates, hence confirming the deprotonation of the alkyne C-H. No 
Au-Cl absorption at around 320 cm-1 is observed in any case, confirming the displacement of 
the chloride ligand from gold. The expected C≡C stretch at around 2100-2260 cm-1 is too weak 
to be assigned in any case. 
 
Complexes 165-168 were successfully characterised by high resolution mass spectrometry 
(ESI-TOF) and the results are shown in Table 5.2. In all cases the [M+Na]⁺ peak was observed. 
a) 
b) 
CD2Cl2 
H2O 
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Table 5.2. HRMS (ESI-TOF) Calculated and Found m/z Values 
Complex Peak m/z Calculated m/z Found 
165 [M]+ 696.1837 696.1807 
166 [M+Na]+ 636.1126 636.1134 
167 [M+Na]+ 686.1282 686.1263 
168 [M+Na]+ 638.1031 638.1041 
 
Complexes 165, 167 and 168 were characterised by single crystal X-ray diffraction. Suitable 
crystals were grown by the slow diffusion of pentane into a solution of the complex in 
dichloromethane. The molecular structures are shown in Figure 5.14. 
 
 
Figure 5.14. Molecular structures of complexes 165, 167 and 168. Selected bond lengths [Å] and angles [°] 165: 
Au(1)-C(1) 2.024(5), Au(1)-P(1) 2.2709(13), C(1)-C(2) 1.169(7), C(2)-C(3) 1.492(7), C(1)-Au(1)-P(1) 
178.84(14), C(1)-C(2)-C(3) 176.6(5); 167: Au(1)-C(1) 2.002(2), Au(1)-P(1) 2.2693(9), C(1)-C(2) 1.196(3), C(2)-
C(3) 1.471(3), C(1)-Au(1)-P(1) 175.55(5), C(1)-C(2)-C(3) 173.68(19); 168: Au(1)-C(1) 1.998(3), Au(1)-P(1) 
2.2780(8), C(1)-C(2) 1.194(5), C(2)-C(3) 1.474(4), N(1)-N(2) 1.355(4), N(2)-N(3) 1.296(4), C(1)-Au(1)-P(1) 
175.26(9), C(1)-C(2)-C(3) 178.9(3). 
 
In all cases a linear arrangement about the gold centre is observed with angles C(1)-Au(1)-P(1) 
of 178.84(14)° for 165, 175.55(5)° for 167 and 175.26(9)° for 168. The C-C bond distances in 
the propargyl unit are typical for those expected for a single and triple bond respectively with 
values C(1)-C(2) 1.169(7) Å and C(2)-C(3) 1.492(7) Å for 165; C(1)-C(2) 1.196(3) Å and 
C(2)-C(3) 1.471(3) Å for 167; and C(1)-C(2) 1.194(5) Å and C(2)-C(3) 1.474(4) Å for 168. 
 
In the crystal structure of complex 167, the molecules are associated in dimers with 
intermolecular contacts observed between the carbazole units. The six-membered ring of one 
a) b) c) 
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molecule lies over the five-membered ring of another with a π-stacking-type interaction (Figure 
5.15). Intermolecular distances centroid-centroid 3.551 Å and C(7)-N(1)’ 3.546 Å are 
observed. 
 
Figure 5.15. Intermolecular contacts for complex 167. 
 
Intermolecular contacts are also observed in the structure of complex 168 (Figure 5.16). In this 
case a slipped π-stacking interaction between the benzotriazole rings with a distance of 3.654 Å 
is observed.  
 
Figure 5.16. Intermolecular contacts for complex 168. 
 
Attempts were also made to prepare a gold(I) triphenylphosphine derivative from 
dimethylpropargylamine (Scheme 5.9). Reaction of the amine with [AuCl(PPh3)] and KOH in 
methanol did lead to the precipitation of a white solid and initial NMR studies show this to be 
the expected complex 169 (Figure 5.17(a), Figure 5.18(a)). However, after 12 hours in solution 
in dichloromethane, new peaks appear in the 1H NMR spectrum (Figure 5.17(b)) and the 
31P{1H} spectrum becomes much broader (Figure 5.18(b)).  
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Scheme 5.9. Synthesis of complex 169.  
 
 
 
 
 
 
 
Figure 5.17. 1H NMR spectrum for complex 169 in CD2Cl2 at room temperature after 5 min (a) and after 12 h 
(b). 
CD2Cl2 
CD2Cl2 
H2O 
H2O 
a) 
b) 
New peaks 
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Figure 5.18. 31P NMR spectrum for complex 169 in CD2Cl2 at room temperature after 5 min (a) and after 12 h 
(b). 
 
One possible explanation could be the formation of a dimeric species 170 (Scheme 5.10). 
 
Scheme 5.10. Proposed formation of dimeric complex 170. 
 
Another possibility could be the dissociation of the complex and the formation of the 
homoleptic species (Scheme 5.11). This could lead to a more complex supramolecular structure 
with stabilising aurophilic interactions (Figure 5.19). 
 
 
Scheme 5.11. Possible formation of homoleptic species by dissociation of complex 169. 
 
 
 
a) 
b) 
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Figure 5.19. Possible supramolecular structure for homoleptic species derived from complex 169. 
 
Complex 171, analogous to complex 165 but bearing diphenyl-2-pyridylphosphine rather than 
triphenylphosphine, was prepared by reaction of N-propargyl-di(2-picolyl)amine with 
[Au(acac)(PPh2Py)] (Scheme 5.12). The product was obtained as a pale brown solid in a good 
yield, 84%. The pyridyl group in the phosphine could potentially provide an additional 
coordination site and changing the phosphine could also potentially affect the biological 
properties. 
 
 
Scheme 5.12. Synthesis of complex 171. 
 
As with complex 165, successful formation of the product could be confirmed by NMR studies 
(Figure 5.20). The 1H NMR spectrum lacks the alkyne CH signal, confirming deprotonation. 
The propargyl CH2 signal is observed as a singlet. A single sharp signal is observed in the 
31P 
NMR spectrum at 41.41 ppm. The identity of the complex was also confirmed by high 
resolution mass spectrometry (ESI-TOF) with the molecular ion peak m/z [M]⁺ calculated 
C32H29AuN4P 697.1790 and found 697.1795.  
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Figure 5.20. 1H NMR spectrum (a) and 31P{1H} NMR spectrum (b) of complex 171 in CD2Cl2 at room 
temperature. 
 
5.3.2. Derivatives with Oxygen and Sulfur Substrates 
Derivatives with propargyl ethers and propargyl thioethers were prepared analogously to those 
with the nitrogen based substrates, by either reaction with [Au(acac)(PPh3)] in dichloromethane 
or reaction with [AuCl(PPh3)] and potassium hydroxide in methanol (Scheme 5.13). The 
products 172-175 were obtained in good yields as air-stable solids. 
 
For complex 172, the propargyl methyl ether was prepared in situ by reaction of propargyl 
bromide with potassium hydroxide and methanol, in a typical Williamson ether synthesis 
reaction. This ether was not isolated but reacted directly with [AuCl(PPh3)] and potassium 
hydroxide to give the propargyl gold(I) complex 172 (Scheme 5.14).  
a) 
b) 
CD2Cl2 
H2O 
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Scheme 5.13. Synthesis of complexes 172-175. 
 
 
Scheme 5.14. Synthesis of complex 172 from propargyl bromide. 
 
The successful formation of complex 172 could be confirmed by NMR spectroscopy. The 1H 
NMR spectrum shows a sharp singlet at 3.35 ppm which integrates as three protons 
corresponding to the methyl group (Figure 5.21(a)). A single sharp peak at 42.07 ppm is 
observed in the 31P{1H} NMR spectrum (Figure 5.21(b)). In the 13C APT spectrum the ipso, 
ortho, meta and para carbon atoms are observed as doublets due to coupling with the 
phosphorus atom. The CH2 group of the propargyl unit is observed as a singlet at 61.17 ppm 
with negative phase. The methyl group is observed as a singlet with positive phase at 57.35 
ppm. The other quaternary carbon atoms of the propargyl unit are not observed 
(Figure 5.21(c)).  
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Figure 5.21. 1H NMR spectrum (a), 31P{1H} NMR spectrum (b) and 13C APT spectrum (c) of complex 172 in 
CD2Cl2 at room temperature. 
 
The 1H NMR spectrum of complex 173 displays the typical splitting patterns expected for the 
allyl unit. The CH2 is observed as a doublet of doublet of doublets due to coupling with each 
of the other three protons. The terminal vinyl protons are each observed as doublet of doublet 
of triplets. The trans vinylic coupling is larger than the cis. The final vinylic CH is observed as 
a doublet of doublet of triplets due to coupling with both the cis and trans terminal vinylic CH 
protons and the CH2 group (Figure 5.22). The propargyl CH2 is again observed as a singlet and 
no propargyl CH signal is observed. The 31P{1H} NMR spectrum shows a single sharp peak at 
42.19 ppm.  
 
a) 
b) 
c) 
CD2Cl2 
H2O 
Me 
CH2 Ph 
CD2Cl2 
Me 
CH2 
o-Ph m-Ph 
p-Ph 
i-Ph 
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Figure 5.22. 1H NMR spectrum of complex 173 in CDCl3 at room temperature. 
 
Complexes 172-175 were characterised by high resolution mass spectrometry with the 
molecular ion peak observed for complex 174 and the [M+Na]+ peaks observed for complexes 
172, 173 and 175. The results are shown in Table 5.3. 
 
Table 5.3. HRMS (ESI-TOF) Calculated and Found m/z Values 
Complex Peak m/z Calculated m/z Found 
172 [M+Na]+ 551.0809 551.0831 
173 [M+Na]+ 557.0966 557.0977 
174 [M]+ 1011.1489 1011.1454 
175 [M+Na]+ 629.0738 629.0744 
 
Complexes 174 and 175 were characterised by single crystal X-ray diffraction. Suitable crystals 
were grown by the slow diffusion of pentane into a solution of the complex in dichloromethane. 
The molecular structures are shown in Figure 5.23. In both cases the triple and single carbon-
carbon bonds of the propargyl unit can clearly be seen with distances C(1)-C(2) 1.204(7) Å 
and C(2)-C(3) 1.4519 Å for complex 174 and C(1)-C(2) 1.204(5) Å and C(2)-C(3) 1.468(5) Å 
for complex 175. The propargyl unit has a linear geometry with angles C(1)-C(2)-C(3) 
177.5(7)° for complex 174 and C(1)-C(2)-C(3) 175.3(4) for complex 175. The geometry about 
the gold centre is slightly distorted from being linear, probably due to some steric hindrance 
CDCl3 
H2O 
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with the bulky triphenylphosphine groups, with angles C(1)-Au(1)-P(1) 169.12(14)° for 
complex 10 and C(1)-C(2)-C(3) 175.3(4)° for complex 175. 
 
Figure 5.23. Molecular structures of complexes 174 (a) and 175 (b) (Hydrogen atoms are omitted for clarity). 
Selected bond lengths [Å] and angles [°] 174: Au(1)-C(1) 2.001(5), Au(1)-P(1) 2.2744(13), C(1)-C(2) 1.204(7), 
C(2)-C(3) 1.451(9), C(1)-Au(1)-P(1) 169.12(14), C(1)-C(2)-C(3) 177.5(7); 175: Au(1)-C(1) 1.994(3), Au(1)-P(1) 
2.2751(8), C(1)-C(2) 1.204(5), C(2)-C(3) 1.468(5), C(1)-Au(1)-P(1) 173.60(9), C(1)-C(2)-C(3) 175.3(4). 
 
In the crystal structure of complex 174 the molecules are associated in chains due to 
intermolecular aurophilic interactions with an Au-Au distance of 3.291 Å (Figure 5.24). 
 
Figure 5.24. Intermolecular aurophilic interactions in the crystal structure of complex 174 (Phenyl rings and 
hydrogen atoms are omitted for clarity). 
 
5.3.3. Synthesis of a Heterometallic Dinuclear Complex 
Dinuclear complex 176 was prepared by reaction of complex 168 with [Cu(NO3)(PPh3)2] in 
dichloromethane (Scheme 5.15). The product was obtained in a high yield (90%) as a yellow 
solid. The identity of the product can be confirmed by NMR studies. The 1H NMR spectrum is 
similar to that for complex 168 but 49 protons are now observed in the aromatic region, 4 from 
the benzotriazole group and 45 from the three triphenylphosphine groups (Figure 5.25(a)). The 
31P{1H} NMR spectrum at room temperature shows two broad peaks, one at around 40 ppm 
a) b) 
 Chapter 5 – Propargyl Gold Complexes 
360 
corresponding to the phosphine coordinated to gold and one at 0 ppm corresponding to the two 
equivalent triphenylphosphine groups bounds to the copper (Figure 5.25(b)). 
 
 
Scheme 5.15. Synthesis of complex 176.  
 
 
 
Figure 5.25. 1H NMR spectrum (a), and 31P{1H} NMR spectrum (b) of complex 176 in CD2Cl2 at room 
temperature. 
 
Complex 176 was luminescent in the solid state both at room temperature and at 77 K. The 
excitation bands, emission bands and lifetimes are shown in Table 5.4. At room temperature 
three different excitation maxima are observed. Excitation at 390 nm results in an emission at 
558 nm (Figure 5.26(a)) with a lifetime of 647 μs, indicating phosphorescence. This band can 
be tentatively assigned to a 3IL(ππ*) transition where the metal is weakly involved. Additional 
excitation maxima are observed at 445 and 503 nm, both resulting in emission at 646 nm 
(Figure 5.26(b)). The emission as a result of excitation at 503 nm has a lifetime of 103 μs, again 
CD2Cl2 
H2O 
a) 
b) 
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indicating a phosphorescent emission. These bands are assigned to a MLCT transition 
involving the copper. At 77 K an excitation maximum at 353 nm is observed which gives a 
vibronic-structured emission band at around 499 nm (Figure 5.27(a)). This is assigned as an 
intraligand charge transfer transition in the phenyl rings of the triphenylphosphine ligand. This 
band was not observed at room temperature due to its low intensity. Three additional excitation 
maxima are observed: excitation at 380 nm which corresponds to an emission at 539 nm, 
excitation at 433 nm which corresponds to emission at 633 nm, and a weak excitation band at 
488 nm which also leads to an emission at 633 nm (Figure 5.27(b)). As with at room 
temperature, the excitation at 380 nm and emission at 539 nm are assigned to a 3IL(ππ*) 
transition and the other bands are assigned to a MLCT transition involving the copper. 
 
Table 5.4. Excitation and Emission Maxima for Complex 176 
Temperature (K) Excitation λmax (nm) Emission λmax (nm) τ0 (μs) 
298 390 558 647.8 
 445 646  
 503 646 103.8 
77 352 499 (structured)  
 380 539 957.6 
 433 633  
 488 633  
 
 
Figure 5.26. Excitation and emission maxima for complex 176 at room temperature.  
a) b) 
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Figure 5.27. Excitation and emission maxima for complex 176 at 77 K.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) b) 
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5.4. Biological Activity 
The biological activity of complexes 165-168 and 171-176 was studied by MTT assay for lung 
carcinoma cell line A549. The calculated IC50 values for the complexes after 24 h incubation 
time are shown in Table 5.5. 
 
The carbazole derivative, complex 167, was the only complex not to show any antiproliferative 
activity against A549 cells with an IC50 value of >100 μM. The other complexes showed 
excellent IC50 values for 24 h incubation with the cancer cells. No significant differences are 
observed upon changing the heteroatom of the propargyl substrate as all of the IC50 values are 
within a similar range 9-13 μM, the sulfur derivative having the lowest IC50 value of the gold 
triphenylphosphine complexes at 9.11 ± 1.93 μM.  
 
Changing the phosphine from triphenylphosphine to diphenyl-2-pyridylphosphine did give a 
slight improvement in activity with complex 165 having an IC50 of 13.32 ± 0.51 μM and 
complex 171 an IC50 of 8.72 ± 1.47 μM. This can be seen in the graph of cell viability against 
concentration (Figure 5.28).  
 
Dinuclear gold triphenyl phosphine complex 174, derivative of dipropargylether did not show 
a greater activity than the mononuclear propargylether derivatives 172 and 173. There is 
therefore no correlation between the number of gold triphenylphosphine units in the complex 
and the overall activity.  
 
The heterometallic complex 176 had the highest activity of the complexes measured with and 
IC50 of 2.50 ± 0.19 μM compared to the starting mononuclear gold complex 168 which has an 
IC50 of 11.91 ± 1.54 μM. Even at very low concentrations complex 176 is cytotoxic to the A549 
cells (Figure 5.29).  
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Table 5.5. IC50 Values for Complexes 1-4 and 7-12 after 24 h Incubation with A549 Cells 
Complex IC50 (μM) Complex IC50 (μM) 
 
13.32 ± 0.51 
 
10.27 ± 0.76 
 
12.73 ± 0.58 
 
10.61 ± 0.93 
 
>100 
 
12.28 ± 2.66 
 
11.91 ± 1.54 
 
9.11 ± 1.93 
 
8.72 ± 1.47 
 
2.50 ± 0.19 
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Figure 5.28. Cell viability (% of control) vs Concentration (μM) of complexes 1 and 7 for 24 h incubation with 
A549 cells. 
 
Figure 5.29. Cell viability (% of control) vs Concentration (μM) of complexes 4 and 12 for 24 h incubation with 
A549 cells.
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5.5. Conclusions 
A series biologically active of propargyl gold complexes have been prepared from propargyl 
amines, propargyl functionalised heterocyclic compounds, propargyl ethers and a propargyl 
sulfide.  
 
The propargyl-di(2-picolyl)amine ligand was readily prepared from di(2-picolyl)amine and 
propargyl bromide in the presence of the weak base, potassium carbonate. The propargyl 
functionalised derivatives of the heterocyclic compounds, indole and carbazole, were prepared 
similarly by N-alkylation using propargyl bromide, however in these cases a stronger base was 
required to deprotonate the substrates and hence potassium hydroxide was used. The ligands 
were characterised by NMR spectroscopy.  
 
The propargyl gold compounds could be prepared by two different methods: addition of 
[Au(acac)(PPh3)] to a solution of the substrate in dichloromethane, or reaction of the substrate 
with potassium hydroxide and [AuCl(PPh3)] in methanol. Similar yields were obtained in both 
cases. The complex derived from dimethylpropargylamine was unstable in solution, slowly 
converting into a different species. Based on NMR studies this was proposed to be either a 
dimer formed by association of the molecules or the homoleptic complex formed by 
dissociation of the ligands. All of the other complexes were highly stable and several examples 
were characterised by single crystal X-ray diffraction.  
 
A heterometallic dinuclear complex with one gold and one copper centre derived from the 
propargyl functionalised benzotriazole substrate was prepared and characterised. This complex 
was found to be luminescent in the solid state, both at room temperature and at 77 K. The 
excitation and emission maxima were determined and assigned to 3IL(ππ*) and MLCT 
transitions.  
 
The antiproliferative activity of the complexes against lung cancer cell line A549 was tested 
by MTT assay. The carbazole derivative showed no antiproliferative activity at the 
concentrations tested, however all of the other complexes tested showed excellent activities 
with IC50 values <14 μM in all cases. Changing the heteroatom of the propargyl substrate did 
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not make a significant difference to the anticancer activity of the complex, however the sulfur 
derivative was the most active of the gold triphenylphosphine complexes with an IC50 of 9.11 
± 1.93 μM. Changing the phosphine from triphenylphosphine to diphenyl-2-pyridyl phosphine 
did improve the activity slightly. The most active of the complexes was the cationic dinuclear 
complex bearing one copper and one gold centre which had an IC50 value of 2.50 ± 0.19 μM. 
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5.6. Experimental 
 
Di(2-picolyl)amine (0.45 ml, 2.5 mmol) and propargyl bromide (0.32 ml, 80% in toluene, 2.93 
mmol) were mixed in THF (15 ml) with excess K2CO3 and stirred at room temperature under 
argon for 12 h. The reaction mixture was then diluted with ethyl acetate and filtered through a 
pad of K2CO3. The solution was concentrated to give 156 as a brown liquid. 
1H NMR (400 MHz, CDCl3) δ 8.55 (ddd, J = 4.9, 1.8, 0.9 Hz, 2H, Py), 7.65 (td, J = 7.6, 1.9 
Hz, 2H, Py), 7.51 (dt, J = 7.8, 1.1 Hz, 2H, Py), 7.15 (ddd, J = 7.5, 4.9, 1.2 Hz, 2H, Py), 3.91 (s, 
4H, CH2Py), 3.42 (d, 
4JHH = 2.4 Hz, 2H, CH2C≡CH), 2.29 (t, 4JHH = 2.4 Hz, 1H, C≡CH). 
 
 
To a solution of indole (0.1171 g, 1.0 mmol) in DMF (15 ml) was added tetrabutylammonium 
bromide (0.0322 g, 0.1 mmol) and KOH (0.0561 g, 1.0 mmol) and the mixture stirred for 5 
min. Propargyl bromide (0.13 ml, 80% in toluene, 1.2 mmol) and the mixture stirred for 12 h 
at room temperature. Ethyl acetate (20 ml) was added and the solution washed with H2O (3 x 
25 ml) and dried over Na2SO4. The solution was concentrated under reduced pressure to 
approximately 1 ml, and hexane added to precipitate a white solid which was collected and 
vacuum dried to give the product (0.1257 g, 81%). 
1H NMR (400 MHz, CDCl3) δ 7.65 (dt, J = 7.9, 1.0 Hz, 1H, H7 indole), 7.45 – 7.38 (m, 1H, 
H4 indole), 7.30 – 7.23 (m, 2H, H6 indole), 7.22 (d, 3JHH = 3.2 Hz, 1H, H2 indole), 7.15 (ddd, 
3JHH = 8.0, 
3JHH = 7.0, 
4JHH = 1.0 Hz, 1H, H5 indole), 6.55 (dd, 
3JHH = 3.2, 
4JHH
 = 0.9 Hz, 1H, 
H3 indole), 4.89 (d, 4JHH = 2.6 Hz, 2H, CH2C≡CH), 2.41 (t, 4JHH = 2.5 Hz, 1H, C≡CH). 
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To a solution of carbazole (0.1672 g, 1.0 mmol) in DMF (15 ml) was added 
tetrabutylammonium bromide (0.0322 g, 0.1 mmol) and KOH (0.0561 g, 1.0 mmol) and the 
mixture stirred for 5 min. Propargyl bromide (0.13 ml, 80% in toluene, 1.2 mmol) and the 
mixture stirred for 12 h at room temperature. Ethyl acetate (20 ml) was added and the solution 
washed with H2O (3 x 25 ml) and dried over Na2SO4. The solution was concentrated under 
reduced pressure to approximately 1 ml, and hexane added to precipitate a white solid which 
was collected and vacuum dried to give the product (0.1375 g, 67%). 
1H NMR (400 MHz, CDCl3) δ 8.10 (dt, 3JHH = 7.8, 4JHH = 1.0 Hz, 2H, H4/H5 carbazole), 7.52 
– 7.48 (m, 4H, H1/H2/H7/H8 carbazole), 7.30 – 7.27 (m, 2H, H3/H6 carbazole), 5.06 (d, 4JHH 
= 2.5 Hz, 2H, CH2), 2.25 (t, 
4JHH = 2.5 Hz, 1H, C≡CH). 
 
 
To a solution of 156 (0.0237 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au(acac)(PPh3)] 
(0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O added to 
precipitate a pale yellow solid (0.0494 g, 71%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C33H30AuN3P 696.1837; Found 696.1807. 
1H NMR (300 MHz, CD2Cl2) δ 8.51 (ddd, 3JHH = 4.9, 4JHH = 1.9, 5JHH = 1.0 Hz, 2H, Py), 7.70 
– 7.41 (m, 18H, PPh3/Py), 7.14 (ddd, 3JHH = 7.4, 4JHH = 4.9, 5JHH = 1.4 Hz, 2H, Py), 3.91 (s, 
4H, CH2Py), 3.42 (s, 2H, CH2C≡C). 
31P NMR (121 MHz, CD2Cl2) δ 42.20 (s, PPh3). 
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13C APT (75 MHz, CD2Cl2) δ 160.35 (s, Py), 149.56 (s, Py), 136.74 (s, Py), 134.86 (d, 2JCP = 
13.9 Hz, o-PPh3), 132.08 (s, p-PPh3), 129.71 (d, 
3JCP = 11.2 Hz, m-PPh3), 123.58 (s, Py), 122.36 
(s, Py), 97.68 (s, CH2C≡CAu), 60.00 (s, CH2Py), 44.15 (s, CH2C≡CAu). 
 
 
To a solution of 157 (0.0310 g, 0.2 mmol) in MeOH  (15 ml) was added [AuCl(PPh3)] (0.0989 
g, 0.2 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 12 h. A white 
precipitate formed which was collected, washed with Et2O and vacuum dried to give the 
product (0.0761 g, 62%). 
HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C29H23AuNNaP 636.1126; Found 636.1134. 
1H NMR (400 MHz, CDCl3) δ 7.61 (dt, J = 7.8, 1.0 Hz, 1H, H7 indole), 7.55 – 7.40 (m, 17H, 
PPh3/H2+H4 indole), 7.21 (ddd, 
3JHH = 8.3, 
3JHH = 7.0, 
4JHH = 1.2 Hz, 1H, H6 indole), 7.09 
(ddd, 3JHH = 7.9,  
3JHH = 7.0, 
4JHH = 1.0 Hz, 1H, H5 indole), 6.49 (dd, 
3JHH = 3.2 Hz, 
4JHH = 0.9 
Hz, 1H, H3 indole), 5.04 (d, 5JHP = 1.5 Hz, 2H, CH2C≡C). 
31P NMR (162 MHz, CDCl3) δ 42.14 (s, PPh3). 
13C APT (101 MHz, CDCl3) δ 134.41 (d, 2JCP = 13.8 Hz, o-PPh3), 131.72 (s, p-PPh3), 130.05 
(s, C7a indole), 129.49 (s, C3a indole), 129.29 (d, 3JCP = 11.3 Hz, m-PPh3), 127.74 (s, indole), 
126.66 (d, 1JCP = 142.1 Hz, i-PPh3), 121.46 (s, indole), 120.92 (s, indole), 119.43 (C7 indole), 
109.74 (s, C5 indole), 101.22 (s, C4 indole), 97.06 (d, 2JCP = 26.8 Hz, CH2C≡CAu), 37.01 (s, 
CH2C≡CAu). 
 
 
To a solution of 158 (0.0410 g, 0.2 mmol) in MeOH  (15 ml) was added [AuCl(PPh3)] (0.0989 
g, 0.2 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 12 h. A white 
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precipitate formed which was collected, washed with Et2O and vacuum dried to give the 
product ( 
HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C33H25AuNNaP 686.1282; Found 686.1263. 
1H NMR (300 MHz, CDCl3) δ 8.07 (d, 3JHH = 7.6 Hz, 2H, H4/H5 carbazole), 7.61 (dt, 3JHH = 
8.2 Hz, 4JHH = 0.9 Hz, 2H, H1/H8, carbazole), 7.52 – 7.36 (m, 17H, PPh3 + H2/H7 carbazole), 
7.21 (ddd, 3JHH = 7.9 Hz, 
3JHH = 7.1 Hz, 
4JHH = 1.0 Hz, 2H, H3/H6 carbazole), 5.21 (d, 
5JHP = 
1.4 Hz, 2H, CH2C≡CAu). 
31P NMR (162 MHz, CDCl3) δ 42.11 (s, PPh3). 
13C APT (75 MHz, CDCl3) δ 134.39 (d, 2JCP = 13.8 Hz, o-PPh3), 131.65 (d, 4JCP = 2.4 Hz, p-
PPh3), 129.24 (d, 
3JCP = 11.3 Hz, m-PPh3), 125.77 (s, C2/C7 carbazole), 120.29 (s, C4/C5 
carbazole), 119.06 (s, C3/C6 carbazole), 109.38 (s, C1/C8 carbazole), 33.55 (s, CH2C≡CAu). 
 
 
Method 1: To a solution of 159 (0.0157 g, 0.1 mmol) in CH2Cl2 (5 ml) was added 
[Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered 
through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.0455 g, 74%). 
Method 2: To a solution of 159 (0.0315 g, 0.2 mmol) in MeOH (15 ml) was added [AuCl(PPh3)] 
(0.0989 g, 0.2 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 12 h. A white 
precipitate formed which was collected, washed with Et2O and vacuum dried to give the 
product (0.0895 g, 73%). 
HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C27H21AuN3NaP 638.1031; Found 638.1041. 
1H NMR (300 MHz, CD2Cl2) δ 8.02 (d, 3JHH = 8.4 Hz, 1H, H4), 7.90 (d, 3JHH = 8.3 Hz, 1H, 
H7), 7.59 – 7.42 (m, 16H, PPh3/H5), 7.38 (ddd, 3JHH = 8.1 Hz, 3JHH = 6.9 Hz, 4JHH =1.1 Hz, 
1H, H5), 5.54 (s, 2H, CH2C≡CAu). 
31P NMR (121 MHz, CD2Cl2) δ 41.67 (s, PPh3). 
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13C APT (75 MHz, CD2Cl2) δ 146.23 (s, C7a), 134.20 (d, 2JCP = 13.8 Hz, o-PPh3), 132.60 (s, 
C4a), 131.58 (d, 4JCP = 2.5 Hz, p-PPh3), 129.13 (d, 
3JCP = 11.3 Hz, m-PPh3), 127.00 (s, C6), 
123.69 (s, C5), 119.54 (s, C4), 110.66 (C7), 93.46 (s, CH2C≡CAu), 39.34 (s, CH2C≡CAu). 
 
 
Method 1: To a solution of 160 (16.3 μl, 0.1 mmol) in CH2Cl2 (5 ml) was added 
[Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered 
through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.0540 g, 99%). 
Method 2: To a solution of 160 (32.6 μl, 0.2 mmol) in MeOH (15 ml) was added [AuCl(PPh3)] 
(0.0989 g, 0.2 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 12 h. A white 
precipitate formed which was collected, washed with Et2O and vacuum dried to give the 
product (0.0129 g, 12%). 
1H NMR (400 MHz, CD2Cl2) δ 7.62 – 7.38 (m, 15H, PPh3), 3.28 (s, 2H, CH2), 2.25 (s, 6H, 
Me). 
31P NMR (162 MHz, CD2Cl2) δ 42.30 (s, PPh3). 
 
 
To a solution of 156 (0.0237 g, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au(acac)(PPh2Py)] 
(0.0560 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O added to 
precipitate a pale yellow solid (0.0585 g, 84%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C32H29AuN4P 697.1790; Found 697.1795. 
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1H NMR (300 MHz, CD2Cl2) δ 8.79 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H, Py), 8.51 (ddd, J = 4.9, 
1.9, 1.0 Hz, 2H, Py), 7.92 (t, J = 7.5 Hz, 2H, Py), 7.87 – 7.36 (m, 15H, PPh2Py + Py), 7.14 
(ddd, J = 7.4, 4.9, 1.4 Hz, 2H, Py), 3.91 (s, 4H, CH2Py), 3.43 (s, 2H, CH2C≡C). 
31P NMR (121 MHz, CD2Cl2) δ 41.40 (s, PPh2Py). 
13C APT (75 MHz, CD2Cl2) δ 160.39 (s, C2 Py), 151.79 (d, 2JCP = 15.2 Hz, C3 Py (PPh2Py)), 
149.56 (s, Py), 137.11 (d, 3JCP = 10.6 Hz, C4 Py (PPh2Py)), 136.73 (s, Py), 135.25 (d, 
2JCP = 
13.7 Hz, o-Ph), 132.15 (s, p-Ph), 131.74 (s, C5 Py (PPh2Py)), 129.54 (d, 
3JCP = 11.4 Hz, m-Ph), 
125.69 (d, 3JPP = 2.3 Hz, C6 Py (PPh2Py)), 123.57 (s, Py), 122.35 (s, Py), 60.03 (s, CH2Py), 
44.18 (s, CH2C≡CAu). 
 
 
To a solution of propargyl bromide (10.8 μl, 0.1 mmol) in MeOH (15 ml) was added 
[AuCl(PPh3)] (0.0495 g, 0.1 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 
12 h. A white precipitate formed which was collected, washed with Et2O and vacuum dried to 
give the product (0.0388 g, 73%). 
HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C22H20AuNaOP 551.0809; Found 551.0831. 
1H NMR (300 MHz, CD2Cl2) δ 7.69 – 7.36 (m, 15H, PPh3), 4.16 (s, 2H, CH2), 3.35 (s, 3H, 
Me). 
31P NMR (121 MHz, CD2Cl2) δ 42.07 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 134.86 (d, 2JCP = 13.9 Hz, o-PPh3), 132.13 (d, 4JCP = 2.5 Hz, p-
PPh3), 130.48 (d, 
1JCP = 55.6 Hz, i-PPh3), 129.72 (d, 
3JCP = 11.2 Hz, m-PPh3), 61.17 (s, CH2), 
57.35 (s, Me). 
 
 
To a solution of 162 (16.7 μl, 0.1 mmol) in CH2Cl2 (5 ml) was added [Au(acac)(PPh3)] 
(0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered through celite, 
the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O (10 ml) added 
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to precipitate a white solid which was collected and vacuum dried to give the product (0.0484 g, 
87%). 
HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C24H22AuNaOP 557.0966; Found 557.0977. 
1H NMR (300 MHz, CD2Cl2) δ 7.66 – 7.39 (m, 15H, PPh3), 5.92 (ddt, 3JHH = 17.3 Hz, 3JHH = 
10.4 Hz, 3JHH = 5.5 Hz, 1H), 5.27 (m, 1H, trans H), 5.15 (ddt, 
3JHH = 10.4 Hz, 
2JHH  = 2.0 Hz, 
4JHH = 1.3 Hz, 1H, cis H), 4.23 (s, 2H, CH2C≡C), 4.07 (ddd, 3JHH = 5.5 Hz, 4JHH = 1.5 Hz, 2H, 
CH2CHC=CH2). 
31P NMR (121 MHz, CD2Cl2) δ 42.05 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 135.63 (s, CH2CH=CH2), 134.85 (d, 2JCP = 13.8 Hz, o-PPh3), 
132.12 (d, 4JCP = 2.4 Hz, p-PPh3), 130.45 (d, 
1JCP = 55.8 Hz, i-PPh3), 129.71 (d, 
3JCP = 11.2 
Hz, m-PPh3), 116.86 (s, CH2CH=CH2), 99.16 (d, 
2JCP = 26.4 Hz, CH2C≡CAu), 70.45 (s, 
CH2CH=CH2), 58.89 (s, CH2C≡C). 
 
 
Method 1: To a solution of 163 (7.7 μl, 0.05 mmol) in CH2Cl2 (5 ml) was added 
[Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered 
through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.0242 g, 48%). 
Method 2: To a solution of 163 (15.4 μl, 0.1 mmol) in MeOH (15 ml) was added [AuCl(PPh3)] 
(0.0989 g, 0.2 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 12 h. A white 
precipitate formed which was collected, washed with Et2O and vacuum dried to give the 
product (0.0534 g, 53%). 
HRMS (ESI/QTOF) m/z: [M]+ Calcd for C42H35Au2OP2 1011.1489; Found 1011.1454. 
1H NMR (300 MHz, CD2Cl2) δ 7.66 – 7.43 (m, 30H, PPh3), 4.34 (s, 4H, CH2). 
31P NMR (121 MHz, CD2Cl2) δ 42.07 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 134.89 (d, 2JCP = 13.9 Hz, o-PPh3), 132.08 (d, 4JHH = 2.4 Hz, p-
PPh3), 130.54 (d, 
1JCP = 55.5 Hz, i-PPh3), 129.70 (d, 
3JCP = 11.3 Hz, m-PPh3), 98.99 (d, 
2JCP = 
26.5 Hz, CH2C≡CAu), 57.33 (s, CH2C≡C). 
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Method 1: To a solution of 164 (20.6 μl, 0.1 mmol) in CH2Cl2 (5 ml) was added 
[Au(acac)(PPh3)] (0.0559 g, 0.1 mmol) and the solution stirred for 2 h. The solution was filtered 
through celite, the filtrate concentrated under reduced pressure to approximately 1 ml and Et2O 
(10 ml) added to precipitate a white solid which was collected and vacuum dried to give the 
product (0.0606 g, 99%). 
Method 2: To a solution of 164 (20.6 μl, 0.1 mmol) in MeOH (15 ml) was added [AuCl(PPh3)] 
(0.0495 g, 0.1 mmol) and KOH (0.0168 g, 0.3 mmol) and the mixture stirred for 12 h. A white 
precipitate formed which was collected, washed with Et2O and vacuum dried to give the 
product (0.0551 g, 91%). 
HRMS (ESI/QTOF) m/z: [M+Na]+ Calcd for C27H22AuNaPS 629.0738; Found 629.0744. 
1H NMR (300 MHz, CD2Cl2) δ 7.62 – 7.13 (m, 20H, PPh3 + Ph), 3.78 (s, 2H, CH2). 
31P NMR (121 MHz, CD2Cl2) δ 41.97 (s, PPh3). 
13C APT (75 MHz, CD2Cl2) δ 136.86 (s, Ph), 134.23 (d, 2JCP = 13.9 Hz, o-PPh3), 131.50 (d, 
4JHH = 2.4 Hz, p-PPh3), 129.84 (d, 
1JCP = 55.6 Hz, i-PPh3), 129.09 (d, 
3JCP = 11.4 Hz, m-PPh3), 
128.75 (s, Ph), 128.50 (s, Ph), 125.78 (s, Ph), 23.34 (s, CH2). 
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General Conclusions 
Gold has a rich organometallic chemistry due to the huge number of possible coordination 
complexes and the exceptional ability of gold to form intra or intermolecular aurophilic 
interactions. Gold complexes can also exhibit properties such as luminescence or biological 
activity, giving them a variety of potential applications such as OLEDs, bioimaging or as 
anticancer agents. In this PhD thesis the coordination chemistry of gold with ylide, allenyl, 
NHC and propargyl ligands has been explored. Several new organogold complexes have been 
synthesised and the luminescence and biological properties have been studied. 
 
In Chapter 2 the synthesis of several gold(I) and gold(III) derivatives of 
cyanomethyltriphenylphosphonium chloride is described. These include complexes in which 
the phosphonium salt is deprotonated once to give the ylide, which can bind to one metal centre; 
and complexes in which the phosphonium salt is deprotonated twice to give the yldiide unit 
which can bridge two metal centres to give dinuclear or polynuclear derivatives. Silver(I) and 
copper(I) derivatives were also prepared and structurally characterised. The tendency of these 
metals to adopt a tetrahedral geometry results in complexes in which additional coordination 
of the nitrile nitrogen atom of another molecule to the metal centre occurs, giving oligomeric 
or polymeric structures. For the gold derivatives a linear coordination is observed in all cases 
with no additional coordination of the nitrile nitrogen to the gold centres. The nitrile group can 
also provide an additional coordination site allowing the synthesis of heterometallic 
polynuclear complexes. Two luminescent polynuclear derivatives were prepared which exhibit 
phosphorescent emissions at 77 K. Several of the complexes also exhibited antiproliferative 
activity against lung cancer cell line A549. The triphenylphosphine derivatives were the most 
active with IC50 values considerable lower than that of cisplatin. 
 
In Chapter 3 the synthesis of gold derivatives of propargyl functionalised phosphonium, 
ammonium and sulfonium salts is described. Triphenylpropargylphosphonium bromide was 
found to readily tautomerise to the allenyl form in solution in all solvents except acetonitrile. 
This phosphonium salt was successfully used to prepare the first examples of allenyl gold 
complexes and an interesting regioselectivity was found depending on the oxidation state of 
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gold. The coordination of gold(III) to the γ-carbon atom of the allenyl group resulted in the 
formation of axially chiral allenyl gold(III) derivatives. An analogous tautomerism was not 
observed in propargyl functionalised ammonium salts in solution and consequently gold(I) 
derivatives were prepared in which the coordination to gold occurs only through the terminal 
alkyne carbon of the propargyl unit. The antiproliferative activity of these complexes against 
A549 cells was studied with low IC50 values found in all cases and increased activity observed 
for the dinuclear complex compared to the mononuclear derivatives. A propargyl 
functionalised sulfonium salt was also prepared and was found to only partially tautomerise to 
the allenyl derivative under forcing conditions (1 week at reflux in acetonitrile). Reaction of 
this salt with [Au(acac)(PPh3)] led to a mixture of the propargyl and allenyl gold derivatives. 
 
A new method for the synthesis of NHC gold complexes is described in Chapter 4. This method 
has several advantages over previously reported methods in that the reactions can be carried 
out in air, reaction times are short and both bulky and small imidazolium salt precursors can be 
used. Moreover, the use of different gold precursors allows different groups to be incorporated 
into the complexes directly, without the need to first prepare the [AuCl(NHC)] complex and 
subsequently abstract the halide ligand. The new method was used to prepare a series of 
propargyl functionalised NHC gold complexes including bromo, pentafluorophenyl, bis-NHC 
and phosphine derivatives. It was found that a bulky phosphine is required for the formation of 
[Au(NHC)(PR3)]
+, as equilibria were observed in solution for derivatives with smaller 
phosphines. Di- and trinuclear complexes were prepared by functionalisation of the propargyl 
side-arm of the NHC, with coordination of the terminal alkyne carbon to gold observed. 
Tautomerism of the propargyl unit to the allenyl form was only observed when the 
transmetallation method with silver oxide was used for the preparation of the NHC gold 
complexes. Both the silver complex and the corresponding gold derivative were characterised 
by single crystal X-ray diffraction, confirming the presence of the allenyl tautomer. Of all the 
complexes prepared, only the NHC gold phosphine derivatives were luminescent with 
phosphorescent emissions observed both at room temperature and at 77 K. These were assigned 
to ligand-to-metal-to-ligand charge transfer (LMLCT) transitions. While the imidazolium salt 
precursors showed no anticancer activity against A549 cells, the gold complexes were active. 
The best of these were the phosphine derivatives which showed antiproliferative activity far 
superior to that of cisplatin. 
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In the final chapter propargyl gold complexes were prepared and characterised. The gold(I) 
triphenylphosphine derivatives were synthesised by two different routes, however, in both 
cases similar yields were obtained. Several derivatives were structurally characterised by single 
crystal X-ray diffraction with intermolecular contacts observed. A heterometallic dinuclear 
gold(I) copper(I) complex was prepared which was luminescent at room temperature and at 77 
K. Emission maxima were assigned to ligand-to-metal charge transfer (LMCT) and intraligand 
(IL) ππ* transitions. All of the complexes displayed antiproliferative activity against A549 cells 
with the exception of the carbazole derivative. Changing the heteroatom of the propargyl ligand 
did not significantly affect the activity. The cationic dinuclear gold copper complex, however, 
was considerably more activity than the mononuclear complexes. Since this complex also 
displays luminescence it has the potential for future application in bioimaging studies. 
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Conclusiones Generales 
El oro tiene una rica química organometálica rica debido al gran número de complejos de 
coordinación que puede presentar y a su excepcional capacidad para formar interacciones 
aurofílicas intra o intermoleculares. Los complejos de oro además pueden presentar 
propiedades notables como la luminiscencia o la actividad biológica, dotándolos de una gran 
variedad de aplicaciones potenciales tales como por ejemplo OLEDs, estudios de bioimagen o 
como agentes anticancerígenos. En esta tesis doctoral se ha explorado la química de 
coordinación de oro con ligandos iluro, alenilo, NHC y propargilo. Se han sintetizado nuevos 
complejos organometálicos de oro y se ha estudiado su luminiscencia y sus propiedades 
biológicas.  
 
En el capítulo 2 se ha descrito la síntesis de varios derivados de oro(I) y de oro(III) con cloruro 
de cianometiltrifenilfosfonio. Éstos incluyen complejos en los que la sal de fosfonio se 
desprotona una vez para dar el iluro, que se puede coordinar a un centro metálico, y complejos 
en los que la sal de fosfonio se desprotona dos veces para dar la unidad ildiuro, que puede 
actuar como puente entre dos centros metálicos para dar complejos dinucleares o polinucleares. 
Además, se han preparado y caracterizado derivados de plata(I) y cobre(I) obteniéndose 
también su estructura molecular por difracción de rayos-X de monocristal. Debido a la 
tendencia de estos metales a adoptar una geometría tetraédrica, los complejos resultantes 
presentan estructuras oligoméricas o poliméricas en las que existe una coordinación adicional 
del nitrógeno del grupo nitrilo de una molécula al centro metálico de otra. En todos los 
derivados de oro sintetizados se observa una coordinación linear sin ninguna coordinación 
adicional por parte del nitrógeno del grupo nitrilo a los centros áuricos. El grupo nitrilo, 
además, puede proporcionar un sitio de coordinación adicional, permitiendo así la síntesis de 
complejos polinucleares heterometálicos. Se han preparado dos derivados polinucleares 
luminiscentes que presentan emisiones fosforescentes a 77 K. Varios de los complejos además 
mostraron actividad antiproliferativa contra el cáncer del pulmón linear celular A549. Los 
derivados de trifenilfosfonio resultaron ser los más activos con valores de IC50 
considerablemente más bajos que el cisplatino. 
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En el capítulo 3 se ha descrito la síntesis de derivados de sales de fosfonio, amonio y sulfonio 
funcionalizados con propargilo. Se ha observado que el bromuro de trifenilpropargilofosfonio 
tautomeriza fácilmente en disolución en todos los disolventes a excepción de acetonitrilo. Se 
ha utilizado esta sal de fosfonio para preparar los primeros ejemplos de complejos oro alenilo 
y se ha encontrado una regioselectividad interesante dependiendo del estado de oxidación del 
oro. La coordinación del carbono-γ del grupo alenilo al oro(III) dio lugar a la formación de 
complejos oro(III) alenilo axialmente quirales. No se ha observado un tautomerismo análogo 
en las disoluciones de sales de amonio funcionalizadas con propargilo y por consiguiente se 
han preparado derivados de oro(I) en los que la coordinación al metal se produce únicamente 
a través del carbono terminal del alquino de la unidad propargilo. Se ha estudiado la actividad 
antiproliferativa de estos complejos en células A549, mostrando valores de IC50 bajos en todos 
los casos y se observó un aumento de actividad para el derivado dinuclear comparándolo con 
los derivados mononucleares. Además, se ha preparado una sal de sulfonio funcionalizada con 
propargilo y se observó que solo tautomeriza parcialmente al derivado alenilo bajo condiciones 
forzadas (una semana a reflujo en acetonitrilo). La reacción de esta sal con [Au(acac)(PPh3)] 
dio lugar a una mezcla de los derivados de oro propargilo y alenilo. 
 
Se ha descrito un nuevo método para la síntesis de complejos de oro NHC en el capítulo 4. Este 
método tiene varias ventajas con respecto a los métodos previamente descritos ya que las 
reacciones se pueden realizar al aire, los tiempos de reacción son menores y permite el uso de 
sales de imidazolio tanto pequeñas como voluminosas como precursores. Además, el uso de 
precursores diferentes de oro permite la incorporación directa de distintos grupos en el 
complejo sin la necesidad de preparar primero el complejo de [AuCl(NHC)] con la posterior 
abstracción del ligando halogenuro. Se ha utilizado este nuevo método para preparar una serie 
de complejos de oro NHC funcionalizados con propargilo, que incluyen bromuro, 
pentaflorofenilo, bis-NHC y fosfina. Se descubrió que para la formación de complejos 
[Au(NHC)(PR3)]
+ se requiere una fosfina voluminosa, ya que se observaron equilibrios en 
disolución al usar fosfinas pequeñas. Se han preparado derivados di- y trinucleares mediante la 
funcionalización del grupo propargilo del NHC, en los que se observa la coordinación del 
carbono alquino terminal al oro. Solo se ha observado tautomerismo de la unidad propargilo al 
alenilo al usar el método de transmetalación con oxido de plata para preparar los complejos oro 
NHC. Tanto el complejo de plata como el derivado de oro correspondiente se han caracterizado 
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por difracción de rayos-X de monocristal, confirmándose la presencia del tautomero alenilo. 
De todos los complejos preparados, solo los derivados fosfina oro NHC resultaron ser 
luminiscentes con emisiones fosforescentes a temperatura ambiente y a 77 K. Estas emisiones 
se han asignado a transiciones de transferencia de carga del ligando al metal al ligando 
(LMLCT). A pesar de que las sales de imidazolio no mostraron actividad anticancerígena en 
células A549, sí lo hicieron sus correspondientes complejos de oro. Los derivados de fosfinas 
mostraron una actividad antiproliferativa muy superior a la del cisplatino, siendo los 
compuestos con mayor actividad anticancerígena. 
 
En el último capítulo se han preparado y caracterizado diversos complejos de oro propargilo. 
Se han sintetizado los derivados trifenilfosfina oro(I) mediante dos métodos diferentes. En los 
dos casos se obtuvieron rendimientos similares. Se han caracterizado estructuralmente varios 
derivados por difracción de rayos-X de monocristal y se han observado diversos contactos 
intermoleculares en varios casos. Se ha preparado un derivado dinuclear heterometálico de 
oro(I) y cobre(I) que mostró luminiscencia tanto a temperatura ambiente como a 77 K. Se han 
asignado bandas de emisión a transiciones de transferencia de carga del ligando al metal 
(LMCT) e intraligando (IL) ππ*. Todos los complejos mostraron actividad antiproliferativa en 
la línea celular A549 con la excepción del derivado de carbazol. No se observó ningún efecto 
significativo en la actividad al cambiar el heteroatomo del ligando propargilo. Sin embargo, el 
complejo catiónico dinuclear de oro y cobre fue considerablemente más activo que los 
complejos mononucleares, y al ser este complejo también luminiscente, presenta un gran 
potencial para futuras aplicaciones en estudios de bioimagen. 
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